data_2mw7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mw7 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.18 -0.674 . . . . 73.129999999999995 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 p -147.91 140.1 24.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.534 0.334 . . . . 73.310000000000002 110.722 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.553 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 109.95 -4.22 30.37 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 114.973 0.749 . . . . 74.099999999999994 114.973 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -100.2 176.29 5.44 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.338 0.655 . . . . 74.0 112.073 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -61.37 117.16 5.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.78 0.832 . . . . 75.400000000000006 110.623 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.4 m-20 64.14 21.42 12.55 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.97 1.308 . . . . 75.430000000000007 111.624 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -112.84 132.22 22.39 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 108.126 -1.064 . . . . 71.409999999999997 108.126 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.6 Cg_endo -53.88 140.91 67.91 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 123.232 2.621 . . . . 65.329999999999998 112.864 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 28.4 p -88.66 133.4 34.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.919 0.487 . . . . 71.140000000000001 109.938 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.9 p -93.16 104.92 17.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.693 0.797 . . . . 71.109999999999999 109.985 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -78.06 129.18 9.25 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.52 -0.632 . . . . 71.030000000000001 111.52 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -89.22 168.06 16.3 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.833 0.853 . . . . 64.099999999999994 111.665 -170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.25 -33.07 53.46 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.349 2.699 . . . . 74.129999999999995 114.564 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.26 -8.92 58.13 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.908 0.483 . . . . 64.439999999999998 111.619 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.12 -24.99 29.34 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 114.163 0.425 . . . . 75.120000000000005 114.163 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 128.09 34.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.966 0.383 . . . . 73.439999999999998 110.629 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 39.3 mtmt -76.64 129.86 36.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 108.899 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 87.4 t -77.84 117.81 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.086 0.47 . . . . 73.540000000000006 110.121 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.8 m -146.48 136.56 23.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.003 1.321 . . . . 75.409999999999997 107.538 169.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.63 139.6 38.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.523 -0.918 . . . . 72.019999999999996 108.523 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.32 141.83 96.22 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 122.747 0.419 . . . . 75.099999999999994 110.104 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -96.12 19.36 32.14 Favored 'Cis proline' 0 C--N 1.375 1.929 0 N-CA-C 114.649 0.98 . . . . 74.439999999999998 114.649 4.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -67.97 125.95 27.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.001 -0.37 . . . . 74.310000000000002 110.001 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.55 129.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.727 1.211 . . . . 72.219999999999999 109.817 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.664 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 39.0 t -78.77 110.25 13.76 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.999 0.52 . . . . 75.120000000000005 109.781 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.52 140.46 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.721 -0.844 . . . . 73.030000000000001 108.721 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 -37.42 87.33 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.537 0.94 . . . . 51.229999999999997 113.537 -165.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -75.26 -50.93 14.54 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.919 0.39 . . . . 54.5 110.204 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -70.65 -26.36 63.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.699 0.8 . . . . 63.399999999999999 111.874 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p 54.29 27.08 7.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.033 1.733 . . . . 65.140000000000001 112.688 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 12.0 ptp180 -126.94 142.4 51.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.962 0.905 . . . . 74.430000000000007 110.294 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 30.8 m -75.38 100.17 4.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.334 0.654 . . . . 64.530000000000001 109.8 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 -177.96 3.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.564 0.746 . . . . 72.150000000000006 110.492 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -71.96 139.4 82.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 122.61 0.364 . . . . 72.439999999999998 110.787 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.381 2.284 0 C-N-CA 123.093 2.529 . . . . 72.430000000000007 112.342 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.734 0 N-CA-C 109.88 -0.415 . . . . 71.319999999999993 109.88 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.87 149.82 50.37 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.068 0.547 . . . . 62.43 109.926 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 97.71 2.26 58.6 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.171 0.828 . . . . 72.430000000000007 115.171 170.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.63 164.96 13.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.359 0.663 . . . . 74.340000000000003 109.849 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.24 137.46 50.84 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.356 0.263 . . . . 74.409999999999997 110.396 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.34 28.31 17.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.446 1.498 . . . . 63.450000000000003 111.064 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.99 134.87 14.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 108.801 -0.814 . . . . 75.040000000000006 108.801 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.3 Cg_endo -54.47 146.22 53.54 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 123.995 3.13 . . . . 75.010000000000005 114.09 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.5 p -91.82 137.68 32.17 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.588 -0.733 . . . . 74.239999999999995 109.409 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -80.16 88.36 5.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.136 -1.061 . . . . 74.530000000000001 108.136 171.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.19 120.83 5.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 114.978 -1.01 . . . . 64.420000000000002 111.981 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -74.68 151.15 86.88 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.136 0.974 . . . . 75.209999999999994 111.44 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.87 -22.54 68.86 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.958 2.439 . . . . 73.219999999999999 113.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.04 -15.27 58.46 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.659 0.784 . . . . 72.319999999999993 111.222 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.64 -6.15 24.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.891 -0.394 . . . . 74.230000000000004 114.041 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.77 98.51 3.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.104 0.478 . . . . 74.120000000000005 110.94 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 43.6 mtmt -71.83 112.8 8.23 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.533 0.733 . . . . 75.409999999999997 109.273 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 85.9 t -78.82 110.09 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 122.771 0.429 . . . . 74.349999999999994 110.588 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 62.9 m -147.7 151.01 35.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.858 1.263 . . . . 73.129999999999995 109.0 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -84.26 138.91 32.68 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.779 -0.822 . . . . 75.230000000000004 108.779 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.5 146.3 97.69 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.145 0.578 . . . . 71.329999999999998 110.814 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.18 10.14 60.0 Favored 'Cis proline' 0 C--N 1.376 1.978 0 N-CA-C 114.697 0.999 . . . . 54.409999999999997 114.697 3.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -73.09 114.01 10.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.133 0.573 . . . . 73.430000000000007 111.006 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.46 133.53 37.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.7 1.2 . . . . 73.439999999999998 109.77 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.3 t -70.72 105.41 3.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.127 0.489 . . . . 72.510000000000005 110.675 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.5 118.4 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.084 -1.08 . . . . 74.010000000000005 108.084 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.42 -36.97 84.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.065 0.946 . . . . 71.230000000000004 112.559 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.3 p -62.51 -38.78 91.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.556 0.742 . . . . 72.129999999999995 111.643 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.9 p -97.12 -7.76 31.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.307 0.643 . . . . 65.239999999999995 111.493 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p 55.08 21.27 3.74 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.231 1.812 . . . . 53.229999999999997 113.521 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 ptp180 -133.16 148.92 52.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.796 0.438 . . . . 74.040000000000006 111.751 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.7 m -74.08 114.82 12.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.773 -0.649 . . . . 75.230000000000004 109.672 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.1 -171.17 2.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.477 1.111 . . . . 61.109999999999999 109.001 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.82 148.25 87.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 119.08 -0.486 . . . . 75.200000000000003 111.325 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.375 1.927 0 C-N-CA 123.401 2.734 . . . . 72.129999999999995 112.501 169.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 74.519999999999996 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.93 134.47 40.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.665 0.386 . . . . 72.120000000000005 110.612 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.504 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 118.92 0.73 14.87 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.572 0.989 . . . . 71.400000000000006 115.572 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 9.4 m-20 -92.79 174.82 7.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.106 0.953 . . . . 72.219999999999999 110.655 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -68.06 122.97 19.39 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.799 -0.815 . . . . 75.010000000000005 108.799 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 66.56 19.48 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.876 1.671 . . . . 65.310000000000002 112.418 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -113.17 129.59 24.41 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.855 0.862 . . . . 73.219999999999999 109.108 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -43.56 126.74 5.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 124.274 3.316 . . . . 73.230000000000004 112.981 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.5 p -84.52 130.76 34.71 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.114 -0.698 . . . . 73.519999999999996 109.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.1 p -80.63 139.56 36.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.464 -0.569 . . . . 73.319999999999993 109.464 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.34 114.71 4.94 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.315 -0.314 . . . . 65.319999999999993 112.315 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -61.5 148.78 85.59 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.196 0.998 . . . . 72.430000000000007 111.248 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.45 -5.14 13.31 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.91 2.407 . . . . 71.120000000000005 114.413 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.41 2.12 47.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.521 0.728 . . . . 74.439999999999998 111.625 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.57 4.04 62.43 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.892 -0.393 . . . . 70.230000000000004 113.862 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 155.81 19.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.042 0.421 . . . . 65.040000000000006 110.301 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -101.95 127.45 48.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.152 0.581 . . . . 75.219999999999999 109.883 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.8 t -78.5 109.67 13.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.895 -0.78 . . . . 74.209999999999994 108.895 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 71.8 m -141.64 141.1 33.41 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.592 1.182 . . . . 71.140000000000001 108.604 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 7.2 p30 -78.88 135.27 36.96 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.428 -1.323 . . . . 74.519999999999996 107.428 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.61 141.7 98.32 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.343 0.657 . . . . 75.120000000000005 110.073 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -99.26 28.33 15.15 Favored 'Cis proline' 0 C--N 1.371 1.744 0 CA-C-N 119.766 0.952 . . . . 75.540000000000006 114.446 5.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -85.29 143.21 28.84 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.785 -0.45 . . . . 72.400000000000006 109.785 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 37' ' ' PRO . 27.9 m -126.0 140.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 109.797 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.0 t -80.62 116.6 20.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.49 0.716 . . . . 73.129999999999995 111.398 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.29 123.75 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.762 -1.57 . . . . 74.540000000000006 106.762 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.31 -29.15 70.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.606 0.762 . . . . 74.530000000000001 111.527 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m -71.04 -36.65 72.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.776 0.831 . . . . 71.519999999999996 111.098 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.9 p -92.1 -21.04 20.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.342 0.657 . . . . 74.129999999999995 111.034 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.7 p 53.38 37.95 26.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.825 1.65 . . . . 75.109999999999999 111.784 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -145.06 146.89 32.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.259 0.624 . . . . 75.420000000000002 111.192 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 22.4 m -75.98 123.22 25.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.277 0.631 . . . . 72.340000000000003 109.644 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.92 -177.75 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.163 0.985 . . . . 74.319999999999993 109.622 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.34 127.85 86.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.229 0.612 . . . . 74.439999999999998 109.711 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HG3' HG23 ' A' ' 26' ' ' VAL . 15.1 Cg_exo . . . . . 0 C--N 1.373 1.846 0 C-N-CA 123.034 2.489 . . . . 73.439999999999998 111.847 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.242 0.672 0 CA-C-O 120.75 0.309 . . . . 71.329999999999998 110.33 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.05 150.51 34.05 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.672 0.389 . . . . 62.539999999999999 110.733 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.672 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.07 -6.85 58.44 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 114.923 0.729 . . . . 71.030000000000001 114.923 170.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.45 ' HA ' HD22 ' A' ' 22' ' ' ASN . 2.9 m-20 -94.78 175.38 6.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.494 0.718 . . . . 73.120000000000005 110.902 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -67.11 122.87 18.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.312 -0.625 . . . . 75.319999999999993 109.312 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 80.3 m-20 63.36 31.66 15.06 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.564 1.146 . . . . 72.450000000000003 110.662 -176.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.14 131.32 23.92 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.27 -1.011 . . . . 63.240000000000002 108.27 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.14 130.55 32.44 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.626 2.884 . . . . 74.010000000000005 112.382 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 29.0 p -79.29 127.2 31.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.8 -0.444 . . . . 74.400000000000006 109.8 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.86 125.09 29.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.367 0.667 . . . . 74.109999999999999 109.311 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.22 132.17 10.98 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.935 -0.575 . . . . 73.530000000000001 113.337 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -73.72 139.01 77.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.534 1.134 . . . . 74.400000000000006 111.059 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.45 -31.46 48.33 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.385 2.723 . . . . 73.409999999999997 113.876 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.26 -27.53 63.51 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.725 0.41 . . . . 74.400000000000006 111.267 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.35 0.83 11.28 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.705 -0.497 . . . . 72.239999999999995 114.219 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 163.05 26.92 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.675 0.737 . . . . 71.430000000000007 110.583 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HZ3' ' HB2' ' A' ' 19' ' ' LYS . 10.0 mtmp? -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 74.349999999999994 108.568 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.55 110.6 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.408 0.683 . . . . 73.450000000000003 109.58 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 84.4 m -139.2 138.52 36.96 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 72.400000000000006 108.988 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 6' ' ' ASP . 9.4 p30 -79.5 142.53 35.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.623 -0.88 . . . . 74.540000000000006 108.623 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.61 144.82 97.92 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 122.959 0.504 . . . . 71.120000000000005 110.874 -174.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -93.12 14.76 46.76 Favored 'Cis proline' 0 C--N 1.377 2.055 0 C-N-CA 124.704 -0.957 . . . . 75.409999999999997 114.309 4.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.89 132.27 46.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.694 0.398 . . . . 74.319999999999993 110.938 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -115.77 126.89 73.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.338 1.055 . . . . 75.140000000000001 108.835 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -75.14 112.76 11.73 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.686 0.279 . . . . 74.519999999999996 110.984 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.88 132.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.26 -1.015 . . . . 75.200000000000003 108.26 172.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.07 -46.25 88.73 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 124.01 0.819 . . . . 74.430000000000007 111.782 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -66.58 -45.61 78.68 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.978 0.799 . . . . 63.299999999999997 111.499 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -80.91 -15.38 56.44 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.105 0.562 . . . . 74.019999999999996 111.17 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p 54.26 24.51 5.07 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.627 1.571 . . . . 74.329999999999998 113.029 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 36.4 ptt180 -131.28 148.78 52.72 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.634 0.774 . . . . 73.439999999999998 109.24 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.672 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 53.8 m -71.81 94.37 1.4 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.832 -0.803 . . . . 65.319999999999993 108.832 173.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -99.33 170.35 8.71 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.801 -1.09 . . . . 71.109999999999999 108.843 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.58 139.16 88.81 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.666 0.386 . . . . 75.420000000000002 110.25 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--N 1.369 1.606 0 C-N-CA 122.904 2.402 . . . . 74.140000000000001 112.022 173.436 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.556 1.174 0 N-CA-C 110.492 -0.188 . . . . 65.519999999999996 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.5 p -155.31 128.68 8.36 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.742 -0.599 . . . . 75.409999999999997 111.458 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 136.65 -13.37 3.95 Favored Glycine 0 C--N 1.355 1.639 0 N-CA-C 116.062 1.185 . . . . 71.409999999999997 116.062 164.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 23.2 m-20 -94.86 175.72 6.54 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.71 1.255 . . . . 74.120000000000005 112.37 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.93 131.33 50.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.151 -0.931 . . . . 71.439999999999998 110.096 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.583 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 62.3 m-20 57.98 27.13 14.33 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.737 1.215 . . . . 75.200000000000003 112.195 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 14.3 tp10 -119.69 125.98 27.17 Favored Pre-proline 0 N--CA 1.472 0.627 0 C-N-CA 123.971 0.909 . . . . 75.109999999999999 108.587 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 10.8 Cg_endo -49.2 140.76 25.04 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.934 3.089 . . . . 75.439999999999998 112.65 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 29.0 p -88.2 136.69 32.86 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 75.319999999999993 109.695 177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -85.53 134.36 34.03 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.605 -0.887 . . . . 55.240000000000002 108.605 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.2 138.4 13.91 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.502 -0.317 . . . . 70.209999999999994 112.559 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.72 151.22 57.92 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.431 1.092 . . . . 72.310000000000002 108.834 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.49 -34.93 83.84 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.154 2.569 . . . . 72.109999999999999 114.088 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.72 -13.61 60.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.887 0.475 . . . . 74.129999999999995 111.831 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.86 12.3 20.96 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.496 0.558 . . . . 64.400000000000006 114.496 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.58 136.32 38.26 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.273 0.536 . . . . 72.209999999999994 110.614 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -95.85 114.58 26.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.205 0.602 . . . . 74.310000000000002 109.652 176.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.5 t -79.6 101.76 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.416 0.686 . . . . 75.439999999999998 110.183 -177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 59.0 m -138.64 140.58 38.94 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.864 1.266 . . . . 71.219999999999999 108.565 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.16 144.18 33.23 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.161 -0.681 . . . . 75.200000000000003 109.161 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.6 139.84 97.27 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.212 0.605 . . . . 70.129999999999995 110.901 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -94.01 13.96 45.95 Favored 'Cis proline' 0 C--N 1.375 1.95 0 N-CA-C 114.642 0.978 . . . . 74.209999999999994 114.642 6.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -67.88 126.15 28.52 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 118.031 0.378 . . . . 61.43 110.629 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.63 129.52 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.841 1.256 . . . . 73.540000000000006 108.403 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 48.8 t -72.09 108.2 5.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.763 0.316 . . . . 73.310000000000002 110.612 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -79.36 120.27 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 107.775 -1.194 . . . . 74.129999999999995 107.775 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.58 -34.45 77.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.629 0.772 . . . . 73.150000000000006 112.42 -170.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -76.4 -25.32 54.41 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.654 0.382 . . . . 74.239999999999995 111.408 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.9 p -95.43 -14.16 24.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.91 0.484 . . . . 73.439999999999998 110.637 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.6 p 54.96 33.91 21.2 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.16 1.784 . . . . 75.400000000000006 113.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.583 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.4 ptp180 -144.53 150.82 38.17 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 74.049999999999997 111.032 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 34.3 m -70.09 121.69 17.96 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.655 -0.702 . . . . 61.5 109.244 172.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 14.1 mm-40 -132.26 173.76 10.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.526 1.131 . . . . 74.200000000000003 110.502 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -75.37 126.7 87.39 Favored Pre-proline 0 CA--C 1.558 1.255 0 N-CA-C 108.857 -0.794 . . . . 73.420000000000002 108.857 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.383 2.371 0 C-N-CA 123.161 2.574 . . . . 71.420000000000002 112.344 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.637 0.256 . . . . 71.310000000000002 110.526 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 27.2 p -101.32 148.47 25.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.554 0.576 . . . . 72.109999999999999 112.554 -170.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.92 -11.8 24.84 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.257 -0.883 . . . . 74.030000000000001 113.645 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 4.2 m-20 -96.96 161.46 13.83 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.676 0.738 . . . . 64.510000000000005 111.044 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 12.4 tmtt? -73.6 133.11 43.43 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.973 -1.012 . . . . 73.420000000000002 108.996 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 82.2 m-20 61.92 20.18 11.3 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.698 1.599 . . . . 63.539999999999999 112.282 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -120.11 152.06 53.89 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.774 1.23 . . . . 72.409999999999997 108.02 172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 18.1 Cg_endo -55.11 153.8 24.97 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.744 2.962 . . . . 74.530000000000001 113.294 -175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 28.4 p -100.4 122.54 43.32 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.362 -0.977 . . . . 75.030000000000001 108.362 166.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.522 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.0 p -84.2 107.31 16.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.81 -0.811 . . . . 70.340000000000003 108.81 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.42 122.56 5.97 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.786 -0.525 . . . . 72.450000000000003 111.786 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -57.4 156.64 15.2 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.638 1.175 . . . . 72.140000000000001 110.026 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -42.58 -39.26 6.81 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 123.764 2.976 . . . . 75.140000000000001 115.872 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -72.48 -31.21 65.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.932 0.893 . . . . 73.340000000000003 111.336 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.81 14.75 4.6 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.958 -0.565 . . . . 70.329999999999998 113.437 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.93 103.37 9.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.066 0.546 . . . . 65.310000000000002 110.997 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -71.62 123.64 22.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 75.340000000000003 110.606 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.522 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 90.1 t -78.91 104.87 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 110.383 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 78.4 m -141.75 136.07 30.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.428 -1.26 . . . . 72.329999999999998 108.868 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -80.17 146.49 31.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.585 -0.524 . . . . 64.439999999999998 109.585 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.36 145.58 93.34 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.047 0.539 . . . . 72.430000000000007 110.722 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -90.85 13.18 54.18 Favored 'Cis proline' 0 C--N 1.38 2.201 0 CA-C-N 119.977 1.028 . . . . 73.209999999999994 113.882 2.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -70.88 118.75 14.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.358 0.663 . . . . 74.219999999999999 110.779 -174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.83 135.02 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.252 1.021 . . . . 75.450000000000003 109.023 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 54.0 t -78.57 122.47 25.95 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.578 0.351 . . . . 72.129999999999995 111.033 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.98 136.87 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.176 -1.046 . . . . 71.420000000000002 108.176 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -39.97 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.021 0.528 . . . . 74.340000000000003 110.689 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 m -58.88 -36.91 75.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.975 . . . . 55.439999999999998 111.643 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 p -94.15 -25.97 16.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.76 0.824 . . . . 73.209999999999994 111.283 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p 54.22 32.18 15.55 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.774 1.63 . . . . 74.25 112.187 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.8 ptt180 -124.28 144.89 49.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.811 0.844 . . . . 73.319999999999993 109.773 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 33.6 m -69.32 127.27 32.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.846 -0.798 . . . . 74.409999999999997 108.846 169.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 16.1 pt-20 -156.54 -168.29 2.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.461 0.705 . . . . 74.540000000000006 109.323 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -59.15 154.21 41.85 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 122.88 0.472 . . . . 74.340000000000003 112.182 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.372 1.806 0 C-N-CA 122.415 2.077 . . . . 75.329999999999998 110.773 169.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.784 -0.45 . . . . 74.510000000000005 109.784 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -132.83 137.55 46.78 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.054 0.39 . . . . 74.310000000000002 112.054 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.4 5.32 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.076 -0.847 . . . . 73.099999999999994 114.134 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.55 163.25 17.59 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.94 0.87 . . . . 54.100000000000001 110.505 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HG3' ' HA ' ' A' ' 35' ' ' GLU . 59.5 tttm -64.98 141.58 58.73 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.076 0.55 . . . . 73.420000000000002 110.742 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 56.17 19.14 3.64 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.113 1.765 . . . . 64.310000000000002 112.057 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.99 146.89 37.12 Favored Pre-proline 0 N--CA 1.476 0.832 0 N-CA-C 107.314 -1.365 . . . . 72.310000000000002 107.314 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.75 141.68 92.03 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.081 2.521 . . . . 74.5 111.934 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 27.6 p -92.84 117.82 30.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.566 -0.902 . . . . 74.099999999999994 108.566 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.472 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 11.5 p -87.73 130.3 34.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.85 -0.426 . . . . 72.319999999999993 109.85 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.55 145.05 20.07 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 116.383 -0.371 . . . . 73.420000000000002 112.924 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -104.58 156.62 35.62 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.594 0.758 . . . . 73.420000000000002 109.132 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 -21.04 71.56 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.839 2.359 . . . . 75.340000000000003 114.426 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.01 -24.92 59.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.096 0.558 . . . . 51.43 110.701 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.8 38.17 2.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.556 -0.747 . . . . 74.150000000000006 112.819 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.37 141.05 48.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.031 0.532 . . . . 75.019999999999996 111.059 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.609 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 10.0 mmpt? -88.14 123.26 32.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.834 0.853 . . . . 70.200000000000003 110.093 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.472 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 94.9 t -77.76 101.4 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.39 0.614 . . . . 75.019999999999996 109.846 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 72.3 m -145.91 135.69 23.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.042 1.337 . . . . 73.549999999999997 107.924 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -79.48 142.21 36.04 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.887 -0.412 . . . . 74.010000000000005 109.887 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -67.26 144.24 98.02 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 122.72 0.408 . . . . 75.530000000000001 109.924 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.67 19.7 36.36 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 119.77 0.954 . . . . 60.299999999999997 114.062 3.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -85.31 130.27 34.63 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.264 0.626 . . . . 71.430000000000007 109.567 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.45 148.6 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.077 0.951 . . . . 63.240000000000002 109.541 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.1 t -84.77 131.89 34.5 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.818 0.342 . . . . 73.340000000000003 111.315 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.1 122.22 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 106.919 -1.511 . . . . 72.420000000000002 106.919 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.59 -32.32 73.75 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.528 0.731 . . . . 74.340000000000003 111.652 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.3 m -60.93 -42.04 97.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.05 0.94 . . . . 73.25 111.227 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.2 p -90.52 -15.34 30.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.454 0.702 . . . . 71.109999999999999 111.571 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.3 p 54.47 26.66 7.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.264 1.425 . . . . 53.229999999999997 112.349 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.48 150.81 45.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.176 0.591 . . . . 72.430000000000007 110.438 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 m -72.53 132.8 44.29 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.372 -0.603 . . . . 74.530000000000001 109.372 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HA ' ' HG3' ' A' ' 7' ' ' LYS . 48.1 mt-10 -144.86 -175.01 4.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.054 0.941 . . . . 73.310000000000002 110.308 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.8 138.13 85.46 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 73.019999999999996 110.422 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.563 1.96 0 C-N-CA 122.159 1.906 . . . . 72.140000000000001 111.735 172.58 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 108.523 -0.918 . . . . 72.209999999999994 108.523 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -148.59 142.52 25.8 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.976 0.807 . . . . 74.099999999999994 111.91 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 89.74 32.82 9.66 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.786 -0.643 . . . . 55.149999999999999 113.624 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.16 177.61 7.54 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.127 0.971 . . . . 75.510000000000005 109.612 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -71.23 128.58 36.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 74.030000000000001 109.572 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.62 19.83 9.75 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.009 1.324 . . . . 65.040000000000006 112.708 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.39 132.79 23.37 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 118.477 -0.773 . . . . 73.200000000000003 109.505 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.4 133.54 25.47 Favored 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 124.072 3.182 . . . . 73.349999999999994 113.584 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 19' ' ' LYS . 31.7 p -80.34 123.1 27.71 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.584 -0.525 . . . . 63.140000000000001 109.584 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -80.19 131.29 35.68 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.409 -0.589 . . . . 62.43 109.409 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.84 119.65 5.12 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.206 -0.452 . . . . 61.030000000000001 112.07 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -59.25 145.46 81.18 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.401 1.08 . . . . 72.540000000000006 111.591 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 -27.6 82.17 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.558 2.172 . . . . 64.230000000000004 112.56 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.85 -24.22 59.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.308 0.643 . . . . 72.519999999999996 111.531 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.3 10.73 14.75 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-O 119.691 -0.505 . . . . 73.400000000000006 114.346 173.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.65 162.51 18.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.324 0.562 . . . . 74.340000000000003 110.915 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 75.1 mmtt -100.77 126.35 47.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.043 -0.725 . . . . 75.409999999999997 109.043 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.453 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 80.8 t -77.84 109.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.428 -0.582 . . . . 74.219999999999999 109.428 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 85.4 m -145.09 139.54 27.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.499 1.12 . . . . 65.329999999999998 109.33 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -78.32 143.66 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.267 0.627 . . . . 71.219999999999999 109.717 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.22 145.2 85.43 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.377 -0.344 . . . . 71.129999999999995 110.101 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.38 19.63 34.79 Favored 'Cis proline' 0 C--N 1.377 2.029 0 CA-C-N 119.571 0.882 . . . . 72.530000000000001 113.249 -0.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -74.62 128.09 34.71 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.611 0.764 . . . . 75.010000000000005 110.166 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.02 143.04 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.494 1.117 . . . . 73.010000000000005 109.606 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 45.1 t -79.05 113.9 17.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.065 -0.346 . . . . 64.400000000000006 110.065 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.89 121.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.647 -1.242 . . . . 72.549999999999997 107.647 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.83 -26.37 65.74 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.662 0.785 . . . . 73.129999999999995 112.996 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -68.16 -50.91 51.42 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.499 0.72 . . . . 71.010000000000005 111.217 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.3 p -86.05 -14.66 43.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.667 0.787 . . . . 62.039999999999999 111.852 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.1 p 53.07 32.29 12.74 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 125.508 1.523 . . . . 55.130000000000003 112.236 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -144.84 150.6 37.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.506 0.67 . . . . 74.430000000000007 112.682 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 m -80.02 96.77 6.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.687 -1.142 . . . . 73.109999999999999 111.013 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.74 -173.23 2.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.921 0.888 . . . . 73.340000000000003 110.156 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.59 132.13 92.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 122.917 0.487 . . . . 71.129999999999995 110.833 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.373 1.827 0 C-N-CA 122.601 2.201 . . . . 75.109999999999999 111.937 171.346 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.254 -0.276 . . . . 74.129999999999995 110.254 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -132.67 147.32 52.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.37 0.668 . . . . 64.120000000000005 109.405 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.755 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.73 11.16 57.12 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 115.123 0.809 . . . . 70.450000000000003 115.123 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.9 -179.95 3.79 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.663 0.732 . . . . 75.400000000000006 110.86 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -60.09 118.46 6.34 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.413 0.685 . . . . 72.030000000000001 111.073 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.9 m-20 66.95 20.0 10.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.307 1.443 . . . . 73.340000000000003 111.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -118.77 130.51 24.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.184 -1.043 . . . . 75.319999999999993 108.184 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 13.2 Cg_endo -53.22 138.57 63.86 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.752 2.968 . . . . 63.299999999999997 113.269 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.566 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.0 p -79.7 127.95 32.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.058 -0.519 . . . . 74.319999999999993 110.103 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 145.78 32.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.335 -0.617 . . . . 65.409999999999997 109.335 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.06 125.41 8.52 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 120.002 -0.332 . . . . 60.310000000000002 112.521 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.96 152.56 93.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.602 0.761 . . . . 74.549999999999997 109.782 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.01 -31.41 95.67 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.763 2.308 . . . . 73.5 112.994 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -73.13 -27.42 61.67 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.655 0.782 . . . . 74.349999999999994 111.345 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.66 1.69 11.88 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.803 0.681 . . . . 73.25 114.803 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.85 119.01 14.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.375 0.588 . . . . 73.349999999999994 111.112 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -71.33 114.54 9.5 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.054 -0.721 . . . . 74.209999999999994 109.054 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.69 115.86 20.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.074 0.949 . . . . 72.019999999999996 110.072 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.7 m -147.9 141.11 25.1 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.563 1.164 . . . . 71.319999999999993 108.281 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.15 137.17 35.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.576 -0.898 . . . . 72.329999999999998 108.576 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.94 143.6 98.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.136 0.574 . . . . 74.239999999999995 111.011 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -93.8 16.98 41.13 Favored 'Cis proline' 0 C--N 1.378 2.108 0 N-CA-C 114.57 0.95 . . . . 72.25 114.57 5.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -69.99 120.38 15.63 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.326 -0.62 . . . . 71.439999999999998 109.326 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.89 135.12 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.254 1.022 . . . . 74.409999999999997 108.686 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 47.6 t -69.76 97.39 1.08 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.24 0.543 . . . . 75.230000000000004 109.654 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.24 111.15 13.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 107.273 -1.38 . . . . 73.530000000000001 107.273 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.04 -32.07 69.42 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.573 1.149 . . . . 73.239999999999995 111.399 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 m -56.94 -48.5 78.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.548 1.139 . . . . 72.099999999999994 111.141 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.5 p -96.99 -7.59 32.66 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.587 0.755 . . . . 72.150000000000006 111.83 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p 53.66 36.35 23.46 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 126.053 1.741 . . . . 72.400000000000006 112.455 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.5 ptp180 -141.93 151.2 42.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 73.030000000000001 110.787 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.755 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 35.4 m -73.56 98.56 2.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.943 0.878 . . . . 75.239999999999995 109.051 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -123.11 164.76 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.613 1.165 . . . . 75.219999999999999 108.815 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.87 147.31 73.18 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.22 0.608 . . . . 64.120000000000005 110.885 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.373 1.835 0 C-N-CA 123.169 2.58 . . . . 75.209999999999994 112.297 171.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.006 -0.368 . . . . 73.329999999999998 110.006 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.93 149.31 27.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.833 0.349 . . . . 72.439999999999998 111.282 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.66 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.32 25.28 8.91 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 116.027 1.171 . . . . 72.140000000000001 116.027 164.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -123.06 172.57 8.44 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.577 0.751 . . . . 72.5 109.625 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.99 125.08 23.77 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 109.025 -0.731 . . . . 75.450000000000003 109.025 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.683 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 74.6 m-20 66.78 18.43 10.68 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.549 1.54 . . . . 71.329999999999998 112.681 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -118.3 118.56 33.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.461 -0.94 . . . . 72.010000000000005 108.461 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 8.1 Cg_endo -45.41 124.33 6.37 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.646 3.564 . . . . 74.510000000000005 113.325 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.0 p -76.0 130.14 37.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.745 0.418 . . . . 74.409999999999997 109.929 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.59 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.1 p -84.56 105.8 15.65 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.802 -0.814 . . . . 74.409999999999997 108.802 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.44 122.98 6.08 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.259 -0.736 . . . . 72.510000000000005 111.259 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 97.4 mtt180 -71.54 156.02 91.89 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.708 0.803 . . . . 70.140000000000001 110.587 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.21 -28.57 85.24 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.768 2.312 . . . . 64.349999999999994 113.34 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.77 -28.18 62.45 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.39 0.431 . . . . 73.430000000000007 109.998 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.42 1.24 11.12 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.112 -0.495 . . . . 51.32 113.586 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -78.82 108.81 12.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.819 0.447 . . . . 70.230000000000004 110.605 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 46.5 mtmt -72.67 118.95 16.23 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.374 -0.602 . . . . 73.200000000000003 109.374 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 66.6 t -78.15 108.6 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.042 0.537 . . . . 73.209999999999994 109.664 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 70.7 m -150.97 138.85 19.9 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.085 1.354 . . . . 63.350000000000001 108.269 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.88 136.64 37.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.085 -1.08 . . . . 71.540000000000006 108.085 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.96 144.87 93.58 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.105 0.562 . . . . 71.239999999999995 109.913 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -87.02 1.84 68.37 Favored 'Cis proline' 0 C--N 1.378 2.126 0 C-N-CA 124.55 -1.021 . . . . 74.129999999999995 114.285 7.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -64.24 109.57 1.92 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.991 0.516 . . . . 71.439999999999998 110.113 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.19 140.15 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.066 0.946 . . . . 61.210000000000001 109.578 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.5 t -81.24 118.04 22.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.617 0.367 . . . . 74.099999999999994 111.344 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.21 118.05 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.939 -1.504 . . . . 63.310000000000002 106.939 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.424 HD22 ' HD3' ' A' ' 19' ' ' LYS . 3.7 mm? -67.43 -22.72 65.5 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.567 0.747 . . . . 73.099999999999994 111.925 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -62.23 -42.47 99.34 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.524 0.73 . . . . 71.209999999999994 110.13 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.9 p -95.9 -10.96 27.47 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.905 0.882 . . . . 73.150000000000006 111.055 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.5 p 54.67 26.08 7.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.201 1.801 . . . . 73.200000000000003 113.31 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.683 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 35.2 ptt180 -131.3 151.33 51.61 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.168 0.987 . . . . 65.319999999999993 109.936 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.66 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -73.8 140.92 46.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.679 -1.23 . . . . 74.510000000000005 107.679 170.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.29 165.76 32.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.621 0.368 . . . . 72.319999999999993 110.056 -169.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -61.49 127.71 88.89 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.65 0.78 . . . . 73.510000000000005 111.165 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.374 1.911 0 C-N-CA 122.918 2.412 . . . . 71.349999999999994 111.919 170.46 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.23 145.99 26.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 70.510000000000005 111.354 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.507 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 117.28 -4.41 18.05 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.634 1.014 . . . . 74.209999999999994 115.634 168.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.422 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 6.1 m-20 -94.42 179.09 5.4 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.223 1.012 . . . . 74.409999999999997 111.873 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -70.86 126.63 30.11 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 116.047 -0.524 . . . . 75.310000000000002 109.909 -174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 71.9 m-20 60.63 18.13 8.14 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.775 1.63 . . . . 72.430000000000007 112.359 -172.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -109.06 130.53 22.62 Favored Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 108.564 -0.902 . . . . 73.540000000000006 108.564 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -44.03 120.33 2.4 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.317 3.345 . . . . 72.299999999999997 112.916 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 14.0 p -77.03 147.14 36.92 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.098 0.559 . . . . 71.439999999999998 109.662 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -100.08 146.68 26.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.554 -1.276 . . . . 73.400000000000006 107.554 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.17 137.88 14.54 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 122.469 -0.145 . . . . 64.510000000000005 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.79 147.13 91.52 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.88 0.872 . . . . 73.319999999999993 109.458 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.98 -25.73 59.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.406 2.07 . . . . 61.399999999999999 112.191 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.29 -8.82 57.67 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.054 0.942 . . . . 72.329999999999998 111.767 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.18 -0.96 37.88 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 114.793 0.677 . . . . 74.420000000000002 114.793 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.23 130.05 35.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 117.554 0.677 . . . . 71.239999999999995 111.074 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD2' HD11 ' A' ' 29' ' ' LEU . 11.6 mmpt? -84.71 122.0 28.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.287 0.635 . . . . 74.420000000000002 109.648 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.54 108.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 123.243 0.617 . . . . 74.319999999999993 109.985 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 68.0 m -146.99 149.67 33.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.987 -1.006 . . . . 51.130000000000003 108.331 175.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 8.1 p30 -77.07 128.12 33.89 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.53 -1.285 . . . . 75.530000000000001 107.53 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.08 142.14 97.71 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.028 -173.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.2 12.56 36.36 Favored 'Cis proline' 0 C--N 1.373 1.828 0 CA-C-N 119.548 0.874 . . . . 72.329999999999998 114.235 6.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -64.31 130.25 43.11 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.993 -0.373 . . . . 74.219999999999999 109.993 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.84 142.65 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.153 0.981 . . . . 74.329999999999998 110.232 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.6 t -83.53 112.28 19.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.393 0.277 . . . . 75.430000000000007 110.545 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.01 121.76 31.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 107.353 -1.351 . . . . 73.439999999999998 107.353 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD11 ' HD2' ' A' ' 19' ' ' LYS . 4.2 mm? -65.28 -26.65 68.17 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.63 0.772 . . . . 74.010000000000005 112.59 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.2 m -63.21 -51.31 66.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.1 0.56 . . . . 75.349999999999994 110.876 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 33' ' ' ARG . 55.5 p -87.68 -18.01 30.5 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.212 -0.904 . . . . 71.239999999999995 111.603 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.7 p 52.75 31.77 11.01 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.77 1.628 . . . . 73.219999999999999 112.482 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 11.6 ptp180 -131.1 150.92 51.93 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.621 0.768 . . . . 75.420000000000002 110.152 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.507 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 14.1 m -81.56 113.03 19.31 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.804 -0.634 . . . . 73.209999999999994 110.109 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.41 -169.36 1.92 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.659 1.184 . . . . 74.019999999999996 109.684 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.09 149.93 89.68 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 122.908 0.483 . . . . 75.120000000000005 110.979 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.374 1.879 0 C-N-CA 122.527 2.151 . . . . 55.439999999999998 111.09 170.482 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.277 -0.638 . . . . 72.409999999999997 109.277 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.5 145.85 23.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 122.503 0.321 . . . . 74.510000000000005 110.955 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.677 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 102.57 4.31 49.48 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 115.436 0.934 . . . . 73.209999999999994 115.436 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' HD22 ' A' ' 22' ' ' ASN . 7.1 m-20 -92.15 170.44 9.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.46 0.63 . . . . 75.129999999999995 110.599 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -69.96 125.13 25.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.69 -0.856 . . . . 75.109999999999999 108.69 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 62.51 29.04 17.01 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.256 1.422 . . . . 75.140000000000001 111.832 -173.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -127.05 141.24 40.1 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.059 0.944 . . . . 72.120000000000005 108.513 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -55.16 132.14 50.51 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.045 2.497 . . . . 74.409999999999997 112.619 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.9 p -82.65 141.89 32.14 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.422 0.689 . . . . 64.209999999999994 109.479 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.553 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.5 p -92.67 126.93 37.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.107 -1.071 . . . . 75.230000000000004 108.107 170.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 126.61 8.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 112.231 -0.348 . . . . 62.43 112.231 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -67.5 144.11 97.58 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.133 0.973 . . . . 72.430000000000007 109.916 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.95 -24.78 74.59 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.969 2.446 . . . . 70.109999999999999 113.245 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.75 -8.72 59.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.941 0.896 . . . . 73.409999999999997 112.138 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.08 -9.97 27.06 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.736 -0.48 . . . . 54.310000000000002 114.106 172.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 149.39 41.2 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.387 0.593 . . . . 75.299999999999997 110.788 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -100.23 117.32 34.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.898 -0.778 . . . . 65.420000000000002 108.898 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.553 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 46.8 t -77.65 94.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.689 -0.856 . . . . 72.219999999999999 108.689 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 66.7 m -128.25 141.68 51.38 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.064 -1.425 . . . . 74.319999999999993 107.867 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.489 HD22 ' HA ' ' A' ' 6' ' ' ASP . 9.6 p30 -78.76 135.83 37.22 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.415 -0.957 . . . . 74.409999999999997 108.415 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.09 143.3 88.53 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 124.047 0.939 . . . . 74.430000000000007 111.264 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.2 25.71 20.56 Favored 'Cis proline' 0 C--N 1.383 2.374 0 CA-C-N 119.829 0.975 . . . . 71.329999999999998 113.844 1.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -77.28 142.12 39.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.565 0.346 . . . . 64.310000000000002 110.269 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.03 137.28 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 75.319999999999993 109.217 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -82.59 124.03 29.77 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.563 0.345 . . . . 74.219999999999999 110.894 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 123.68 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.777 -1.564 . . . . 71.150000000000006 106.777 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.58 -44.19 97.48 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.331 1.02 . . . . 72.019999999999996 111.843 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -68.88 -39.02 80.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.07 0.948 . . . . 74.150000000000006 111.421 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -84.29 -15.87 45.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.118 0.567 . . . . 71.430000000000007 111.279 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 54.12 37.04 26.23 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.444 1.498 . . . . 55.43 112.262 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 30.4 ptt180 -134.73 139.71 45.4 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.313 0.645 . . . . 74.140000000000001 110.771 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.677 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 38.3 m -75.94 128.08 34.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.005 -0.739 . . . . 74.129999999999995 109.005 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -147.05 170.09 17.88 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.332 -0.988 . . . . 73.230000000000004 108.332 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.97 134.54 96.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 122.921 0.488 . . . . 64.540000000000006 111.071 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 122.721 2.281 . . . . 71.510000000000005 111.893 174.574 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.18 -0.674 . . . . 72.409999999999997 109.18 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -128.96 148.04 50.91 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 122.715 0.406 . . . . 62.420000000000002 110.968 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.585 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.02 -9.95 31.69 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 114.436 0.535 . . . . 65.430000000000007 114.436 169.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.66 169.09 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.358 0.663 . . . . 74.030000000000001 110.866 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -65.65 122.92 18.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.167 0.587 . . . . 74.299999999999997 110.113 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.535 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 76.8 m-20 64.59 16.96 10.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.508 1.523 . . . . 75.430000000000007 113.769 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -104.88 136.55 19.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 108.276 -1.009 . . . . 71.409999999999997 108.276 170.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.09 137.03 76.98 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.203 2.602 . . . . 75.129999999999995 112.139 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 31.6 p -77.36 133.01 38.84 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.25 -0.648 . . . . 62.149999999999999 109.25 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.22 107.21 10.65 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.464 0.649 . . . . 73.219999999999999 109.481 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.21 108.42 2.69 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.52 -1.218 . . . . 74.230000000000004 112.168 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -68.22 145.12 97.35 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.108 0.963 . . . . 70.030000000000001 110.251 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -47.84 -36.66 27.08 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.651 3.568 . . . . 74.239999999999995 115.128 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -68.97 -20.13 64.18 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.676 0.79 . . . . 64.329999999999998 111.934 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.83 5.17 11.09 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.235 -0.439 . . . . 63.340000000000003 113.443 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.42 131.54 38.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.988 0.515 . . . . 74.329999999999998 111.703 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -92.7 114.45 27.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.085 -1.08 . . . . 73.319999999999993 108.085 171.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.46 124.76 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.564 0.346 . . . . 75.319999999999993 110.825 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.9 m -137.12 149.22 47.19 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.246 1.019 . . . . 75.340000000000003 109.234 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -84.71 141.02 30.87 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.111 -0.7 . . . . 74.420000000000002 109.111 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.09 148.42 98.85 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.641 0.776 . . . . 74.239999999999995 110.759 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.01 23.61 26.26 Favored 'Cis proline' 0 C--N 1.375 1.95 0 CA-C-N 119.527 0.867 . . . . 72.239999999999995 113.91 3.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.09 140.03 31.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.874 0.47 . . . . 74.129999999999995 110.246 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.33 138.0 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.935 1.294 . . . . 71.530000000000001 109.002 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 42.6 t -73.37 109.9 7.25 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.914 0.388 . . . . 73.340000000000003 110.722 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.52 114.31 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.731 -1.211 . . . . 73.030000000000001 107.731 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.3 -26.16 68.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.298 1.039 . . . . 75.299999999999997 112.223 -171.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -63.56 -46.47 85.78 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.806 0.843 . . . . 63.25 110.429 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 p -95.77 -8.87 33.2 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.222 1.009 . . . . 63.539999999999999 111.937 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p 54.84 28.12 9.94 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.793 1.637 . . . . 74.420000000000002 113.018 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 5.3 ptp180 -138.58 151.91 47.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.145 0.578 . . . . 75.140000000000001 110.613 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.585 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 13.6 m -77.67 125.67 29.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.144 -0.934 . . . . 64.230000000000004 109.804 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.49 176.14 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.256 1.023 . . . . 72.439999999999998 109.834 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.11 143.0 90.8 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.165 -0.445 . . . . 72.439999999999998 110.01 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 CA--C 1.563 1.966 0 C-N-CA 122.734 2.289 . . . . 72.329999999999998 112.0 173.419 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.127 -0.694 . . . . 64.200000000000003 109.127 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.52 144.63 25.47 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.152 -0.342 . . . . 74.230000000000004 110.626 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.637 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.41 20.09 30.76 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 115.291 0.876 . . . . 72.439999999999998 115.291 168.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.77 -179.92 3.88 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.406 0.682 . . . . 75.340000000000003 110.55 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -61.28 122.43 15.08 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.744 0.818 . . . . 75.030000000000001 110.846 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 60.26 27.13 16.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.011 1.324 . . . . 73.219999999999999 111.159 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -124.07 125.41 25.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 109.148 -0.686 . . . . 73.540000000000006 109.148 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.48 125.31 10.63 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 124.328 3.352 . . . . 75.109999999999999 112.858 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p -77.69 132.19 38.06 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.94 -0.763 . . . . 64.439999999999998 108.94 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -81.42 153.04 27.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.84 0.856 . . . . 72.340000000000003 109.091 175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.64 131.56 10.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.932 -0.48 . . . . 75.219999999999999 112.835 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.4 ' NE ' HG23 ' A' ' 20' ' ' VAL . 39.9 mmt180 -66.57 157.58 82.29 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.959 1.303 . . . . 75.329999999999998 110.999 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.76 -35.41 98.81 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.624 2.216 . . . . 64.409999999999997 112.69 172.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.51 -30.06 57.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.987 0.915 . . . . 72.439999999999998 111.088 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.03 1.54 12.87 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 115.247 0.859 . . . . 62.009999999999998 115.247 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.1 146.75 47.31 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.056 0.928 . . . . 72.400000000000006 110.384 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -86.44 122.67 30.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.538 -0.542 . . . . 74.530000000000001 109.538 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.46 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 24.8 t -79.18 109.45 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.55 0.74 . . . . 72.0 109.832 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.6 m -137.24 139.93 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.82 -1.178 . . . . 71.239999999999995 107.82 169.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -78.06 146.82 35.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.164 -1.05 . . . . 74.420000000000002 108.164 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.55 141.47 97.93 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.041 0.536 . . . . 71.140000000000001 110.716 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -98.65 18.07 27.37 Favored 'Cis proline' 0 C--N 1.372 1.766 0 CA-C-N 119.267 0.774 . . . . 74.530000000000001 113.957 -1.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -65.13 141.58 58.65 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.033 0.533 . . . . 74.439999999999998 110.028 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.57 136.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.343 1.057 . . . . 73.420000000000002 110.302 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.5 t -80.98 113.61 19.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.978 0.511 . . . . 70.319999999999993 110.655 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.7 118.82 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.657 -1.609 . . . . 74.239999999999995 106.657 170.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.2 -36.22 82.93 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.11 0.964 . . . . 74.439999999999998 111.564 -171.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -61.42 -43.46 98.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.749 0.82 . . . . 75.219999999999999 111.002 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.5 p -92.51 -11.06 35.58 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.11 0.564 . . . . 71.239999999999995 111.212 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.5 p 54.66 28.84 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.987 1.715 . . . . 73.5 113.137 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -140.49 151.12 44.56 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.328 0.651 . . . . 74.5 110.265 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.637 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 18.4 m -82.75 116.45 22.11 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.838 0.455 . . . . 74.329999999999998 110.794 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -104.48 -170.36 1.75 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.468 1.107 . . . . 74.219999999999999 109.04 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.75 156.77 91.52 Favored Pre-proline 0 N--CA 1.485 1.279 0 CA-C-O 119.051 -0.5 . . . . 74.340000000000003 110.577 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.601 2.201 . . . . 75.120000000000005 111.801 175.743 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 10.3 pt-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 71.239999999999995 109.259 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.8 p -97.24 136.92 37.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.122 -0.361 . . . . 75.319999999999993 110.65 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.696 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.6 1.21 64.07 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 115.228 0.851 . . . . 42.130000000000003 115.228 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.04 -179.58 4.73 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.286 0.634 . . . . 64.319999999999993 111.004 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -65.01 121.56 14.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.068 0.947 . . . . 64.129999999999995 110.416 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 60.03 18.04 7.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.418 1.487 . . . . 51.399999999999999 112.694 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 54.4 mm-40 -107.75 138.95 20.16 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.891 0.877 . . . . 64.109999999999999 109.695 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.43 122.61 12.1 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 123.145 2.563 . . . . 74.310000000000002 112.277 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.707 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 28.0 p -74.48 128.69 36.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.774 -0.454 . . . . 65.349999999999994 109.774 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 120.03 23.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.268 -0.641 . . . . 70.400000000000006 109.268 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.44 126.01 8.36 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.842 -0.617 . . . . 75.150000000000006 113.552 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.43 144.35 88.43 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.157 0.983 . . . . 74.019999999999996 110.805 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.13 -17.57 60.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.502 2.134 . . . . 65.430000000000007 112.98 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.72 -8.09 58.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.835 0.854 . . . . 74.430000000000007 111.999 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.2 35.72 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 114.566 0.586 . . . . 74.230000000000004 114.566 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.48 139.57 47.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.543 0.672 . . . . 75.230000000000004 110.293 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.707 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -96.06 116.19 28.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.353 0.661 . . . . 75.019999999999996 110.278 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.94 108.48 18.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.159 -0.682 . . . . 74.010000000000005 109.159 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.3 m -128.81 148.86 50.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 124.671 1.188 . . . . 73.409999999999997 108.316 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.74 150.69 25.65 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.658 -0.867 . . . . 72.319999999999993 108.658 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -68.4 143.06 95.14 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 122.942 0.497 . . . . 73.400000000000006 110.888 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -93.63 14.46 46.08 Favored 'Cis proline' 0 C--N 1.38 2.229 0 CA-C-N 119.59 0.889 . . . . 73.420000000000002 113.995 0.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -71.59 134.06 46.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.299 0.64 . . . . 75.120000000000005 110.645 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.08 139.73 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.623 1.169 . . . . 71.450000000000003 109.076 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.9 t -79.75 120.05 23.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.114 0.416 . . . . 63.009999999999998 111.244 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.09 120.33 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 106.651 -1.611 . . . . 75.519999999999996 106.651 168.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.35 -39.27 92.12 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.197 0.599 . . . . 74.340000000000003 111.583 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -61.49 -32.47 72.49 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.791 0.837 . . . . 72.25 111.456 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.2 p -95.84 -16.48 21.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.084 0.554 . . . . 74.219999999999999 111.276 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p 54.56 35.38 23.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.245 1.818 . . . . 73.420000000000002 112.045 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -146.88 150.59 35.55 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.112 0.565 . . . . 75.049999999999997 111.093 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.696 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 19.8 m -82.74 115.22 21.56 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.005 0.522 . . . . 70.019999999999996 110.547 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -122.26 178.78 4.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 74.310000000000002 109.311 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.41 138.82 97.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.142 0.577 . . . . 65.209999999999994 111.542 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 C--N 1.376 2.023 0 C-N-CA 123.245 2.63 . . . . 74.310000000000002 112.003 176.584 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.17 -0.307 . . . . 74.420000000000002 110.17 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.2 p -154.44 150.22 27.63 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 122.607 0.363 . . . . 71.219999999999999 110.952 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.689 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 89.47 3.53 74.85 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.511 0.564 . . . . 71.019999999999996 114.511 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -95.88 178.81 5.31 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.297 0.639 . . . . 71.319999999999993 110.341 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 123.68 21.13 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.507 0.723 . . . . 75.400000000000006 109.675 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 58.92 35.56 24.2 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.491 1.516 . . . . 73.239999999999995 111.661 -172.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 12.8 tp10 -130.23 125.68 21.92 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 118.073 -0.965 . . . . 74.409999999999997 109.585 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 2.2 Cg_endo -37.87 121.59 0.46 Allowed 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 124.916 3.744 . . . . 74.299999999999997 113.952 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 30.1 p -76.26 115.11 15.68 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.543 -0.91 . . . . 64.239999999999995 108.543 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.0 p -80.48 108.73 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.186 0.594 . . . . 73.150000000000006 110.395 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.68 121.65 5.56 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.01 -0.541 . . . . 63.219999999999999 112.977 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.4 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 63.7 mtt180 -61.61 155.16 61.67 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.206 1.003 . . . . 74.25 110.873 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.98 -23.36 21.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.633 2.889 . . . . 72.420000000000002 115.715 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.73 -24.86 33.38 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.745 0.418 . . . . 71.340000000000003 111.416 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.22 3.85 10.37 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.825 -0.43 . . . . 71.019999999999996 113.793 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.4 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -75.41 123.38 25.3 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.968 0.507 . . . . 74.540000000000006 111.462 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.642 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -80.39 110.19 15.61 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.653 0.781 . . . . 70.329999999999998 109.713 176.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.0 t -79.43 111.18 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.096 0.558 . . . . 74.400000000000006 110.154 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 82.5 m -140.53 135.39 31.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.575 -1.193 . . . . 75.150000000000006 108.193 171.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.59 127.15 31.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.311 -0.996 . . . . 74.120000000000005 108.311 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.37 144.61 97.54 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.24 0.616 . . . . 52.420000000000002 110.558 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.13 8.15 67.01 Favored 'Cis proline' 0 C--N 1.379 2.174 0 N-CA-C 114.706 1.002 . . . . 71.0 114.706 8.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.37 127.47 33.08 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.89 138.64 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.759 0.824 . . . . 74.450000000000003 109.788 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.0 t -77.67 113.42 15.5 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.232 0.469 . . . . 62.450000000000003 110.224 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 35' ' ' GLU . 2.7 mp -78.81 111.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.385 -1.709 . . . . 75.329999999999998 106.385 168.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.52 -28.24 69.81 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.014 0.925 . . . . 74.340000000000003 112.12 -170.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.9 m -60.0 -54.05 50.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.678 0.791 . . . . 63.130000000000003 110.342 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -83.74 -12.77 55.32 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.798 0.839 . . . . 70.549999999999997 111.432 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.0 p 53.69 33.96 17.82 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.661 1.584 . . . . 54.200000000000003 112.312 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -136.98 150.38 48.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.697 0.799 . . . . 71.239999999999995 110.144 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.689 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -81.59 119.15 23.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.882 -0.785 . . . . 50.240000000000002 108.882 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 28' ' ' ILE . 35.2 mt-10 -121.01 170.44 9.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.472 0.709 . . . . 71.319999999999993 109.951 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.3 134.15 82.79 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.893 -0.594 . . . . 73.230000000000004 110.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.569 2.236 0 C-N-CA 122.574 2.183 . . . . 74.019999999999996 111.609 172.033 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 108.273 -1.01 . . . . 74.430000000000007 108.273 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -140.89 138.15 33.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.326 -0.233 . . . . 64.109999999999999 111.145 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 105.99 5.18 38.46 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.412 0.525 . . . . 72.420000000000002 114.412 174.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.67 172.37 8.3 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.582 0.753 . . . . 54.539999999999999 111.225 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -67.64 122.17 17.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.44 1.096 . . . . 71.519999999999996 109.253 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 64.39 20.99 12.37 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.166 1.386 . . . . 74.420000000000002 112.319 -175.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -126.32 135.83 27.73 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.193 -0.908 . . . . 73.349999999999994 110.129 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.58 133.16 3.68 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.853 3.702 . . . . 70.420000000000002 114.645 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.1 p -93.23 128.35 39.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.48 0.712 . . . . 73.010000000000005 109.304 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.9 p -83.95 101.07 11.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.658 -0.868 . . . . 70.409999999999997 108.658 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -87.39 118.78 5.07 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.671 -0.695 . . . . 74.019999999999996 112.539 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 96.6 mtt180 -56.81 152.83 25.11 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.76 1.224 . . . . 73.019999999999996 111.394 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.68 -23.63 58.61 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.349 2.7 . . . . 73.349999999999994 114.318 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.22 5.52 29.86 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.855 0.862 . . . . 72.239999999999995 112.152 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.0 9.98 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.355 -0.136 . . . . 63.340000000000003 112.97 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -114.73 97.94 6.56 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.432 -0.581 . . . . 73.310000000000002 109.432 175.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HZ3' ' HB2' ' A' ' 19' ' ' LYS . 10.1 mtmp? -71.4 111.18 6.51 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.192 0.597 . . . . 75.200000000000003 109.477 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -76.15 113.93 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.08 -0.711 . . . . 73.329999999999998 109.08 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 77.5 m -141.47 143.4 33.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.95 1.3 . . . . 75.400000000000006 108.838 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -80.82 143.64 32.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.161 -1.052 . . . . 72.439999999999998 108.161 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.19 147.76 90.85 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.78 0.432 . . . . 62.409999999999997 110.53 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.52 28.17 17.15 Favored 'Cis proline' 0 C--N 1.378 2.116 0 CA-C-N 119.747 0.946 . . . . 73.120000000000005 113.454 1.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -82.2 117.98 22.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.804 0.442 . . . . 75.329999999999998 110.207 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -97.46 131.29 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.33 1.052 . . . . 73.430000000000007 109.805 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.689 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.9 t -79.87 113.5 18.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.65 0.262 . . . . 63.539999999999999 110.755 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.8 mt -79.9 129.03 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.935 -1.135 . . . . 73.420000000000002 107.935 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.29 -42.1 99.06 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.808 0.843 . . . . 72.409999999999997 111.278 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -59.59 -36.69 76.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.194 0.997 . . . . 70.219999999999999 111.836 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.5 p -95.5 -19.26 19.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 74.230000000000004 111.467 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p 54.62 30.98 14.21 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.163 1.785 . . . . 64.439999999999998 112.77 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.467 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 12.1 ptp180 -140.45 149.28 42.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.353 0.661 . . . . 75.409999999999997 110.998 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 8.2 m -81.65 99.76 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.276 0.63 . . . . 74.049999999999997 110.639 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 36.4 mt-10 -107.72 -172.99 2.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.975 0.91 . . . . 72.209999999999994 111.004 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.1 158.9 74.57 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.743 0.817 . . . . 74.129999999999995 111.022 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 CA--C 1.561 1.872 0 C-N-CA 122.677 2.251 . . . . 71.400000000000006 111.217 166.809 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.035 -0.728 . . . . 65.25 109.035 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.9 p -143.42 143.23 31.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.039 0.381 . . . . 42.549999999999997 111.842 -173.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 105.01 30.49 4.78 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 114.651 0.62 . . . . 71.310000000000002 114.651 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.65 174.26 8.85 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.039 0.936 . . . . 63.329999999999998 110.446 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -68.84 123.76 21.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.244 1.018 . . . . 73.439999999999998 109.1 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 84.9 m-20 60.51 29.88 19.34 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.785 1.234 . . . . 72.450000000000003 112.338 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -113.92 141.05 25.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 107.768 -1.197 . . . . 74.340000000000003 107.768 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.97 145.52 10.25 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 123.397 2.731 . . . . 71.109999999999999 112.035 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -100.74 132.7 46.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.513 -0.551 . . . . 72.230000000000004 109.513 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.31 88.18 6.95 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.322 -0.992 . . . . 74.219999999999999 108.322 170.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -80.89 121.39 5.4 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 115.213 -0.903 . . . . 60.229999999999997 112.849 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -82.29 144.64 50.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.513 -0.551 . . . . 73.239999999999995 109.513 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.09 -12.22 34.46 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.205 2.603 . . . . 74.120000000000005 114.375 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 -17.67 57.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.932 0.893 . . . . 72.319999999999993 111.384 172.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.7 -13.5 9.29 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 113.581 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.17 97.61 6.97 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.067 0.46 . . . . 44.299999999999997 110.65 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 34.6 mtmt -82.45 118.64 23.37 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.846 0.858 . . . . 73.239999999999995 108.687 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.602 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.4 t -77.4 95.53 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 122.079 0.943 . . . . 73.340000000000003 109.691 -175.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 75.2 m -130.24 152.0 50.14 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 112.973 -1.922 . . . . 74.5 108.99 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -79.58 140.72 37.07 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.954 -0.758 . . . . 72.450000000000003 108.954 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.21 147.41 82.96 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.064 0.546 . . . . 72.230000000000004 109.997 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -94.25 22.86 28.01 Favored 'Cis proline' 0 C--N 1.376 2.002 0 CA-C-N 119.39 0.818 . . . . 71.519999999999996 113.284 1.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -79.81 124.94 29.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.414 0.685 . . . . 75.109999999999999 109.221 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.42 144.99 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.703 0.801 . . . . 73.299999999999997 109.803 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.3 t -84.31 113.32 21.05 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.002 0.521 . . . . 61.350000000000001 110.037 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.89 119.37 29.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 106.813 -1.551 . . . . 75.409999999999997 106.813 171.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.48 -26.99 65.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.713 . . . . 70.219999999999999 112.645 -173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.3 m -59.65 -54.78 42.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.783 0.833 . . . . 73.319999999999993 111.184 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 p -87.87 -18.79 28.45 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.9 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.8 p 52.27 44.37 29.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.175 1.79 . . . . 71.439999999999998 112.802 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 8' ' ' ASP . 2.2 ptm180 -146.45 144.9 29.99 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.275 0.559 . . . . 73.219999999999999 110.393 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 m -76.47 88.27 3.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.251 1.02 . . . . 74.439999999999998 110.362 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 44.9 mt-10 -103.37 -171.65 1.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.972 0.909 . . . . 72.310000000000002 109.935 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -62.22 139.44 96.21 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 123.851 0.86 . . . . 73.209999999999994 110.987 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.375 1.943 0 C-N-CA 122.902 2.402 . . . . 64.439999999999998 112.262 173.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.421 0.153 . . . . 71.319999999999993 110.66 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -157.97 113.22 2.7 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.846 0.458 . . . . 74.409999999999997 109.842 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 140.12 -9.12 3.0 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 115.547 0.979 . . . . 71.230000000000004 115.547 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.7 173.55 7.55 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.058 0.543 . . . . 75.439999999999998 111.215 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.22 116.11 9.27 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.101 0.96 . . . . 71.040000000000006 109.684 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 73.75 16.32 3.83 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.099 2.16 . . . . 74.239999999999995 112.603 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -106.97 135.65 19.54 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 123.892 0.877 . . . . 74.340000000000003 109.442 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.59 133.28 57.13 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.392 2.728 . . . . 71.319999999999993 111.834 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.1 p -80.75 121.67 26.19 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.564 -0.532 . . . . 72.030000000000001 109.564 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 2.4 p -78.82 88.64 4.65 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.87 -0.789 . . . . 72.030000000000001 108.87 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -79.78 118.07 4.65 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.827 -1.079 . . . . 74.329999999999998 112.417 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -69.32 152.95 96.33 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.45 1.1 . . . . 73.310000000000002 110.387 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.65 -21.52 63.1 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.2 2.6 . . . . 71.530000000000001 114.699 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.93 -21.92 58.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.496 0.719 . . . . 73.540000000000006 111.551 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.79 -0.91 13.67 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 116.016 -0.538 . . . . 55.210000000000001 113.423 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.78 99.31 4.38 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 116.864 0.332 . . . . 75.019999999999996 111.114 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 41.9 mtmt -73.18 114.5 11.42 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.222 -1.029 . . . . 73.129999999999995 108.222 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 97.7 t -76.58 106.66 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.038 -0.727 . . . . 71.319999999999993 109.038 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 79.9 m -143.5 135.82 27.02 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 125.297 1.439 . . . . 52.420000000000002 109.227 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.63 120.57 24.14 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.194 -1.039 . . . . 71.310000000000002 108.194 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.07 149.23 94.24 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.311 0.645 . . . . 63.119999999999997 110.517 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -88.59 15.29 46.39 Favored 'Cis proline' 0 C--N 1.379 2.154 0 CA-C-N 120.082 1.065 . . . . 73.319999999999993 114.707 9.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -75.98 109.41 9.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 75.019999999999996 109.709 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.88 130.89 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.097 0.959 . . . . 75.310000000000002 110.139 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.621 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 51.9 t -71.19 110.81 6.08 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.716 0.293 . . . . 73.010000000000005 110.765 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.31 127.18 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.963 -1.125 . . . . 72.049999999999997 107.963 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.27 -34.35 77.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.259 0.624 . . . . 64.129999999999995 111.328 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -57.56 -43.76 84.74 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.763 0.825 . . . . 62.0 111.169 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 p -91.01 -16.12 28.49 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.953 0.901 . . . . 73.140000000000001 111.767 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p 52.93 30.43 9.27 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.594 1.558 . . . . 73.299999999999997 112.18 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -140.74 147.75 39.65 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.648 0.379 . . . . 75.129999999999995 111.138 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.4 m -74.15 130.71 40.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.349 0.66 . . . . 60.329999999999998 110.375 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.44 176.76 10.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.56 0.744 . . . . 74.340000000000003 109.939 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.52 123.01 81.67 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 119.441 -0.314 . . . . 70.420000000000002 110.333 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 C--N 1.386 2.507 0 C-N-CA 122.918 2.412 . . . . 74.129999999999995 112.011 179.119 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.193 -0.669 . . . . 73.0 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.62 151.11 7.48 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.341 0.257 . . . . 62.310000000000002 111.493 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.71 -8.09 29.9 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 115.563 0.985 . . . . 60.240000000000002 115.563 166.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.71 172.6 8.07 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.411 0.605 . . . . 70.530000000000001 111.655 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 3.6 tmtp? -63.35 125.1 23.03 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.862 0.726 . . . . 75.439999999999998 110.033 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 97.2 m-20 61.51 24.39 14.5 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.162 1.385 . . . . 73.430000000000007 112.328 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -123.1 142.55 38.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.885 0.874 . . . . 74.349999999999994 109.112 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.98 139.87 79.56 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.701 2.934 . . . . 75.340000000000003 112.926 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.735 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 26.5 p -90.47 128.04 36.4 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.372 0.669 . . . . 63.039999999999999 109.31 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -78.5 119.53 21.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.845 0.355 . . . . 75.129999999999995 110.191 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.32 120.7 5.5 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 116.058 -0.519 . . . . 64.430000000000007 113.246 -174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -71.08 156.33 92.08 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.24 1.016 . . . . 73.409999999999997 110.838 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.38 -43.82 51.31 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.178 2.585 . . . . 74.25 113.222 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.53 -25.17 67.87 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.257 1.023 . . . . 74.420000000000002 112.364 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.17 2.38 12.34 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-O 119.637 -0.535 . . . . 73.230000000000004 113.844 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.33 115.39 8.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 117.255 0.528 . . . . 74.299999999999997 111.583 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.735 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -75.81 106.47 7.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.643 0.777 . . . . 74.109999999999999 109.207 173.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.555 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 60.0 t -79.62 119.61 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.023 0.529 . . . . 70.329999999999998 110.773 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.5 m -142.37 154.15 44.39 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.009 1.323 . . . . 65.239999999999995 109.034 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.55 145.28 25.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.179 -0.675 . . . . 71.209999999999994 109.179 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.24 146.16 94.27 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 122.961 0.504 . . . . 72.400000000000006 110.606 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -91.0 14.88 49.33 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.581 0.886 . . . . 64.540000000000006 114.225 5.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -78.23 124.41 28.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.949 0.404 . . . . 74.040000000000006 110.369 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.19 131.25 59.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.455 1.102 . . . . 65.430000000000007 108.6 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.8 t -69.11 107.63 3.26 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.016 0.436 . . . . 71.230000000000004 110.029 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.29 113.24 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.386 -1.339 . . . . 75.120000000000005 107.386 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.01 -28.47 66.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.521 1.128 . . . . 74.420000000000002 111.638 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.9 m -64.45 -52.39 58.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.785 0.834 . . . . 75.439999999999998 111.208 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.8 p -90.96 -4.06 56.79 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.135 0.574 . . . . 73.340000000000003 111.564 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p 53.55 29.56 9.33 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.952 1.701 . . . . 72.450000000000003 113.022 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.4 ptt180 -138.28 148.73 44.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.667 0.787 . . . . 75.349999999999994 109.509 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 45.6 m -71.09 91.27 0.9 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.961 -0.755 . . . . 65.099999999999994 108.961 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 36' ' ' ASN . 29.6 tt0 -101.18 -178.79 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.356 1.062 . . . . 75.230000000000004 108.627 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.458 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 3.1 p-10 -72.62 145.76 87.67 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 109.602 -0.518 . . . . 75.530000000000001 109.602 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.365 1.423 0 C-N-CA 122.902 2.401 . . . . 74.420000000000002 112.807 173.327 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.715 -0.476 . . . . 71.310000000000002 109.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.64 13.84 66.4 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.779 0.675 . . . . 74.010000000000005 113.572 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.7 178.66 4.49 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.067 0.947 . . . . 73.129999999999995 109.18 -175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 p -147.91 140.1 24.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.534 0.334 . . . . 73.310000000000002 110.722 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.553 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 109.95 -4.22 30.37 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 114.973 0.749 . . . . 74.099999999999994 114.973 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -100.2 176.29 5.44 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.338 0.655 . . . . 74.0 112.073 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -61.37 117.16 5.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.78 0.832 . . . . 75.400000000000006 110.623 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.4 m-20 64.14 21.42 12.55 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.97 1.308 . . . . 75.430000000000007 111.624 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -112.84 132.22 22.39 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 108.126 -1.064 . . . . 71.409999999999997 108.126 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.6 Cg_endo -53.88 140.91 67.91 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 123.232 2.621 . . . . 65.329999999999998 112.864 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.612 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 28.4 p -88.66 133.4 34.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.919 0.487 . . . . 71.140000000000001 109.938 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.9 p -93.16 104.92 17.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.693 0.797 . . . . 71.109999999999999 109.985 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -78.06 129.18 9.25 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.52 -0.632 . . . . 71.030000000000001 111.52 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -89.22 168.06 16.3 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.833 0.853 . . . . 64.099999999999994 111.665 -170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.25 -33.07 53.46 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.349 2.699 . . . . 74.129999999999995 114.564 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.26 -8.92 58.13 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.908 0.483 . . . . 64.439999999999998 111.619 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.12 -24.99 29.34 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 114.163 0.425 . . . . 75.120000000000005 114.163 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 128.09 34.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.966 0.383 . . . . 73.439999999999998 110.629 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 39.3 mtmt -76.64 129.86 36.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 108.899 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 87.4 t -77.84 117.81 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.086 0.47 . . . . 73.540000000000006 110.121 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.8 m -146.48 136.56 23.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.003 1.321 . . . . 75.409999999999997 107.538 169.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.63 139.6 38.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.523 -0.918 . . . . 72.019999999999996 108.523 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.32 141.83 96.22 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 122.747 0.419 . . . . 75.099999999999994 110.104 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -96.12 19.36 32.14 Favored 'Cis proline' 0 C--N 1.375 1.929 0 N-CA-C 114.649 0.98 . . . . 74.439999999999998 114.649 4.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -67.97 125.95 27.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.001 -0.37 . . . . 74.310000000000002 110.001 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.55 129.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.727 1.211 . . . . 72.219999999999999 109.817 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.664 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 39.0 t -78.77 110.25 13.76 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.999 0.52 . . . . 75.120000000000005 109.781 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.52 140.46 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.721 -0.844 . . . . 73.030000000000001 108.721 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 -37.42 87.33 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.537 0.94 . . . . 51.229999999999997 113.537 -165.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -75.26 -50.93 14.54 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.919 0.39 . . . . 54.5 110.204 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -70.65 -26.36 63.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.699 0.8 . . . . 63.399999999999999 111.874 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p 54.29 27.08 7.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.033 1.733 . . . . 65.140000000000001 112.688 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 12.0 ptp180 -126.94 142.4 51.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.962 0.905 . . . . 74.430000000000007 110.294 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 30.8 m -75.38 100.17 4.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.334 0.654 . . . . 64.530000000000001 109.8 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 -177.96 3.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.564 0.746 . . . . 72.150000000000006 110.492 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -71.96 139.4 82.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 122.61 0.364 . . . . 72.439999999999998 110.787 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.381 2.284 0 C-N-CA 123.093 2.529 . . . . 72.430000000000007 112.342 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.429 -0.582 . . . . 74.109999999999999 109.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.95 -30.38 9.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.237 -0.438 . . . . 61.229999999999997 112.736 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.81 176.93 5.0 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.156 0.582 . . . . 71.319999999999993 109.88 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.87 149.82 50.37 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.068 0.547 . . . . 62.43 109.926 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.462 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 97.71 2.26 58.6 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.171 0.828 . . . . 72.430000000000007 115.171 170.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.63 164.96 13.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.359 0.663 . . . . 74.340000000000003 109.849 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.24 137.46 50.84 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.356 0.263 . . . . 74.409999999999997 110.396 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.34 28.31 17.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.446 1.498 . . . . 63.450000000000003 111.064 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.99 134.87 14.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 108.801 -0.814 . . . . 75.040000000000006 108.801 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.3 Cg_endo -54.47 146.22 53.54 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 123.995 3.13 . . . . 75.010000000000005 114.09 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.5 p -91.82 137.68 32.17 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.588 -0.733 . . . . 74.239999999999995 109.409 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -80.16 88.36 5.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.136 -1.061 . . . . 74.530000000000001 108.136 171.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.19 120.83 5.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 114.978 -1.01 . . . . 64.420000000000002 111.981 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -74.68 151.15 86.88 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.136 0.974 . . . . 75.209999999999994 111.44 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.87 -22.54 68.86 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.958 2.439 . . . . 73.219999999999999 113.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.04 -15.27 58.46 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.659 0.784 . . . . 72.319999999999993 111.222 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.64 -6.15 24.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.891 -0.394 . . . . 74.230000000000004 114.041 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.77 98.51 3.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.104 0.478 . . . . 74.120000000000005 110.94 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 43.6 mtmt -71.83 112.8 8.23 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.533 0.733 . . . . 75.409999999999997 109.273 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 85.9 t -78.82 110.09 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 122.771 0.429 . . . . 74.349999999999994 110.588 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 62.9 m -147.7 151.01 35.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.858 1.263 . . . . 73.129999999999995 109.0 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -84.26 138.91 32.68 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.779 -0.822 . . . . 75.230000000000004 108.779 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.5 146.3 97.69 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.145 0.578 . . . . 71.329999999999998 110.814 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.18 10.14 60.0 Favored 'Cis proline' 0 C--N 1.376 1.978 0 N-CA-C 114.697 0.999 . . . . 54.409999999999997 114.697 3.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -73.09 114.01 10.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.133 0.573 . . . . 73.430000000000007 111.006 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.46 133.53 37.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.7 1.2 . . . . 73.439999999999998 109.77 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.3 t -70.72 105.41 3.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.127 0.489 . . . . 72.510000000000005 110.675 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.5 118.4 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.084 -1.08 . . . . 74.010000000000005 108.084 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.42 -36.97 84.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.065 0.946 . . . . 71.230000000000004 112.559 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.3 p -62.51 -38.78 91.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.556 0.742 . . . . 72.129999999999995 111.643 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.9 p -97.12 -7.76 31.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.307 0.643 . . . . 65.239999999999995 111.493 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p 55.08 21.27 3.74 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.231 1.812 . . . . 53.229999999999997 113.521 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 ptp180 -133.16 148.92 52.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.796 0.438 . . . . 74.040000000000006 111.751 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.7 m -74.08 114.82 12.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.773 -0.649 . . . . 75.230000000000004 109.672 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.1 -171.17 2.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.477 1.111 . . . . 61.109999999999999 109.001 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.82 148.25 87.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 119.08 -0.486 . . . . 75.200000000000003 111.325 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.375 1.927 0 C-N-CA 123.401 2.734 . . . . 72.129999999999995 112.501 169.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 109.438 -0.578 . . . . 75.109999999999999 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.92 -22.37 7.23 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 119.681 -0.511 . . . . 75.400000000000006 113.496 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -97.11 -166.35 1.38 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 117.446 0.623 . . . . 74.519999999999996 109.51 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.93 134.47 40.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.665 0.386 . . . . 72.120000000000005 110.612 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.504 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 118.92 0.73 14.87 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.572 0.989 . . . . 71.400000000000006 115.572 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 9.4 m-20 -92.79 174.82 7.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.106 0.953 . . . . 72.219999999999999 110.655 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -68.06 122.97 19.39 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.799 -0.815 . . . . 75.010000000000005 108.799 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 66.56 19.48 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.876 1.671 . . . . 65.310000000000002 112.418 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -113.17 129.59 24.41 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.855 0.862 . . . . 73.219999999999999 109.108 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -43.56 126.74 5.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 124.274 3.316 . . . . 73.230000000000004 112.981 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.5 p -84.52 130.76 34.71 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.114 -0.698 . . . . 73.519999999999996 109.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.1 p -80.63 139.56 36.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.464 -0.569 . . . . 73.319999999999993 109.464 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.34 114.71 4.94 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.315 -0.314 . . . . 65.319999999999993 112.315 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -61.5 148.78 85.59 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.196 0.998 . . . . 72.430000000000007 111.248 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.45 -5.14 13.31 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.91 2.407 . . . . 71.120000000000005 114.413 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.41 2.12 47.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.521 0.728 . . . . 74.439999999999998 111.625 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.57 4.04 62.43 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.892 -0.393 . . . . 70.230000000000004 113.862 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 155.81 19.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.042 0.421 . . . . 65.040000000000006 110.301 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -101.95 127.45 48.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.152 0.581 . . . . 75.219999999999999 109.883 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.8 t -78.5 109.67 13.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.895 -0.78 . . . . 74.209999999999994 108.895 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 71.8 m -141.64 141.1 33.41 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.592 1.182 . . . . 71.140000000000001 108.604 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 7.2 p30 -78.88 135.27 36.96 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.428 -1.323 . . . . 74.519999999999996 107.428 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.61 141.7 98.32 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.343 0.657 . . . . 75.120000000000005 110.073 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -99.26 28.33 15.15 Favored 'Cis proline' 0 C--N 1.371 1.744 0 CA-C-N 119.766 0.952 . . . . 75.540000000000006 114.446 5.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -85.29 143.21 28.84 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.785 -0.45 . . . . 72.400000000000006 109.785 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 37' ' ' PRO . 27.9 m -126.0 140.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 109.797 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.0 t -80.62 116.6 20.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.49 0.716 . . . . 73.129999999999995 111.398 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.29 123.75 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.762 -1.57 . . . . 74.540000000000006 106.762 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.31 -29.15 70.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.606 0.762 . . . . 74.530000000000001 111.527 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m -71.04 -36.65 72.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.776 0.831 . . . . 71.519999999999996 111.098 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.9 p -92.1 -21.04 20.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.342 0.657 . . . . 74.129999999999995 111.034 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.7 p 53.38 37.95 26.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.825 1.65 . . . . 75.109999999999999 111.784 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -145.06 146.89 32.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.259 0.624 . . . . 75.420000000000002 111.192 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 22.4 m -75.98 123.22 25.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.277 0.631 . . . . 72.340000000000003 109.644 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.92 -177.75 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.163 0.985 . . . . 74.319999999999993 109.622 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.34 127.85 86.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.229 0.612 . . . . 74.439999999999998 109.711 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HG3' HG23 ' A' ' 26' ' ' VAL . 15.1 Cg_exo . . . . . 0 C--N 1.373 1.846 0 C-N-CA 123.034 2.489 . . . . 73.439999999999998 111.847 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.463 -0.569 . . . . 75.230000000000004 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.78 -31.57 3.31 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.32 0.388 . . . . 60.399999999999999 113.823 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -85.58 177.62 7.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.584 0.754 . . . . 71.329999999999998 110.33 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.05 150.51 34.05 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.672 0.389 . . . . 62.539999999999999 110.733 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.672 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.07 -6.85 58.44 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 114.923 0.729 . . . . 71.030000000000001 114.923 170.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.45 ' HA ' HD22 ' A' ' 22' ' ' ASN . 2.9 m-20 -94.78 175.38 6.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.494 0.718 . . . . 73.120000000000005 110.902 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -67.11 122.87 18.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.312 -0.625 . . . . 75.319999999999993 109.312 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 80.3 m-20 63.36 31.66 15.06 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.564 1.146 . . . . 72.450000000000003 110.662 -176.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.14 131.32 23.92 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.27 -1.011 . . . . 63.240000000000002 108.27 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.14 130.55 32.44 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.626 2.884 . . . . 74.010000000000005 112.382 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 29.0 p -79.29 127.2 31.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.8 -0.444 . . . . 74.400000000000006 109.8 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.86 125.09 29.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.367 0.667 . . . . 74.109999999999999 109.311 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.22 132.17 10.98 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.935 -0.575 . . . . 73.530000000000001 113.337 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -73.72 139.01 77.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.534 1.134 . . . . 74.400000000000006 111.059 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.45 -31.46 48.33 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.385 2.723 . . . . 73.409999999999997 113.876 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.26 -27.53 63.51 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.725 0.41 . . . . 74.400000000000006 111.267 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.35 0.83 11.28 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.705 -0.497 . . . . 72.239999999999995 114.219 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 163.05 26.92 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.675 0.737 . . . . 71.430000000000007 110.583 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HZ3' ' HB2' ' A' ' 19' ' ' LYS . 10.0 mtmp? -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 74.349999999999994 108.568 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.55 110.6 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.408 0.683 . . . . 73.450000000000003 109.58 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 84.4 m -139.2 138.52 36.96 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 72.400000000000006 108.988 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 6' ' ' ASP . 9.4 p30 -79.5 142.53 35.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.623 -0.88 . . . . 74.540000000000006 108.623 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.61 144.82 97.92 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 122.959 0.504 . . . . 71.120000000000005 110.874 -174.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -93.12 14.76 46.76 Favored 'Cis proline' 0 C--N 1.377 2.055 0 C-N-CA 124.704 -0.957 . . . . 75.409999999999997 114.309 4.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.89 132.27 46.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.694 0.398 . . . . 74.319999999999993 110.938 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -115.77 126.89 73.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.338 1.055 . . . . 75.140000000000001 108.835 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -75.14 112.76 11.73 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.686 0.279 . . . . 74.519999999999996 110.984 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.88 132.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.26 -1.015 . . . . 75.200000000000003 108.26 172.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.07 -46.25 88.73 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 124.01 0.819 . . . . 74.430000000000007 111.782 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -66.58 -45.61 78.68 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.978 0.799 . . . . 63.299999999999997 111.499 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -80.91 -15.38 56.44 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.105 0.562 . . . . 74.019999999999996 111.17 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p 54.26 24.51 5.07 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.627 1.571 . . . . 74.329999999999998 113.029 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 36.4 ptt180 -131.28 148.78 52.72 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.634 0.774 . . . . 73.439999999999998 109.24 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.672 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 53.8 m -71.81 94.37 1.4 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.832 -0.803 . . . . 65.319999999999993 108.832 173.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -99.33 170.35 8.71 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.801 -1.09 . . . . 71.109999999999999 108.843 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.58 139.16 88.81 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.666 0.386 . . . . 75.420000000000002 110.25 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--N 1.369 1.606 0 C-N-CA 122.904 2.402 . . . . 74.140000000000001 112.022 173.436 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.429 ' H2 ' ' HG2' ' A' ' 3' ' ' GLU . 1.2 m-20 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 109.49 -0.559 . . . . 71.209999999999994 109.49 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.28 -25.24 27.91 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.979 -0.448 . . . . 54.340000000000003 111.979 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HG2' ' H2 ' ' A' ' 1' ' ' ASP . 10.4 pt-20 -70.87 -168.29 0.26 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.827 1.251 . . . . 65.519999999999996 110.492 167.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.5 p -155.31 128.68 8.36 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.742 -0.599 . . . . 75.409999999999997 111.458 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 136.65 -13.37 3.95 Favored Glycine 0 C--N 1.355 1.639 0 N-CA-C 116.062 1.185 . . . . 71.409999999999997 116.062 164.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 23.2 m-20 -94.86 175.72 6.54 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.71 1.255 . . . . 74.120000000000005 112.37 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.93 131.33 50.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.151 -0.931 . . . . 71.439999999999998 110.096 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.583 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 62.3 m-20 57.98 27.13 14.33 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.737 1.215 . . . . 75.200000000000003 112.195 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 14.3 tp10 -119.69 125.98 27.17 Favored Pre-proline 0 N--CA 1.472 0.627 0 C-N-CA 123.971 0.909 . . . . 75.109999999999999 108.587 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 10.8 Cg_endo -49.2 140.76 25.04 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.934 3.089 . . . . 75.439999999999998 112.65 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 29.0 p -88.2 136.69 32.86 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 75.319999999999993 109.695 177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -85.53 134.36 34.03 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.605 -0.887 . . . . 55.240000000000002 108.605 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.2 138.4 13.91 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.502 -0.317 . . . . 70.209999999999994 112.559 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.72 151.22 57.92 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.431 1.092 . . . . 72.310000000000002 108.834 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.49 -34.93 83.84 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.154 2.569 . . . . 72.109999999999999 114.088 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.72 -13.61 60.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.887 0.475 . . . . 74.129999999999995 111.831 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.86 12.3 20.96 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.496 0.558 . . . . 64.400000000000006 114.496 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.58 136.32 38.26 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.273 0.536 . . . . 72.209999999999994 110.614 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -95.85 114.58 26.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.205 0.602 . . . . 74.310000000000002 109.652 176.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.5 t -79.6 101.76 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.416 0.686 . . . . 75.439999999999998 110.183 -177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 59.0 m -138.64 140.58 38.94 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.864 1.266 . . . . 71.219999999999999 108.565 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.16 144.18 33.23 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.161 -0.681 . . . . 75.200000000000003 109.161 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.6 139.84 97.27 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.212 0.605 . . . . 70.129999999999995 110.901 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -94.01 13.96 45.95 Favored 'Cis proline' 0 C--N 1.375 1.95 0 N-CA-C 114.642 0.978 . . . . 74.209999999999994 114.642 6.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -67.88 126.15 28.52 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 118.031 0.378 . . . . 61.43 110.629 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.63 129.52 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.841 1.256 . . . . 73.540000000000006 108.403 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 48.8 t -72.09 108.2 5.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.763 0.316 . . . . 73.310000000000002 110.612 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -79.36 120.27 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 107.775 -1.194 . . . . 74.129999999999995 107.775 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.58 -34.45 77.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.629 0.772 . . . . 73.150000000000006 112.42 -170.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -76.4 -25.32 54.41 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.654 0.382 . . . . 74.239999999999995 111.408 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.9 p -95.43 -14.16 24.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.91 0.484 . . . . 73.439999999999998 110.637 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.6 p 54.96 33.91 21.2 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.16 1.784 . . . . 75.400000000000006 113.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.583 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.4 ptp180 -144.53 150.82 38.17 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 74.049999999999997 111.032 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 34.3 m -70.09 121.69 17.96 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.655 -0.702 . . . . 61.5 109.244 172.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 14.1 mm-40 -132.26 173.76 10.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.526 1.131 . . . . 74.200000000000003 110.502 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -75.37 126.7 87.39 Favored Pre-proline 0 CA--C 1.558 1.255 0 N-CA-C 108.857 -0.794 . . . . 73.420000000000002 108.857 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.383 2.371 0 C-N-CA 123.161 2.574 . . . . 71.420000000000002 112.344 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.694 -0.484 . . . . 74.200000000000003 109.694 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.17 -30.05 7.94 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-O 119.991 -0.338 . . . . 61.43 113.602 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -84.75 144.87 28.22 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.09 0.445 . . . . 71.310000000000002 110.526 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 27.2 p -101.32 148.47 25.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.554 0.576 . . . . 72.109999999999999 112.554 -170.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.92 -11.8 24.84 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.257 -0.883 . . . . 74.030000000000001 113.645 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 4.2 m-20 -96.96 161.46 13.83 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.676 0.738 . . . . 64.510000000000005 111.044 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 12.4 tmtt? -73.6 133.11 43.43 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.973 -1.012 . . . . 73.420000000000002 108.996 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 82.2 m-20 61.92 20.18 11.3 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.698 1.599 . . . . 63.539999999999999 112.282 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -120.11 152.06 53.89 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.774 1.23 . . . . 72.409999999999997 108.02 172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 18.1 Cg_endo -55.11 153.8 24.97 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.744 2.962 . . . . 74.530000000000001 113.294 -175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 28.4 p -100.4 122.54 43.32 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.362 -0.977 . . . . 75.030000000000001 108.362 166.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.522 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.0 p -84.2 107.31 16.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.81 -0.811 . . . . 70.340000000000003 108.81 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.42 122.56 5.97 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.786 -0.525 . . . . 72.450000000000003 111.786 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -57.4 156.64 15.2 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.638 1.175 . . . . 72.140000000000001 110.026 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -42.58 -39.26 6.81 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 123.764 2.976 . . . . 75.140000000000001 115.872 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -72.48 -31.21 65.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.932 0.893 . . . . 73.340000000000003 111.336 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.81 14.75 4.6 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.958 -0.565 . . . . 70.329999999999998 113.437 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.93 103.37 9.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.066 0.546 . . . . 65.310000000000002 110.997 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -71.62 123.64 22.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 75.340000000000003 110.606 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.522 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 90.1 t -78.91 104.87 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 110.383 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 78.4 m -141.75 136.07 30.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.428 -1.26 . . . . 72.329999999999998 108.868 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -80.17 146.49 31.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.585 -0.524 . . . . 64.439999999999998 109.585 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.36 145.58 93.34 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.047 0.539 . . . . 72.430000000000007 110.722 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -90.85 13.18 54.18 Favored 'Cis proline' 0 C--N 1.38 2.201 0 CA-C-N 119.977 1.028 . . . . 73.209999999999994 113.882 2.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -70.88 118.75 14.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.358 0.663 . . . . 74.219999999999999 110.779 -174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.83 135.02 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.252 1.021 . . . . 75.450000000000003 109.023 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 54.0 t -78.57 122.47 25.95 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.578 0.351 . . . . 72.129999999999995 111.033 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.98 136.87 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.176 -1.046 . . . . 71.420000000000002 108.176 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -39.97 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.021 0.528 . . . . 74.340000000000003 110.689 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 m -58.88 -36.91 75.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.975 . . . . 55.439999999999998 111.643 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 p -94.15 -25.97 16.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.76 0.824 . . . . 73.209999999999994 111.283 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p 54.22 32.18 15.55 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.774 1.63 . . . . 74.25 112.187 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.8 ptt180 -124.28 144.89 49.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.811 0.844 . . . . 73.319999999999993 109.773 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 33.6 m -69.32 127.27 32.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.846 -0.798 . . . . 74.409999999999997 108.846 169.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 16.1 pt-20 -156.54 -168.29 2.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.461 0.705 . . . . 74.540000000000006 109.323 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -59.15 154.21 41.85 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 122.88 0.472 . . . . 74.340000000000003 112.182 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.372 1.806 0 C-N-CA 122.415 2.077 . . . . 75.329999999999998 110.773 169.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 109.202 -0.666 . . . . 74.299999999999997 109.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.27 31.88 27.0 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.158 0.286 . . . . 73.120000000000005 112.722 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.39 159.77 15.89 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.166 0.986 . . . . 74.510000000000005 109.784 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -132.83 137.55 46.78 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.054 0.39 . . . . 74.310000000000002 112.054 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.4 5.32 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.076 -0.847 . . . . 73.099999999999994 114.134 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.55 163.25 17.59 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.94 0.87 . . . . 54.100000000000001 110.505 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HG3' ' HA ' ' A' ' 35' ' ' GLU . 59.5 tttm -64.98 141.58 58.73 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.076 0.55 . . . . 73.420000000000002 110.742 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 56.17 19.14 3.64 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.113 1.765 . . . . 64.310000000000002 112.057 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.99 146.89 37.12 Favored Pre-proline 0 N--CA 1.476 0.832 0 N-CA-C 107.314 -1.365 . . . . 72.310000000000002 107.314 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.75 141.68 92.03 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.081 2.521 . . . . 74.5 111.934 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 27.6 p -92.84 117.82 30.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.566 -0.902 . . . . 74.099999999999994 108.566 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.472 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 11.5 p -87.73 130.3 34.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.85 -0.426 . . . . 72.319999999999993 109.85 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.55 145.05 20.07 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 116.383 -0.371 . . . . 73.420000000000002 112.924 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -104.58 156.62 35.62 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.594 0.758 . . . . 73.420000000000002 109.132 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 -21.04 71.56 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.839 2.359 . . . . 75.340000000000003 114.426 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.01 -24.92 59.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.096 0.558 . . . . 51.43 110.701 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.8 38.17 2.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.556 -0.747 . . . . 74.150000000000006 112.819 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.37 141.05 48.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.031 0.532 . . . . 75.019999999999996 111.059 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.609 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 10.0 mmpt? -88.14 123.26 32.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.834 0.853 . . . . 70.200000000000003 110.093 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.472 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 94.9 t -77.76 101.4 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.39 0.614 . . . . 75.019999999999996 109.846 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 72.3 m -145.91 135.69 23.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.042 1.337 . . . . 73.549999999999997 107.924 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -79.48 142.21 36.04 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.887 -0.412 . . . . 74.010000000000005 109.887 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -67.26 144.24 98.02 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 122.72 0.408 . . . . 75.530000000000001 109.924 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.67 19.7 36.36 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 119.77 0.954 . . . . 60.299999999999997 114.062 3.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -85.31 130.27 34.63 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.264 0.626 . . . . 71.430000000000007 109.567 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.45 148.6 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.077 0.951 . . . . 63.240000000000002 109.541 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.1 t -84.77 131.89 34.5 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.818 0.342 . . . . 73.340000000000003 111.315 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.1 122.22 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 106.919 -1.511 . . . . 72.420000000000002 106.919 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.59 -32.32 73.75 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.528 0.731 . . . . 74.340000000000003 111.652 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.3 m -60.93 -42.04 97.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.05 0.94 . . . . 73.25 111.227 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.2 p -90.52 -15.34 30.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.454 0.702 . . . . 71.109999999999999 111.571 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.3 p 54.47 26.66 7.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.264 1.425 . . . . 53.229999999999997 112.349 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.48 150.81 45.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.176 0.591 . . . . 72.430000000000007 110.438 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 m -72.53 132.8 44.29 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.372 -0.603 . . . . 74.530000000000001 109.372 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HA ' ' HG3' ' A' ' 7' ' ' LYS . 48.1 mt-10 -144.86 -175.01 4.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.054 0.941 . . . . 73.310000000000002 110.308 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.8 138.13 85.46 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 73.019999999999996 110.422 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.563 1.96 0 C-N-CA 122.159 1.906 . . . . 72.140000000000001 111.735 172.58 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.085 -0.339 . . . . 72.439999999999998 110.085 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.67 24.22 72.56 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.47 0.481 . . . . 75.310000000000002 113.651 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -120.27 -166.53 1.32 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.635 1.174 . . . . 72.209999999999994 108.523 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -148.59 142.52 25.8 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.976 0.807 . . . . 74.099999999999994 111.91 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 89.74 32.82 9.66 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.786 -0.643 . . . . 55.149999999999999 113.624 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.16 177.61 7.54 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.127 0.971 . . . . 75.510000000000005 109.612 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -71.23 128.58 36.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 74.030000000000001 109.572 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.62 19.83 9.75 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.009 1.324 . . . . 65.040000000000006 112.708 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.39 132.79 23.37 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 118.477 -0.773 . . . . 73.200000000000003 109.505 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.4 133.54 25.47 Favored 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 124.072 3.182 . . . . 73.349999999999994 113.584 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 19' ' ' LYS . 31.7 p -80.34 123.1 27.71 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.584 -0.525 . . . . 63.140000000000001 109.584 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -80.19 131.29 35.68 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.409 -0.589 . . . . 62.43 109.409 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.84 119.65 5.12 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.206 -0.452 . . . . 61.030000000000001 112.07 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -59.25 145.46 81.18 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.401 1.08 . . . . 72.540000000000006 111.591 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 -27.6 82.17 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.558 2.172 . . . . 64.230000000000004 112.56 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.85 -24.22 59.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.308 0.643 . . . . 72.519999999999996 111.531 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.3 10.73 14.75 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-O 119.691 -0.505 . . . . 73.400000000000006 114.346 173.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.65 162.51 18.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.324 0.562 . . . . 74.340000000000003 110.915 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 75.1 mmtt -100.77 126.35 47.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.043 -0.725 . . . . 75.409999999999997 109.043 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.453 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 80.8 t -77.84 109.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.428 -0.582 . . . . 74.219999999999999 109.428 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 85.4 m -145.09 139.54 27.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.499 1.12 . . . . 65.329999999999998 109.33 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -78.32 143.66 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.267 0.627 . . . . 71.219999999999999 109.717 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.22 145.2 85.43 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.377 -0.344 . . . . 71.129999999999995 110.101 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.38 19.63 34.79 Favored 'Cis proline' 0 C--N 1.377 2.029 0 CA-C-N 119.571 0.882 . . . . 72.530000000000001 113.249 -0.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -74.62 128.09 34.71 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.611 0.764 . . . . 75.010000000000005 110.166 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.02 143.04 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.494 1.117 . . . . 73.010000000000005 109.606 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 45.1 t -79.05 113.9 17.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.065 -0.346 . . . . 64.400000000000006 110.065 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.89 121.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.647 -1.242 . . . . 72.549999999999997 107.647 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.83 -26.37 65.74 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.662 0.785 . . . . 73.129999999999995 112.996 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -68.16 -50.91 51.42 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.499 0.72 . . . . 71.010000000000005 111.217 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.3 p -86.05 -14.66 43.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.667 0.787 . . . . 62.039999999999999 111.852 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.1 p 53.07 32.29 12.74 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 125.508 1.523 . . . . 55.130000000000003 112.236 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -144.84 150.6 37.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.506 0.67 . . . . 74.430000000000007 112.682 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 m -80.02 96.77 6.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.687 -1.142 . . . . 73.109999999999999 111.013 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.74 -173.23 2.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.921 0.888 . . . . 73.340000000000003 110.156 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.59 132.13 92.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 122.917 0.487 . . . . 71.129999999999995 110.833 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.373 1.827 0 C-N-CA 122.601 2.201 . . . . 75.109999999999999 111.937 171.346 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.491 0.186 . . . . 75.540000000000006 110.588 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.7 74.15 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 114.861 0.704 . . . . 75.129999999999995 114.861 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.64 -170.55 1.66 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.387 0.593 . . . . 74.129999999999995 110.254 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -132.67 147.32 52.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.37 0.668 . . . . 64.120000000000005 109.405 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.755 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.73 11.16 57.12 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 115.123 0.809 . . . . 70.450000000000003 115.123 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.9 -179.95 3.79 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.663 0.732 . . . . 75.400000000000006 110.86 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -60.09 118.46 6.34 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.413 0.685 . . . . 72.030000000000001 111.073 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.9 m-20 66.95 20.0 10.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.307 1.443 . . . . 73.340000000000003 111.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -118.77 130.51 24.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.184 -1.043 . . . . 75.319999999999993 108.184 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 13.2 Cg_endo -53.22 138.57 63.86 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.752 2.968 . . . . 63.299999999999997 113.269 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.566 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.0 p -79.7 127.95 32.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.058 -0.519 . . . . 74.319999999999993 110.103 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 145.78 32.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.335 -0.617 . . . . 65.409999999999997 109.335 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.06 125.41 8.52 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 120.002 -0.332 . . . . 60.310000000000002 112.521 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.96 152.56 93.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.602 0.761 . . . . 74.549999999999997 109.782 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.01 -31.41 95.67 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.763 2.308 . . . . 73.5 112.994 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -73.13 -27.42 61.67 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.655 0.782 . . . . 74.349999999999994 111.345 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.66 1.69 11.88 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.803 0.681 . . . . 73.25 114.803 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.85 119.01 14.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.375 0.588 . . . . 73.349999999999994 111.112 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -71.33 114.54 9.5 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.054 -0.721 . . . . 74.209999999999994 109.054 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.69 115.86 20.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.074 0.949 . . . . 72.019999999999996 110.072 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.7 m -147.9 141.11 25.1 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.563 1.164 . . . . 71.319999999999993 108.281 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.15 137.17 35.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.576 -0.898 . . . . 72.329999999999998 108.576 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.94 143.6 98.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.136 0.574 . . . . 74.239999999999995 111.011 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -93.8 16.98 41.13 Favored 'Cis proline' 0 C--N 1.378 2.108 0 N-CA-C 114.57 0.95 . . . . 72.25 114.57 5.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -69.99 120.38 15.63 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.326 -0.62 . . . . 71.439999999999998 109.326 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.89 135.12 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.254 1.022 . . . . 74.409999999999997 108.686 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 47.6 t -69.76 97.39 1.08 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.24 0.543 . . . . 75.230000000000004 109.654 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.24 111.15 13.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 107.273 -1.38 . . . . 73.530000000000001 107.273 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.04 -32.07 69.42 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.573 1.149 . . . . 73.239999999999995 111.399 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 m -56.94 -48.5 78.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.548 1.139 . . . . 72.099999999999994 111.141 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.5 p -96.99 -7.59 32.66 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.587 0.755 . . . . 72.150000000000006 111.83 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p 53.66 36.35 23.46 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 126.053 1.741 . . . . 72.400000000000006 112.455 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.5 ptp180 -141.93 151.2 42.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 73.030000000000001 110.787 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.755 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 35.4 m -73.56 98.56 2.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.943 0.878 . . . . 75.239999999999995 109.051 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -123.11 164.76 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.613 1.165 . . . . 75.219999999999999 108.815 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.87 147.31 73.18 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.22 0.608 . . . . 64.120000000000005 110.885 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.373 1.835 0 C-N-CA 123.169 2.58 . . . . 75.209999999999994 112.297 171.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.4 t70 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.145 -0.687 . . . . 74.540000000000006 109.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.13 -29.7 4.2 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.895 0.283 . . . . 71.329999999999998 113.479 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -121.57 -170.24 2.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.247 1.019 . . . . 73.329999999999998 110.006 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.93 149.31 27.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.833 0.349 . . . . 72.439999999999998 111.282 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.66 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.32 25.28 8.91 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 116.027 1.171 . . . . 72.140000000000001 116.027 164.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -123.06 172.57 8.44 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.577 0.751 . . . . 72.5 109.625 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.99 125.08 23.77 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 109.025 -0.731 . . . . 75.450000000000003 109.025 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.683 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 74.6 m-20 66.78 18.43 10.68 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.549 1.54 . . . . 71.329999999999998 112.681 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -118.3 118.56 33.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.461 -0.94 . . . . 72.010000000000005 108.461 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 8.1 Cg_endo -45.41 124.33 6.37 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.646 3.564 . . . . 74.510000000000005 113.325 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.0 p -76.0 130.14 37.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.745 0.418 . . . . 74.409999999999997 109.929 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.59 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.1 p -84.56 105.8 15.65 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.802 -0.814 . . . . 74.409999999999997 108.802 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.44 122.98 6.08 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.259 -0.736 . . . . 72.510000000000005 111.259 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 97.4 mtt180 -71.54 156.02 91.89 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.708 0.803 . . . . 70.140000000000001 110.587 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.21 -28.57 85.24 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.768 2.312 . . . . 64.349999999999994 113.34 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.77 -28.18 62.45 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.39 0.431 . . . . 73.430000000000007 109.998 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.42 1.24 11.12 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.112 -0.495 . . . . 51.32 113.586 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -78.82 108.81 12.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.819 0.447 . . . . 70.230000000000004 110.605 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD2' ' HB3' ' A' ' 27' ' ' CYS . 46.5 mtmt -72.67 118.95 16.23 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.374 -0.602 . . . . 73.200000000000003 109.374 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 66.6 t -78.15 108.6 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.042 0.537 . . . . 73.209999999999994 109.664 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 70.7 m -150.97 138.85 19.9 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.085 1.354 . . . . 63.350000000000001 108.269 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.88 136.64 37.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.085 -1.08 . . . . 71.540000000000006 108.085 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.96 144.87 93.58 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.105 0.562 . . . . 71.239999999999995 109.913 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -87.02 1.84 68.37 Favored 'Cis proline' 0 C--N 1.378 2.126 0 C-N-CA 124.55 -1.021 . . . . 74.129999999999995 114.285 7.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -64.24 109.57 1.92 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.991 0.516 . . . . 71.439999999999998 110.113 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.19 140.15 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.066 0.946 . . . . 61.210000000000001 109.578 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.5 t -81.24 118.04 22.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.617 0.367 . . . . 74.099999999999994 111.344 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.21 118.05 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.939 -1.504 . . . . 63.310000000000002 106.939 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.424 HD22 ' HD3' ' A' ' 19' ' ' LYS . 3.7 mm? -67.43 -22.72 65.5 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.567 0.747 . . . . 73.099999999999994 111.925 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -62.23 -42.47 99.34 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.524 0.73 . . . . 71.209999999999994 110.13 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.9 p -95.9 -10.96 27.47 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.905 0.882 . . . . 73.150000000000006 111.055 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.5 p 54.67 26.08 7.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.201 1.801 . . . . 73.200000000000003 113.31 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.683 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 35.2 ptt180 -131.3 151.33 51.61 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.168 0.987 . . . . 65.319999999999993 109.936 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.66 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -73.8 140.92 46.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.679 -1.23 . . . . 74.510000000000005 107.679 170.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.29 165.76 32.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.621 0.368 . . . . 72.319999999999993 110.056 -169.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -61.49 127.71 88.89 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.65 0.78 . . . . 73.510000000000005 111.165 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.374 1.911 0 C-N-CA 122.918 2.412 . . . . 71.349999999999994 111.919 170.46 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 108.928 -0.767 . . . . 74.310000000000002 108.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.73 -33.34 4.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.074 -0.512 . . . . 65.420000000000002 112.409 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.98 160.29 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.23 145.99 26.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 70.510000000000005 111.354 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.507 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 117.28 -4.41 18.05 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.634 1.014 . . . . 74.209999999999994 115.634 168.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.422 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 6.1 m-20 -94.42 179.09 5.4 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.223 1.012 . . . . 74.409999999999997 111.873 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -70.86 126.63 30.11 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 116.047 -0.524 . . . . 75.310000000000002 109.909 -174.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 71.9 m-20 60.63 18.13 8.14 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.775 1.63 . . . . 72.430000000000007 112.359 -172.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -109.06 130.53 22.62 Favored Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 108.564 -0.902 . . . . 73.540000000000006 108.564 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -44.03 120.33 2.4 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.317 3.345 . . . . 72.299999999999997 112.916 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 14.0 p -77.03 147.14 36.92 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.098 0.559 . . . . 71.439999999999998 109.662 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -100.08 146.68 26.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.554 -1.276 . . . . 73.400000000000006 107.554 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.17 137.88 14.54 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 122.469 -0.145 . . . . 64.510000000000005 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.79 147.13 91.52 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.88 0.872 . . . . 73.319999999999993 109.458 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.98 -25.73 59.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.406 2.07 . . . . 61.399999999999999 112.191 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.29 -8.82 57.67 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.054 0.942 . . . . 72.329999999999998 111.767 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.18 -0.96 37.88 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 114.793 0.677 . . . . 74.420000000000002 114.793 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.23 130.05 35.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 117.554 0.677 . . . . 71.239999999999995 111.074 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD2' HD11 ' A' ' 29' ' ' LEU . 11.6 mmpt? -84.71 122.0 28.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.287 0.635 . . . . 74.420000000000002 109.648 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.54 108.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 123.243 0.617 . . . . 74.319999999999993 109.985 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 68.0 m -146.99 149.67 33.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.987 -1.006 . . . . 51.130000000000003 108.331 175.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 8.1 p30 -77.07 128.12 33.89 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.53 -1.285 . . . . 75.530000000000001 107.53 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.08 142.14 97.71 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.028 -173.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.2 12.56 36.36 Favored 'Cis proline' 0 C--N 1.373 1.828 0 CA-C-N 119.548 0.874 . . . . 72.329999999999998 114.235 6.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -64.31 130.25 43.11 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.993 -0.373 . . . . 74.219999999999999 109.993 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.84 142.65 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.153 0.981 . . . . 74.329999999999998 110.232 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.6 t -83.53 112.28 19.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.393 0.277 . . . . 75.430000000000007 110.545 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.01 121.76 31.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 107.353 -1.351 . . . . 73.439999999999998 107.353 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD11 ' HD2' ' A' ' 19' ' ' LYS . 4.2 mm? -65.28 -26.65 68.17 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.63 0.772 . . . . 74.010000000000005 112.59 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.2 m -63.21 -51.31 66.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.1 0.56 . . . . 75.349999999999994 110.876 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 33' ' ' ARG . 55.5 p -87.68 -18.01 30.5 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.212 -0.904 . . . . 71.239999999999995 111.603 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.7 p 52.75 31.77 11.01 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.77 1.628 . . . . 73.219999999999999 112.482 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 11.6 ptp180 -131.1 150.92 51.93 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.621 0.768 . . . . 75.420000000000002 110.152 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.507 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 14.1 m -81.56 113.03 19.31 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.804 -0.634 . . . . 73.209999999999994 110.109 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.41 -169.36 1.92 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.659 1.184 . . . . 74.019999999999996 109.684 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.09 149.93 89.68 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 122.908 0.483 . . . . 75.120000000000005 110.979 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.374 1.879 0 C-N-CA 122.527 2.151 . . . . 55.439999999999998 111.09 170.482 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.249 -0.278 . . . . 71.439999999999998 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.91 -31.92 7.13 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.481 -0.327 . . . . 72.209999999999994 112.567 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 -175.39 3.15 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.554 0.741 . . . . 72.409999999999997 109.277 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.5 145.85 23.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 122.503 0.321 . . . . 74.510000000000005 110.955 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.677 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 102.57 4.31 49.48 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 115.436 0.934 . . . . 73.209999999999994 115.436 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' HD22 ' A' ' 22' ' ' ASN . 7.1 m-20 -92.15 170.44 9.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.46 0.63 . . . . 75.129999999999995 110.599 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -69.96 125.13 25.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.69 -0.856 . . . . 75.109999999999999 108.69 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 62.51 29.04 17.01 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.256 1.422 . . . . 75.140000000000001 111.832 -173.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -127.05 141.24 40.1 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.059 0.944 . . . . 72.120000000000005 108.513 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -55.16 132.14 50.51 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.045 2.497 . . . . 74.409999999999997 112.619 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.9 p -82.65 141.89 32.14 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.422 0.689 . . . . 64.209999999999994 109.479 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.553 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.5 p -92.67 126.93 37.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.107 -1.071 . . . . 75.230000000000004 108.107 170.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 126.61 8.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 112.231 -0.348 . . . . 62.43 112.231 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -67.5 144.11 97.58 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.133 0.973 . . . . 72.430000000000007 109.916 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.95 -24.78 74.59 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.969 2.446 . . . . 70.109999999999999 113.245 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.75 -8.72 59.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.941 0.896 . . . . 73.409999999999997 112.138 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.08 -9.97 27.06 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.736 -0.48 . . . . 54.310000000000002 114.106 172.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 149.39 41.2 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.387 0.593 . . . . 75.299999999999997 110.788 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -100.23 117.32 34.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.898 -0.778 . . . . 65.420000000000002 108.898 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.553 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 46.8 t -77.65 94.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.689 -0.856 . . . . 72.219999999999999 108.689 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 66.7 m -128.25 141.68 51.38 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.064 -1.425 . . . . 74.319999999999993 107.867 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.489 HD22 ' HA ' ' A' ' 6' ' ' ASP . 9.6 p30 -78.76 135.83 37.22 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.415 -0.957 . . . . 74.409999999999997 108.415 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.09 143.3 88.53 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 124.047 0.939 . . . . 74.430000000000007 111.264 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.2 25.71 20.56 Favored 'Cis proline' 0 C--N 1.383 2.374 0 CA-C-N 119.829 0.975 . . . . 71.329999999999998 113.844 1.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -77.28 142.12 39.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.565 0.346 . . . . 64.310000000000002 110.269 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.03 137.28 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 75.319999999999993 109.217 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -82.59 124.03 29.77 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.563 0.345 . . . . 74.219999999999999 110.894 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 123.68 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.777 -1.564 . . . . 71.150000000000006 106.777 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.58 -44.19 97.48 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.331 1.02 . . . . 72.019999999999996 111.843 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -68.88 -39.02 80.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.07 0.948 . . . . 74.150000000000006 111.421 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -84.29 -15.87 45.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.118 0.567 . . . . 71.430000000000007 111.279 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 54.12 37.04 26.23 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.444 1.498 . . . . 55.43 112.262 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 30.4 ptt180 -134.73 139.71 45.4 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.313 0.645 . . . . 74.140000000000001 110.771 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.677 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 38.3 m -75.94 128.08 34.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.005 -0.739 . . . . 74.129999999999995 109.005 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -147.05 170.09 17.88 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.332 -0.988 . . . . 73.230000000000004 108.332 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.97 134.54 96.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 122.921 0.488 . . . . 64.540000000000006 111.071 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 122.721 2.281 . . . . 71.510000000000005 111.893 174.574 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.149 -0.315 . . . . 72.209999999999994 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.25 -25.05 26.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.044 -0.525 . . . . 73.040000000000006 113.025 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.66 175.09 9.45 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.18 -0.674 . . . . 72.409999999999997 109.18 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -128.96 148.04 50.91 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 122.715 0.406 . . . . 62.420000000000002 110.968 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.585 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.02 -9.95 31.69 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 114.436 0.535 . . . . 65.430000000000007 114.436 169.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.66 169.09 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.358 0.663 . . . . 74.030000000000001 110.866 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -65.65 122.92 18.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.167 0.587 . . . . 74.299999999999997 110.113 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.535 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 76.8 m-20 64.59 16.96 10.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.508 1.523 . . . . 75.430000000000007 113.769 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -104.88 136.55 19.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 108.276 -1.009 . . . . 71.409999999999997 108.276 170.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.09 137.03 76.98 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.203 2.602 . . . . 75.129999999999995 112.139 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 31.6 p -77.36 133.01 38.84 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.25 -0.648 . . . . 62.149999999999999 109.25 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.22 107.21 10.65 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.464 0.649 . . . . 73.219999999999999 109.481 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.21 108.42 2.69 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.52 -1.218 . . . . 74.230000000000004 112.168 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -68.22 145.12 97.35 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.108 0.963 . . . . 70.030000000000001 110.251 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -47.84 -36.66 27.08 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.651 3.568 . . . . 74.239999999999995 115.128 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -68.97 -20.13 64.18 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.676 0.79 . . . . 64.329999999999998 111.934 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.83 5.17 11.09 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.235 -0.439 . . . . 63.340000000000003 113.443 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.42 131.54 38.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.988 0.515 . . . . 74.329999999999998 111.703 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -92.7 114.45 27.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.085 -1.08 . . . . 73.319999999999993 108.085 171.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.46 124.76 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.564 0.346 . . . . 75.319999999999993 110.825 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.9 m -137.12 149.22 47.19 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.246 1.019 . . . . 75.340000000000003 109.234 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -84.71 141.02 30.87 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.111 -0.7 . . . . 74.420000000000002 109.111 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.09 148.42 98.85 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.641 0.776 . . . . 74.239999999999995 110.759 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.01 23.61 26.26 Favored 'Cis proline' 0 C--N 1.375 1.95 0 CA-C-N 119.527 0.867 . . . . 72.239999999999995 113.91 3.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.09 140.03 31.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.874 0.47 . . . . 74.129999999999995 110.246 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.33 138.0 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.935 1.294 . . . . 71.530000000000001 109.002 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 42.6 t -73.37 109.9 7.25 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.914 0.388 . . . . 73.340000000000003 110.722 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.52 114.31 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.731 -1.211 . . . . 73.030000000000001 107.731 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.3 -26.16 68.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.298 1.039 . . . . 75.299999999999997 112.223 -171.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -63.56 -46.47 85.78 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.806 0.843 . . . . 63.25 110.429 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 p -95.77 -8.87 33.2 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.222 1.009 . . . . 63.539999999999999 111.937 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p 54.84 28.12 9.94 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.793 1.637 . . . . 74.420000000000002 113.018 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 5.3 ptp180 -138.58 151.91 47.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.145 0.578 . . . . 75.140000000000001 110.613 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.585 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 13.6 m -77.67 125.67 29.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.144 -0.934 . . . . 64.230000000000004 109.804 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.49 176.14 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.256 1.023 . . . . 72.439999999999998 109.834 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.11 143.0 90.8 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.165 -0.445 . . . . 72.439999999999998 110.01 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 CA--C 1.563 1.966 0 C-N-CA 122.734 2.289 . . . . 72.329999999999998 112.0 173.419 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.149 -0.315 . . . . 72.310000000000002 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.61 -31.17 4.65 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 116.41 -0.359 . . . . 64.230000000000004 112.47 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -114.0 176.88 4.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.216 1.406 . . . . 64.200000000000003 109.127 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.52 144.63 25.47 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.152 -0.342 . . . . 74.230000000000004 110.626 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.637 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.41 20.09 30.76 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 115.291 0.876 . . . . 72.439999999999998 115.291 168.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.77 -179.92 3.88 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.406 0.682 . . . . 75.340000000000003 110.55 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -61.28 122.43 15.08 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.744 0.818 . . . . 75.030000000000001 110.846 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 60.26 27.13 16.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.011 1.324 . . . . 73.219999999999999 111.159 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -124.07 125.41 25.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 109.148 -0.686 . . . . 73.540000000000006 109.148 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.48 125.31 10.63 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 124.328 3.352 . . . . 75.109999999999999 112.858 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p -77.69 132.19 38.06 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.94 -0.763 . . . . 64.439999999999998 108.94 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -81.42 153.04 27.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.84 0.856 . . . . 72.340000000000003 109.091 175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.64 131.56 10.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.932 -0.48 . . . . 75.219999999999999 112.835 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.4 ' NE ' HG23 ' A' ' 20' ' ' VAL . 39.9 mmt180 -66.57 157.58 82.29 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.959 1.303 . . . . 75.329999999999998 110.999 175.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.76 -35.41 98.81 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.624 2.216 . . . . 64.409999999999997 112.69 172.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.51 -30.06 57.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.987 0.915 . . . . 72.439999999999998 111.088 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.03 1.54 12.87 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 115.247 0.859 . . . . 62.009999999999998 115.247 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.1 146.75 47.31 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.056 0.928 . . . . 72.400000000000006 110.384 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -86.44 122.67 30.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.538 -0.542 . . . . 74.530000000000001 109.538 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.46 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 24.8 t -79.18 109.45 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.55 0.74 . . . . 72.0 109.832 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.6 m -137.24 139.93 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.82 -1.178 . . . . 71.239999999999995 107.82 169.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -78.06 146.82 35.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.164 -1.05 . . . . 74.420000000000002 108.164 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.55 141.47 97.93 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.041 0.536 . . . . 71.140000000000001 110.716 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -98.65 18.07 27.37 Favored 'Cis proline' 0 C--N 1.372 1.766 0 CA-C-N 119.267 0.774 . . . . 74.530000000000001 113.957 -1.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -65.13 141.58 58.65 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.033 0.533 . . . . 74.439999999999998 110.028 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.57 136.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.343 1.057 . . . . 73.420000000000002 110.302 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.5 t -80.98 113.61 19.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.978 0.511 . . . . 70.319999999999993 110.655 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.7 118.82 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.657 -1.609 . . . . 74.239999999999995 106.657 170.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.2 -36.22 82.93 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.11 0.964 . . . . 74.439999999999998 111.564 -171.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -61.42 -43.46 98.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.749 0.82 . . . . 75.219999999999999 111.002 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.5 p -92.51 -11.06 35.58 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.11 0.564 . . . . 71.239999999999995 111.212 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.5 p 54.66 28.84 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.987 1.715 . . . . 73.5 113.137 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -140.49 151.12 44.56 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.328 0.651 . . . . 74.5 110.265 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.637 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 18.4 m -82.75 116.45 22.11 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.838 0.455 . . . . 74.329999999999998 110.794 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -104.48 -170.36 1.75 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.468 1.107 . . . . 74.219999999999999 109.04 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.75 156.77 91.52 Favored Pre-proline 0 N--CA 1.485 1.279 0 CA-C-O 119.051 -0.5 . . . . 74.340000000000003 110.577 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.601 2.201 . . . . 75.120000000000005 111.801 175.743 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.471 0.176 . . . . 75.25 110.8 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.82 -4.14 9.91 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.724 -0.487 . . . . 72.430000000000007 113.576 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 10.3 pt-20 -87.55 139.43 30.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 71.239999999999995 109.259 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.8 p -97.24 136.92 37.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.122 -0.361 . . . . 75.319999999999993 110.65 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.696 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.6 1.21 64.07 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 115.228 0.851 . . . . 42.130000000000003 115.228 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.04 -179.58 4.73 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.286 0.634 . . . . 64.319999999999993 111.004 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -65.01 121.56 14.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.068 0.947 . . . . 64.129999999999995 110.416 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 60.03 18.04 7.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.418 1.487 . . . . 51.399999999999999 112.694 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 54.4 mm-40 -107.75 138.95 20.16 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.891 0.877 . . . . 64.109999999999999 109.695 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.43 122.61 12.1 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 123.145 2.563 . . . . 74.310000000000002 112.277 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.707 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 28.0 p -74.48 128.69 36.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.774 -0.454 . . . . 65.349999999999994 109.774 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 120.03 23.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.268 -0.641 . . . . 70.400000000000006 109.268 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.44 126.01 8.36 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.842 -0.617 . . . . 75.150000000000006 113.552 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.43 144.35 88.43 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.157 0.983 . . . . 74.019999999999996 110.805 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.13 -17.57 60.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.502 2.134 . . . . 65.430000000000007 112.98 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.72 -8.09 58.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.835 0.854 . . . . 74.430000000000007 111.999 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.2 35.72 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 114.566 0.586 . . . . 74.230000000000004 114.566 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.48 139.57 47.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.543 0.672 . . . . 75.230000000000004 110.293 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.707 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -96.06 116.19 28.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.353 0.661 . . . . 75.019999999999996 110.278 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.94 108.48 18.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.159 -0.682 . . . . 74.010000000000005 109.159 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.3 m -128.81 148.86 50.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 124.671 1.188 . . . . 73.409999999999997 108.316 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.74 150.69 25.65 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.658 -0.867 . . . . 72.319999999999993 108.658 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -68.4 143.06 95.14 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 122.942 0.497 . . . . 73.400000000000006 110.888 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -93.63 14.46 46.08 Favored 'Cis proline' 0 C--N 1.38 2.229 0 CA-C-N 119.59 0.889 . . . . 73.420000000000002 113.995 0.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -71.59 134.06 46.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.299 0.64 . . . . 75.120000000000005 110.645 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.08 139.73 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.623 1.169 . . . . 71.450000000000003 109.076 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.9 t -79.75 120.05 23.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.114 0.416 . . . . 63.009999999999998 111.244 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.09 120.33 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 106.651 -1.611 . . . . 75.519999999999996 106.651 168.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.35 -39.27 92.12 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.197 0.599 . . . . 74.340000000000003 111.583 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -61.49 -32.47 72.49 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.791 0.837 . . . . 72.25 111.456 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.2 p -95.84 -16.48 21.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.084 0.554 . . . . 74.219999999999999 111.276 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p 54.56 35.38 23.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.245 1.818 . . . . 73.420000000000002 112.045 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -146.88 150.59 35.55 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.112 0.565 . . . . 75.049999999999997 111.093 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.696 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 19.8 m -82.74 115.22 21.56 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.005 0.522 . . . . 70.019999999999996 110.547 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -122.26 178.78 4.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 74.310000000000002 109.311 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.41 138.82 97.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.142 0.577 . . . . 65.209999999999994 111.542 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 C--N 1.376 2.023 0 C-N-CA 123.245 2.63 . . . . 74.310000000000002 112.003 176.584 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.48 0.181 . . . . 73.329999999999998 110.847 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.95 30.78 78.9 Favored Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.581 -0.608 . . . . 75.209999999999994 111.581 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -119.37 175.66 5.71 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.182 0.993 . . . . 74.420000000000002 110.17 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.2 p -154.44 150.22 27.63 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 122.607 0.363 . . . . 71.219999999999999 110.952 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.689 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 89.47 3.53 74.85 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.511 0.564 . . . . 71.019999999999996 114.511 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -95.88 178.81 5.31 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.297 0.639 . . . . 71.319999999999993 110.341 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 123.68 21.13 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.507 0.723 . . . . 75.400000000000006 109.675 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 58.92 35.56 24.2 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.491 1.516 . . . . 73.239999999999995 111.661 -172.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 12.8 tp10 -130.23 125.68 21.92 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 118.073 -0.965 . . . . 74.409999999999997 109.585 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 2.2 Cg_endo -37.87 121.59 0.46 Allowed 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 124.916 3.744 . . . . 74.299999999999997 113.952 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 30.1 p -76.26 115.11 15.68 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.543 -0.91 . . . . 64.239999999999995 108.543 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.0 p -80.48 108.73 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.186 0.594 . . . . 73.150000000000006 110.395 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.68 121.65 5.56 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.01 -0.541 . . . . 63.219999999999999 112.977 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.4 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 63.7 mtt180 -61.61 155.16 61.67 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.206 1.003 . . . . 74.25 110.873 172.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.98 -23.36 21.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.633 2.889 . . . . 72.420000000000002 115.715 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.73 -24.86 33.38 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.745 0.418 . . . . 71.340000000000003 111.416 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.22 3.85 10.37 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.825 -0.43 . . . . 71.019999999999996 113.793 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.4 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -75.41 123.38 25.3 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.968 0.507 . . . . 74.540000000000006 111.462 -178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.642 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -80.39 110.19 15.61 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.653 0.781 . . . . 70.329999999999998 109.713 176.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.0 t -79.43 111.18 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.096 0.558 . . . . 74.400000000000006 110.154 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 82.5 m -140.53 135.39 31.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.575 -1.193 . . . . 75.150000000000006 108.193 171.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.59 127.15 31.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.311 -0.996 . . . . 74.120000000000005 108.311 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.37 144.61 97.54 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.24 0.616 . . . . 52.420000000000002 110.558 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.13 8.15 67.01 Favored 'Cis proline' 0 C--N 1.379 2.174 0 N-CA-C 114.706 1.002 . . . . 71.0 114.706 8.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.37 127.47 33.08 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.89 138.64 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.759 0.824 . . . . 74.450000000000003 109.788 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.0 t -77.67 113.42 15.5 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.232 0.469 . . . . 62.450000000000003 110.224 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 35' ' ' GLU . 2.7 mp -78.81 111.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.385 -1.709 . . . . 75.329999999999998 106.385 168.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.52 -28.24 69.81 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.014 0.925 . . . . 74.340000000000003 112.12 -170.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.9 m -60.0 -54.05 50.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.678 0.791 . . . . 63.130000000000003 110.342 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -83.74 -12.77 55.32 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.798 0.839 . . . . 70.549999999999997 111.432 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.0 p 53.69 33.96 17.82 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.661 1.584 . . . . 54.200000000000003 112.312 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -136.98 150.38 48.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.697 0.799 . . . . 71.239999999999995 110.144 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.689 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -81.59 119.15 23.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.882 -0.785 . . . . 50.240000000000002 108.882 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 28' ' ' ILE . 35.2 mt-10 -121.01 170.44 9.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.472 0.709 . . . . 71.319999999999993 109.951 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.3 134.15 82.79 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.893 -0.594 . . . . 73.230000000000004 110.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.569 2.236 0 C-N-CA 122.574 2.183 . . . . 74.019999999999996 111.609 172.033 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 108.498 -0.927 . . . . 73.530000000000001 108.498 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.3 -30.34 7.69 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.533 -0.627 . . . . 74.140000000000001 111.533 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.24 167.06 11.87 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.493 1.117 . . . . 74.430000000000007 108.273 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -140.89 138.15 33.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.326 -0.233 . . . . 64.109999999999999 111.145 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 105.99 5.18 38.46 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.412 0.525 . . . . 72.420000000000002 114.412 174.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.67 172.37 8.3 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.582 0.753 . . . . 54.539999999999999 111.225 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -67.64 122.17 17.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.44 1.096 . . . . 71.519999999999996 109.253 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 64.39 20.99 12.37 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.166 1.386 . . . . 74.420000000000002 112.319 -175.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -126.32 135.83 27.73 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.193 -0.908 . . . . 73.349999999999994 110.129 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -41.58 133.16 3.68 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.853 3.702 . . . . 70.420000000000002 114.645 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.1 p -93.23 128.35 39.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.48 0.712 . . . . 73.010000000000005 109.304 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.9 p -83.95 101.07 11.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.658 -0.868 . . . . 70.409999999999997 108.658 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -87.39 118.78 5.07 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.671 -0.695 . . . . 74.019999999999996 112.539 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 96.6 mtt180 -56.81 152.83 25.11 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.76 1.224 . . . . 73.019999999999996 111.394 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.68 -23.63 58.61 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.349 2.7 . . . . 73.349999999999994 114.318 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.22 5.52 29.86 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.855 0.862 . . . . 72.239999999999995 112.152 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.0 9.98 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.355 -0.136 . . . . 63.340000000000003 112.97 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -114.73 97.94 6.56 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.432 -0.581 . . . . 73.310000000000002 109.432 175.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HZ3' ' HB2' ' A' ' 19' ' ' LYS . 10.1 mtmp? -71.4 111.18 6.51 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.192 0.597 . . . . 75.200000000000003 109.477 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -76.15 113.93 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.08 -0.711 . . . . 73.329999999999998 109.08 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 77.5 m -141.47 143.4 33.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.95 1.3 . . . . 75.400000000000006 108.838 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -80.82 143.64 32.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.161 -1.052 . . . . 72.439999999999998 108.161 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.19 147.76 90.85 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.78 0.432 . . . . 62.409999999999997 110.53 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.52 28.17 17.15 Favored 'Cis proline' 0 C--N 1.378 2.116 0 CA-C-N 119.747 0.946 . . . . 73.120000000000005 113.454 1.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -82.2 117.98 22.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.804 0.442 . . . . 75.329999999999998 110.207 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -97.46 131.29 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.33 1.052 . . . . 73.430000000000007 109.805 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.689 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.9 t -79.87 113.5 18.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.65 0.262 . . . . 63.539999999999999 110.755 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.8 mt -79.9 129.03 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.935 -1.135 . . . . 73.420000000000002 107.935 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.29 -42.1 99.06 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.808 0.843 . . . . 72.409999999999997 111.278 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -59.59 -36.69 76.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.194 0.997 . . . . 70.219999999999999 111.836 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.5 p -95.5 -19.26 19.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 74.230000000000004 111.467 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p 54.62 30.98 14.21 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.163 1.785 . . . . 64.439999999999998 112.77 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.467 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 12.1 ptp180 -140.45 149.28 42.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.353 0.661 . . . . 75.409999999999997 110.998 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 8.2 m -81.65 99.76 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.276 0.63 . . . . 74.049999999999997 110.639 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 36.4 mt-10 -107.72 -172.99 2.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.975 0.91 . . . . 72.209999999999994 111.004 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.1 158.9 74.57 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.743 0.817 . . . . 74.129999999999995 111.022 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 CA--C 1.561 1.872 0 C-N-CA 122.677 2.251 . . . . 71.400000000000006 111.217 166.809 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 109.299 -0.63 . . . . 72.150000000000006 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.93 -30.74 9.51 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 123.526 0.584 . . . . 72.239999999999995 112.426 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.3 169.56 8.79 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.569 1.147 . . . . 65.25 109.035 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.9 p -143.42 143.23 31.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.039 0.381 . . . . 42.549999999999997 111.842 -173.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 105.01 30.49 4.78 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 114.651 0.62 . . . . 71.310000000000002 114.651 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.65 174.26 8.85 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.039 0.936 . . . . 63.329999999999998 110.446 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -68.84 123.76 21.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.244 1.018 . . . . 73.439999999999998 109.1 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 84.9 m-20 60.51 29.88 19.34 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.785 1.234 . . . . 72.450000000000003 112.338 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -113.92 141.05 25.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 107.768 -1.197 . . . . 74.340000000000003 107.768 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.97 145.52 10.25 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 123.397 2.731 . . . . 71.109999999999999 112.035 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -100.74 132.7 46.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.513 -0.551 . . . . 72.230000000000004 109.513 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.31 88.18 6.95 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.322 -0.992 . . . . 74.219999999999999 108.322 170.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -80.89 121.39 5.4 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 115.213 -0.903 . . . . 60.229999999999997 112.849 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -82.29 144.64 50.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.513 -0.551 . . . . 73.239999999999995 109.513 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.09 -12.22 34.46 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.205 2.603 . . . . 74.120000000000005 114.375 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 -17.67 57.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.932 0.893 . . . . 72.319999999999993 111.384 172.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.7 -13.5 9.29 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 113.581 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.17 97.61 6.97 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.067 0.46 . . . . 44.299999999999997 110.65 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 34.6 mtmt -82.45 118.64 23.37 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.846 0.858 . . . . 73.239999999999995 108.687 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.602 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.4 t -77.4 95.53 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 122.079 0.943 . . . . 73.340000000000003 109.691 -175.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 75.2 m -130.24 152.0 50.14 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 112.973 -1.922 . . . . 74.5 108.99 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -79.58 140.72 37.07 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.954 -0.758 . . . . 72.450000000000003 108.954 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.21 147.41 82.96 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.064 0.546 . . . . 72.230000000000004 109.997 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -94.25 22.86 28.01 Favored 'Cis proline' 0 C--N 1.376 2.002 0 CA-C-N 119.39 0.818 . . . . 71.519999999999996 113.284 1.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -79.81 124.94 29.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.414 0.685 . . . . 75.109999999999999 109.221 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.42 144.99 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.703 0.801 . . . . 73.299999999999997 109.803 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.3 t -84.31 113.32 21.05 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.002 0.521 . . . . 61.350000000000001 110.037 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.89 119.37 29.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 106.813 -1.551 . . . . 75.409999999999997 106.813 171.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.48 -26.99 65.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.713 . . . . 70.219999999999999 112.645 -173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.3 m -59.65 -54.78 42.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.783 0.833 . . . . 73.319999999999993 111.184 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 p -87.87 -18.79 28.45 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.9 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.8 p 52.27 44.37 29.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.175 1.79 . . . . 71.439999999999998 112.802 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 8' ' ' ASP . 2.2 ptm180 -146.45 144.9 29.99 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.275 0.559 . . . . 73.219999999999999 110.393 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 m -76.47 88.27 3.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.251 1.02 . . . . 74.439999999999998 110.362 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 44.9 mt-10 -103.37 -171.65 1.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.972 0.909 . . . . 72.310000000000002 109.935 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -62.22 139.44 96.21 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 123.851 0.86 . . . . 73.209999999999994 110.987 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.375 1.943 0 C-N-CA 122.902 2.402 . . . . 64.439999999999998 112.262 173.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 119.527 -0.273 . . . . 73.109999999999999 110.68 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.33 21.5 68.48 Favored Glycine 0 C--N 1.358 1.752 0 O-C-N 123.57 0.544 . . . . 65.409999999999997 113.756 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -105.68 161.9 13.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.001 0.92 . . . . 71.319999999999993 110.66 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -157.97 113.22 2.7 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.846 0.458 . . . . 74.409999999999997 109.842 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 140.12 -9.12 3.0 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 115.547 0.979 . . . . 71.230000000000004 115.547 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.7 173.55 7.55 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.058 0.543 . . . . 75.439999999999998 111.215 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.22 116.11 9.27 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.101 0.96 . . . . 71.040000000000006 109.684 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 73.75 16.32 3.83 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.099 2.16 . . . . 74.239999999999995 112.603 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -106.97 135.65 19.54 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 123.892 0.877 . . . . 74.340000000000003 109.442 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.59 133.28 57.13 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.392 2.728 . . . . 71.319999999999993 111.834 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.1 p -80.75 121.67 26.19 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.564 -0.532 . . . . 72.030000000000001 109.564 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 2.4 p -78.82 88.64 4.65 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.87 -0.789 . . . . 72.030000000000001 108.87 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -79.78 118.07 4.65 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.827 -1.079 . . . . 74.329999999999998 112.417 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -69.32 152.95 96.33 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.45 1.1 . . . . 73.310000000000002 110.387 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.65 -21.52 63.1 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.2 2.6 . . . . 71.530000000000001 114.699 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.93 -21.92 58.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.496 0.719 . . . . 73.540000000000006 111.551 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.79 -0.91 13.67 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 116.016 -0.538 . . . . 55.210000000000001 113.423 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.78 99.31 4.38 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 116.864 0.332 . . . . 75.019999999999996 111.114 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 41.9 mtmt -73.18 114.5 11.42 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.222 -1.029 . . . . 73.129999999999995 108.222 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 97.7 t -76.58 106.66 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.038 -0.727 . . . . 71.319999999999993 109.038 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 79.9 m -143.5 135.82 27.02 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 125.297 1.439 . . . . 52.420000000000002 109.227 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.63 120.57 24.14 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.194 -1.039 . . . . 71.310000000000002 108.194 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.07 149.23 94.24 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.311 0.645 . . . . 63.119999999999997 110.517 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -88.59 15.29 46.39 Favored 'Cis proline' 0 C--N 1.379 2.154 0 CA-C-N 120.082 1.065 . . . . 73.319999999999993 114.707 9.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -75.98 109.41 9.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 75.019999999999996 109.709 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.88 130.89 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.097 0.959 . . . . 75.310000000000002 110.139 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.621 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 51.9 t -71.19 110.81 6.08 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.716 0.293 . . . . 73.010000000000005 110.765 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.31 127.18 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.963 -1.125 . . . . 72.049999999999997 107.963 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.27 -34.35 77.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.259 0.624 . . . . 64.129999999999995 111.328 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -57.56 -43.76 84.74 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.763 0.825 . . . . 62.0 111.169 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 p -91.01 -16.12 28.49 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.953 0.901 . . . . 73.140000000000001 111.767 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p 52.93 30.43 9.27 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.594 1.558 . . . . 73.299999999999997 112.18 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -140.74 147.75 39.65 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.648 0.379 . . . . 75.129999999999995 111.138 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.4 m -74.15 130.71 40.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.349 0.66 . . . . 60.329999999999998 110.375 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.44 176.76 10.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.56 0.744 . . . . 74.340000000000003 109.939 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.52 123.01 81.67 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 119.441 -0.314 . . . . 70.420000000000002 110.333 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 C--N 1.386 2.507 0 C-N-CA 122.918 2.412 . . . . 74.129999999999995 112.011 179.119 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.335 -0.246 . . . . 64.530000000000001 110.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.1 -33.14 5.59 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.786 -0.526 . . . . 74.239999999999995 111.786 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -122.07 -178.23 3.8 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.866 0.867 . . . . 73.0 109.193 171.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.62 151.11 7.48 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.341 0.257 . . . . 62.310000000000002 111.493 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.627 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.71 -8.09 29.9 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 115.563 0.985 . . . . 60.240000000000002 115.563 166.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.71 172.6 8.07 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.411 0.605 . . . . 70.530000000000001 111.655 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 3.6 tmtp? -63.35 125.1 23.03 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.862 0.726 . . . . 75.439999999999998 110.033 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 97.2 m-20 61.51 24.39 14.5 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.162 1.385 . . . . 73.430000000000007 112.328 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -123.1 142.55 38.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.885 0.874 . . . . 74.349999999999994 109.112 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.98 139.87 79.56 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.701 2.934 . . . . 75.340000000000003 112.926 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.735 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 26.5 p -90.47 128.04 36.4 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.372 0.669 . . . . 63.039999999999999 109.31 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -78.5 119.53 21.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.845 0.355 . . . . 75.129999999999995 110.191 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.32 120.7 5.5 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 116.058 -0.519 . . . . 64.430000000000007 113.246 -174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -71.08 156.33 92.08 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.24 1.016 . . . . 73.409999999999997 110.838 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.38 -43.82 51.31 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.178 2.585 . . . . 74.25 113.222 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.53 -25.17 67.87 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.257 1.023 . . . . 74.420000000000002 112.364 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.17 2.38 12.34 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-O 119.637 -0.535 . . . . 73.230000000000004 113.844 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.33 115.39 8.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 117.255 0.528 . . . . 74.299999999999997 111.583 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.735 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -75.81 106.47 7.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.643 0.777 . . . . 74.109999999999999 109.207 173.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.555 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 60.0 t -79.62 119.61 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.023 0.529 . . . . 70.329999999999998 110.773 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.5 m -142.37 154.15 44.39 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.009 1.323 . . . . 65.239999999999995 109.034 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.55 145.28 25.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.179 -0.675 . . . . 71.209999999999994 109.179 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.24 146.16 94.27 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 122.961 0.504 . . . . 72.400000000000006 110.606 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -91.0 14.88 49.33 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.581 0.886 . . . . 64.540000000000006 114.225 5.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -78.23 124.41 28.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.949 0.404 . . . . 74.040000000000006 110.369 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.19 131.25 59.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.455 1.102 . . . . 65.430000000000007 108.6 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.8 t -69.11 107.63 3.26 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.016 0.436 . . . . 71.230000000000004 110.029 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.29 113.24 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.386 -1.339 . . . . 75.120000000000005 107.386 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.01 -28.47 66.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.521 1.128 . . . . 74.420000000000002 111.638 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.9 m -64.45 -52.39 58.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.785 0.834 . . . . 75.439999999999998 111.208 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.8 p -90.96 -4.06 56.79 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.135 0.574 . . . . 73.340000000000003 111.564 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p 53.55 29.56 9.33 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.952 1.701 . . . . 72.450000000000003 113.022 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.4 ptt180 -138.28 148.73 44.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.667 0.787 . . . . 75.349999999999994 109.509 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 45.6 m -71.09 91.27 0.9 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.961 -0.755 . . . . 65.099999999999994 108.961 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 36' ' ' ASN . 29.6 tt0 -101.18 -178.79 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.356 1.062 . . . . 75.230000000000004 108.627 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 3.1 p-10 -72.62 145.76 87.67 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 109.602 -0.518 . . . . 75.530000000000001 109.602 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.365 1.423 0 C-N-CA 122.902 2.401 . . . . 74.420000000000002 112.807 173.327 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.18 -0.674 . . . . 72.01 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 p -147.91 140.1 24.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.534 0.334 . . . . 73.31 110.722 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.541 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 109.95 -4.22 30.37 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 114.973 0.749 . . . . 62.33 114.973 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -100.2 176.29 5.44 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.338 0.655 . . . . 74.0 112.073 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -61.37 117.16 5.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.78 0.832 . . . . 71.23 110.623 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.4 m-20 64.14 21.42 12.55 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.97 1.308 . . . . 75.43 111.624 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -112.84 132.22 22.39 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 108.126 -1.064 . . . . 65.52 108.126 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.6 Cg_endo -53.88 140.91 67.91 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 123.232 2.621 . . . . 65.03 112.864 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 28.4 p -88.66 133.4 34.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.919 0.487 . . . . 71.14 109.938 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.9 p -93.16 104.92 17.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.693 0.797 . . . . 70.34 109.985 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -78.06 129.18 9.25 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.52 -0.632 . . . . 65.34 111.52 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -89.22 168.06 16.3 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.833 0.853 . . . . 64.1 111.665 -170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.25 -33.07 53.46 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.349 2.699 . . . . 71.42 114.564 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.26 -8.92 58.13 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.908 0.483 . . . . 63.3 111.619 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.12 -24.99 29.34 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 114.163 0.425 . . . . 64.22 114.163 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 128.09 34.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.966 0.383 . . . . 55.23 110.629 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 39.3 mtmt -76.64 129.86 36.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.056 0.942 . . . . 74.15 108.899 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 87.4 t -77.84 117.81 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.086 0.47 . . . . 73.54 110.121 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.8 m -146.48 136.56 23.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.003 1.321 . . . . 75.41 107.538 169.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.63 139.6 38.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.523 -0.918 . . . . 64.1 108.523 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.32 141.83 96.22 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 122.747 0.419 . . . . 75.1 110.104 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -96.12 19.36 32.14 Favored 'Cis proline' 0 C--N 1.375 1.929 0 N-CA-C 114.649 0.98 . . . . 72.32 114.649 4.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -67.97 125.95 27.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.001 -0.37 . . . . 74.15 110.001 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.55 129.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.727 1.211 . . . . 72.22 109.817 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.686 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 39.0 t -78.77 110.25 13.76 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.999 0.52 . . . . 75.12 109.781 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.52 140.46 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.721 -0.844 . . . . 73.03 108.721 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 -37.42 87.33 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.537 0.94 . . . . 42.25 113.537 -165.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -75.26 -50.93 14.54 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.919 0.39 . . . . 54.5 110.204 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -70.65 -26.36 63.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.699 0.8 . . . . 63.4 111.874 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p 54.29 27.08 7.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.033 1.733 . . . . 64.54 112.688 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 12.0 ptp180 -126.94 142.4 51.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.962 0.905 . . . . 64.34 110.294 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 30.8 m -75.38 100.17 4.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.334 0.654 . . . . 64.53 109.8 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 -177.96 3.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.564 0.746 . . . . 63.25 110.492 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -71.96 139.4 82.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 122.61 0.364 . . . . 72.44 110.787 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.381 2.284 0 C-N-CA 123.093 2.529 . . . . 71.54 112.342 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.734 0 N-CA-C 109.88 -0.415 . . . . 71.32 109.88 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.87 149.82 50.37 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.068 0.547 . . . . 52.13 109.926 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.448 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 97.71 2.26 58.6 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.171 0.828 . . . . 72.43 115.171 170.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.63 164.96 13.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.359 0.663 . . . . 74.34 109.849 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.24 137.46 50.84 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.356 0.263 . . . . 72.13 110.396 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.34 28.31 17.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.446 1.498 . . . . 63.45 111.064 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.99 134.87 14.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 108.801 -0.814 . . . . 61.12 108.801 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.3 Cg_endo -54.47 146.22 53.54 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 123.995 3.13 . . . . 75.01 114.09 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.5 p -91.82 137.68 32.17 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.588 -0.733 . . . . 74.24 109.409 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -80.16 88.36 5.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.136 -1.061 . . . . 74.53 108.136 171.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.19 120.83 5.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 114.978 -1.01 . . . . 64.42 111.981 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -74.68 151.15 86.88 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.136 0.974 . . . . 54.42 111.44 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.87 -22.54 68.86 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.958 2.439 . . . . 71.43 113.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.04 -15.27 58.46 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.659 0.784 . . . . 72.32 111.222 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.64 -6.15 24.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.891 -0.394 . . . . 60.21 114.041 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.77 98.51 3.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.104 0.478 . . . . 74.12 110.94 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.83 112.8 8.23 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.533 0.733 . . . . 72.23 109.273 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 85.9 t -78.82 110.09 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 122.771 0.429 . . . . 63.23 110.588 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 62.9 m -147.7 151.01 35.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.858 1.263 . . . . 61.43 109.0 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -84.26 138.91 32.68 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.779 -0.822 . . . . 75.23 108.779 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.5 146.3 97.69 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.145 0.578 . . . . 71.33 110.814 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.18 10.14 60.0 Favored 'Cis proline' 0 C--N 1.376 1.978 0 N-CA-C 114.697 0.999 . . . . 54.41 114.697 3.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -73.09 114.01 10.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.133 0.573 . . . . 73.43 111.006 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.46 133.53 37.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.7 1.2 . . . . 53.01 109.77 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.3 t -70.72 105.41 3.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.127 0.489 . . . . 72.51 110.675 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.5 118.4 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.084 -1.08 . . . . 65.34 108.084 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.42 -36.97 84.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.065 0.946 . . . . 62.12 112.559 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.3 p -62.51 -38.78 91.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.556 0.742 . . . . 71.23 111.643 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.9 p -97.12 -7.76 31.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.307 0.643 . . . . 65.24 111.493 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p 55.08 21.27 3.74 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.231 1.812 . . . . 53.23 113.521 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 ptp180 -133.16 148.92 52.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.796 0.438 . . . . 74.04 111.751 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.7 m -74.08 114.82 12.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.773 -0.649 . . . . 63.14 109.672 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.1 -171.17 2.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.477 1.111 . . . . 61.11 109.001 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.82 148.25 87.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 119.08 -0.486 . . . . 75.2 111.325 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.375 1.927 0 C-N-CA 123.401 2.734 . . . . 72.13 112.501 169.876 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 61.44 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.93 134.47 40.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.665 0.386 . . . . 72.12 110.612 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 118.92 0.73 14.87 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.572 0.989 . . . . 70.5 115.572 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.79 174.82 7.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.106 0.953 . . . . 72.22 110.655 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -68.06 122.97 19.39 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.799 -0.815 . . . . 64.13 108.799 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 66.56 19.48 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.876 1.671 . . . . 65.31 112.418 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 4.6 tp10 -113.17 129.59 24.41 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.855 0.862 . . . . 73.22 109.108 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 5.2 Cg_endo -43.56 126.74 5.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 124.274 3.316 . . . . 62.31 112.981 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.5 p -84.52 130.76 34.71 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.114 -0.698 . . . . 73.52 109.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.1 p -80.63 139.56 36.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.464 -0.569 . . . . 73.32 109.464 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.34 114.71 4.94 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.315 -0.314 . . . . 65.32 112.315 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -61.5 148.78 85.59 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.196 0.998 . . . . 72.43 111.248 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.45 -5.14 13.31 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.91 2.407 . . . . 55.24 114.413 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.41 2.12 47.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.521 0.728 . . . . 74.44 111.625 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.57 4.04 62.43 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.892 -0.393 . . . . 52.03 113.862 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 155.81 19.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.042 0.421 . . . . 52.12 110.301 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -101.95 127.45 48.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.152 0.581 . . . . 54.43 109.883 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.8 t -78.5 109.67 13.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.895 -0.78 . . . . 55.02 108.895 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 71.8 m -141.64 141.1 33.41 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.592 1.182 . . . . 71.14 108.604 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -78.88 135.27 36.96 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.428 -1.323 . . . . 73.15 107.428 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.61 141.7 98.32 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.343 0.657 . . . . 44.24 110.073 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -99.26 28.33 15.15 Favored 'Cis proline' 0 C--N 1.371 1.744 0 CA-C-N 119.766 0.952 . . . . 62.43 114.446 5.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -85.29 143.21 28.84 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.785 -0.45 . . . . 71.21 109.785 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' A' ' 37' ' ' PRO . 27.9 m -126.0 140.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.432 0.693 . . . . 63.42 109.797 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.0 t -80.62 116.6 20.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.49 0.716 . . . . 73.13 111.398 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.29 123.75 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.762 -1.57 . . . . 72.04 106.762 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.31 -29.15 70.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.606 0.762 . . . . 71.22 111.527 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m -71.04 -36.65 72.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.776 0.831 . . . . 65.44 111.098 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.9 p -92.1 -21.04 20.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.342 0.657 . . . . 71.34 111.034 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.7 p 53.38 37.95 26.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.825 1.65 . . . . 52.03 111.784 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HA ' ' H ' ' A' ' 11' ' ' CYS . 15.9 ptp180 -145.06 146.89 32.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.259 0.624 . . . . 75.2 111.192 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 22.4 m -75.98 123.22 25.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.277 0.631 . . . . 72.34 109.644 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.92 -177.75 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.163 0.985 . . . . 72.44 109.622 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.34 127.85 86.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.229 0.612 . . . . 74.44 109.711 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG3' HG22 ' A' ' 26' ' ' VAL . 15.1 Cg_exo . . . . . 0 C--N 1.373 1.846 0 C-N-CA 123.034 2.489 . . . . 73.44 111.847 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.242 0.672 0 CA-C-O 120.75 0.309 . . . . 71.33 110.33 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.05 150.51 34.05 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.672 0.389 . . . . 62.54 110.733 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.67 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.07 -6.85 58.44 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 114.923 0.729 . . . . 71.03 114.923 170.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.78 175.38 6.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.494 0.718 . . . . 73.12 110.902 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -67.11 122.87 18.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.312 -0.625 . . . . 63.02 109.312 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 80.3 m-20 63.36 31.66 15.06 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.564 1.146 . . . . 72.45 110.662 -176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.14 131.32 23.92 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.27 -1.011 . . . . 63.24 108.27 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.14 130.55 32.44 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.626 2.884 . . . . 54.31 112.382 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 29.0 p -79.29 127.2 31.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.8 -0.444 . . . . 74.4 109.8 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -79.86 125.09 29.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.367 0.667 . . . . 74.11 109.311 177.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.22 132.17 10.98 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.935 -0.575 . . . . 65.33 113.337 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -73.72 139.01 77.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.534 1.134 . . . . 72.14 111.059 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.45 -31.46 48.33 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.385 2.723 . . . . 63.14 113.876 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.26 -27.53 63.51 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.725 0.41 . . . . 74.4 111.267 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.35 0.83 11.28 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.705 -0.497 . . . . 72.24 114.219 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 163.05 26.92 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.675 0.737 . . . . 63.41 110.583 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 64.12 108.568 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 99.6 t -77.55 110.6 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.408 0.683 . . . . 73.45 109.58 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 84.4 m -139.2 138.52 36.96 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 72.15 108.988 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -79.5 142.53 35.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.623 -0.88 . . . . 74.54 108.623 173.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.61 144.82 97.92 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 122.959 0.504 . . . . 64.25 110.874 -174.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -93.12 14.76 46.76 Favored 'Cis proline' 0 C--N 1.377 2.055 0 C-N-CA 124.704 -0.957 . . . . 75.41 114.309 4.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.89 132.27 46.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.694 0.398 . . . . 74.32 110.938 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -115.77 126.89 73.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.338 1.055 . . . . 73.14 108.835 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -75.14 112.76 11.73 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.686 0.279 . . . . 74.52 110.984 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.88 132.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.26 -1.015 . . . . 74.12 108.26 172.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.07 -46.25 88.73 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 124.01 0.819 . . . . 73.11 111.782 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -66.58 -45.61 78.68 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.978 0.799 . . . . 62.33 111.499 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -80.91 -15.38 56.44 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.105 0.562 . . . . 74.02 111.17 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p 54.26 24.51 5.07 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.627 1.571 . . . . 73.22 113.029 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 36.4 ptt180 -131.28 148.78 52.72 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.634 0.774 . . . . 61.54 109.24 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 53.8 m -71.81 94.37 1.4 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.832 -0.803 . . . . 65.32 108.832 173.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -99.33 170.35 8.71 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.801 -1.09 . . . . 63.31 108.843 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.58 139.16 88.81 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.666 0.386 . . . . 75.42 110.25 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--N 1.369 1.606 0 C-N-CA 122.904 2.402 . . . . 74.14 112.022 173.436 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.556 1.174 0 N-CA-C 110.492 -0.188 . . . . 65.52 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.5 p -155.31 128.68 8.36 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.742 -0.599 . . . . 75.41 111.458 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 136.65 -13.37 3.95 Favored Glycine 0 C--N 1.355 1.639 0 N-CA-C 116.062 1.185 . . . . 60.21 116.062 164.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 23.2 m-20 -94.86 175.72 6.54 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.71 1.255 . . . . 74.12 112.37 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.93 131.33 50.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.151 -0.931 . . . . 71.44 110.096 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.591 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 62.3 m-20 57.98 27.13 14.33 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.737 1.215 . . . . 75.2 112.195 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 14.3 tp10 -119.69 125.98 27.17 Favored Pre-proline 0 N--CA 1.472 0.627 0 C-N-CA 123.971 0.909 . . . . 53.21 108.587 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 10.8 Cg_endo -49.2 140.76 25.04 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.934 3.089 . . . . 75.44 112.65 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.558 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 29.0 p -88.2 136.69 32.86 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 41.13 109.695 177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -85.53 134.36 34.03 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.605 -0.887 . . . . 52.25 108.605 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.2 138.4 13.91 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.502 -0.317 . . . . 65.54 112.559 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.72 151.22 57.92 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.431 1.092 . . . . 65.15 108.834 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.49 -34.93 83.84 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.154 2.569 . . . . 72.11 114.088 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.72 -13.61 60.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.887 0.475 . . . . 74.13 111.831 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.86 12.3 20.96 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.496 0.558 . . . . 44.22 114.496 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.58 136.32 38.26 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.273 0.536 . . . . 72.21 110.614 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -95.85 114.58 26.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.205 0.602 . . . . 60.45 109.652 176.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.563 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.5 t -79.6 101.76 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.416 0.686 . . . . 75.44 110.183 -177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 59.0 m -138.64 140.58 38.94 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.864 1.266 . . . . 45.54 108.565 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.16 144.18 33.23 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.161 -0.681 . . . . 75.2 109.161 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.6 139.84 97.27 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.212 0.605 . . . . 70.13 110.901 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -94.01 13.96 45.95 Favored 'Cis proline' 0 C--N 1.375 1.95 0 N-CA-C 114.642 0.978 . . . . 73.23 114.642 6.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -67.88 126.15 28.52 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 118.031 0.378 . . . . 61.43 110.629 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.63 129.52 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.841 1.256 . . . . 73.54 108.403 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 48.8 t -72.09 108.2 5.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.763 0.316 . . . . 73.31 110.612 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -79.36 120.27 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 107.775 -1.194 . . . . 62.21 107.775 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.58 -34.45 77.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.629 0.772 . . . . 73.15 112.42 -170.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -76.4 -25.32 54.41 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.654 0.382 . . . . 74.24 111.408 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.9 p -95.43 -14.16 24.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.91 0.484 . . . . 70.41 110.637 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.6 p 54.96 33.91 21.2 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.16 1.784 . . . . 75.4 113.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.591 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.4 ptp180 -144.53 150.82 38.17 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 74.05 111.032 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 34.3 m -70.09 121.69 17.96 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.655 -0.702 . . . . 61.5 109.244 172.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 14.1 mm-40 -132.26 173.76 10.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.526 1.131 . . . . 74.2 110.502 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -75.37 126.7 87.39 Favored Pre-proline 0 CA--C 1.558 1.255 0 N-CA-C 108.857 -0.794 . . . . 73.42 108.857 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.383 2.371 0 C-N-CA 123.161 2.574 . . . . 71.42 112.344 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.637 0.256 . . . . 71.31 110.526 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 27.2 p -101.32 148.47 25.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.554 0.576 . . . . 72.11 112.554 -170.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.92 -11.8 24.84 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.257 -0.883 . . . . 74.03 113.645 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 4.2 m-20 -96.96 161.46 13.83 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.676 0.738 . . . . 64.51 111.044 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 12.4 tmtt? -73.6 133.11 43.43 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.973 -1.012 . . . . 70.24 108.996 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 82.2 m-20 61.92 20.18 11.3 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.698 1.599 . . . . 52.33 112.282 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -120.11 152.06 53.89 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.774 1.23 . . . . 71.22 108.02 172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 Cg_endo -55.11 153.8 24.97 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.744 2.962 . . . . 62.35 113.294 -175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 28.4 p -100.4 122.54 43.32 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.362 -0.977 . . . . 65.42 108.362 166.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.0 p -84.2 107.31 16.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.81 -0.811 . . . . 70.34 108.81 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.42 122.56 5.97 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.786 -0.525 . . . . 72.45 111.786 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -57.4 156.64 15.2 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.638 1.175 . . . . 70.01 110.026 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -42.58 -39.26 6.81 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 123.764 2.976 . . . . 75.14 115.872 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -72.48 -31.21 65.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.932 0.893 . . . . 70.32 111.336 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.81 14.75 4.6 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.958 -0.565 . . . . 70.21 113.437 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.93 103.37 9.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.066 0.546 . . . . 65.31 110.997 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -71.62 123.64 22.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 70.43 110.606 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 90.1 t -78.91 104.87 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.229 0.538 . . . . 71.34 110.383 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 78.4 m -141.75 136.07 30.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.428 -1.26 . . . . 72.33 108.868 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -80.17 146.49 31.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.585 -0.524 . . . . 64.44 109.585 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.36 145.58 93.34 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.047 0.539 . . . . 72.43 110.722 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -90.85 13.18 54.18 Favored 'Cis proline' 0 C--N 1.38 2.201 0 CA-C-N 119.977 1.028 . . . . 73.21 113.882 2.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -70.88 118.75 14.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.358 0.663 . . . . 73.54 110.779 -174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.83 135.02 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.252 1.021 . . . . 75.45 109.023 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 54.0 t -78.57 122.47 25.95 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.578 0.351 . . . . 72.13 111.033 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.98 136.87 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.176 -1.046 . . . . 63.15 108.176 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -39.97 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.021 0.528 . . . . 73.24 110.689 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 m -58.88 -36.91 75.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.975 . . . . 55.44 111.643 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 p -94.15 -25.97 16.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.76 0.824 . . . . 73.21 111.283 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p 54.22 32.18 15.55 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.774 1.63 . . . . 51.21 112.187 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 37.8 ptt180 -124.28 144.89 49.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.811 0.844 . . . . 71.31 109.773 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 33.6 m -69.32 127.27 32.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.846 -0.798 . . . . 74.41 108.846 169.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 16.1 pt-20 -156.54 -168.29 2.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.461 0.705 . . . . 74.54 109.323 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -59.15 154.21 41.85 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 122.88 0.472 . . . . 74.34 112.182 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.372 1.806 0 C-N-CA 122.415 2.077 . . . . 75.33 110.773 169.033 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.784 -0.45 . . . . 74.51 109.784 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -132.83 137.55 46.78 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.054 0.39 . . . . 74.31 112.054 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.4 5.32 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.076 -0.847 . . . . 73.1 114.134 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.55 163.25 17.59 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.94 0.87 . . . . 54.1 110.505 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 35' ' ' GLU . 59.5 tttm -64.98 141.58 58.73 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.076 0.55 . . . . 64.23 110.742 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 56.17 19.14 3.64 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.113 1.765 . . . . 55.43 112.057 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.99 146.89 37.12 Favored Pre-proline 0 N--CA 1.476 0.832 0 N-CA-C 107.314 -1.365 . . . . 64.21 107.314 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.75 141.68 92.03 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.081 2.521 . . . . 70.41 111.934 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 27.6 p -92.84 117.82 30.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.566 -0.902 . . . . 74.1 108.566 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 11.5 p -87.73 130.3 34.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.85 -0.426 . . . . 61.0 109.85 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.55 145.05 20.07 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 116.383 -0.371 . . . . 73.42 112.924 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -104.58 156.62 35.62 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.594 0.758 . . . . 73.42 109.132 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 -21.04 71.56 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.839 2.359 . . . . 75.34 114.426 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.01 -24.92 59.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.096 0.558 . . . . 51.43 110.701 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.8 38.17 2.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.556 -0.747 . . . . 74.15 112.819 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.37 141.05 48.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.031 0.532 . . . . 43.32 111.059 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 10.0 mmpt? -88.14 123.26 32.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.834 0.853 . . . . 63.54 110.093 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 94.9 t -77.76 101.4 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.39 0.614 . . . . 74.42 109.846 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 72.3 m -145.91 135.69 23.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.042 1.337 . . . . 72.53 107.924 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -79.48 142.21 36.04 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.887 -0.412 . . . . 74.01 109.887 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -67.26 144.24 98.02 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 122.72 0.408 . . . . 73.25 109.924 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.67 19.7 36.36 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 119.77 0.954 . . . . 60.3 114.062 3.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -85.31 130.27 34.63 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.264 0.626 . . . . 71.43 109.567 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.45 148.6 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.077 0.951 . . . . 53.03 109.541 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.1 t -84.77 131.89 34.5 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.818 0.342 . . . . 64.01 111.315 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.1 122.22 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 106.919 -1.511 . . . . 72.42 106.919 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.59 -32.32 73.75 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.528 0.731 . . . . 74.34 111.652 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.3 m -60.93 -42.04 97.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.05 0.94 . . . . 73.14 111.227 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.2 p -90.52 -15.34 30.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.454 0.702 . . . . 61.11 111.571 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.3 p 54.47 26.66 7.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.264 1.425 . . . . 53.23 112.349 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.48 150.81 45.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.176 0.591 . . . . 72.43 110.438 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 m -72.53 132.8 44.29 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.372 -0.603 . . . . 74.53 109.372 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HA ' ' HG3' ' A' ' 7' ' ' LYS . 48.1 mt-10 -144.86 -175.01 4.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.054 0.941 . . . . 73.23 110.308 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.8 138.13 85.46 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 65.24 110.422 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.563 1.96 0 C-N-CA 122.159 1.906 . . . . 64.25 111.735 172.58 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 108.523 -0.918 . . . . 63.31 108.523 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -148.59 142.52 25.8 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.976 0.807 . . . . 74.1 111.91 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 89.74 32.82 9.66 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.786 -0.643 . . . . 21.31 113.624 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.16 177.61 7.54 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.127 0.971 . . . . 63.45 109.612 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -71.23 128.58 36.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 74.03 109.572 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.62 19.83 9.75 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.009 1.324 . . . . 63.34 112.708 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.39 132.79 23.37 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 118.477 -0.773 . . . . 73.2 109.505 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.4 133.54 25.47 Favored 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 124.072 3.182 . . . . 73.35 113.584 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 19' ' ' LYS . 31.7 p -80.34 123.1 27.71 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.584 -0.525 . . . . 63.14 109.584 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -80.19 131.29 35.68 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.409 -0.589 . . . . 23.52 109.409 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.84 119.65 5.12 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.206 -0.452 . . . . 61.03 112.07 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -59.25 145.46 81.18 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.401 1.08 . . . . 72.54 111.591 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 -27.6 82.17 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.558 2.172 . . . . 64.23 112.56 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.85 -24.22 59.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.308 0.643 . . . . 72.52 111.531 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.3 10.73 14.75 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-O 119.691 -0.505 . . . . 73.4 114.346 173.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.65 162.51 18.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.324 0.562 . . . . 74.34 110.915 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 75.1 mmtt -100.77 126.35 47.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.043 -0.725 . . . . 73.43 109.043 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 80.8 t -77.84 109.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.428 -0.582 . . . . 61.44 109.428 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 85.4 m -145.09 139.54 27.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.499 1.12 . . . . 65.33 109.33 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -78.32 143.66 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.267 0.627 . . . . 71.22 109.717 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.22 145.2 85.43 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.377 -0.344 . . . . 71.13 110.101 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.38 19.63 34.79 Favored 'Cis proline' 0 C--N 1.377 2.029 0 CA-C-N 119.571 0.882 . . . . 72.53 113.249 -0.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -74.62 128.09 34.71 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.611 0.764 . . . . 64.55 110.166 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.02 143.04 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.494 1.117 . . . . 73.01 109.606 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 45.1 t -79.05 113.9 17.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.065 -0.346 . . . . 51.23 110.065 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.89 121.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.647 -1.242 . . . . 70.51 107.647 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.83 -26.37 65.74 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.662 0.785 . . . . 72.03 112.996 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -68.16 -50.91 51.42 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.499 0.72 . . . . 52.44 111.217 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.3 p -86.05 -14.66 43.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.667 0.787 . . . . 62.04 111.852 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.1 p 53.07 32.29 12.74 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 125.508 1.523 . . . . 55.13 112.236 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -144.84 150.6 37.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.506 0.67 . . . . 74.43 112.682 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 m -80.02 96.77 6.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.687 -1.142 . . . . 70.02 111.013 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.74 -173.23 2.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.921 0.888 . . . . 71.5 110.156 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.59 132.13 92.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 122.917 0.487 . . . . 71.13 110.833 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.373 1.827 0 C-N-CA 122.601 2.201 . . . . 75.11 111.937 171.346 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.254 -0.276 . . . . 74.13 110.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -132.67 147.32 52.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.37 0.668 . . . . 64.12 109.405 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.754 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.73 11.16 57.12 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 115.123 0.809 . . . . 60.42 115.123 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.9 -179.95 3.79 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.663 0.732 . . . . 51.22 110.86 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -60.09 118.46 6.34 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.413 0.685 . . . . 72.03 111.073 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.661 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.9 m-20 66.95 20.0 10.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.307 1.443 . . . . 73.34 111.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -118.77 130.51 24.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.184 -1.043 . . . . 63.1 108.184 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 13.2 Cg_endo -53.22 138.57 63.86 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.752 2.968 . . . . 63.3 113.269 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.0 p -79.7 127.95 32.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.058 -0.519 . . . . 74.32 110.103 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 145.78 32.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.335 -0.617 . . . . 65.41 109.335 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.06 125.41 8.52 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 120.002 -0.332 . . . . 60.31 112.521 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.96 152.56 93.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.602 0.761 . . . . 74.55 109.782 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.01 -31.41 95.67 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.763 2.308 . . . . 73.01 112.994 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -73.13 -27.42 61.67 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.655 0.782 . . . . 73.22 111.345 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.66 1.69 11.88 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.803 0.681 . . . . 73.25 114.803 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.85 119.01 14.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.375 0.588 . . . . 73.35 111.112 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -71.33 114.54 9.5 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.054 -0.721 . . . . 63.02 109.054 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.69 115.86 20.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.074 0.949 . . . . 64.54 110.072 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.7 m -147.9 141.11 25.1 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.563 1.164 . . . . 60.12 108.281 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -82.15 137.17 35.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.576 -0.898 . . . . 54.24 108.576 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.94 143.6 98.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.136 0.574 . . . . 74.24 111.011 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -93.8 16.98 41.13 Favored 'Cis proline' 0 C--N 1.378 2.108 0 N-CA-C 114.57 0.95 . . . . 72.25 114.57 5.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -69.99 120.38 15.63 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.326 -0.62 . . . . 62.33 109.326 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.89 135.12 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.254 1.022 . . . . 74.41 108.686 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 47.6 t -69.76 97.39 1.08 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.24 0.543 . . . . 75.23 109.654 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.24 111.15 13.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 107.273 -1.38 . . . . 73.53 107.273 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.42 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.9 mm? -59.04 -32.07 69.42 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.573 1.149 . . . . 73.24 111.399 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 m -56.94 -48.5 78.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.548 1.139 . . . . 72.1 111.141 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.5 p -96.99 -7.59 32.66 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.587 0.755 . . . . 70.12 111.83 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p 53.66 36.35 23.46 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 126.053 1.741 . . . . 72.13 112.455 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.5 ptp180 -141.93 151.2 42.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 73.03 110.787 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.754 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 35.4 m -73.56 98.56 2.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.943 0.878 . . . . 75.24 109.051 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -123.11 164.76 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.613 1.165 . . . . 75.22 108.815 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.87 147.31 73.18 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.22 0.608 . . . . 64.12 110.885 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.373 1.835 0 C-N-CA 123.169 2.58 . . . . 75.21 112.297 171.833 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.006 -0.368 . . . . 72.12 110.006 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.93 149.31 27.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.833 0.349 . . . . 72.44 111.282 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.32 25.28 8.91 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 116.027 1.171 . . . . 72.14 116.027 164.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 9' ' ' GLU . 8.9 m-20 -123.06 172.57 8.44 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.577 0.751 . . . . 72.5 109.625 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.99 125.08 23.77 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 109.025 -0.731 . . . . 75.02 109.025 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 74.6 m-20 66.78 18.43 10.68 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.549 1.54 . . . . 71.33 112.681 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.477 ' HB3' ' H ' ' A' ' 6' ' ' ASP . 15.4 tp10 -118.3 118.56 33.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.461 -0.94 . . . . 72.01 108.461 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 8.1 Cg_endo -45.41 124.33 6.37 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.646 3.564 . . . . 74.51 113.325 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.0 p -76.0 130.14 37.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.745 0.418 . . . . 74.41 109.929 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.1 p -84.56 105.8 15.65 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.802 -0.814 . . . . 73.3 108.802 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.44 122.98 6.08 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.259 -0.736 . . . . 54.21 111.259 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 97.4 mtt180 -71.54 156.02 91.89 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.708 0.803 . . . . 70.14 110.587 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.21 -28.57 85.24 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.768 2.312 . . . . 64.35 113.34 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.77 -28.18 62.45 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.39 0.431 . . . . 73.43 109.998 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.42 1.24 11.12 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.112 -0.495 . . . . 31.53 113.586 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -78.82 108.81 12.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.819 0.447 . . . . 70.23 110.605 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 29' ' ' LEU . 46.5 mtmt -72.67 118.95 16.23 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.374 -0.602 . . . . 70.21 109.374 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.584 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 66.6 t -78.15 108.6 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.042 0.537 . . . . 52.25 109.664 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 70.7 m -150.97 138.85 19.9 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.085 1.354 . . . . 44.44 108.269 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.88 136.64 37.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.085 -1.08 . . . . 70.32 108.085 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.96 144.87 93.58 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.105 0.562 . . . . 71.24 109.913 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -87.02 1.84 68.37 Favored 'Cis proline' 0 C--N 1.378 2.126 0 C-N-CA 124.55 -1.021 . . . . 74.13 114.285 7.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -64.24 109.57 1.92 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.991 0.516 . . . . 63.04 110.113 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.19 140.15 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.066 0.946 . . . . 61.21 109.578 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.5 t -81.24 118.04 22.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.617 0.367 . . . . 74.1 111.344 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.21 118.05 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.939 -1.504 . . . . 63.25 106.939 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 19' ' ' LYS . 3.7 mm? -67.43 -22.72 65.5 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.567 0.747 . . . . 63.32 111.925 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -62.23 -42.47 99.34 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.524 0.73 . . . . 71.21 110.13 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.9 p -95.9 -10.96 27.47 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.905 0.882 . . . . 71.12 111.055 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.5 p 54.67 26.08 7.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.201 1.801 . . . . 71.33 113.31 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.695 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 35.2 ptt180 -131.3 151.33 51.61 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.168 0.987 . . . . 63.43 109.936 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -73.8 140.92 46.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.679 -1.23 . . . . 74.51 107.679 170.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.29 165.76 32.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.621 0.368 . . . . 72.32 110.056 -169.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -61.49 127.71 88.89 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.65 0.78 . . . . 73.31 111.165 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.374 1.911 0 C-N-CA 122.918 2.412 . . . . 60.12 111.919 170.46 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.265 -0.643 . . . . 74.31 109.265 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.23 145.99 26.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 62.32 111.354 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 117.28 -4.41 18.05 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.634 1.014 . . . . 74.21 115.634 168.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.42 179.09 5.4 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.223 1.012 . . . . 74.41 111.873 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -70.86 126.63 30.11 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 116.047 -0.524 . . . . 75.31 109.909 -174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.53 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 71.9 m-20 60.63 18.13 8.14 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.775 1.63 . . . . 72.43 112.359 -172.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -109.06 130.53 22.62 Favored Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 108.564 -0.902 . . . . 65.42 108.564 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -44.03 120.33 2.4 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.317 3.345 . . . . 72.3 112.916 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 14.0 p -77.03 147.14 36.92 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.098 0.559 . . . . 71.44 109.662 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -100.08 146.68 26.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.554 -1.276 . . . . 64.54 107.554 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.17 137.88 14.54 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 122.469 -0.145 . . . . 64.51 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.79 147.13 91.52 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.88 0.872 . . . . 70.31 109.458 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.98 -25.73 59.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.406 2.07 . . . . 61.4 112.191 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.29 -8.82 57.67 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.054 0.942 . . . . 72.33 111.767 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.18 -0.96 37.88 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 114.793 0.677 . . . . 74.42 114.793 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.23 130.05 35.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 117.554 0.677 . . . . 71.24 111.074 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD2' HD11 ' A' ' 29' ' ' LEU . 11.6 mmpt? -84.71 122.0 28.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.287 0.635 . . . . 74.11 109.648 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.54 108.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 123.243 0.617 . . . . 61.15 109.985 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 68.0 m -146.99 149.67 33.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.987 -1.006 . . . . 51.13 108.331 175.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -77.07 128.12 33.89 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.53 -1.285 . . . . 74.22 107.53 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.08 142.14 97.71 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 116.188 -0.46 . . . . 62.01 110.028 -173.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.2 12.56 36.36 Favored 'Cis proline' 0 C--N 1.373 1.828 0 CA-C-N 119.548 0.874 . . . . 72.33 114.235 6.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -64.31 130.25 43.11 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.993 -0.373 . . . . 65.11 109.993 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.84 142.65 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.153 0.981 . . . . 73.22 110.232 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.6 t -83.53 112.28 19.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.393 0.277 . . . . 75.43 110.545 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.01 121.76 31.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 107.353 -1.351 . . . . 54.13 107.353 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' HD2' ' A' ' 19' ' ' LYS . 4.2 mm? -65.28 -26.65 68.17 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.63 0.772 . . . . 64.05 112.59 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.2 m -63.21 -51.31 66.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.1 0.56 . . . . 75.35 110.876 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' ARG . 55.5 p -87.68 -18.01 30.5 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.212 -0.904 . . . . 71.24 111.603 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.7 p 52.75 31.77 11.01 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.77 1.628 . . . . 73.22 112.482 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.53 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 11.6 ptp180 -131.1 150.92 51.93 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.621 0.768 . . . . 75.42 110.152 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 14.1 m -81.56 113.03 19.31 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.804 -0.634 . . . . 72.44 110.109 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.41 -169.36 1.92 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.659 1.184 . . . . 74.02 109.684 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.09 149.93 89.68 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 122.908 0.483 . . . . 75.12 110.979 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.374 1.879 0 C-N-CA 122.527 2.151 . . . . 38.12 111.09 170.482 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.277 -0.638 . . . . 72.41 109.277 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.5 145.85 23.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 122.503 0.321 . . . . 74.51 110.955 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.681 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 102.57 4.31 49.48 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 115.436 0.934 . . . . 54.02 115.436 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.1 m-20 -92.15 170.44 9.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.46 0.63 . . . . 75.13 110.599 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -69.96 125.13 25.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.69 -0.856 . . . . 75.11 108.69 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 62.51 29.04 17.01 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.256 1.422 . . . . 75.14 111.832 -173.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -127.05 141.24 40.1 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.059 0.944 . . . . 61.43 108.513 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 19.9 Cg_endo -55.16 132.14 50.51 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.045 2.497 . . . . 74.41 112.619 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.608 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.9 p -82.65 141.89 32.14 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.422 0.689 . . . . 64.21 109.479 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.5 p -92.67 126.93 37.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.107 -1.071 . . . . 75.23 108.107 170.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 126.61 8.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 112.231 -0.348 . . . . 61.54 112.231 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -67.5 144.11 97.58 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.133 0.973 . . . . 72.34 109.916 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.95 -24.78 74.59 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.969 2.446 . . . . 54.53 113.245 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.75 -8.72 59.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.941 0.896 . . . . 72.13 112.138 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.08 -9.97 27.06 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.736 -0.48 . . . . 54.31 114.106 172.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 149.39 41.2 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.387 0.593 . . . . 75.3 110.788 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -100.23 117.32 34.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.898 -0.778 . . . . 61.3 108.898 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 46.8 t -77.65 94.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.689 -0.856 . . . . 61.12 108.689 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 66.7 m -128.25 141.68 51.38 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.064 -1.425 . . . . 74.32 107.867 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -78.76 135.83 37.22 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.415 -0.957 . . . . 61.21 108.415 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.09 143.3 88.53 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 124.047 0.939 . . . . 74.43 111.264 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.2 25.71 20.56 Favored 'Cis proline' 0 C--N 1.383 2.374 0 CA-C-N 119.829 0.975 . . . . 54.31 113.844 1.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -77.28 142.12 39.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.565 0.346 . . . . 54.33 110.269 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.03 137.28 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 75.32 109.217 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -82.59 124.03 29.77 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.563 0.345 . . . . 62.45 110.894 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 123.68 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.777 -1.564 . . . . 64.2 106.777 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.5 mm? -61.58 -44.19 97.48 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.331 1.02 . . . . 72.02 111.843 -165.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -68.88 -39.02 80.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.07 0.948 . . . . 74.15 111.421 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -84.29 -15.87 45.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.118 0.567 . . . . 71.43 111.279 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 54.12 37.04 26.23 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.444 1.498 . . . . 55.43 112.262 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 30.4 ptt180 -134.73 139.71 45.4 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.313 0.645 . . . . 64.34 110.771 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.681 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 38.3 m -75.94 128.08 34.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.005 -0.739 . . . . 74.13 109.005 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -147.05 170.09 17.88 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.332 -0.988 . . . . 63.44 108.332 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.97 134.54 96.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 122.921 0.488 . . . . 64.54 111.071 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 122.721 2.281 . . . . 71.51 111.893 174.574 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.18 -0.674 . . . . 53.51 109.18 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -128.96 148.04 50.91 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 122.715 0.406 . . . . 52.13 110.968 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.02 -9.95 31.69 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 114.436 0.535 . . . . 65.43 114.436 169.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.66 169.09 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.358 0.663 . . . . 74.03 110.866 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -65.65 122.92 18.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.167 0.587 . . . . 65.43 110.113 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 76.8 m-20 64.59 16.96 10.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.508 1.523 . . . . 73.32 113.769 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -104.88 136.55 19.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 108.276 -1.009 . . . . 62.2 108.276 170.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.09 137.03 76.98 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.203 2.602 . . . . 75.13 112.139 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.6 p -77.36 133.01 38.84 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.25 -0.648 . . . . 62.15 109.25 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.22 107.21 10.65 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.464 0.649 . . . . 73.22 109.481 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.21 108.42 2.69 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.52 -1.218 . . . . 60.52 112.168 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -68.22 145.12 97.35 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.108 0.963 . . . . 70.03 110.251 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -47.84 -36.66 27.08 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.651 3.568 . . . . 74.24 115.128 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -68.97 -20.13 64.18 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.676 0.79 . . . . 64.33 111.934 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.83 5.17 11.09 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.235 -0.439 . . . . 63.34 113.443 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.42 131.54 38.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.988 0.515 . . . . 73.1 111.703 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -92.7 114.45 27.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.085 -1.08 . . . . 73.32 108.085 171.443 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.46 124.76 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.564 0.346 . . . . 65.25 110.825 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.9 m -137.12 149.22 47.19 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.246 1.019 . . . . 62.43 109.234 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -84.71 141.02 30.87 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.111 -0.7 . . . . 74.42 109.111 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.09 148.42 98.85 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.641 0.776 . . . . 74.11 110.759 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.01 23.61 26.26 Favored 'Cis proline' 0 C--N 1.375 1.95 0 CA-C-N 119.527 0.867 . . . . 72.24 113.91 3.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.09 140.03 31.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.874 0.47 . . . . 55.45 110.246 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.33 138.0 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.935 1.294 . . . . 71.53 109.002 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 42.6 t -73.37 109.9 7.25 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.914 0.388 . . . . 73.34 110.722 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.52 114.31 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.731 -1.211 . . . . 70.22 107.731 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.3 -26.16 68.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.298 1.039 . . . . 75.3 112.223 -171.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -63.56 -46.47 85.78 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.806 0.843 . . . . 63.25 110.429 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 p -95.77 -8.87 33.2 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.222 1.009 . . . . 63.54 111.937 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p 54.84 28.12 9.94 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.793 1.637 . . . . 43.43 113.018 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 5.3 ptp180 -138.58 151.91 47.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.145 0.578 . . . . 74.0 110.613 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.572 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 13.6 m -77.67 125.67 29.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.144 -0.934 . . . . 64.23 109.804 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.49 176.14 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.256 1.023 . . . . 72.44 109.834 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.11 143.0 90.8 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.165 -0.445 . . . . 72.44 110.01 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 CA--C 1.563 1.966 0 C-N-CA 122.734 2.289 . . . . 44.25 112.0 173.419 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.127 -0.694 . . . . 64.2 109.127 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.52 144.63 25.47 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.152 -0.342 . . . . 74.23 110.626 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.636 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.41 20.09 30.76 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 115.291 0.876 . . . . 72.44 115.291 168.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.77 -179.92 3.88 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.406 0.682 . . . . 75.34 110.55 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -61.28 122.43 15.08 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.744 0.818 . . . . 54.55 110.846 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 60.26 27.13 16.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.011 1.324 . . . . 63.23 111.159 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -124.07 125.41 25.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 109.148 -0.686 . . . . 73.54 109.148 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.48 125.31 10.63 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 124.328 3.352 . . . . 60.23 112.858 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p -77.69 132.19 38.06 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.94 -0.763 . . . . 64.44 108.94 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -81.42 153.04 27.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.84 0.856 . . . . 72.34 109.091 175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.64 131.56 10.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.932 -0.48 . . . . 75.22 112.835 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -66.57 157.58 82.29 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.959 1.303 . . . . 74.14 110.999 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.76 -35.41 98.81 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.624 2.216 . . . . 64.41 112.69 172.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.51 -30.06 57.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.987 0.915 . . . . 60.23 111.088 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.03 1.54 12.87 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 115.247 0.859 . . . . 61.34 115.247 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.1 146.75 47.31 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.056 0.928 . . . . 71.35 110.384 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -86.44 122.67 30.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.538 -0.542 . . . . 74.53 109.538 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 24.8 t -79.18 109.45 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.55 0.74 . . . . 63.14 109.832 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.6 m -137.24 139.93 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.82 -1.178 . . . . 62.02 107.82 169.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -78.06 146.82 35.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.164 -1.05 . . . . 74.42 108.164 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.55 141.47 97.93 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.041 0.536 . . . . 71.14 110.716 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -98.65 18.07 27.37 Favored 'Cis proline' 0 C--N 1.372 1.766 0 CA-C-N 119.267 0.774 . . . . 44.14 113.957 -1.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -65.13 141.58 58.65 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.033 0.533 . . . . 74.44 110.028 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.57 136.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.343 1.057 . . . . 73.42 110.302 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.5 t -80.98 113.61 19.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.978 0.511 . . . . 54.2 110.655 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.7 118.82 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.657 -1.609 . . . . 73.35 106.657 170.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.2 -36.22 82.93 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.11 0.964 . . . . 74.44 111.564 -171.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -61.42 -43.46 98.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.749 0.82 . . . . 72.34 111.002 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.5 p -92.51 -11.06 35.58 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.11 0.564 . . . . 71.24 111.212 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.5 p 54.66 28.84 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.987 1.715 . . . . 65.22 113.137 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -140.49 151.12 44.56 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.328 0.651 . . . . 73.2 110.265 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 18.4 m -82.75 116.45 22.11 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.838 0.455 . . . . 74.33 110.794 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -104.48 -170.36 1.75 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.468 1.107 . . . . 73.24 109.04 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.75 156.77 91.52 Favored Pre-proline 0 N--CA 1.485 1.279 0 CA-C-O 119.051 -0.5 . . . . 74.34 110.577 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.601 2.201 . . . . 75.12 111.801 175.743 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 10.3 pt-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 63.33 109.259 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.8 p -97.24 136.92 37.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.122 -0.361 . . . . 75.32 110.65 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.6 1.21 64.07 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 115.228 0.851 . . . . 42.13 115.228 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.04 -179.58 4.73 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.286 0.634 . . . . 64.32 111.004 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -65.01 121.56 14.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.068 0.947 . . . . 62.42 110.416 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 60.03 18.04 7.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.418 1.487 . . . . 43.42 112.694 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 54.4 mm-40 -107.75 138.95 20.16 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.891 0.877 . . . . 63.12 109.695 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.43 122.61 12.1 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 123.145 2.563 . . . . 74.31 112.277 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 28.0 p -74.48 128.69 36.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.774 -0.454 . . . . 61.24 109.774 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 120.03 23.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.268 -0.641 . . . . 70.4 109.268 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.44 126.01 8.36 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.842 -0.617 . . . . 75.15 113.552 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.43 144.35 88.43 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.157 0.983 . . . . 74.02 110.805 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.13 -17.57 60.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.502 2.134 . . . . 63.24 112.98 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.72 -8.09 58.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.835 0.854 . . . . 62.32 111.999 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.2 35.72 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 114.566 0.586 . . . . 74.23 114.566 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.48 139.57 47.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.543 0.672 . . . . 70.02 110.293 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -96.06 116.19 28.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.353 0.661 . . . . 50.33 110.278 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.94 108.48 18.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.159 -0.682 . . . . 74.01 109.159 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.3 m -128.81 148.86 50.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 124.671 1.188 . . . . 73.41 108.316 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -83.74 150.69 25.65 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.658 -0.867 . . . . 71.41 108.658 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -68.4 143.06 95.14 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 122.942 0.497 . . . . 73.33 110.888 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -93.63 14.46 46.08 Favored 'Cis proline' 0 C--N 1.38 2.229 0 CA-C-N 119.59 0.889 . . . . 73.42 113.995 0.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -71.59 134.06 46.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.299 0.64 . . . . 72.12 110.645 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.08 139.73 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.623 1.169 . . . . 65.35 109.076 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.9 t -79.75 120.05 23.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.114 0.416 . . . . 63.01 111.244 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.09 120.33 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 106.651 -1.611 . . . . 75.52 106.651 168.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.35 -39.27 92.12 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.197 0.599 . . . . 54.15 111.583 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -61.49 -32.47 72.49 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.791 0.837 . . . . 60.11 111.456 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.2 p -95.84 -16.48 21.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.084 0.554 . . . . 64.04 111.276 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p 54.56 35.38 23.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.245 1.818 . . . . 65.44 112.045 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -146.88 150.59 35.55 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.112 0.565 . . . . 71.13 111.093 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 19.8 m -82.74 115.22 21.56 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.005 0.522 . . . . 70.02 110.547 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -122.26 178.78 4.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 74.31 109.311 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.41 138.82 97.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.142 0.577 . . . . 62.22 111.542 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 C--N 1.376 2.023 0 C-N-CA 123.245 2.63 . . . . 64.34 112.003 176.584 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.17 -0.307 . . . . 74.42 110.17 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.2 p -154.44 150.22 27.63 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 122.607 0.363 . . . . 62.44 110.952 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.688 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 89.47 3.53 74.85 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.511 0.564 . . . . 71.02 114.511 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -95.88 178.81 5.31 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.297 0.639 . . . . 71.32 110.341 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 123.68 21.13 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.507 0.723 . . . . 71.41 109.675 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 58.92 35.56 24.2 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.491 1.516 . . . . 73.24 111.661 -172.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 12.8 tp10 -130.23 125.68 21.92 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 118.073 -0.965 . . . . 72.32 109.585 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 2.2 Cg_endo -37.87 121.59 0.46 Allowed 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 124.916 3.744 . . . . 74.3 113.952 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.646 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 30.1 p -76.26 115.11 15.68 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.543 -0.91 . . . . 64.24 108.543 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.0 p -80.48 108.73 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.186 0.594 . . . . 73.15 110.395 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.68 121.65 5.56 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.01 -0.541 . . . . 54.23 112.977 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -61.61 155.16 61.67 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.206 1.003 . . . . 72.55 110.873 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.98 -23.36 21.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.633 2.889 . . . . 72.33 115.715 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.73 -24.86 33.38 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.745 0.418 . . . . 71.34 111.416 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.22 3.85 10.37 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.825 -0.43 . . . . 71.02 113.793 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 123.38 25.3 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.968 0.507 . . . . 74.54 111.462 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.646 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -80.39 110.19 15.61 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.653 0.781 . . . . 70.33 109.713 176.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.0 t -79.43 111.18 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.096 0.558 . . . . 70.44 110.154 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 82.5 m -140.53 135.39 31.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.575 -1.193 . . . . 54.32 108.193 171.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -79.59 127.15 31.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.311 -0.996 . . . . 74.12 108.311 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.37 144.61 97.54 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.24 0.616 . . . . 51.54 110.558 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.13 8.15 67.01 Favored 'Cis proline' 0 C--N 1.379 2.174 0 N-CA-C 114.706 1.002 . . . . 60.3 114.706 8.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.37 127.47 33.08 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.499 -0.556 . . . . 74.32 109.499 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.89 138.64 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.759 0.824 . . . . 74.45 109.788 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.0 t -77.67 113.42 15.5 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.232 0.469 . . . . 62.45 110.224 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.439 HD13 ' HB2' ' A' ' 35' ' ' GLU . 2.7 mp -78.81 111.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.385 -1.709 . . . . 62.53 106.385 168.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.52 -28.24 69.81 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.014 0.925 . . . . 74.34 112.12 -170.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.9 m -60.0 -54.05 50.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.678 0.791 . . . . 62.41 110.342 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -83.74 -12.77 55.32 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.798 0.839 . . . . 70.55 111.432 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.0 p 53.69 33.96 17.82 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.661 1.584 . . . . 54.2 112.312 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -136.98 150.38 48.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.697 0.799 . . . . 71.24 110.144 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -81.59 119.15 23.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.882 -0.785 . . . . 33.51 108.882 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' HD13 ' A' ' 28' ' ' ILE . 35.2 mt-10 -121.01 170.44 9.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.472 0.709 . . . . 62.35 109.951 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.3 134.15 82.79 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.893 -0.594 . . . . 73.23 110.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.569 2.236 0 C-N-CA 122.574 2.183 . . . . 73.35 111.609 172.033 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 108.273 -1.01 . . . . 74.43 108.273 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -140.89 138.15 33.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.326 -0.233 . . . . 44.31 111.145 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.547 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 105.99 5.18 38.46 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.412 0.525 . . . . 34.22 114.412 174.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.67 172.37 8.3 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.582 0.753 . . . . 51.21 111.225 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -67.64 122.17 17.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.44 1.096 . . . . 70.14 109.253 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 64.39 20.99 12.37 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.166 1.386 . . . . 74.42 112.319 -175.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -126.32 135.83 27.73 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.193 -0.908 . . . . 70.22 110.129 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' SER . 1.6 Cg_endo -41.58 133.16 3.68 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.853 3.702 . . . . 63.14 114.645 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.1 p -93.23 128.35 39.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.48 0.712 . . . . 72.32 109.304 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.9 p -83.95 101.07 11.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.658 -0.868 . . . . 70.41 108.658 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -87.39 118.78 5.07 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.671 -0.695 . . . . 74.02 112.539 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 96.6 mtt180 -56.81 152.83 25.11 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.76 1.224 . . . . 73.02 111.394 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.68 -23.63 58.61 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.349 2.7 . . . . 72.44 114.318 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.22 5.52 29.86 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.855 0.862 . . . . 72.24 112.152 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.0 9.98 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.355 -0.136 . . . . 63.34 112.97 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -114.73 97.94 6.56 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.432 -0.581 . . . . 44.44 109.432 175.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 10.1 mtmp? -71.4 111.18 6.51 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.192 0.597 . . . . 75.2 109.477 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -76.15 113.93 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.08 -0.711 . . . . 73.33 109.08 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 77.5 m -141.47 143.4 33.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.95 1.3 . . . . 63.42 108.838 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -80.82 143.64 32.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.161 -1.052 . . . . 72.44 108.161 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.19 147.76 90.85 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.78 0.432 . . . . 62.41 110.53 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.52 28.17 17.15 Favored 'Cis proline' 0 C--N 1.378 2.116 0 CA-C-N 119.747 0.946 . . . . 71.05 113.454 1.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -82.2 117.98 22.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.804 0.442 . . . . 75.31 110.207 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -97.46 131.29 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.33 1.052 . . . . 73.43 109.805 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.9 t -79.87 113.5 18.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.65 0.262 . . . . 63.54 110.755 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.8 mt -79.9 129.03 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.935 -1.135 . . . . 43.34 107.935 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.29 -42.1 99.06 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.808 0.843 . . . . 72.41 111.278 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -59.59 -36.69 76.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.194 0.997 . . . . 55.42 111.836 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.5 p -95.5 -19.26 19.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 50.24 111.467 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 88.0 p 54.62 30.98 14.21 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.163 1.785 . . . . 51.35 112.77 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 12.1 ptp180 -140.45 149.28 42.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.353 0.661 . . . . 74.13 110.998 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 8.2 m -81.65 99.76 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.276 0.63 . . . . 74.05 110.639 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 36.4 mt-10 -107.72 -172.99 2.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.975 0.91 . . . . 72.21 111.004 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.1 158.9 74.57 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.743 0.817 . . . . 73.14 111.022 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 CA--C 1.561 1.872 0 C-N-CA 122.677 2.251 . . . . 71.4 111.217 166.809 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.035 -0.728 . . . . 65.25 109.035 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.9 p -143.42 143.23 31.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.039 0.381 . . . . 42.55 111.842 -173.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 105.01 30.49 4.78 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 114.651 0.62 . . . . 63.42 114.651 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.65 174.26 8.85 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.039 0.936 . . . . 62.24 110.446 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -68.84 123.76 21.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.244 1.018 . . . . 73.13 109.1 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 84.9 m-20 60.51 29.88 19.34 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.785 1.234 . . . . 72.45 112.338 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -113.92 141.05 25.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 107.768 -1.197 . . . . 74.34 107.768 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.97 145.52 10.25 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 123.397 2.731 . . . . 71.11 112.035 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -100.74 132.7 46.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.513 -0.551 . . . . 70.41 109.513 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.31 88.18 6.95 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.322 -0.992 . . . . 62.03 108.322 170.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -80.89 121.39 5.4 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 115.213 -0.903 . . . . 53.21 112.849 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -82.29 144.64 50.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.513 -0.551 . . . . 73.24 109.513 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.09 -12.22 34.46 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.205 2.603 . . . . 74.12 114.375 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 -17.67 57.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.932 0.893 . . . . 71.31 111.384 172.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.7 -13.5 9.29 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 116.135 -0.484 . . . . 75.23 113.581 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.17 97.61 6.97 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.067 0.46 . . . . 44.14 110.65 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 34.6 mtmt -82.45 118.64 23.37 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.846 0.858 . . . . 64.33 108.687 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.602 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.4 t -77.4 95.53 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 122.079 0.943 . . . . 72.53 109.691 -175.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 75.2 m -130.24 152.0 50.14 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 112.973 -1.922 . . . . 74.5 108.99 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -79.58 140.72 37.07 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.954 -0.758 . . . . 72.45 108.954 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.21 147.41 82.96 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.064 0.546 . . . . 65.11 109.997 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -94.25 22.86 28.01 Favored 'Cis proline' 0 C--N 1.376 2.002 0 CA-C-N 119.39 0.818 . . . . 51.21 113.284 1.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -79.81 124.94 29.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.414 0.685 . . . . 75.11 109.221 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.42 144.99 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.703 0.801 . . . . 73.3 109.803 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.3 t -84.31 113.32 21.05 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.002 0.521 . . . . 61.35 110.037 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.8 mp -79.89 119.37 29.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 106.813 -1.551 . . . . 75.41 106.813 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.48 -26.99 65.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.713 . . . . 70.22 112.645 -173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.3 m -59.65 -54.78 42.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.783 0.833 . . . . 72.24 111.184 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 p -87.87 -18.79 28.45 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.717 0.807 . . . . 74.1 110.9 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.8 p 52.27 44.37 29.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.175 1.79 . . . . 51.25 112.802 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 2.2 ptm180 -146.45 144.9 29.99 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.275 0.559 . . . . 70.13 110.393 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 m -76.47 88.27 3.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.251 1.02 . . . . 74.44 110.362 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 44.9 mt-10 -103.37 -171.65 1.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.972 0.909 . . . . 65.23 109.935 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -62.22 139.44 96.21 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 123.851 0.86 . . . . 73.21 110.987 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.375 1.943 0 C-N-CA 122.902 2.402 . . . . 64.42 112.262 173.188 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.421 0.153 . . . . 64.23 110.66 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -157.97 113.22 2.7 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.846 0.458 . . . . 53.24 109.842 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.456 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 140.12 -9.12 3.0 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 115.547 0.979 . . . . 61.43 115.547 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.7 173.55 7.55 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.058 0.543 . . . . 35.25 111.215 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.22 116.11 9.27 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.101 0.96 . . . . 62.11 109.684 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 73.75 16.32 3.83 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.099 2.16 . . . . 74.23 112.603 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -106.97 135.65 19.54 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 123.892 0.877 . . . . 74.12 109.442 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.59 133.28 57.13 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.392 2.728 . . . . 71.32 111.834 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.1 p -80.75 121.67 26.19 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.564 -0.532 . . . . 72.03 109.564 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 2.4 p -78.82 88.64 4.65 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.87 -0.789 . . . . 64.14 108.87 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.78 118.07 4.65 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.827 -1.079 . . . . 74.12 112.417 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -69.32 152.95 96.33 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.45 1.1 . . . . 73.31 110.387 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.65 -21.52 63.1 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.2 2.6 . . . . 62.51 114.699 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.93 -21.92 58.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.496 0.719 . . . . 73.54 111.551 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.79 -0.91 13.67 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 116.016 -0.538 . . . . 55.21 113.423 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.78 99.31 4.38 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 116.864 0.332 . . . . 72.21 111.114 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -73.18 114.5 11.42 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.222 -1.029 . . . . 73.13 108.222 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 97.7 t -76.58 106.66 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.038 -0.727 . . . . 54.44 109.038 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 79.9 m -143.5 135.82 27.02 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 125.297 1.439 . . . . 52.42 109.227 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -79.63 120.57 24.14 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.194 -1.039 . . . . 71.31 108.194 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.07 149.23 94.24 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.311 0.645 . . . . 61.12 110.517 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -88.59 15.29 46.39 Favored 'Cis proline' 0 C--N 1.379 2.154 0 CA-C-N 120.082 1.065 . . . . 73.31 114.707 9.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -75.98 109.41 9.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 75.02 109.709 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.88 130.89 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.097 0.959 . . . . 75.31 110.139 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 51.9 t -71.19 110.81 6.08 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.716 0.293 . . . . 72.43 110.765 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.31 127.18 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.963 -1.125 . . . . 71.43 107.963 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.27 -34.35 77.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.259 0.624 . . . . 62.5 111.328 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -57.56 -43.76 84.74 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.763 0.825 . . . . 50.2 111.169 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 p -91.01 -16.12 28.49 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.953 0.901 . . . . 61.0 111.767 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p 52.93 30.43 9.27 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.594 1.558 . . . . 63.04 112.18 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -140.74 147.75 39.65 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.648 0.379 . . . . 74.21 111.138 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.4 m -74.15 130.71 40.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.349 0.66 . . . . 54.44 110.375 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.44 176.76 10.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.56 0.744 . . . . 74.34 109.939 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.52 123.01 81.67 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 119.441 -0.314 . . . . 70.42 110.333 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 C--N 1.386 2.507 0 C-N-CA 122.918 2.412 . . . . 74.13 112.011 179.119 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.193 -0.669 . . . . 64.31 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.62 151.11 7.48 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.341 0.257 . . . . 62.23 111.493 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.62 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.71 -8.09 29.9 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 115.563 0.985 . . . . 23.23 115.563 166.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.71 172.6 8.07 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.411 0.605 . . . . 70.04 111.655 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 3.6 tmtp? -63.35 125.1 23.03 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.862 0.726 . . . . 75.44 110.033 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 97.2 m-20 61.51 24.39 14.5 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.162 1.385 . . . . 73.43 112.328 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -123.1 142.55 38.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.885 0.874 . . . . 74.35 109.112 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.98 139.87 79.56 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.701 2.934 . . . . 53.24 112.926 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 26.5 p -90.47 128.04 36.4 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.372 0.669 . . . . 63.04 109.31 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -78.5 119.53 21.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.845 0.355 . . . . 75.13 110.191 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.32 120.7 5.5 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 116.058 -0.519 . . . . 64.43 113.246 -174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -71.08 156.33 92.08 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.24 1.016 . . . . 64.4 110.838 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.38 -43.82 51.31 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.178 2.585 . . . . 74.25 113.222 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.53 -25.17 67.87 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.257 1.023 . . . . 74.42 112.364 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.17 2.38 12.34 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-O 119.637 -0.535 . . . . 73.0 113.844 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.33 115.39 8.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 117.255 0.528 . . . . 72.41 111.583 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.739 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -75.81 106.47 7.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.643 0.777 . . . . 74.11 109.207 173.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.559 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 60.0 t -79.62 119.61 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.023 0.529 . . . . 64.02 110.773 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.5 m -142.37 154.15 44.39 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.009 1.323 . . . . 65.24 109.034 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.55 145.28 25.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.179 -0.675 . . . . 71.21 109.179 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.24 146.16 94.27 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 122.961 0.504 . . . . 44.25 110.606 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -91.0 14.88 49.33 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.581 0.886 . . . . 23.34 114.225 5.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -78.23 124.41 28.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.949 0.404 . . . . 73.44 110.369 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.19 131.25 59.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.455 1.102 . . . . 65.43 108.6 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.8 t -69.11 107.63 3.26 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.016 0.436 . . . . 45.21 110.029 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.29 113.24 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.386 -1.339 . . . . 72.13 107.386 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.01 -28.47 66.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.521 1.128 . . . . 73.14 111.638 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.9 m -64.45 -52.39 58.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.785 0.834 . . . . 64.24 111.208 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.8 p -90.96 -4.06 56.79 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.135 0.574 . . . . 73.34 111.564 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p 53.55 29.56 9.33 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.952 1.701 . . . . 63.25 113.022 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.4 ptt180 -138.28 148.73 44.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.667 0.787 . . . . 75.35 109.509 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 45.6 m -71.09 91.27 0.9 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.961 -0.755 . . . . 65.1 108.961 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 36' ' ' ASN . 29.6 tt0 -101.18 -178.79 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.356 1.062 . . . . 74.54 108.627 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 3.1 p-10 -72.62 145.76 87.67 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 109.602 -0.518 . . . . 64.11 109.602 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.365 1.423 0 C-N-CA 122.902 2.401 . . . . 74.42 112.807 173.327 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.715 -0.476 . . . . 71.31 109.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.64 13.84 66.4 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.779 0.675 . . . . 74.01 113.572 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.7 178.66 4.49 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.067 0.947 . . . . 72.01 109.18 -175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 p -147.91 140.1 24.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.534 0.334 . . . . 73.31 110.722 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.541 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 109.95 -4.22 30.37 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 114.973 0.749 . . . . 62.33 114.973 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -100.2 176.29 5.44 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.338 0.655 . . . . 74.0 112.073 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -61.37 117.16 5.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.78 0.832 . . . . 71.23 110.623 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.4 m-20 64.14 21.42 12.55 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.97 1.308 . . . . 75.43 111.624 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -112.84 132.22 22.39 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 108.126 -1.064 . . . . 65.52 108.126 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.6 Cg_endo -53.88 140.91 67.91 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 123.232 2.621 . . . . 65.03 112.864 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 28.4 p -88.66 133.4 34.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.919 0.487 . . . . 71.14 109.938 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.9 p -93.16 104.92 17.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.693 0.797 . . . . 70.34 109.985 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -78.06 129.18 9.25 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.52 -0.632 . . . . 65.34 111.52 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -89.22 168.06 16.3 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.833 0.853 . . . . 64.1 111.665 -170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.25 -33.07 53.46 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.349 2.699 . . . . 71.42 114.564 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.26 -8.92 58.13 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.908 0.483 . . . . 63.3 111.619 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.12 -24.99 29.34 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 114.163 0.425 . . . . 64.22 114.163 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 128.09 34.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.966 0.383 . . . . 55.23 110.629 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 39.3 mtmt -76.64 129.86 36.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.056 0.942 . . . . 74.15 108.899 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 87.4 t -77.84 117.81 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.086 0.47 . . . . 73.54 110.121 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.8 m -146.48 136.56 23.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.003 1.321 . . . . 75.41 107.538 169.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.63 139.6 38.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.523 -0.918 . . . . 64.1 108.523 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.32 141.83 96.22 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 122.747 0.419 . . . . 75.1 110.104 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -96.12 19.36 32.14 Favored 'Cis proline' 0 C--N 1.375 1.929 0 N-CA-C 114.649 0.98 . . . . 72.32 114.649 4.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -67.97 125.95 27.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.001 -0.37 . . . . 74.15 110.001 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.55 129.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.727 1.211 . . . . 72.22 109.817 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.686 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 39.0 t -78.77 110.25 13.76 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.999 0.52 . . . . 75.12 109.781 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.52 140.46 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.721 -0.844 . . . . 73.03 108.721 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 -37.42 87.33 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.537 0.94 . . . . 42.25 113.537 -165.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -75.26 -50.93 14.54 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.919 0.39 . . . . 54.5 110.204 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -70.65 -26.36 63.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.699 0.8 . . . . 63.4 111.874 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p 54.29 27.08 7.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.033 1.733 . . . . 64.54 112.688 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 12.0 ptp180 -126.94 142.4 51.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.962 0.905 . . . . 64.34 110.294 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 30.8 m -75.38 100.17 4.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.334 0.654 . . . . 64.53 109.8 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 -177.96 3.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.564 0.746 . . . . 63.25 110.492 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -71.96 139.4 82.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 122.61 0.364 . . . . 72.44 110.787 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.381 2.284 0 C-N-CA 123.093 2.529 . . . . 71.54 112.342 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.429 -0.582 . . . . 74.11 109.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.95 -30.38 9.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.237 -0.438 . . . . 61.23 112.736 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.81 176.93 5.0 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.156 0.582 . . . . 71.32 109.88 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.87 149.82 50.37 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.068 0.547 . . . . 52.13 109.926 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.448 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 97.71 2.26 58.6 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.171 0.828 . . . . 72.43 115.171 170.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.63 164.96 13.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.359 0.663 . . . . 74.34 109.849 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.24 137.46 50.84 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.356 0.263 . . . . 72.13 110.396 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.34 28.31 17.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.446 1.498 . . . . 63.45 111.064 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.99 134.87 14.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 108.801 -0.814 . . . . 61.12 108.801 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.3 Cg_endo -54.47 146.22 53.54 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 123.995 3.13 . . . . 75.01 114.09 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.5 p -91.82 137.68 32.17 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.588 -0.733 . . . . 74.24 109.409 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -80.16 88.36 5.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.136 -1.061 . . . . 74.53 108.136 171.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.19 120.83 5.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 114.978 -1.01 . . . . 64.42 111.981 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -74.68 151.15 86.88 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.136 0.974 . . . . 54.42 111.44 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.87 -22.54 68.86 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.958 2.439 . . . . 71.43 113.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.04 -15.27 58.46 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.659 0.784 . . . . 72.32 111.222 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.64 -6.15 24.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.891 -0.394 . . . . 60.21 114.041 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.77 98.51 3.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.104 0.478 . . . . 74.12 110.94 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.83 112.8 8.23 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.533 0.733 . . . . 72.23 109.273 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 85.9 t -78.82 110.09 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 122.771 0.429 . . . . 63.23 110.588 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 62.9 m -147.7 151.01 35.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.858 1.263 . . . . 61.43 109.0 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -84.26 138.91 32.68 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.779 -0.822 . . . . 75.23 108.779 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.5 146.3 97.69 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.145 0.578 . . . . 71.33 110.814 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.18 10.14 60.0 Favored 'Cis proline' 0 C--N 1.376 1.978 0 N-CA-C 114.697 0.999 . . . . 54.41 114.697 3.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -73.09 114.01 10.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.133 0.573 . . . . 73.43 111.006 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.46 133.53 37.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.7 1.2 . . . . 53.01 109.77 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.3 t -70.72 105.41 3.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.127 0.489 . . . . 72.51 110.675 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.5 118.4 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.084 -1.08 . . . . 65.34 108.084 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.42 -36.97 84.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.065 0.946 . . . . 62.12 112.559 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.3 p -62.51 -38.78 91.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.556 0.742 . . . . 71.23 111.643 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.9 p -97.12 -7.76 31.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.307 0.643 . . . . 65.24 111.493 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p 55.08 21.27 3.74 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.231 1.812 . . . . 53.23 113.521 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 ptp180 -133.16 148.92 52.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.796 0.438 . . . . 74.04 111.751 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.7 m -74.08 114.82 12.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.773 -0.649 . . . . 63.14 109.672 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.1 -171.17 2.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.477 1.111 . . . . 61.11 109.001 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.82 148.25 87.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 119.08 -0.486 . . . . 75.2 111.325 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.375 1.927 0 C-N-CA 123.401 2.734 . . . . 72.13 112.501 169.876 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 109.438 -0.578 . . . . 75.11 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.92 -22.37 7.23 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 119.681 -0.511 . . . . 74.45 113.496 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -97.11 -166.35 1.38 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 117.446 0.623 . . . . 61.44 109.51 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.93 134.47 40.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.665 0.386 . . . . 72.12 110.612 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 118.92 0.73 14.87 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.572 0.989 . . . . 70.5 115.572 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.79 174.82 7.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.106 0.953 . . . . 72.22 110.655 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -68.06 122.97 19.39 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.799 -0.815 . . . . 64.13 108.799 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 66.56 19.48 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.876 1.671 . . . . 65.31 112.418 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 4.6 tp10 -113.17 129.59 24.41 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.855 0.862 . . . . 73.22 109.108 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 5.2 Cg_endo -43.56 126.74 5.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 124.274 3.316 . . . . 62.31 112.981 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.5 p -84.52 130.76 34.71 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.114 -0.698 . . . . 73.52 109.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.1 p -80.63 139.56 36.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.464 -0.569 . . . . 73.32 109.464 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.34 114.71 4.94 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.315 -0.314 . . . . 65.32 112.315 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -61.5 148.78 85.59 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.196 0.998 . . . . 72.43 111.248 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.45 -5.14 13.31 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.91 2.407 . . . . 55.24 114.413 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.41 2.12 47.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.521 0.728 . . . . 74.44 111.625 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.57 4.04 62.43 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.892 -0.393 . . . . 52.03 113.862 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 155.81 19.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.042 0.421 . . . . 52.12 110.301 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -101.95 127.45 48.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.152 0.581 . . . . 54.43 109.883 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.8 t -78.5 109.67 13.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.895 -0.78 . . . . 55.02 108.895 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 71.8 m -141.64 141.1 33.41 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.592 1.182 . . . . 71.14 108.604 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -78.88 135.27 36.96 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.428 -1.323 . . . . 73.15 107.428 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.61 141.7 98.32 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.343 0.657 . . . . 44.24 110.073 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -99.26 28.33 15.15 Favored 'Cis proline' 0 C--N 1.371 1.744 0 CA-C-N 119.766 0.952 . . . . 62.43 114.446 5.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -85.29 143.21 28.84 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.785 -0.45 . . . . 71.21 109.785 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' A' ' 37' ' ' PRO . 27.9 m -126.0 140.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.432 0.693 . . . . 63.42 109.797 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.0 t -80.62 116.6 20.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.49 0.716 . . . . 73.13 111.398 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.29 123.75 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.762 -1.57 . . . . 72.04 106.762 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.31 -29.15 70.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.606 0.762 . . . . 71.22 111.527 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m -71.04 -36.65 72.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.776 0.831 . . . . 65.44 111.098 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.9 p -92.1 -21.04 20.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.342 0.657 . . . . 71.34 111.034 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.7 p 53.38 37.95 26.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.825 1.65 . . . . 52.03 111.784 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HA ' ' H ' ' A' ' 11' ' ' CYS . 15.9 ptp180 -145.06 146.89 32.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.259 0.624 . . . . 75.2 111.192 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 22.4 m -75.98 123.22 25.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.277 0.631 . . . . 72.34 109.644 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.92 -177.75 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.163 0.985 . . . . 72.44 109.622 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.34 127.85 86.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.229 0.612 . . . . 74.44 109.711 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG3' HG22 ' A' ' 26' ' ' VAL . 15.1 Cg_exo . . . . . 0 C--N 1.373 1.846 0 C-N-CA 123.034 2.489 . . . . 73.44 111.847 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.463 -0.569 . . . . 71.33 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.78 -31.57 3.31 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.32 0.388 . . . . 43.32 113.823 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -85.58 177.62 7.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.584 0.754 . . . . 71.33 110.33 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.05 150.51 34.05 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.672 0.389 . . . . 62.54 110.733 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.67 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.07 -6.85 58.44 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 114.923 0.729 . . . . 71.03 114.923 170.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.78 175.38 6.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.494 0.718 . . . . 73.12 110.902 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -67.11 122.87 18.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.312 -0.625 . . . . 63.02 109.312 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 80.3 m-20 63.36 31.66 15.06 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.564 1.146 . . . . 72.45 110.662 -176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.14 131.32 23.92 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.27 -1.011 . . . . 63.24 108.27 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.14 130.55 32.44 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.626 2.884 . . . . 54.31 112.382 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 29.0 p -79.29 127.2 31.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.8 -0.444 . . . . 74.4 109.8 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -79.86 125.09 29.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.367 0.667 . . . . 74.11 109.311 177.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.22 132.17 10.98 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.935 -0.575 . . . . 65.33 113.337 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -73.72 139.01 77.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.534 1.134 . . . . 72.14 111.059 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.45 -31.46 48.33 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.385 2.723 . . . . 63.14 113.876 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.26 -27.53 63.51 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.725 0.41 . . . . 74.4 111.267 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.35 0.83 11.28 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.705 -0.497 . . . . 72.24 114.219 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 163.05 26.92 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.675 0.737 . . . . 63.41 110.583 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 64.12 108.568 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 99.6 t -77.55 110.6 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.408 0.683 . . . . 73.45 109.58 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 84.4 m -139.2 138.52 36.96 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 72.15 108.988 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -79.5 142.53 35.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.623 -0.88 . . . . 74.54 108.623 173.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.61 144.82 97.92 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 122.959 0.504 . . . . 64.25 110.874 -174.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -93.12 14.76 46.76 Favored 'Cis proline' 0 C--N 1.377 2.055 0 C-N-CA 124.704 -0.957 . . . . 75.41 114.309 4.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.89 132.27 46.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.694 0.398 . . . . 74.32 110.938 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -115.77 126.89 73.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.338 1.055 . . . . 73.14 108.835 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -75.14 112.76 11.73 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.686 0.279 . . . . 74.52 110.984 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.88 132.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.26 -1.015 . . . . 74.12 108.26 172.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.07 -46.25 88.73 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 124.01 0.819 . . . . 73.11 111.782 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -66.58 -45.61 78.68 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.978 0.799 . . . . 62.33 111.499 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -80.91 -15.38 56.44 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.105 0.562 . . . . 74.02 111.17 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p 54.26 24.51 5.07 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.627 1.571 . . . . 73.22 113.029 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 36.4 ptt180 -131.28 148.78 52.72 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.634 0.774 . . . . 61.54 109.24 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 53.8 m -71.81 94.37 1.4 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.832 -0.803 . . . . 65.32 108.832 173.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -99.33 170.35 8.71 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.801 -1.09 . . . . 63.31 108.843 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.58 139.16 88.81 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.666 0.386 . . . . 75.42 110.25 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--N 1.369 1.606 0 C-N-CA 122.904 2.402 . . . . 74.14 112.022 173.436 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 109.49 -0.559 . . . . 71.21 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.28 -25.24 27.91 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.979 -0.448 . . . . 54.34 111.979 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.87 -168.29 0.26 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.827 1.251 . . . . 65.52 110.492 167.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.5 p -155.31 128.68 8.36 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.742 -0.599 . . . . 75.41 111.458 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 136.65 -13.37 3.95 Favored Glycine 0 C--N 1.355 1.639 0 N-CA-C 116.062 1.185 . . . . 60.21 116.062 164.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 23.2 m-20 -94.86 175.72 6.54 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.71 1.255 . . . . 74.12 112.37 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.93 131.33 50.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.151 -0.931 . . . . 71.44 110.096 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.591 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 62.3 m-20 57.98 27.13 14.33 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.737 1.215 . . . . 75.2 112.195 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 14.3 tp10 -119.69 125.98 27.17 Favored Pre-proline 0 N--CA 1.472 0.627 0 C-N-CA 123.971 0.909 . . . . 53.21 108.587 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 10.8 Cg_endo -49.2 140.76 25.04 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.934 3.089 . . . . 75.44 112.65 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.558 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 29.0 p -88.2 136.69 32.86 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 41.13 109.695 177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -85.53 134.36 34.03 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.605 -0.887 . . . . 52.25 108.605 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.2 138.4 13.91 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.502 -0.317 . . . . 65.54 112.559 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.72 151.22 57.92 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.431 1.092 . . . . 65.15 108.834 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.49 -34.93 83.84 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.154 2.569 . . . . 72.11 114.088 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.72 -13.61 60.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.887 0.475 . . . . 74.13 111.831 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.86 12.3 20.96 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.496 0.558 . . . . 44.22 114.496 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.58 136.32 38.26 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.273 0.536 . . . . 72.21 110.614 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -95.85 114.58 26.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.205 0.602 . . . . 60.45 109.652 176.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.563 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.5 t -79.6 101.76 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.416 0.686 . . . . 75.44 110.183 -177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 59.0 m -138.64 140.58 38.94 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.864 1.266 . . . . 45.54 108.565 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.16 144.18 33.23 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.161 -0.681 . . . . 75.2 109.161 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.6 139.84 97.27 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.212 0.605 . . . . 70.13 110.901 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -94.01 13.96 45.95 Favored 'Cis proline' 0 C--N 1.375 1.95 0 N-CA-C 114.642 0.978 . . . . 73.23 114.642 6.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -67.88 126.15 28.52 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 118.031 0.378 . . . . 61.43 110.629 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.63 129.52 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.841 1.256 . . . . 73.54 108.403 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 48.8 t -72.09 108.2 5.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.763 0.316 . . . . 73.31 110.612 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -79.36 120.27 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 107.775 -1.194 . . . . 62.21 107.775 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.58 -34.45 77.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.629 0.772 . . . . 73.15 112.42 -170.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -76.4 -25.32 54.41 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.654 0.382 . . . . 74.24 111.408 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.9 p -95.43 -14.16 24.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.91 0.484 . . . . 70.41 110.637 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.6 p 54.96 33.91 21.2 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.16 1.784 . . . . 75.4 113.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.591 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.4 ptp180 -144.53 150.82 38.17 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 74.05 111.032 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 34.3 m -70.09 121.69 17.96 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.655 -0.702 . . . . 61.5 109.244 172.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 14.1 mm-40 -132.26 173.76 10.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.526 1.131 . . . . 74.2 110.502 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -75.37 126.7 87.39 Favored Pre-proline 0 CA--C 1.558 1.255 0 N-CA-C 108.857 -0.794 . . . . 73.42 108.857 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.383 2.371 0 C-N-CA 123.161 2.574 . . . . 71.42 112.344 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.694 -0.484 . . . . 74.2 109.694 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.17 -30.05 7.94 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-O 119.991 -0.338 . . . . 61.43 113.602 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -84.75 144.87 28.22 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.09 0.445 . . . . 71.31 110.526 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 27.2 p -101.32 148.47 25.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.554 0.576 . . . . 72.11 112.554 -170.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.92 -11.8 24.84 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.257 -0.883 . . . . 74.03 113.645 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 4.2 m-20 -96.96 161.46 13.83 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.676 0.738 . . . . 64.51 111.044 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 12.4 tmtt? -73.6 133.11 43.43 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.973 -1.012 . . . . 70.24 108.996 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 82.2 m-20 61.92 20.18 11.3 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.698 1.599 . . . . 52.33 112.282 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -120.11 152.06 53.89 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.774 1.23 . . . . 71.22 108.02 172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 Cg_endo -55.11 153.8 24.97 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.744 2.962 . . . . 62.35 113.294 -175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 28.4 p -100.4 122.54 43.32 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.362 -0.977 . . . . 65.42 108.362 166.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.0 p -84.2 107.31 16.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.81 -0.811 . . . . 70.34 108.81 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.42 122.56 5.97 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.786 -0.525 . . . . 72.45 111.786 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -57.4 156.64 15.2 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.638 1.175 . . . . 70.01 110.026 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -42.58 -39.26 6.81 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 123.764 2.976 . . . . 75.14 115.872 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -72.48 -31.21 65.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.932 0.893 . . . . 70.32 111.336 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.81 14.75 4.6 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.958 -0.565 . . . . 70.21 113.437 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.93 103.37 9.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.066 0.546 . . . . 65.31 110.997 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -71.62 123.64 22.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 70.43 110.606 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 90.1 t -78.91 104.87 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.229 0.538 . . . . 71.34 110.383 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 78.4 m -141.75 136.07 30.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.428 -1.26 . . . . 72.33 108.868 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -80.17 146.49 31.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.585 -0.524 . . . . 64.44 109.585 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.36 145.58 93.34 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.047 0.539 . . . . 72.43 110.722 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -90.85 13.18 54.18 Favored 'Cis proline' 0 C--N 1.38 2.201 0 CA-C-N 119.977 1.028 . . . . 73.21 113.882 2.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -70.88 118.75 14.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.358 0.663 . . . . 73.54 110.779 -174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.83 135.02 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.252 1.021 . . . . 75.45 109.023 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 54.0 t -78.57 122.47 25.95 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.578 0.351 . . . . 72.13 111.033 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.98 136.87 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.176 -1.046 . . . . 63.15 108.176 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -39.97 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.021 0.528 . . . . 73.24 110.689 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 m -58.88 -36.91 75.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.975 . . . . 55.44 111.643 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 p -94.15 -25.97 16.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.76 0.824 . . . . 73.21 111.283 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p 54.22 32.18 15.55 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.774 1.63 . . . . 51.21 112.187 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 37.8 ptt180 -124.28 144.89 49.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.811 0.844 . . . . 71.31 109.773 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 33.6 m -69.32 127.27 32.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.846 -0.798 . . . . 74.41 108.846 169.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 16.1 pt-20 -156.54 -168.29 2.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.461 0.705 . . . . 74.54 109.323 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -59.15 154.21 41.85 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 122.88 0.472 . . . . 74.34 112.182 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.372 1.806 0 C-N-CA 122.415 2.077 . . . . 75.33 110.773 169.033 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 109.202 -0.666 . . . . 74.3 109.202 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.27 31.88 27.0 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.158 0.286 . . . . 73.12 112.722 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.39 159.77 15.89 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.166 0.986 . . . . 74.51 109.784 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -132.83 137.55 46.78 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.054 0.39 . . . . 74.31 112.054 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.4 5.32 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.076 -0.847 . . . . 73.1 114.134 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.55 163.25 17.59 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.94 0.87 . . . . 54.1 110.505 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 35' ' ' GLU . 59.5 tttm -64.98 141.58 58.73 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.076 0.55 . . . . 64.23 110.742 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 56.17 19.14 3.64 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.113 1.765 . . . . 55.43 112.057 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.99 146.89 37.12 Favored Pre-proline 0 N--CA 1.476 0.832 0 N-CA-C 107.314 -1.365 . . . . 64.21 107.314 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.75 141.68 92.03 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.081 2.521 . . . . 70.41 111.934 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 27.6 p -92.84 117.82 30.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.566 -0.902 . . . . 74.1 108.566 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 11.5 p -87.73 130.3 34.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.85 -0.426 . . . . 61.0 109.85 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.55 145.05 20.07 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 116.383 -0.371 . . . . 73.42 112.924 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -104.58 156.62 35.62 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.594 0.758 . . . . 73.42 109.132 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 -21.04 71.56 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.839 2.359 . . . . 75.34 114.426 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.01 -24.92 59.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.096 0.558 . . . . 51.43 110.701 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.8 38.17 2.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.556 -0.747 . . . . 74.15 112.819 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.37 141.05 48.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.031 0.532 . . . . 43.32 111.059 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 10.0 mmpt? -88.14 123.26 32.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.834 0.853 . . . . 63.54 110.093 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 94.9 t -77.76 101.4 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.39 0.614 . . . . 74.42 109.846 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 72.3 m -145.91 135.69 23.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.042 1.337 . . . . 72.53 107.924 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -79.48 142.21 36.04 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.887 -0.412 . . . . 74.01 109.887 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -67.26 144.24 98.02 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 122.72 0.408 . . . . 73.25 109.924 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.67 19.7 36.36 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 119.77 0.954 . . . . 60.3 114.062 3.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -85.31 130.27 34.63 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.264 0.626 . . . . 71.43 109.567 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.45 148.6 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.077 0.951 . . . . 53.03 109.541 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.1 t -84.77 131.89 34.5 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.818 0.342 . . . . 64.01 111.315 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.1 122.22 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 106.919 -1.511 . . . . 72.42 106.919 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.59 -32.32 73.75 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.528 0.731 . . . . 74.34 111.652 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.3 m -60.93 -42.04 97.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.05 0.94 . . . . 73.14 111.227 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.2 p -90.52 -15.34 30.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.454 0.702 . . . . 61.11 111.571 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.3 p 54.47 26.66 7.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.264 1.425 . . . . 53.23 112.349 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.48 150.81 45.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.176 0.591 . . . . 72.43 110.438 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 m -72.53 132.8 44.29 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.372 -0.603 . . . . 74.53 109.372 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HA ' ' HG3' ' A' ' 7' ' ' LYS . 48.1 mt-10 -144.86 -175.01 4.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.054 0.941 . . . . 73.23 110.308 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.8 138.13 85.46 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 65.24 110.422 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.563 1.96 0 C-N-CA 122.159 1.906 . . . . 64.25 111.735 172.58 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.085 -0.339 . . . . 72.44 110.085 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.67 24.22 72.56 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.47 0.481 . . . . 75.31 113.651 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -120.27 -166.53 1.32 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.635 1.174 . . . . 63.31 108.523 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -148.59 142.52 25.8 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.976 0.807 . . . . 74.1 111.91 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 89.74 32.82 9.66 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.786 -0.643 . . . . 21.31 113.624 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.16 177.61 7.54 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.127 0.971 . . . . 63.45 109.612 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -71.23 128.58 36.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 74.03 109.572 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.62 19.83 9.75 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.009 1.324 . . . . 63.34 112.708 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.39 132.79 23.37 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 118.477 -0.773 . . . . 73.2 109.505 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.4 133.54 25.47 Favored 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 124.072 3.182 . . . . 73.35 113.584 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 19' ' ' LYS . 31.7 p -80.34 123.1 27.71 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.584 -0.525 . . . . 63.14 109.584 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -80.19 131.29 35.68 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.409 -0.589 . . . . 23.52 109.409 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.84 119.65 5.12 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.206 -0.452 . . . . 61.03 112.07 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -59.25 145.46 81.18 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.401 1.08 . . . . 72.54 111.591 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 -27.6 82.17 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.558 2.172 . . . . 64.23 112.56 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.85 -24.22 59.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.308 0.643 . . . . 72.52 111.531 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.3 10.73 14.75 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-O 119.691 -0.505 . . . . 73.4 114.346 173.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.65 162.51 18.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.324 0.562 . . . . 74.34 110.915 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 75.1 mmtt -100.77 126.35 47.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.043 -0.725 . . . . 73.43 109.043 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 80.8 t -77.84 109.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.428 -0.582 . . . . 61.44 109.428 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 85.4 m -145.09 139.54 27.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.499 1.12 . . . . 65.33 109.33 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -78.32 143.66 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.267 0.627 . . . . 71.22 109.717 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.22 145.2 85.43 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.377 -0.344 . . . . 71.13 110.101 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.38 19.63 34.79 Favored 'Cis proline' 0 C--N 1.377 2.029 0 CA-C-N 119.571 0.882 . . . . 72.53 113.249 -0.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -74.62 128.09 34.71 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.611 0.764 . . . . 64.55 110.166 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.02 143.04 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.494 1.117 . . . . 73.01 109.606 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 45.1 t -79.05 113.9 17.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.065 -0.346 . . . . 51.23 110.065 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.89 121.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.647 -1.242 . . . . 70.51 107.647 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.83 -26.37 65.74 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.662 0.785 . . . . 72.03 112.996 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -68.16 -50.91 51.42 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.499 0.72 . . . . 52.44 111.217 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.3 p -86.05 -14.66 43.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.667 0.787 . . . . 62.04 111.852 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.1 p 53.07 32.29 12.74 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 125.508 1.523 . . . . 55.13 112.236 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -144.84 150.6 37.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.506 0.67 . . . . 74.43 112.682 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 m -80.02 96.77 6.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.687 -1.142 . . . . 70.02 111.013 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.74 -173.23 2.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.921 0.888 . . . . 71.5 110.156 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.59 132.13 92.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 122.917 0.487 . . . . 71.13 110.833 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.373 1.827 0 C-N-CA 122.601 2.201 . . . . 75.11 111.937 171.346 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.491 0.186 . . . . 72.3 110.588 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.7 74.15 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 114.861 0.704 . . . . 75.13 114.861 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.64 -170.55 1.66 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.387 0.593 . . . . 74.13 110.254 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -132.67 147.32 52.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.37 0.668 . . . . 64.12 109.405 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.754 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.73 11.16 57.12 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 115.123 0.809 . . . . 60.42 115.123 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.9 -179.95 3.79 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.663 0.732 . . . . 51.22 110.86 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -60.09 118.46 6.34 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.413 0.685 . . . . 72.03 111.073 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.661 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.9 m-20 66.95 20.0 10.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.307 1.443 . . . . 73.34 111.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -118.77 130.51 24.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.184 -1.043 . . . . 63.1 108.184 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 13.2 Cg_endo -53.22 138.57 63.86 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.752 2.968 . . . . 63.3 113.269 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.0 p -79.7 127.95 32.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.058 -0.519 . . . . 74.32 110.103 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 145.78 32.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.335 -0.617 . . . . 65.41 109.335 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.06 125.41 8.52 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 120.002 -0.332 . . . . 60.31 112.521 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.96 152.56 93.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.602 0.761 . . . . 74.55 109.782 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.01 -31.41 95.67 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.763 2.308 . . . . 73.01 112.994 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -73.13 -27.42 61.67 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.655 0.782 . . . . 73.22 111.345 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.66 1.69 11.88 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.803 0.681 . . . . 73.25 114.803 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.85 119.01 14.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.375 0.588 . . . . 73.35 111.112 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -71.33 114.54 9.5 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.054 -0.721 . . . . 63.02 109.054 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.69 115.86 20.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.074 0.949 . . . . 64.54 110.072 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.7 m -147.9 141.11 25.1 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.563 1.164 . . . . 60.12 108.281 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -82.15 137.17 35.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.576 -0.898 . . . . 54.24 108.576 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.94 143.6 98.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.136 0.574 . . . . 74.24 111.011 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -93.8 16.98 41.13 Favored 'Cis proline' 0 C--N 1.378 2.108 0 N-CA-C 114.57 0.95 . . . . 72.25 114.57 5.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -69.99 120.38 15.63 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.326 -0.62 . . . . 62.33 109.326 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.89 135.12 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.254 1.022 . . . . 74.41 108.686 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 47.6 t -69.76 97.39 1.08 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.24 0.543 . . . . 75.23 109.654 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.24 111.15 13.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 107.273 -1.38 . . . . 73.53 107.273 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.42 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.9 mm? -59.04 -32.07 69.42 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.573 1.149 . . . . 73.24 111.399 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 m -56.94 -48.5 78.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.548 1.139 . . . . 72.1 111.141 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.5 p -96.99 -7.59 32.66 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.587 0.755 . . . . 70.12 111.83 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p 53.66 36.35 23.46 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 126.053 1.741 . . . . 72.13 112.455 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.5 ptp180 -141.93 151.2 42.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 73.03 110.787 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.754 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 35.4 m -73.56 98.56 2.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.943 0.878 . . . . 75.24 109.051 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -123.11 164.76 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.613 1.165 . . . . 75.22 108.815 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.87 147.31 73.18 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.22 0.608 . . . . 64.12 110.885 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.373 1.835 0 C-N-CA 123.169 2.58 . . . . 75.21 112.297 171.833 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.4 t70 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.145 -0.687 . . . . 74.54 109.145 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.13 -29.7 4.2 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.895 0.283 . . . . 71.33 113.479 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -121.57 -170.24 2.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.247 1.019 . . . . 72.12 110.006 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.93 149.31 27.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.833 0.349 . . . . 72.44 111.282 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.32 25.28 8.91 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 116.027 1.171 . . . . 72.14 116.027 164.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 9' ' ' GLU . 8.9 m-20 -123.06 172.57 8.44 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.577 0.751 . . . . 72.5 109.625 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.99 125.08 23.77 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 109.025 -0.731 . . . . 75.02 109.025 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 74.6 m-20 66.78 18.43 10.68 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.549 1.54 . . . . 71.33 112.681 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' HB3' ' H ' ' A' ' 6' ' ' ASP . 15.4 tp10 -118.3 118.56 33.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.461 -0.94 . . . . 72.01 108.461 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 8.1 Cg_endo -45.41 124.33 6.37 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.646 3.564 . . . . 74.51 113.325 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.0 p -76.0 130.14 37.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.745 0.418 . . . . 74.41 109.929 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.1 p -84.56 105.8 15.65 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.802 -0.814 . . . . 73.3 108.802 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.44 122.98 6.08 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.259 -0.736 . . . . 54.21 111.259 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 97.4 mtt180 -71.54 156.02 91.89 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.708 0.803 . . . . 70.14 110.587 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.21 -28.57 85.24 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.768 2.312 . . . . 64.35 113.34 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.77 -28.18 62.45 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.39 0.431 . . . . 73.43 109.998 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.42 1.24 11.12 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.112 -0.495 . . . . 31.53 113.586 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -78.82 108.81 12.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.819 0.447 . . . . 70.23 110.605 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 29' ' ' LEU . 46.5 mtmt -72.67 118.95 16.23 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.374 -0.602 . . . . 70.21 109.374 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.584 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 66.6 t -78.15 108.6 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.042 0.537 . . . . 52.25 109.664 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 70.7 m -150.97 138.85 19.9 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.085 1.354 . . . . 44.44 108.269 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.88 136.64 37.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.085 -1.08 . . . . 70.32 108.085 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.96 144.87 93.58 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.105 0.562 . . . . 71.24 109.913 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -87.02 1.84 68.37 Favored 'Cis proline' 0 C--N 1.378 2.126 0 C-N-CA 124.55 -1.021 . . . . 74.13 114.285 7.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -64.24 109.57 1.92 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.991 0.516 . . . . 63.04 110.113 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.19 140.15 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.066 0.946 . . . . 61.21 109.578 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.5 t -81.24 118.04 22.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.617 0.367 . . . . 74.1 111.344 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.21 118.05 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.939 -1.504 . . . . 63.25 106.939 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 19' ' ' LYS . 3.7 mm? -67.43 -22.72 65.5 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.567 0.747 . . . . 63.32 111.925 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -62.23 -42.47 99.34 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.524 0.73 . . . . 71.21 110.13 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.9 p -95.9 -10.96 27.47 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.905 0.882 . . . . 71.12 111.055 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.5 p 54.67 26.08 7.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.201 1.801 . . . . 71.33 113.31 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.695 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 35.2 ptt180 -131.3 151.33 51.61 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.168 0.987 . . . . 63.43 109.936 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -73.8 140.92 46.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.679 -1.23 . . . . 74.51 107.679 170.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.29 165.76 32.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.621 0.368 . . . . 72.32 110.056 -169.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -61.49 127.71 88.89 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.65 0.78 . . . . 73.31 111.165 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.374 1.911 0 C-N-CA 122.918 2.412 . . . . 60.12 111.919 170.46 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 108.928 -0.767 . . . . 74.31 108.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.73 -33.34 4.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.074 -0.512 . . . . 65.42 112.409 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.98 160.29 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.265 -0.643 . . . . 74.31 109.265 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.23 145.99 26.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 62.32 111.354 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 117.28 -4.41 18.05 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.634 1.014 . . . . 74.21 115.634 168.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.42 179.09 5.4 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.223 1.012 . . . . 74.41 111.873 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -70.86 126.63 30.11 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 116.047 -0.524 . . . . 75.31 109.909 -174.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.53 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 71.9 m-20 60.63 18.13 8.14 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.775 1.63 . . . . 72.43 112.359 -172.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -109.06 130.53 22.62 Favored Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 108.564 -0.902 . . . . 65.42 108.564 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -44.03 120.33 2.4 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.317 3.345 . . . . 72.3 112.916 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 14.0 p -77.03 147.14 36.92 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.098 0.559 . . . . 71.44 109.662 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -100.08 146.68 26.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.554 -1.276 . . . . 64.54 107.554 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.17 137.88 14.54 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 122.469 -0.145 . . . . 64.51 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.79 147.13 91.52 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.88 0.872 . . . . 70.31 109.458 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.98 -25.73 59.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.406 2.07 . . . . 61.4 112.191 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.29 -8.82 57.67 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.054 0.942 . . . . 72.33 111.767 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.18 -0.96 37.88 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 114.793 0.677 . . . . 74.42 114.793 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.23 130.05 35.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 117.554 0.677 . . . . 71.24 111.074 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD2' HD11 ' A' ' 29' ' ' LEU . 11.6 mmpt? -84.71 122.0 28.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.287 0.635 . . . . 74.11 109.648 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.54 108.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 123.243 0.617 . . . . 61.15 109.985 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 68.0 m -146.99 149.67 33.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.987 -1.006 . . . . 51.13 108.331 175.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -77.07 128.12 33.89 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.53 -1.285 . . . . 74.22 107.53 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.08 142.14 97.71 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 116.188 -0.46 . . . . 62.01 110.028 -173.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.2 12.56 36.36 Favored 'Cis proline' 0 C--N 1.373 1.828 0 CA-C-N 119.548 0.874 . . . . 72.33 114.235 6.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -64.31 130.25 43.11 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.993 -0.373 . . . . 65.11 109.993 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.84 142.65 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.153 0.981 . . . . 73.22 110.232 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.6 t -83.53 112.28 19.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.393 0.277 . . . . 75.43 110.545 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.01 121.76 31.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 107.353 -1.351 . . . . 54.13 107.353 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' HD2' ' A' ' 19' ' ' LYS . 4.2 mm? -65.28 -26.65 68.17 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.63 0.772 . . . . 64.05 112.59 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.2 m -63.21 -51.31 66.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.1 0.56 . . . . 75.35 110.876 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' ARG . 55.5 p -87.68 -18.01 30.5 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.212 -0.904 . . . . 71.24 111.603 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.7 p 52.75 31.77 11.01 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.77 1.628 . . . . 73.22 112.482 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.53 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 11.6 ptp180 -131.1 150.92 51.93 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.621 0.768 . . . . 75.42 110.152 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 14.1 m -81.56 113.03 19.31 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.804 -0.634 . . . . 72.44 110.109 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.41 -169.36 1.92 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.659 1.184 . . . . 74.02 109.684 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.09 149.93 89.68 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 122.908 0.483 . . . . 75.12 110.979 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.374 1.879 0 C-N-CA 122.527 2.151 . . . . 38.12 111.09 170.482 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.249 -0.278 . . . . 55.33 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.91 -31.92 7.13 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.481 -0.327 . . . . 72.21 112.567 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 -175.39 3.15 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.554 0.741 . . . . 72.41 109.277 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.5 145.85 23.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 122.503 0.321 . . . . 74.51 110.955 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.681 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 102.57 4.31 49.48 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 115.436 0.934 . . . . 54.02 115.436 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.1 m-20 -92.15 170.44 9.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.46 0.63 . . . . 75.13 110.599 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -69.96 125.13 25.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.69 -0.856 . . . . 75.11 108.69 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 62.51 29.04 17.01 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.256 1.422 . . . . 75.14 111.832 -173.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -127.05 141.24 40.1 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.059 0.944 . . . . 61.43 108.513 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 19.9 Cg_endo -55.16 132.14 50.51 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.045 2.497 . . . . 74.41 112.619 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.608 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.9 p -82.65 141.89 32.14 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.422 0.689 . . . . 64.21 109.479 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.5 p -92.67 126.93 37.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.107 -1.071 . . . . 75.23 108.107 170.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 126.61 8.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 112.231 -0.348 . . . . 61.54 112.231 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -67.5 144.11 97.58 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.133 0.973 . . . . 72.34 109.916 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.95 -24.78 74.59 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.969 2.446 . . . . 54.53 113.245 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.75 -8.72 59.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.941 0.896 . . . . 72.13 112.138 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.08 -9.97 27.06 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.736 -0.48 . . . . 54.31 114.106 172.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 149.39 41.2 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.387 0.593 . . . . 75.3 110.788 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -100.23 117.32 34.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.898 -0.778 . . . . 61.3 108.898 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 46.8 t -77.65 94.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.689 -0.856 . . . . 61.12 108.689 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 66.7 m -128.25 141.68 51.38 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.064 -1.425 . . . . 74.32 107.867 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -78.76 135.83 37.22 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.415 -0.957 . . . . 61.21 108.415 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.09 143.3 88.53 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 124.047 0.939 . . . . 74.43 111.264 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.2 25.71 20.56 Favored 'Cis proline' 0 C--N 1.383 2.374 0 CA-C-N 119.829 0.975 . . . . 54.31 113.844 1.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -77.28 142.12 39.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.565 0.346 . . . . 54.33 110.269 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.03 137.28 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 75.32 109.217 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -82.59 124.03 29.77 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.563 0.345 . . . . 62.45 110.894 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 123.68 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.777 -1.564 . . . . 64.2 106.777 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.5 mm? -61.58 -44.19 97.48 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.331 1.02 . . . . 72.02 111.843 -165.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -68.88 -39.02 80.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.07 0.948 . . . . 74.15 111.421 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -84.29 -15.87 45.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.118 0.567 . . . . 71.43 111.279 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 54.12 37.04 26.23 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.444 1.498 . . . . 55.43 112.262 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 30.4 ptt180 -134.73 139.71 45.4 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.313 0.645 . . . . 64.34 110.771 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.681 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 38.3 m -75.94 128.08 34.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.005 -0.739 . . . . 74.13 109.005 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -147.05 170.09 17.88 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.332 -0.988 . . . . 63.44 108.332 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.97 134.54 96.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 122.921 0.488 . . . . 64.54 111.071 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 122.721 2.281 . . . . 71.51 111.893 174.574 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.149 -0.315 . . . . 72.21 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.25 -25.05 26.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.044 -0.525 . . . . 73.04 113.025 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.66 175.09 9.45 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.18 -0.674 . . . . 53.51 109.18 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -128.96 148.04 50.91 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 122.715 0.406 . . . . 52.13 110.968 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.02 -9.95 31.69 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 114.436 0.535 . . . . 65.43 114.436 169.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.66 169.09 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.358 0.663 . . . . 74.03 110.866 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -65.65 122.92 18.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.167 0.587 . . . . 65.43 110.113 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 76.8 m-20 64.59 16.96 10.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.508 1.523 . . . . 73.32 113.769 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -104.88 136.55 19.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 108.276 -1.009 . . . . 62.2 108.276 170.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.09 137.03 76.98 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.203 2.602 . . . . 75.13 112.139 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.6 p -77.36 133.01 38.84 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.25 -0.648 . . . . 62.15 109.25 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.22 107.21 10.65 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.464 0.649 . . . . 73.22 109.481 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.21 108.42 2.69 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.52 -1.218 . . . . 60.52 112.168 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -68.22 145.12 97.35 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.108 0.963 . . . . 70.03 110.251 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -47.84 -36.66 27.08 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.651 3.568 . . . . 74.24 115.128 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -68.97 -20.13 64.18 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.676 0.79 . . . . 64.33 111.934 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.83 5.17 11.09 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.235 -0.439 . . . . 63.34 113.443 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.42 131.54 38.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.988 0.515 . . . . 73.1 111.703 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -92.7 114.45 27.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.085 -1.08 . . . . 73.32 108.085 171.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.46 124.76 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.564 0.346 . . . . 65.25 110.825 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.9 m -137.12 149.22 47.19 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.246 1.019 . . . . 62.43 109.234 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -84.71 141.02 30.87 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.111 -0.7 . . . . 74.42 109.111 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.09 148.42 98.85 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.641 0.776 . . . . 74.11 110.759 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.01 23.61 26.26 Favored 'Cis proline' 0 C--N 1.375 1.95 0 CA-C-N 119.527 0.867 . . . . 72.24 113.91 3.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.09 140.03 31.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.874 0.47 . . . . 55.45 110.246 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.33 138.0 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.935 1.294 . . . . 71.53 109.002 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 42.6 t -73.37 109.9 7.25 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.914 0.388 . . . . 73.34 110.722 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.52 114.31 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.731 -1.211 . . . . 70.22 107.731 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.3 -26.16 68.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.298 1.039 . . . . 75.3 112.223 -171.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -63.56 -46.47 85.78 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.806 0.843 . . . . 63.25 110.429 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 p -95.77 -8.87 33.2 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.222 1.009 . . . . 63.54 111.937 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p 54.84 28.12 9.94 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.793 1.637 . . . . 43.43 113.018 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 5.3 ptp180 -138.58 151.91 47.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.145 0.578 . . . . 74.0 110.613 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.572 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 13.6 m -77.67 125.67 29.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.144 -0.934 . . . . 64.23 109.804 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.49 176.14 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.256 1.023 . . . . 72.44 109.834 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.11 143.0 90.8 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.165 -0.445 . . . . 72.44 110.01 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 CA--C 1.563 1.966 0 C-N-CA 122.734 2.289 . . . . 44.25 112.0 173.419 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.149 -0.315 . . . . 64.32 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.61 -31.17 4.65 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 116.41 -0.359 . . . . 64.23 112.47 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -114.0 176.88 4.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.216 1.406 . . . . 64.2 109.127 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.52 144.63 25.47 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.152 -0.342 . . . . 74.23 110.626 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.636 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.41 20.09 30.76 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 115.291 0.876 . . . . 72.44 115.291 168.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.77 -179.92 3.88 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.406 0.682 . . . . 75.34 110.55 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -61.28 122.43 15.08 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.744 0.818 . . . . 54.55 110.846 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 60.26 27.13 16.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.011 1.324 . . . . 63.23 111.159 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -124.07 125.41 25.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 109.148 -0.686 . . . . 73.54 109.148 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.48 125.31 10.63 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 124.328 3.352 . . . . 60.23 112.858 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p -77.69 132.19 38.06 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.94 -0.763 . . . . 64.44 108.94 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -81.42 153.04 27.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.84 0.856 . . . . 72.34 109.091 175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.64 131.56 10.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.932 -0.48 . . . . 75.22 112.835 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -66.57 157.58 82.29 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.959 1.303 . . . . 74.14 110.999 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.76 -35.41 98.81 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.624 2.216 . . . . 64.41 112.69 172.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.51 -30.06 57.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.987 0.915 . . . . 60.23 111.088 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.03 1.54 12.87 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 115.247 0.859 . . . . 61.34 115.247 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.1 146.75 47.31 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.056 0.928 . . . . 71.35 110.384 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -86.44 122.67 30.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.538 -0.542 . . . . 74.53 109.538 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 24.8 t -79.18 109.45 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.55 0.74 . . . . 63.14 109.832 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.6 m -137.24 139.93 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.82 -1.178 . . . . 62.02 107.82 169.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -78.06 146.82 35.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.164 -1.05 . . . . 74.42 108.164 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.55 141.47 97.93 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.041 0.536 . . . . 71.14 110.716 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -98.65 18.07 27.37 Favored 'Cis proline' 0 C--N 1.372 1.766 0 CA-C-N 119.267 0.774 . . . . 44.14 113.957 -1.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -65.13 141.58 58.65 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.033 0.533 . . . . 74.44 110.028 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.57 136.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.343 1.057 . . . . 73.42 110.302 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.5 t -80.98 113.61 19.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.978 0.511 . . . . 54.2 110.655 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.7 118.82 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.657 -1.609 . . . . 73.35 106.657 170.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.2 -36.22 82.93 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.11 0.964 . . . . 74.44 111.564 -171.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -61.42 -43.46 98.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.749 0.82 . . . . 72.34 111.002 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.5 p -92.51 -11.06 35.58 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.11 0.564 . . . . 71.24 111.212 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.5 p 54.66 28.84 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.987 1.715 . . . . 65.22 113.137 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -140.49 151.12 44.56 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.328 0.651 . . . . 73.2 110.265 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 18.4 m -82.75 116.45 22.11 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.838 0.455 . . . . 74.33 110.794 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -104.48 -170.36 1.75 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.468 1.107 . . . . 73.24 109.04 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.75 156.77 91.52 Favored Pre-proline 0 N--CA 1.485 1.279 0 CA-C-O 119.051 -0.5 . . . . 74.34 110.577 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.601 2.201 . . . . 75.12 111.801 175.743 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.471 0.176 . . . . 75.25 110.8 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.82 -4.14 9.91 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.724 -0.487 . . . . 33.43 113.576 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 10.3 pt-20 -87.55 139.43 30.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 63.33 109.259 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.8 p -97.24 136.92 37.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.122 -0.361 . . . . 75.32 110.65 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.6 1.21 64.07 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 115.228 0.851 . . . . 42.13 115.228 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.04 -179.58 4.73 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.286 0.634 . . . . 64.32 111.004 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -65.01 121.56 14.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.068 0.947 . . . . 62.42 110.416 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 60.03 18.04 7.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.418 1.487 . . . . 43.42 112.694 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 54.4 mm-40 -107.75 138.95 20.16 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.891 0.877 . . . . 63.12 109.695 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.43 122.61 12.1 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 123.145 2.563 . . . . 74.31 112.277 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 28.0 p -74.48 128.69 36.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.774 -0.454 . . . . 61.24 109.774 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 120.03 23.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.268 -0.641 . . . . 70.4 109.268 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.44 126.01 8.36 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.842 -0.617 . . . . 75.15 113.552 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.43 144.35 88.43 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.157 0.983 . . . . 74.02 110.805 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.13 -17.57 60.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.502 2.134 . . . . 63.24 112.98 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.72 -8.09 58.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.835 0.854 . . . . 62.32 111.999 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.2 35.72 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 114.566 0.586 . . . . 74.23 114.566 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.48 139.57 47.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.543 0.672 . . . . 70.02 110.293 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -96.06 116.19 28.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.353 0.661 . . . . 50.33 110.278 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.94 108.48 18.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.159 -0.682 . . . . 74.01 109.159 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.3 m -128.81 148.86 50.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 124.671 1.188 . . . . 73.41 108.316 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -83.74 150.69 25.65 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.658 -0.867 . . . . 71.41 108.658 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -68.4 143.06 95.14 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 122.942 0.497 . . . . 73.33 110.888 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -93.63 14.46 46.08 Favored 'Cis proline' 0 C--N 1.38 2.229 0 CA-C-N 119.59 0.889 . . . . 73.42 113.995 0.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -71.59 134.06 46.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.299 0.64 . . . . 72.12 110.645 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.08 139.73 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.623 1.169 . . . . 65.35 109.076 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.9 t -79.75 120.05 23.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.114 0.416 . . . . 63.01 111.244 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.09 120.33 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 106.651 -1.611 . . . . 75.52 106.651 168.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.35 -39.27 92.12 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.197 0.599 . . . . 54.15 111.583 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -61.49 -32.47 72.49 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.791 0.837 . . . . 60.11 111.456 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.2 p -95.84 -16.48 21.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.084 0.554 . . . . 64.04 111.276 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p 54.56 35.38 23.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.245 1.818 . . . . 65.44 112.045 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -146.88 150.59 35.55 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.112 0.565 . . . . 71.13 111.093 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 19.8 m -82.74 115.22 21.56 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.005 0.522 . . . . 70.02 110.547 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -122.26 178.78 4.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 74.31 109.311 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.41 138.82 97.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.142 0.577 . . . . 62.22 111.542 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 C--N 1.376 2.023 0 C-N-CA 123.245 2.63 . . . . 64.34 112.003 176.584 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.48 0.181 . . . . 73.33 110.847 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.95 30.78 78.9 Favored Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.581 -0.608 . . . . 75.21 111.581 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -119.37 175.66 5.71 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.182 0.993 . . . . 74.42 110.17 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.2 p -154.44 150.22 27.63 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 122.607 0.363 . . . . 62.44 110.952 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.688 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 89.47 3.53 74.85 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.511 0.564 . . . . 71.02 114.511 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -95.88 178.81 5.31 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.297 0.639 . . . . 71.32 110.341 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 123.68 21.13 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.507 0.723 . . . . 71.41 109.675 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 58.92 35.56 24.2 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.491 1.516 . . . . 73.24 111.661 -172.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 12.8 tp10 -130.23 125.68 21.92 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 118.073 -0.965 . . . . 72.32 109.585 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 2.2 Cg_endo -37.87 121.59 0.46 Allowed 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 124.916 3.744 . . . . 74.3 113.952 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.646 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 30.1 p -76.26 115.11 15.68 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.543 -0.91 . . . . 64.24 108.543 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.0 p -80.48 108.73 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.186 0.594 . . . . 73.15 110.395 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.68 121.65 5.56 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.01 -0.541 . . . . 54.23 112.977 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -61.61 155.16 61.67 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.206 1.003 . . . . 72.55 110.873 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.98 -23.36 21.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.633 2.889 . . . . 72.33 115.715 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.73 -24.86 33.38 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.745 0.418 . . . . 71.34 111.416 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.22 3.85 10.37 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.825 -0.43 . . . . 71.02 113.793 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 123.38 25.3 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.968 0.507 . . . . 74.54 111.462 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.646 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -80.39 110.19 15.61 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.653 0.781 . . . . 70.33 109.713 176.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.0 t -79.43 111.18 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.096 0.558 . . . . 70.44 110.154 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 82.5 m -140.53 135.39 31.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.575 -1.193 . . . . 54.32 108.193 171.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -79.59 127.15 31.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.311 -0.996 . . . . 74.12 108.311 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.37 144.61 97.54 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.24 0.616 . . . . 51.54 110.558 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.13 8.15 67.01 Favored 'Cis proline' 0 C--N 1.379 2.174 0 N-CA-C 114.706 1.002 . . . . 60.3 114.706 8.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.37 127.47 33.08 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.499 -0.556 . . . . 74.32 109.499 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.89 138.64 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.759 0.824 . . . . 74.45 109.788 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.0 t -77.67 113.42 15.5 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.232 0.469 . . . . 62.45 110.224 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.439 HD13 ' HB2' ' A' ' 35' ' ' GLU . 2.7 mp -78.81 111.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.385 -1.709 . . . . 62.53 106.385 168.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.52 -28.24 69.81 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.014 0.925 . . . . 74.34 112.12 -170.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.9 m -60.0 -54.05 50.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.678 0.791 . . . . 62.41 110.342 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -83.74 -12.77 55.32 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.798 0.839 . . . . 70.55 111.432 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.0 p 53.69 33.96 17.82 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.661 1.584 . . . . 54.2 112.312 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -136.98 150.38 48.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.697 0.799 . . . . 71.24 110.144 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -81.59 119.15 23.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.882 -0.785 . . . . 33.51 108.882 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' HD13 ' A' ' 28' ' ' ILE . 35.2 mt-10 -121.01 170.44 9.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.472 0.709 . . . . 62.35 109.951 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.3 134.15 82.79 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.893 -0.594 . . . . 73.23 110.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.569 2.236 0 C-N-CA 122.574 2.183 . . . . 73.35 111.609 172.033 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 108.498 -0.927 . . . . 73.53 108.498 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.3 -30.34 7.69 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.533 -0.627 . . . . 61.32 111.533 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.24 167.06 11.87 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.493 1.117 . . . . 74.43 108.273 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -140.89 138.15 33.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.326 -0.233 . . . . 44.31 111.145 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.547 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 105.99 5.18 38.46 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.412 0.525 . . . . 34.22 114.412 174.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.67 172.37 8.3 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.582 0.753 . . . . 51.21 111.225 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -67.64 122.17 17.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.44 1.096 . . . . 70.14 109.253 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 64.39 20.99 12.37 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.166 1.386 . . . . 74.42 112.319 -175.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -126.32 135.83 27.73 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.193 -0.908 . . . . 70.22 110.129 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' SER . 1.6 Cg_endo -41.58 133.16 3.68 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.853 3.702 . . . . 63.14 114.645 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.1 p -93.23 128.35 39.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.48 0.712 . . . . 72.32 109.304 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.9 p -83.95 101.07 11.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.658 -0.868 . . . . 70.41 108.658 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -87.39 118.78 5.07 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.671 -0.695 . . . . 74.02 112.539 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 96.6 mtt180 -56.81 152.83 25.11 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.76 1.224 . . . . 73.02 111.394 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.68 -23.63 58.61 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.349 2.7 . . . . 72.44 114.318 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.22 5.52 29.86 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.855 0.862 . . . . 72.24 112.152 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.0 9.98 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.355 -0.136 . . . . 63.34 112.97 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -114.73 97.94 6.56 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.432 -0.581 . . . . 44.44 109.432 175.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 10.1 mtmp? -71.4 111.18 6.51 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.192 0.597 . . . . 75.2 109.477 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -76.15 113.93 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.08 -0.711 . . . . 73.33 109.08 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 77.5 m -141.47 143.4 33.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.95 1.3 . . . . 63.42 108.838 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -80.82 143.64 32.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.161 -1.052 . . . . 72.44 108.161 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.19 147.76 90.85 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.78 0.432 . . . . 62.41 110.53 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.52 28.17 17.15 Favored 'Cis proline' 0 C--N 1.378 2.116 0 CA-C-N 119.747 0.946 . . . . 71.05 113.454 1.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -82.2 117.98 22.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.804 0.442 . . . . 75.31 110.207 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -97.46 131.29 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.33 1.052 . . . . 73.43 109.805 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.9 t -79.87 113.5 18.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.65 0.262 . . . . 63.54 110.755 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.8 mt -79.9 129.03 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.935 -1.135 . . . . 43.34 107.935 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.29 -42.1 99.06 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.808 0.843 . . . . 72.41 111.278 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -59.59 -36.69 76.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.194 0.997 . . . . 55.42 111.836 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.5 p -95.5 -19.26 19.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 50.24 111.467 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 88.0 p 54.62 30.98 14.21 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.163 1.785 . . . . 51.35 112.77 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 12.1 ptp180 -140.45 149.28 42.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.353 0.661 . . . . 74.13 110.998 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 8.2 m -81.65 99.76 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.276 0.63 . . . . 74.05 110.639 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 36.4 mt-10 -107.72 -172.99 2.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.975 0.91 . . . . 72.21 111.004 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.1 158.9 74.57 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.743 0.817 . . . . 73.14 111.022 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 CA--C 1.561 1.872 0 C-N-CA 122.677 2.251 . . . . 71.4 111.217 166.809 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 109.299 -0.63 . . . . 72.15 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.93 -30.74 9.51 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 123.526 0.584 . . . . 43.34 112.426 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.3 169.56 8.79 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.569 1.147 . . . . 65.25 109.035 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.9 p -143.42 143.23 31.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.039 0.381 . . . . 42.55 111.842 -173.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 105.01 30.49 4.78 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 114.651 0.62 . . . . 63.42 114.651 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.65 174.26 8.85 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.039 0.936 . . . . 62.24 110.446 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -68.84 123.76 21.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.244 1.018 . . . . 73.13 109.1 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 84.9 m-20 60.51 29.88 19.34 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.785 1.234 . . . . 72.45 112.338 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -113.92 141.05 25.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 107.768 -1.197 . . . . 74.34 107.768 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.97 145.52 10.25 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 123.397 2.731 . . . . 71.11 112.035 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -100.74 132.7 46.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.513 -0.551 . . . . 70.41 109.513 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.31 88.18 6.95 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.322 -0.992 . . . . 62.03 108.322 170.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -80.89 121.39 5.4 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 115.213 -0.903 . . . . 53.21 112.849 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -82.29 144.64 50.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.513 -0.551 . . . . 73.24 109.513 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.09 -12.22 34.46 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.205 2.603 . . . . 74.12 114.375 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 -17.67 57.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.932 0.893 . . . . 71.31 111.384 172.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.7 -13.5 9.29 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 116.135 -0.484 . . . . 75.23 113.581 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.17 97.61 6.97 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.067 0.46 . . . . 44.14 110.65 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 34.6 mtmt -82.45 118.64 23.37 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.846 0.858 . . . . 64.33 108.687 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.602 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.4 t -77.4 95.53 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 122.079 0.943 . . . . 72.53 109.691 -175.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 75.2 m -130.24 152.0 50.14 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 112.973 -1.922 . . . . 74.5 108.99 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -79.58 140.72 37.07 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.954 -0.758 . . . . 72.45 108.954 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.21 147.41 82.96 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.064 0.546 . . . . 65.11 109.997 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -94.25 22.86 28.01 Favored 'Cis proline' 0 C--N 1.376 2.002 0 CA-C-N 119.39 0.818 . . . . 51.21 113.284 1.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -79.81 124.94 29.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.414 0.685 . . . . 75.11 109.221 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.42 144.99 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.703 0.801 . . . . 73.3 109.803 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.3 t -84.31 113.32 21.05 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.002 0.521 . . . . 61.35 110.037 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.8 mp -79.89 119.37 29.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 106.813 -1.551 . . . . 75.41 106.813 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.48 -26.99 65.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.713 . . . . 70.22 112.645 -173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.3 m -59.65 -54.78 42.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.783 0.833 . . . . 72.24 111.184 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 p -87.87 -18.79 28.45 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.717 0.807 . . . . 74.1 110.9 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.8 p 52.27 44.37 29.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.175 1.79 . . . . 51.25 112.802 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 2.2 ptm180 -146.45 144.9 29.99 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.275 0.559 . . . . 70.13 110.393 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 m -76.47 88.27 3.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.251 1.02 . . . . 74.44 110.362 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 44.9 mt-10 -103.37 -171.65 1.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.972 0.909 . . . . 65.23 109.935 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -62.22 139.44 96.21 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 123.851 0.86 . . . . 73.21 110.987 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.375 1.943 0 C-N-CA 122.902 2.402 . . . . 64.42 112.262 173.188 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 119.527 -0.273 . . . . 65.4 110.68 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.33 21.5 68.48 Favored Glycine 0 C--N 1.358 1.752 0 O-C-N 123.57 0.544 . . . . 42.44 113.756 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -105.68 161.9 13.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.001 0.92 . . . . 64.23 110.66 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -157.97 113.22 2.7 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.846 0.458 . . . . 53.24 109.842 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.456 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 140.12 -9.12 3.0 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 115.547 0.979 . . . . 61.43 115.547 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.7 173.55 7.55 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.058 0.543 . . . . 35.25 111.215 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.22 116.11 9.27 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.101 0.96 . . . . 62.11 109.684 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 73.75 16.32 3.83 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.099 2.16 . . . . 74.23 112.603 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -106.97 135.65 19.54 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 123.892 0.877 . . . . 74.12 109.442 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.59 133.28 57.13 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.392 2.728 . . . . 71.32 111.834 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.1 p -80.75 121.67 26.19 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.564 -0.532 . . . . 72.03 109.564 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 2.4 p -78.82 88.64 4.65 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.87 -0.789 . . . . 64.14 108.87 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.78 118.07 4.65 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.827 -1.079 . . . . 74.12 112.417 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -69.32 152.95 96.33 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.45 1.1 . . . . 73.31 110.387 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.65 -21.52 63.1 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.2 2.6 . . . . 62.51 114.699 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.93 -21.92 58.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.496 0.719 . . . . 73.54 111.551 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.79 -0.91 13.67 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 116.016 -0.538 . . . . 55.21 113.423 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.78 99.31 4.38 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 116.864 0.332 . . . . 72.21 111.114 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -73.18 114.5 11.42 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.222 -1.029 . . . . 73.13 108.222 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 97.7 t -76.58 106.66 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.038 -0.727 . . . . 54.44 109.038 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 79.9 m -143.5 135.82 27.02 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 125.297 1.439 . . . . 52.42 109.227 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -79.63 120.57 24.14 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.194 -1.039 . . . . 71.31 108.194 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.07 149.23 94.24 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.311 0.645 . . . . 61.12 110.517 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -88.59 15.29 46.39 Favored 'Cis proline' 0 C--N 1.379 2.154 0 CA-C-N 120.082 1.065 . . . . 73.31 114.707 9.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -75.98 109.41 9.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 75.02 109.709 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.88 130.89 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.097 0.959 . . . . 75.31 110.139 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 51.9 t -71.19 110.81 6.08 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.716 0.293 . . . . 72.43 110.765 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.31 127.18 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.963 -1.125 . . . . 71.43 107.963 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.27 -34.35 77.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.259 0.624 . . . . 62.5 111.328 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -57.56 -43.76 84.74 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.763 0.825 . . . . 50.2 111.169 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 p -91.01 -16.12 28.49 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.953 0.901 . . . . 61.0 111.767 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p 52.93 30.43 9.27 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.594 1.558 . . . . 63.04 112.18 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -140.74 147.75 39.65 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.648 0.379 . . . . 74.21 111.138 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.4 m -74.15 130.71 40.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.349 0.66 . . . . 54.44 110.375 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.44 176.76 10.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.56 0.744 . . . . 74.34 109.939 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.52 123.01 81.67 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 119.441 -0.314 . . . . 70.42 110.333 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 C--N 1.386 2.507 0 C-N-CA 122.918 2.412 . . . . 74.13 112.011 179.119 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.335 -0.246 . . . . 64.53 110.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.1 -33.14 5.59 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.786 -0.526 . . . . 73.4 111.786 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -122.07 -178.23 3.8 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.866 0.867 . . . . 64.31 109.193 171.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.62 151.11 7.48 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.341 0.257 . . . . 62.23 111.493 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.62 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.71 -8.09 29.9 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 115.563 0.985 . . . . 23.23 115.563 166.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.71 172.6 8.07 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.411 0.605 . . . . 70.04 111.655 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 3.6 tmtp? -63.35 125.1 23.03 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.862 0.726 . . . . 75.44 110.033 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 97.2 m-20 61.51 24.39 14.5 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.162 1.385 . . . . 73.43 112.328 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -123.1 142.55 38.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.885 0.874 . . . . 74.35 109.112 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.98 139.87 79.56 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.701 2.934 . . . . 53.24 112.926 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 26.5 p -90.47 128.04 36.4 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.372 0.669 . . . . 63.04 109.31 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -78.5 119.53 21.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.845 0.355 . . . . 75.13 110.191 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.32 120.7 5.5 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 116.058 -0.519 . . . . 64.43 113.246 -174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -71.08 156.33 92.08 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.24 1.016 . . . . 64.4 110.838 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.38 -43.82 51.31 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.178 2.585 . . . . 74.25 113.222 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.53 -25.17 67.87 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.257 1.023 . . . . 74.42 112.364 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.17 2.38 12.34 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-O 119.637 -0.535 . . . . 73.0 113.844 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.33 115.39 8.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 117.255 0.528 . . . . 72.41 111.583 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.739 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -75.81 106.47 7.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.643 0.777 . . . . 74.11 109.207 173.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.559 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 60.0 t -79.62 119.61 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.023 0.529 . . . . 64.02 110.773 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.5 m -142.37 154.15 44.39 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.009 1.323 . . . . 65.24 109.034 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.55 145.28 25.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.179 -0.675 . . . . 71.21 109.179 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.24 146.16 94.27 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 122.961 0.504 . . . . 44.25 110.606 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -91.0 14.88 49.33 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.581 0.886 . . . . 23.34 114.225 5.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -78.23 124.41 28.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.949 0.404 . . . . 73.44 110.369 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.19 131.25 59.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.455 1.102 . . . . 65.43 108.6 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.8 t -69.11 107.63 3.26 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.016 0.436 . . . . 45.21 110.029 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.29 113.24 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.386 -1.339 . . . . 72.13 107.386 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.01 -28.47 66.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.521 1.128 . . . . 73.14 111.638 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.9 m -64.45 -52.39 58.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.785 0.834 . . . . 64.24 111.208 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.8 p -90.96 -4.06 56.79 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.135 0.574 . . . . 73.34 111.564 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p 53.55 29.56 9.33 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.952 1.701 . . . . 63.25 113.022 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.4 ptt180 -138.28 148.73 44.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.667 0.787 . . . . 75.35 109.509 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 45.6 m -71.09 91.27 0.9 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.961 -0.755 . . . . 65.1 108.961 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 36' ' ' ASN . 29.6 tt0 -101.18 -178.79 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.356 1.062 . . . . 74.54 108.627 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 3.1 p-10 -72.62 145.76 87.67 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 109.602 -0.518 . . . . 64.11 109.602 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.365 1.423 0 C-N-CA 122.902 2.401 . . . . 74.42 112.807 173.327 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.18 -0.674 . . . . 72.010000000000005 109.18 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 p -147.91 140.1 24.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.534 0.334 . . . . 73.310000000000002 110.722 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.541 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 109.95 -4.22 30.37 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 114.973 0.749 . . . . 62.329999999999998 114.973 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -100.2 176.29 5.44 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.338 0.655 . . . . 74.0 112.073 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -61.37 117.16 5.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.78 0.832 . . . . 71.230000000000004 110.623 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.4 m-20 64.14 21.42 12.55 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.97 1.308 . . . . 75.430000000000007 111.624 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -112.84 132.22 22.39 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 108.126 -1.064 . . . . 65.519999999999996 108.126 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.6 Cg_endo -53.88 140.91 67.91 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 123.232 2.621 . . . . 65.030000000000001 112.864 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 28.4 p -88.66 133.4 34.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.919 0.487 . . . . 71.140000000000001 109.938 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.9 p -93.16 104.92 17.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.693 0.797 . . . . 70.340000000000003 109.985 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -78.06 129.18 9.25 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.52 -0.632 . . . . 65.340000000000003 111.52 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -89.22 168.06 16.3 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.833 0.853 . . . . 64.099999999999994 111.665 -170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.25 -33.07 53.46 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.349 2.699 . . . . 71.420000000000002 114.564 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.26 -8.92 58.13 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.908 0.483 . . . . 63.299999999999997 111.619 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.12 -24.99 29.34 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 114.163 0.425 . . . . 64.219999999999999 114.163 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 128.09 34.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.966 0.383 . . . . 55.229999999999997 110.629 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 39.3 mtmt -76.64 129.86 36.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 108.899 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 87.4 t -77.84 117.81 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.086 0.47 . . . . 73.540000000000006 110.121 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.8 m -146.48 136.56 23.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.003 1.321 . . . . 75.409999999999997 107.538 169.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.63 139.6 38.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.523 -0.918 . . . . 64.099999999999994 108.523 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.32 141.83 96.22 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 122.747 0.419 . . . . 75.099999999999994 110.104 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -96.12 19.36 32.14 Favored 'Cis proline' 0 C--N 1.375 1.929 0 N-CA-C 114.649 0.98 . . . . 72.319999999999993 114.649 4.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -67.97 125.95 27.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.001 -0.37 . . . . 74.150000000000006 110.001 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.55 129.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.727 1.211 . . . . 72.219999999999999 109.817 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.686 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 39.0 t -78.77 110.25 13.76 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.999 0.52 . . . . 75.120000000000005 109.781 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.52 140.46 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.721 -0.844 . . . . 73.030000000000001 108.721 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 -37.42 87.33 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.537 0.94 . . . . 42.25 113.537 -165.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -75.26 -50.93 14.54 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.919 0.39 . . . . 54.5 110.204 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -70.65 -26.36 63.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.699 0.8 . . . . 63.399999999999999 111.874 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p 54.29 27.08 7.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.033 1.733 . . . . 64.540000000000006 112.688 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 12.0 ptp180 -126.94 142.4 51.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.962 0.905 . . . . 64.340000000000003 110.294 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 30.8 m -75.38 100.17 4.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.334 0.654 . . . . 64.530000000000001 109.8 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 -177.96 3.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.564 0.746 . . . . 63.25 110.492 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -71.96 139.4 82.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 122.61 0.364 . . . . 72.439999999999998 110.787 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.381 2.284 0 C-N-CA 123.093 2.529 . . . . 71.540000000000006 112.342 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.734 0 N-CA-C 109.88 -0.415 . . . . 71.319999999999993 109.88 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.87 149.82 50.37 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.068 0.547 . . . . 52.130000000000003 109.926 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.448 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 97.71 2.26 58.6 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.171 0.828 . . . . 72.430000000000007 115.171 170.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.63 164.96 13.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.359 0.663 . . . . 74.340000000000003 109.849 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.24 137.46 50.84 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.356 0.263 . . . . 72.129999999999995 110.396 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.34 28.31 17.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.446 1.498 . . . . 63.450000000000003 111.064 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.99 134.87 14.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 108.801 -0.814 . . . . 61.119999999999997 108.801 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.3 Cg_endo -54.47 146.22 53.54 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 123.995 3.13 . . . . 75.010000000000005 114.09 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.5 p -91.82 137.68 32.17 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.588 -0.733 . . . . 74.239999999999995 109.409 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -80.16 88.36 5.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.136 -1.061 . . . . 74.530000000000001 108.136 171.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.19 120.83 5.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 114.978 -1.01 . . . . 64.420000000000002 111.981 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -74.68 151.15 86.88 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.136 0.974 . . . . 54.420000000000002 111.44 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.87 -22.54 68.86 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.958 2.439 . . . . 71.430000000000007 113.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.04 -15.27 58.46 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.659 0.784 . . . . 72.319999999999993 111.222 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.64 -6.15 24.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.891 -0.394 . . . . 60.210000000000001 114.041 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.77 98.51 3.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.104 0.478 . . . . 74.120000000000005 110.94 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.83 112.8 8.23 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.533 0.733 . . . . 72.230000000000004 109.273 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 85.9 t -78.82 110.09 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 122.771 0.429 . . . . 63.229999999999997 110.588 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 62.9 m -147.7 151.01 35.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.858 1.263 . . . . 61.43 109.0 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -84.26 138.91 32.68 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.779 -0.822 . . . . 75.230000000000004 108.779 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.5 146.3 97.69 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.145 0.578 . . . . 71.329999999999998 110.814 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.18 10.14 60.0 Favored 'Cis proline' 0 C--N 1.376 1.978 0 N-CA-C 114.697 0.999 . . . . 54.409999999999997 114.697 3.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -73.09 114.01 10.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.133 0.573 . . . . 73.430000000000007 111.006 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.46 133.53 37.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.7 1.2 . . . . 53.009999999999998 109.77 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.3 t -70.72 105.41 3.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.127 0.489 . . . . 72.510000000000005 110.675 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.5 118.4 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.084 -1.08 . . . . 65.340000000000003 108.084 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.42 -36.97 84.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.065 0.946 . . . . 62.119999999999997 112.559 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.3 p -62.51 -38.78 91.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.556 0.742 . . . . 71.230000000000004 111.643 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.9 p -97.12 -7.76 31.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.307 0.643 . . . . 65.239999999999995 111.493 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p 55.08 21.27 3.74 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.231 1.812 . . . . 53.229999999999997 113.521 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 ptp180 -133.16 148.92 52.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.796 0.438 . . . . 74.040000000000006 111.751 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.7 m -74.08 114.82 12.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.773 -0.649 . . . . 63.140000000000001 109.672 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.1 -171.17 2.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.477 1.111 . . . . 61.109999999999999 109.001 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.82 148.25 87.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 119.08 -0.486 . . . . 75.200000000000003 111.325 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.375 1.927 0 C-N-CA 123.401 2.734 . . . . 72.129999999999995 112.501 169.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 61.439999999999998 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.93 134.47 40.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.665 0.386 . . . . 72.120000000000005 110.612 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 118.92 0.73 14.87 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.572 0.989 . . . . 70.5 115.572 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 9.4 m-20 -92.79 174.82 7.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.106 0.953 . . . . 72.219999999999999 110.655 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -68.06 122.97 19.39 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.799 -0.815 . . . . 64.129999999999995 108.799 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 66.56 19.48 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.876 1.671 . . . . 65.310000000000002 112.418 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 4.6 tp10 -113.17 129.59 24.41 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.855 0.862 . . . . 73.219999999999999 109.108 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 5.2 Cg_endo -43.56 126.74 5.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 124.274 3.316 . . . . 62.310000000000002 112.981 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.5 p -84.52 130.76 34.71 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.114 -0.698 . . . . 73.519999999999996 109.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.1 p -80.63 139.56 36.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.464 -0.569 . . . . 73.319999999999993 109.464 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.34 114.71 4.94 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.315 -0.314 . . . . 65.319999999999993 112.315 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -61.5 148.78 85.59 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.196 0.998 . . . . 72.430000000000007 111.248 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.45 -5.14 13.31 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.91 2.407 . . . . 55.240000000000002 114.413 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.41 2.12 47.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.521 0.728 . . . . 74.439999999999998 111.625 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.57 4.04 62.43 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.892 -0.393 . . . . 52.030000000000001 113.862 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 155.81 19.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.042 0.421 . . . . 52.119999999999997 110.301 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -101.95 127.45 48.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.152 0.581 . . . . 54.43 109.883 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.8 t -78.5 109.67 13.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.895 -0.78 . . . . 55.020000000000003 108.895 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 71.8 m -141.64 141.1 33.41 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.592 1.182 . . . . 71.140000000000001 108.604 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 7.2 p30 -78.88 135.27 36.96 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.428 -1.323 . . . . 73.150000000000006 107.428 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.61 141.7 98.32 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.343 0.657 . . . . 44.240000000000002 110.073 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -99.26 28.33 15.15 Favored 'Cis proline' 0 C--N 1.371 1.744 0 CA-C-N 119.766 0.952 . . . . 62.43 114.446 5.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -85.29 143.21 28.84 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.785 -0.45 . . . . 71.209999999999994 109.785 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' A' ' 37' ' ' PRO . 27.9 m -126.0 140.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 109.797 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.0 t -80.62 116.6 20.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.49 0.716 . . . . 73.129999999999995 111.398 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.29 123.75 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.762 -1.57 . . . . 72.040000000000006 106.762 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.31 -29.15 70.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.606 0.762 . . . . 71.219999999999999 111.527 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m -71.04 -36.65 72.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.776 0.831 . . . . 65.439999999999998 111.098 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.9 p -92.1 -21.04 20.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.342 0.657 . . . . 71.340000000000003 111.034 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.7 p 53.38 37.95 26.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.825 1.65 . . . . 52.030000000000001 111.784 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HA ' ' H ' ' A' ' 11' ' ' CYS . 15.9 ptp180 -145.06 146.89 32.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.259 0.624 . . . . 75.200000000000003 111.192 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 22.4 m -75.98 123.22 25.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.277 0.631 . . . . 72.340000000000003 109.644 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.92 -177.75 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.163 0.985 . . . . 72.439999999999998 109.622 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.34 127.85 86.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.229 0.612 . . . . 74.439999999999998 109.711 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG3' HG22 ' A' ' 26' ' ' VAL . 15.1 Cg_exo . . . . . 0 C--N 1.373 1.846 0 C-N-CA 123.034 2.489 . . . . 73.439999999999998 111.847 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--O 1.242 0.672 0 CA-C-O 120.75 0.309 . . . . 71.329999999999998 110.33 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.05 150.51 34.05 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.672 0.389 . . . . 62.539999999999999 110.733 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.67 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.07 -6.85 58.44 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 114.923 0.729 . . . . 71.030000000000001 114.923 170.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.491 ' HA ' HD21 ' A' ' 22' ' ' ASN . 2.9 m-20 -94.78 175.38 6.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.494 0.718 . . . . 73.120000000000005 110.902 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -67.11 122.87 18.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.312 -0.625 . . . . 63.020000000000003 109.312 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 80.3 m-20 63.36 31.66 15.06 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.564 1.146 . . . . 72.450000000000003 110.662 -176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.14 131.32 23.92 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.27 -1.011 . . . . 63.240000000000002 108.27 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.14 130.55 32.44 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.626 2.884 . . . . 54.310000000000002 112.382 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 29.0 p -79.29 127.2 31.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.8 -0.444 . . . . 74.400000000000006 109.8 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -79.86 125.09 29.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.367 0.667 . . . . 74.109999999999999 109.311 177.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.22 132.17 10.98 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.935 -0.575 . . . . 65.329999999999998 113.337 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -73.72 139.01 77.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.534 1.134 . . . . 72.140000000000001 111.059 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.45 -31.46 48.33 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.385 2.723 . . . . 63.140000000000001 113.876 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.26 -27.53 63.51 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.725 0.41 . . . . 74.400000000000006 111.267 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.35 0.83 11.28 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.705 -0.497 . . . . 72.239999999999995 114.219 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 163.05 26.92 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.675 0.737 . . . . 63.409999999999997 110.583 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 64.120000000000005 108.568 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 99.6 t -77.55 110.6 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.408 0.683 . . . . 73.450000000000003 109.58 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 84.4 m -139.2 138.52 36.96 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 72.150000000000006 108.988 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.491 HD21 ' HA ' ' A' ' 6' ' ' ASP . 9.4 p30 -79.5 142.53 35.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.623 -0.88 . . . . 74.540000000000006 108.623 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.61 144.82 97.92 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 122.959 0.504 . . . . 64.25 110.874 -174.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -93.12 14.76 46.76 Favored 'Cis proline' 0 C--N 1.377 2.055 0 C-N-CA 124.704 -0.957 . . . . 75.409999999999997 114.309 4.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.89 132.27 46.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.694 0.398 . . . . 74.319999999999993 110.938 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -115.77 126.89 73.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.338 1.055 . . . . 73.140000000000001 108.835 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -75.14 112.76 11.73 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.686 0.279 . . . . 74.519999999999996 110.984 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.88 132.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.26 -1.015 . . . . 74.120000000000005 108.26 172.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.07 -46.25 88.73 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 124.01 0.819 . . . . 73.109999999999999 111.782 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -66.58 -45.61 78.68 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.978 0.799 . . . . 62.329999999999998 111.499 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -80.91 -15.38 56.44 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.105 0.562 . . . . 74.019999999999996 111.17 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p 54.26 24.51 5.07 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.627 1.571 . . . . 73.219999999999999 113.029 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 36.4 ptt180 -131.28 148.78 52.72 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.634 0.774 . . . . 61.539999999999999 109.24 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 53.8 m -71.81 94.37 1.4 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.832 -0.803 . . . . 65.319999999999993 108.832 173.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -99.33 170.35 8.71 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.801 -1.09 . . . . 63.310000000000002 108.843 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.58 139.16 88.81 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.666 0.386 . . . . 75.420000000000002 110.25 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--N 1.369 1.606 0 C-N-CA 122.904 2.402 . . . . 74.140000000000001 112.022 173.436 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.556 1.174 0 N-CA-C 110.492 -0.188 . . . . 65.519999999999996 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.5 p -155.31 128.68 8.36 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.742 -0.599 . . . . 75.409999999999997 111.458 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 136.65 -13.37 3.95 Favored Glycine 0 C--N 1.355 1.639 0 N-CA-C 116.062 1.185 . . . . 60.210000000000001 116.062 164.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 23.2 m-20 -94.86 175.72 6.54 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.71 1.255 . . . . 74.120000000000005 112.37 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.93 131.33 50.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.151 -0.931 . . . . 71.439999999999998 110.096 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.591 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 62.3 m-20 57.98 27.13 14.33 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.737 1.215 . . . . 75.200000000000003 112.195 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 14.3 tp10 -119.69 125.98 27.17 Favored Pre-proline 0 N--CA 1.472 0.627 0 C-N-CA 123.971 0.909 . . . . 53.210000000000001 108.587 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 10.8 Cg_endo -49.2 140.76 25.04 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.934 3.089 . . . . 75.439999999999998 112.65 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.558 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 29.0 p -88.2 136.69 32.86 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 41.130000000000003 109.695 177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -85.53 134.36 34.03 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.605 -0.887 . . . . 52.25 108.605 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.2 138.4 13.91 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.502 -0.317 . . . . 65.540000000000006 112.559 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.72 151.22 57.92 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.431 1.092 . . . . 65.150000000000006 108.834 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.49 -34.93 83.84 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.154 2.569 . . . . 72.109999999999999 114.088 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.72 -13.61 60.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.887 0.475 . . . . 74.129999999999995 111.831 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.86 12.3 20.96 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.496 0.558 . . . . 44.219999999999999 114.496 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.58 136.32 38.26 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.273 0.536 . . . . 72.209999999999994 110.614 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -95.85 114.58 26.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.205 0.602 . . . . 60.450000000000003 109.652 176.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.563 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.5 t -79.6 101.76 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.416 0.686 . . . . 75.439999999999998 110.183 -177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 59.0 m -138.64 140.58 38.94 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.864 1.266 . . . . 45.539999999999999 108.565 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.16 144.18 33.23 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.161 -0.681 . . . . 75.200000000000003 109.161 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.6 139.84 97.27 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.212 0.605 . . . . 70.129999999999995 110.901 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -94.01 13.96 45.95 Favored 'Cis proline' 0 C--N 1.375 1.95 0 N-CA-C 114.642 0.978 . . . . 73.230000000000004 114.642 6.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -67.88 126.15 28.52 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 118.031 0.378 . . . . 61.43 110.629 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.63 129.52 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.841 1.256 . . . . 73.540000000000006 108.403 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 48.8 t -72.09 108.2 5.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.763 0.316 . . . . 73.310000000000002 110.612 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -79.36 120.27 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 107.775 -1.194 . . . . 62.210000000000001 107.775 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.58 -34.45 77.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.629 0.772 . . . . 73.150000000000006 112.42 -170.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -76.4 -25.32 54.41 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.654 0.382 . . . . 74.239999999999995 111.408 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.9 p -95.43 -14.16 24.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.91 0.484 . . . . 70.409999999999997 110.637 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.6 p 54.96 33.91 21.2 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.16 1.784 . . . . 75.400000000000006 113.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.591 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.4 ptp180 -144.53 150.82 38.17 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 74.049999999999997 111.032 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 34.3 m -70.09 121.69 17.96 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.655 -0.702 . . . . 61.5 109.244 172.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 14.1 mm-40 -132.26 173.76 10.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.526 1.131 . . . . 74.200000000000003 110.502 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -75.37 126.7 87.39 Favored Pre-proline 0 CA--C 1.558 1.255 0 N-CA-C 108.857 -0.794 . . . . 73.420000000000002 108.857 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.383 2.371 0 C-N-CA 123.161 2.574 . . . . 71.420000000000002 112.344 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.637 0.256 . . . . 71.310000000000002 110.526 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 27.2 p -101.32 148.47 25.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.554 0.576 . . . . 72.109999999999999 112.554 -170.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.92 -11.8 24.84 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.257 -0.883 . . . . 74.030000000000001 113.645 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 4.2 m-20 -96.96 161.46 13.83 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.676 0.738 . . . . 64.510000000000005 111.044 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 12.4 tmtt? -73.6 133.11 43.43 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.973 -1.012 . . . . 70.239999999999995 108.996 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 82.2 m-20 61.92 20.18 11.3 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.698 1.599 . . . . 52.329999999999998 112.282 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -120.11 152.06 53.89 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.774 1.23 . . . . 71.219999999999999 108.02 172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 Cg_endo -55.11 153.8 24.97 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.744 2.962 . . . . 62.350000000000001 113.294 -175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 28.4 p -100.4 122.54 43.32 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.362 -0.977 . . . . 65.420000000000002 108.362 166.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.0 p -84.2 107.31 16.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.81 -0.811 . . . . 70.340000000000003 108.81 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.42 122.56 5.97 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.786 -0.525 . . . . 72.450000000000003 111.786 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -57.4 156.64 15.2 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.638 1.175 . . . . 70.010000000000005 110.026 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -42.58 -39.26 6.81 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 123.764 2.976 . . . . 75.140000000000001 115.872 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -72.48 -31.21 65.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.932 0.893 . . . . 70.319999999999993 111.336 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.81 14.75 4.6 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.958 -0.565 . . . . 70.209999999999994 113.437 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.93 103.37 9.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.066 0.546 . . . . 65.310000000000002 110.997 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -71.62 123.64 22.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 70.430000000000007 110.606 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 90.1 t -78.91 104.87 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 110.383 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 78.4 m -141.75 136.07 30.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.428 -1.26 . . . . 72.329999999999998 108.868 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -80.17 146.49 31.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.585 -0.524 . . . . 64.439999999999998 109.585 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.36 145.58 93.34 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.047 0.539 . . . . 72.430000000000007 110.722 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -90.85 13.18 54.18 Favored 'Cis proline' 0 C--N 1.38 2.201 0 CA-C-N 119.977 1.028 . . . . 73.209999999999994 113.882 2.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -70.88 118.75 14.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.358 0.663 . . . . 73.540000000000006 110.779 -174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.83 135.02 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.252 1.021 . . . . 75.450000000000003 109.023 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 54.0 t -78.57 122.47 25.95 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.578 0.351 . . . . 72.129999999999995 111.033 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.98 136.87 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.176 -1.046 . . . . 63.149999999999999 108.176 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -39.97 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.021 0.528 . . . . 73.239999999999995 110.689 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 m -58.88 -36.91 75.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.975 . . . . 55.439999999999998 111.643 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 p -94.15 -25.97 16.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.76 0.824 . . . . 73.209999999999994 111.283 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p 54.22 32.18 15.55 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.774 1.63 . . . . 51.210000000000001 112.187 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 37.8 ptt180 -124.28 144.89 49.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.811 0.844 . . . . 71.310000000000002 109.773 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 33.6 m -69.32 127.27 32.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.846 -0.798 . . . . 74.409999999999997 108.846 169.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 16.1 pt-20 -156.54 -168.29 2.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.461 0.705 . . . . 74.540000000000006 109.323 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -59.15 154.21 41.85 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 122.88 0.472 . . . . 74.340000000000003 112.182 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.372 1.806 0 C-N-CA 122.415 2.077 . . . . 75.329999999999998 110.773 169.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.784 -0.45 . . . . 74.510000000000005 109.784 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -132.83 137.55 46.78 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.054 0.39 . . . . 74.310000000000002 112.054 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.4 5.32 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.076 -0.847 . . . . 73.099999999999994 114.134 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.55 163.25 17.59 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.94 0.87 . . . . 54.100000000000001 110.505 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 35' ' ' GLU . 59.5 tttm -64.98 141.58 58.73 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.076 0.55 . . . . 64.230000000000004 110.742 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 56.17 19.14 3.64 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.113 1.765 . . . . 55.43 112.057 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.99 146.89 37.12 Favored Pre-proline 0 N--CA 1.476 0.832 0 N-CA-C 107.314 -1.365 . . . . 64.209999999999994 107.314 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.75 141.68 92.03 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.081 2.521 . . . . 70.409999999999997 111.934 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 27.6 p -92.84 117.82 30.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.566 -0.902 . . . . 74.099999999999994 108.566 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 11.5 p -87.73 130.3 34.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.85 -0.426 . . . . 61.0 109.85 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.55 145.05 20.07 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 116.383 -0.371 . . . . 73.420000000000002 112.924 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -104.58 156.62 35.62 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.594 0.758 . . . . 73.420000000000002 109.132 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 -21.04 71.56 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.839 2.359 . . . . 75.340000000000003 114.426 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.01 -24.92 59.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.096 0.558 . . . . 51.43 110.701 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.8 38.17 2.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.556 -0.747 . . . . 74.150000000000006 112.819 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.37 141.05 48.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.031 0.532 . . . . 43.32 111.059 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 10.0 mmpt? -88.14 123.26 32.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.834 0.853 . . . . 63.539999999999999 110.093 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 94.9 t -77.76 101.4 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.39 0.614 . . . . 74.420000000000002 109.846 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 72.3 m -145.91 135.69 23.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.042 1.337 . . . . 72.530000000000001 107.924 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -79.48 142.21 36.04 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.887 -0.412 . . . . 74.010000000000005 109.887 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -67.26 144.24 98.02 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 122.72 0.408 . . . . 73.25 109.924 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.67 19.7 36.36 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 119.77 0.954 . . . . 60.299999999999997 114.062 3.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -85.31 130.27 34.63 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.264 0.626 . . . . 71.430000000000007 109.567 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.45 148.6 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.077 0.951 . . . . 53.030000000000001 109.541 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.1 t -84.77 131.89 34.5 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.818 0.342 . . . . 64.010000000000005 111.315 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.1 122.22 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 106.919 -1.511 . . . . 72.420000000000002 106.919 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.59 -32.32 73.75 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.528 0.731 . . . . 74.340000000000003 111.652 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.3 m -60.93 -42.04 97.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.05 0.94 . . . . 73.140000000000001 111.227 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.2 p -90.52 -15.34 30.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.454 0.702 . . . . 61.109999999999999 111.571 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.3 p 54.47 26.66 7.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.264 1.425 . . . . 53.229999999999997 112.349 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.48 150.81 45.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.176 0.591 . . . . 72.430000000000007 110.438 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 m -72.53 132.8 44.29 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.372 -0.603 . . . . 74.530000000000001 109.372 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HA ' ' HG3' ' A' ' 7' ' ' LYS . 48.1 mt-10 -144.86 -175.01 4.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.054 0.941 . . . . 73.230000000000004 110.308 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.8 138.13 85.46 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 65.239999999999995 110.422 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.563 1.96 0 C-N-CA 122.159 1.906 . . . . 64.25 111.735 172.58 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 108.523 -0.918 . . . . 63.310000000000002 108.523 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -148.59 142.52 25.8 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.976 0.807 . . . . 74.099999999999994 111.91 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 89.74 32.82 9.66 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.786 -0.643 . . . . 21.309999999999999 113.624 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.16 177.61 7.54 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.127 0.971 . . . . 63.450000000000003 109.612 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -71.23 128.58 36.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 74.030000000000001 109.572 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.62 19.83 9.75 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.009 1.324 . . . . 63.340000000000003 112.708 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.39 132.79 23.37 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 118.477 -0.773 . . . . 73.200000000000003 109.505 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.4 133.54 25.47 Favored 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 124.072 3.182 . . . . 73.349999999999994 113.584 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 19' ' ' LYS . 31.7 p -80.34 123.1 27.71 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.584 -0.525 . . . . 63.140000000000001 109.584 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -80.19 131.29 35.68 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.409 -0.589 . . . . 23.52 109.409 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.84 119.65 5.12 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.206 -0.452 . . . . 61.030000000000001 112.07 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -59.25 145.46 81.18 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.401 1.08 . . . . 72.540000000000006 111.591 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 -27.6 82.17 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.558 2.172 . . . . 64.230000000000004 112.56 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.85 -24.22 59.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.308 0.643 . . . . 72.519999999999996 111.531 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.3 10.73 14.75 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-O 119.691 -0.505 . . . . 73.400000000000006 114.346 173.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.65 162.51 18.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.324 0.562 . . . . 74.340000000000003 110.915 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 75.1 mmtt -100.77 126.35 47.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.043 -0.725 . . . . 73.430000000000007 109.043 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 80.8 t -77.84 109.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.428 -0.582 . . . . 61.439999999999998 109.428 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 85.4 m -145.09 139.54 27.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.499 1.12 . . . . 65.329999999999998 109.33 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -78.32 143.66 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.267 0.627 . . . . 71.219999999999999 109.717 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.22 145.2 85.43 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.377 -0.344 . . . . 71.129999999999995 110.101 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.38 19.63 34.79 Favored 'Cis proline' 0 C--N 1.377 2.029 0 CA-C-N 119.571 0.882 . . . . 72.530000000000001 113.249 -0.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -74.62 128.09 34.71 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.611 0.764 . . . . 64.549999999999997 110.166 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.02 143.04 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.494 1.117 . . . . 73.010000000000005 109.606 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 45.1 t -79.05 113.9 17.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.065 -0.346 . . . . 51.229999999999997 110.065 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.89 121.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.647 -1.242 . . . . 70.510000000000005 107.647 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.83 -26.37 65.74 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.662 0.785 . . . . 72.030000000000001 112.996 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -68.16 -50.91 51.42 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.499 0.72 . . . . 52.439999999999998 111.217 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.3 p -86.05 -14.66 43.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.667 0.787 . . . . 62.039999999999999 111.852 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.1 p 53.07 32.29 12.74 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 125.508 1.523 . . . . 55.130000000000003 112.236 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -144.84 150.6 37.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.506 0.67 . . . . 74.430000000000007 112.682 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 m -80.02 96.77 6.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.687 -1.142 . . . . 70.019999999999996 111.013 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.74 -173.23 2.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.921 0.888 . . . . 71.5 110.156 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.59 132.13 92.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 122.917 0.487 . . . . 71.129999999999995 110.833 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.373 1.827 0 C-N-CA 122.601 2.201 . . . . 75.109999999999999 111.937 171.346 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 110.254 -0.276 . . . . 74.129999999999995 110.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -132.67 147.32 52.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.37 0.668 . . . . 64.120000000000005 109.405 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.754 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.73 11.16 57.12 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 115.123 0.809 . . . . 60.420000000000002 115.123 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.9 -179.95 3.79 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.663 0.732 . . . . 51.219999999999999 110.86 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -60.09 118.46 6.34 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.413 0.685 . . . . 72.030000000000001 111.073 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.661 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.9 m-20 66.95 20.0 10.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.307 1.443 . . . . 73.340000000000003 111.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -118.77 130.51 24.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.184 -1.043 . . . . 63.100000000000001 108.184 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 13.2 Cg_endo -53.22 138.57 63.86 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.752 2.968 . . . . 63.299999999999997 113.269 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.0 p -79.7 127.95 32.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.058 -0.519 . . . . 74.319999999999993 110.103 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 145.78 32.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.335 -0.617 . . . . 65.409999999999997 109.335 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.06 125.41 8.52 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 120.002 -0.332 . . . . 60.310000000000002 112.521 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.96 152.56 93.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.602 0.761 . . . . 74.549999999999997 109.782 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.01 -31.41 95.67 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.763 2.308 . . . . 73.010000000000005 112.994 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -73.13 -27.42 61.67 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.655 0.782 . . . . 73.219999999999999 111.345 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.66 1.69 11.88 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.803 0.681 . . . . 73.25 114.803 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.85 119.01 14.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.375 0.588 . . . . 73.349999999999994 111.112 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -71.33 114.54 9.5 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.054 -0.721 . . . . 63.020000000000003 109.054 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.69 115.86 20.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.074 0.949 . . . . 64.540000000000006 110.072 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.7 m -147.9 141.11 25.1 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.563 1.164 . . . . 60.119999999999997 108.281 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.15 137.17 35.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.576 -0.898 . . . . 54.240000000000002 108.576 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.94 143.6 98.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.136 0.574 . . . . 74.239999999999995 111.011 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -93.8 16.98 41.13 Favored 'Cis proline' 0 C--N 1.378 2.108 0 N-CA-C 114.57 0.95 . . . . 72.25 114.57 5.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -69.99 120.38 15.63 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.326 -0.62 . . . . 62.329999999999998 109.326 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.89 135.12 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.254 1.022 . . . . 74.409999999999997 108.686 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 47.6 t -69.76 97.39 1.08 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.24 0.543 . . . . 75.230000000000004 109.654 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.24 111.15 13.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 107.273 -1.38 . . . . 73.530000000000001 107.273 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.42 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.9 mm? -59.04 -32.07 69.42 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.573 1.149 . . . . 73.239999999999995 111.399 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 m -56.94 -48.5 78.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.548 1.139 . . . . 72.099999999999994 111.141 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.5 p -96.99 -7.59 32.66 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.587 0.755 . . . . 70.120000000000005 111.83 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p 53.66 36.35 23.46 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 126.053 1.741 . . . . 72.129999999999995 112.455 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.5 ptp180 -141.93 151.2 42.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 73.030000000000001 110.787 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.754 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 35.4 m -73.56 98.56 2.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.943 0.878 . . . . 75.239999999999995 109.051 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -123.11 164.76 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.613 1.165 . . . . 75.219999999999999 108.815 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.87 147.31 73.18 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.22 0.608 . . . . 64.120000000000005 110.885 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.373 1.835 0 C-N-CA 123.169 2.58 . . . . 75.209999999999994 112.297 171.833 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.006 -0.368 . . . . 72.120000000000005 110.006 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.93 149.31 27.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.833 0.349 . . . . 72.439999999999998 111.282 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.32 25.28 8.91 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 116.027 1.171 . . . . 72.140000000000001 116.027 164.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 9' ' ' GLU . 8.9 m-20 -123.06 172.57 8.44 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.577 0.751 . . . . 72.5 109.625 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.99 125.08 23.77 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 109.025 -0.731 . . . . 75.019999999999996 109.025 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 74.6 m-20 66.78 18.43 10.68 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.549 1.54 . . . . 71.329999999999998 112.681 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.477 ' HB3' ' H ' ' A' ' 6' ' ' ASP . 15.4 tp10 -118.3 118.56 33.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.461 -0.94 . . . . 72.010000000000005 108.461 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 8.1 Cg_endo -45.41 124.33 6.37 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.646 3.564 . . . . 74.510000000000005 113.325 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.0 p -76.0 130.14 37.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.745 0.418 . . . . 74.409999999999997 109.929 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.1 p -84.56 105.8 15.65 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.802 -0.814 . . . . 73.299999999999997 108.802 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.44 122.98 6.08 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.259 -0.736 . . . . 54.210000000000001 111.259 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 97.4 mtt180 -71.54 156.02 91.89 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.708 0.803 . . . . 70.140000000000001 110.587 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.21 -28.57 85.24 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.768 2.312 . . . . 64.349999999999994 113.34 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.77 -28.18 62.45 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.39 0.431 . . . . 73.430000000000007 109.998 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.42 1.24 11.12 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.112 -0.495 . . . . 31.530000000000001 113.586 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -78.82 108.81 12.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.819 0.447 . . . . 70.230000000000004 110.605 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 29' ' ' LEU . 46.5 mtmt -72.67 118.95 16.23 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.374 -0.602 . . . . 70.209999999999994 109.374 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.584 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 66.6 t -78.15 108.6 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.042 0.537 . . . . 52.25 109.664 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 70.7 m -150.97 138.85 19.9 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.085 1.354 . . . . 44.439999999999998 108.269 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.88 136.64 37.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.085 -1.08 . . . . 70.319999999999993 108.085 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.96 144.87 93.58 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.105 0.562 . . . . 71.239999999999995 109.913 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -87.02 1.84 68.37 Favored 'Cis proline' 0 C--N 1.378 2.126 0 C-N-CA 124.55 -1.021 . . . . 74.129999999999995 114.285 7.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -64.24 109.57 1.92 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.991 0.516 . . . . 63.039999999999999 110.113 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.19 140.15 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.066 0.946 . . . . 61.210000000000001 109.578 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.5 t -81.24 118.04 22.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.617 0.367 . . . . 74.099999999999994 111.344 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.21 118.05 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.939 -1.504 . . . . 63.25 106.939 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 19' ' ' LYS . 3.7 mm? -67.43 -22.72 65.5 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.567 0.747 . . . . 63.32 111.925 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -62.23 -42.47 99.34 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.524 0.73 . . . . 71.209999999999994 110.13 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.9 p -95.9 -10.96 27.47 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.905 0.882 . . . . 71.120000000000005 111.055 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.5 p 54.67 26.08 7.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.201 1.801 . . . . 71.329999999999998 113.31 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.695 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 35.2 ptt180 -131.3 151.33 51.61 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.168 0.987 . . . . 63.43 109.936 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -73.8 140.92 46.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.679 -1.23 . . . . 74.510000000000005 107.679 170.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.29 165.76 32.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.621 0.368 . . . . 72.319999999999993 110.056 -169.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -61.49 127.71 88.89 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.65 0.78 . . . . 73.310000000000002 111.165 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.374 1.911 0 C-N-CA 122.918 2.412 . . . . 60.119999999999997 111.919 170.46 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.23 145.99 26.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 62.32 111.354 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 117.28 -4.41 18.05 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.634 1.014 . . . . 74.209999999999994 115.634 168.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 6.1 m-20 -94.42 179.09 5.4 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.223 1.012 . . . . 74.409999999999997 111.873 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -70.86 126.63 30.11 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 116.047 -0.524 . . . . 75.310000000000002 109.909 -174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.53 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 71.9 m-20 60.63 18.13 8.14 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.775 1.63 . . . . 72.430000000000007 112.359 -172.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -109.06 130.53 22.62 Favored Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 108.564 -0.902 . . . . 65.420000000000002 108.564 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -44.03 120.33 2.4 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.317 3.345 . . . . 72.299999999999997 112.916 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 14.0 p -77.03 147.14 36.92 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.098 0.559 . . . . 71.439999999999998 109.662 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -100.08 146.68 26.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.554 -1.276 . . . . 64.540000000000006 107.554 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.17 137.88 14.54 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 122.469 -0.145 . . . . 64.510000000000005 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.79 147.13 91.52 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.88 0.872 . . . . 70.310000000000002 109.458 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.98 -25.73 59.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.406 2.07 . . . . 61.399999999999999 112.191 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.29 -8.82 57.67 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.054 0.942 . . . . 72.329999999999998 111.767 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.18 -0.96 37.88 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 114.793 0.677 . . . . 74.420000000000002 114.793 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.23 130.05 35.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 117.554 0.677 . . . . 71.239999999999995 111.074 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD2' HD11 ' A' ' 29' ' ' LEU . 11.6 mmpt? -84.71 122.0 28.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.287 0.635 . . . . 74.109999999999999 109.648 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.54 108.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 123.243 0.617 . . . . 61.149999999999999 109.985 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 68.0 m -146.99 149.67 33.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.987 -1.006 . . . . 51.130000000000003 108.331 175.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 8.1 p30 -77.07 128.12 33.89 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.53 -1.285 . . . . 74.219999999999999 107.53 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.08 142.14 97.71 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 116.188 -0.46 . . . . 62.009999999999998 110.028 -173.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.2 12.56 36.36 Favored 'Cis proline' 0 C--N 1.373 1.828 0 CA-C-N 119.548 0.874 . . . . 72.329999999999998 114.235 6.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -64.31 130.25 43.11 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.993 -0.373 . . . . 65.109999999999999 109.993 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.84 142.65 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.153 0.981 . . . . 73.219999999999999 110.232 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.6 t -83.53 112.28 19.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.393 0.277 . . . . 75.430000000000007 110.545 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.01 121.76 31.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 107.353 -1.351 . . . . 54.130000000000003 107.353 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' HD2' ' A' ' 19' ' ' LYS . 4.2 mm? -65.28 -26.65 68.17 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.63 0.772 . . . . 64.049999999999997 112.59 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.2 m -63.21 -51.31 66.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.1 0.56 . . . . 75.349999999999994 110.876 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' ARG . 55.5 p -87.68 -18.01 30.5 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.212 -0.904 . . . . 71.239999999999995 111.603 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.7 p 52.75 31.77 11.01 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.77 1.628 . . . . 73.219999999999999 112.482 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.53 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 11.6 ptp180 -131.1 150.92 51.93 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.621 0.768 . . . . 75.420000000000002 110.152 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 14.1 m -81.56 113.03 19.31 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.804 -0.634 . . . . 72.439999999999998 110.109 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.41 -169.36 1.92 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.659 1.184 . . . . 74.019999999999996 109.684 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.09 149.93 89.68 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 122.908 0.483 . . . . 75.120000000000005 110.979 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.374 1.879 0 C-N-CA 122.527 2.151 . . . . 38.119999999999997 111.09 170.482 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.277 -0.638 . . . . 72.409999999999997 109.277 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.5 145.85 23.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 122.503 0.321 . . . . 74.510000000000005 110.955 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.681 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 102.57 4.31 49.48 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 115.436 0.934 . . . . 54.020000000000003 115.436 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.531 ' HA ' HD21 ' A' ' 22' ' ' ASN . 7.1 m-20 -92.15 170.44 9.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.46 0.63 . . . . 75.129999999999995 110.599 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -69.96 125.13 25.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.69 -0.856 . . . . 75.109999999999999 108.69 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 62.51 29.04 17.01 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.256 1.422 . . . . 75.140000000000001 111.832 -173.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -127.05 141.24 40.1 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.059 0.944 . . . . 61.43 108.513 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 19.9 Cg_endo -55.16 132.14 50.51 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.045 2.497 . . . . 74.409999999999997 112.619 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.608 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.9 p -82.65 141.89 32.14 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.422 0.689 . . . . 64.209999999999994 109.479 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.5 p -92.67 126.93 37.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.107 -1.071 . . . . 75.230000000000004 108.107 170.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 126.61 8.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 112.231 -0.348 . . . . 61.539999999999999 112.231 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -67.5 144.11 97.58 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.133 0.973 . . . . 72.340000000000003 109.916 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.95 -24.78 74.59 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.969 2.446 . . . . 54.530000000000001 113.245 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.75 -8.72 59.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.941 0.896 . . . . 72.129999999999995 112.138 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.08 -9.97 27.06 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.736 -0.48 . . . . 54.310000000000002 114.106 172.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 149.39 41.2 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.387 0.593 . . . . 75.299999999999997 110.788 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -100.23 117.32 34.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.898 -0.778 . . . . 61.299999999999997 108.898 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 46.8 t -77.65 94.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.689 -0.856 . . . . 61.119999999999997 108.689 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 66.7 m -128.25 141.68 51.38 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.064 -1.425 . . . . 74.319999999999993 107.867 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.531 HD21 ' HA ' ' A' ' 6' ' ' ASP . 9.6 p30 -78.76 135.83 37.22 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.415 -0.957 . . . . 61.210000000000001 108.415 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.09 143.3 88.53 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 124.047 0.939 . . . . 74.430000000000007 111.264 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.2 25.71 20.56 Favored 'Cis proline' 0 C--N 1.383 2.374 0 CA-C-N 119.829 0.975 . . . . 54.310000000000002 113.844 1.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -77.28 142.12 39.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.565 0.346 . . . . 54.329999999999998 110.269 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.03 137.28 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 75.319999999999993 109.217 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -82.59 124.03 29.77 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.563 0.345 . . . . 62.450000000000003 110.894 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 123.68 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.777 -1.564 . . . . 64.200000000000003 106.777 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.5 mm? -61.58 -44.19 97.48 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.331 1.02 . . . . 72.019999999999996 111.843 -165.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -68.88 -39.02 80.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.07 0.948 . . . . 74.150000000000006 111.421 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -84.29 -15.87 45.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.118 0.567 . . . . 71.430000000000007 111.279 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 54.12 37.04 26.23 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.444 1.498 . . . . 55.43 112.262 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 30.4 ptt180 -134.73 139.71 45.4 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.313 0.645 . . . . 64.340000000000003 110.771 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.681 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 38.3 m -75.94 128.08 34.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.005 -0.739 . . . . 74.129999999999995 109.005 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -147.05 170.09 17.88 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.332 -0.988 . . . . 63.439999999999998 108.332 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.97 134.54 96.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 122.921 0.488 . . . . 64.540000000000006 111.071 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 122.721 2.281 . . . . 71.510000000000005 111.893 174.574 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.18 -0.674 . . . . 53.509999999999998 109.18 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -128.96 148.04 50.91 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 122.715 0.406 . . . . 52.130000000000003 110.968 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.02 -9.95 31.69 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 114.436 0.535 . . . . 65.430000000000007 114.436 169.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.66 169.09 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.358 0.663 . . . . 74.030000000000001 110.866 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -65.65 122.92 18.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.167 0.587 . . . . 65.430000000000007 110.113 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 76.8 m-20 64.59 16.96 10.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.508 1.523 . . . . 73.319999999999993 113.769 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -104.88 136.55 19.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 108.276 -1.009 . . . . 62.200000000000003 108.276 170.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.09 137.03 76.98 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.203 2.602 . . . . 75.129999999999995 112.139 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.6 p -77.36 133.01 38.84 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.25 -0.648 . . . . 62.149999999999999 109.25 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.22 107.21 10.65 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.464 0.649 . . . . 73.219999999999999 109.481 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.21 108.42 2.69 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.52 -1.218 . . . . 60.520000000000003 112.168 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -68.22 145.12 97.35 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.108 0.963 . . . . 70.030000000000001 110.251 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -47.84 -36.66 27.08 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.651 3.568 . . . . 74.239999999999995 115.128 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -68.97 -20.13 64.18 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.676 0.79 . . . . 64.329999999999998 111.934 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.83 5.17 11.09 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.235 -0.439 . . . . 63.340000000000003 113.443 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.42 131.54 38.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.988 0.515 . . . . 73.099999999999994 111.703 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -92.7 114.45 27.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.085 -1.08 . . . . 73.319999999999993 108.085 171.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.46 124.76 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.564 0.346 . . . . 65.25 110.825 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.9 m -137.12 149.22 47.19 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.246 1.019 . . . . 62.43 109.234 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -84.71 141.02 30.87 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.111 -0.7 . . . . 74.420000000000002 109.111 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.09 148.42 98.85 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.641 0.776 . . . . 74.109999999999999 110.759 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.01 23.61 26.26 Favored 'Cis proline' 0 C--N 1.375 1.95 0 CA-C-N 119.527 0.867 . . . . 72.239999999999995 113.91 3.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.09 140.03 31.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.874 0.47 . . . . 55.450000000000003 110.246 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.33 138.0 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.935 1.294 . . . . 71.530000000000001 109.002 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 42.6 t -73.37 109.9 7.25 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.914 0.388 . . . . 73.340000000000003 110.722 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.52 114.31 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.731 -1.211 . . . . 70.219999999999999 107.731 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.3 -26.16 68.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.298 1.039 . . . . 75.299999999999997 112.223 -171.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -63.56 -46.47 85.78 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.806 0.843 . . . . 63.25 110.429 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 p -95.77 -8.87 33.2 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.222 1.009 . . . . 63.539999999999999 111.937 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p 54.84 28.12 9.94 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.793 1.637 . . . . 43.43 113.018 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 5.3 ptp180 -138.58 151.91 47.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.145 0.578 . . . . 74.0 110.613 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.572 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 13.6 m -77.67 125.67 29.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.144 -0.934 . . . . 64.230000000000004 109.804 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.49 176.14 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.256 1.023 . . . . 72.439999999999998 109.834 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.11 143.0 90.8 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.165 -0.445 . . . . 72.439999999999998 110.01 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 CA--C 1.563 1.966 0 C-N-CA 122.734 2.289 . . . . 44.25 112.0 173.419 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.127 -0.694 . . . . 64.200000000000003 109.127 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.52 144.63 25.47 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.152 -0.342 . . . . 74.230000000000004 110.626 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.636 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.41 20.09 30.76 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 115.291 0.876 . . . . 72.439999999999998 115.291 168.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.77 -179.92 3.88 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.406 0.682 . . . . 75.340000000000003 110.55 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -61.28 122.43 15.08 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.744 0.818 . . . . 54.549999999999997 110.846 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 60.26 27.13 16.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.011 1.324 . . . . 63.229999999999997 111.159 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -124.07 125.41 25.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 109.148 -0.686 . . . . 73.540000000000006 109.148 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.48 125.31 10.63 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 124.328 3.352 . . . . 60.229999999999997 112.858 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p -77.69 132.19 38.06 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.94 -0.763 . . . . 64.439999999999998 108.94 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -81.42 153.04 27.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.84 0.856 . . . . 72.340000000000003 109.091 175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.64 131.56 10.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.932 -0.48 . . . . 75.219999999999999 112.835 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -66.57 157.58 82.29 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.959 1.303 . . . . 74.140000000000001 110.999 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.76 -35.41 98.81 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.624 2.216 . . . . 64.409999999999997 112.69 172.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.51 -30.06 57.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.987 0.915 . . . . 60.229999999999997 111.088 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.03 1.54 12.87 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 115.247 0.859 . . . . 61.340000000000003 115.247 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.1 146.75 47.31 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.056 0.928 . . . . 71.349999999999994 110.384 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -86.44 122.67 30.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.538 -0.542 . . . . 74.530000000000001 109.538 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 24.8 t -79.18 109.45 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.55 0.74 . . . . 63.140000000000001 109.832 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.6 m -137.24 139.93 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.82 -1.178 . . . . 62.020000000000003 107.82 169.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -78.06 146.82 35.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.164 -1.05 . . . . 74.420000000000002 108.164 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.55 141.47 97.93 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.041 0.536 . . . . 71.140000000000001 110.716 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -98.65 18.07 27.37 Favored 'Cis proline' 0 C--N 1.372 1.766 0 CA-C-N 119.267 0.774 . . . . 44.140000000000001 113.957 -1.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -65.13 141.58 58.65 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.033 0.533 . . . . 74.439999999999998 110.028 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.57 136.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.343 1.057 . . . . 73.420000000000002 110.302 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.683 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.5 t -80.98 113.61 19.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.978 0.511 . . . . 54.200000000000003 110.655 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.7 118.82 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.657 -1.609 . . . . 73.349999999999994 106.657 170.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.2 -36.22 82.93 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.11 0.964 . . . . 74.439999999999998 111.564 -171.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -61.42 -43.46 98.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.749 0.82 . . . . 72.340000000000003 111.002 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.5 p -92.51 -11.06 35.58 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.11 0.564 . . . . 71.239999999999995 111.212 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.5 p 54.66 28.84 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.987 1.715 . . . . 65.219999999999999 113.137 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -140.49 151.12 44.56 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.328 0.651 . . . . 73.200000000000003 110.265 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 18.4 m -82.75 116.45 22.11 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.838 0.455 . . . . 74.329999999999998 110.794 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -104.48 -170.36 1.75 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.468 1.107 . . . . 73.239999999999995 109.04 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.75 156.77 91.52 Favored Pre-proline 0 N--CA 1.485 1.279 0 CA-C-O 119.051 -0.5 . . . . 74.340000000000003 110.577 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.601 2.201 . . . . 75.120000000000005 111.801 175.743 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 10.3 pt-20 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 63.329999999999998 109.259 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.8 p -97.24 136.92 37.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.122 -0.361 . . . . 75.319999999999993 110.65 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.6 1.21 64.07 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 115.228 0.851 . . . . 42.130000000000003 115.228 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.04 -179.58 4.73 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.286 0.634 . . . . 64.319999999999993 111.004 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -65.01 121.56 14.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.068 0.947 . . . . 62.420000000000002 110.416 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 60.03 18.04 7.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.418 1.487 . . . . 43.420000000000002 112.694 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 54.4 mm-40 -107.75 138.95 20.16 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.891 0.877 . . . . 63.119999999999997 109.695 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.43 122.61 12.1 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 123.145 2.563 . . . . 74.310000000000002 112.277 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 28.0 p -74.48 128.69 36.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.774 -0.454 . . . . 61.240000000000002 109.774 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 120.03 23.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.268 -0.641 . . . . 70.400000000000006 109.268 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.44 126.01 8.36 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.842 -0.617 . . . . 75.150000000000006 113.552 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.43 144.35 88.43 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.157 0.983 . . . . 74.019999999999996 110.805 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.13 -17.57 60.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.502 2.134 . . . . 63.240000000000002 112.98 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.72 -8.09 58.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.835 0.854 . . . . 62.32 111.999 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.2 35.72 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 114.566 0.586 . . . . 74.230000000000004 114.566 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.48 139.57 47.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.543 0.672 . . . . 70.019999999999996 110.293 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -96.06 116.19 28.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.353 0.661 . . . . 50.329999999999998 110.278 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.94 108.48 18.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.159 -0.682 . . . . 74.010000000000005 109.159 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.3 m -128.81 148.86 50.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 124.671 1.188 . . . . 73.409999999999997 108.316 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.74 150.69 25.65 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -68.4 143.06 95.14 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 122.942 0.497 . . . . 73.329999999999998 110.888 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -93.63 14.46 46.08 Favored 'Cis proline' 0 C--N 1.38 2.229 0 CA-C-N 119.59 0.889 . . . . 73.420000000000002 113.995 0.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -71.59 134.06 46.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.299 0.64 . . . . 72.120000000000005 110.645 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.08 139.73 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.623 1.169 . . . . 65.349999999999994 109.076 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.9 t -79.75 120.05 23.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.114 0.416 . . . . 63.009999999999998 111.244 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.09 120.33 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 106.651 -1.611 . . . . 75.519999999999996 106.651 168.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.35 -39.27 92.12 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.197 0.599 . . . . 54.149999999999999 111.583 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -61.49 -32.47 72.49 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.791 0.837 . . . . 60.109999999999999 111.456 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.2 p -95.84 -16.48 21.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.084 0.554 . . . . 64.040000000000006 111.276 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p 54.56 35.38 23.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.245 1.818 . . . . 65.439999999999998 112.045 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -146.88 150.59 35.55 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.112 0.565 . . . . 71.129999999999995 111.093 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 19.8 m -82.74 115.22 21.56 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.005 0.522 . . . . 70.019999999999996 110.547 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -122.26 178.78 4.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 74.310000000000002 109.311 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.41 138.82 97.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.142 0.577 . . . . 62.219999999999999 111.542 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 C--N 1.376 2.023 0 C-N-CA 123.245 2.63 . . . . 64.340000000000003 112.003 176.584 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 110.17 -0.307 . . . . 74.420000000000002 110.17 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.2 p -154.44 150.22 27.63 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 122.607 0.363 . . . . 62.439999999999998 110.952 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.688 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 89.47 3.53 74.85 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.511 0.564 . . . . 71.019999999999996 114.511 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -95.88 178.81 5.31 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.297 0.639 . . . . 71.319999999999993 110.341 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 123.68 21.13 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.507 0.723 . . . . 71.409999999999997 109.675 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 58.92 35.56 24.2 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.491 1.516 . . . . 73.239999999999995 111.661 -172.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 12.8 tp10 -130.23 125.68 21.92 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 118.073 -0.965 . . . . 72.319999999999993 109.585 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 2.2 Cg_endo -37.87 121.59 0.46 Allowed 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 124.916 3.744 . . . . 74.299999999999997 113.952 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.646 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 30.1 p -76.26 115.11 15.68 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.543 -0.91 . . . . 64.239999999999995 108.543 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.0 p -80.48 108.73 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.186 0.594 . . . . 73.150000000000006 110.395 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.68 121.65 5.56 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.01 -0.541 . . . . 54.229999999999997 112.977 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -61.61 155.16 61.67 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.206 1.003 . . . . 72.549999999999997 110.873 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.98 -23.36 21.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.633 2.889 . . . . 72.329999999999998 115.715 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.73 -24.86 33.38 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.745 0.418 . . . . 71.340000000000003 111.416 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.22 3.85 10.37 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.825 -0.43 . . . . 71.019999999999996 113.793 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 123.38 25.3 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.968 0.507 . . . . 74.540000000000006 111.462 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.646 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -80.39 110.19 15.61 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.653 0.781 . . . . 70.329999999999998 109.713 176.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.0 t -79.43 111.18 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.096 0.558 . . . . 70.439999999999998 110.154 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 82.5 m -140.53 135.39 31.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.575 -1.193 . . . . 54.32 108.193 171.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.59 127.15 31.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.311 -0.996 . . . . 74.120000000000005 108.311 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.37 144.61 97.54 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.24 0.616 . . . . 51.539999999999999 110.558 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.13 8.15 67.01 Favored 'Cis proline' 0 C--N 1.379 2.174 0 N-CA-C 114.706 1.002 . . . . 60.299999999999997 114.706 8.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.37 127.47 33.08 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.89 138.64 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.759 0.824 . . . . 74.450000000000003 109.788 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.0 t -77.67 113.42 15.5 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.232 0.469 . . . . 62.450000000000003 110.224 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.439 HD13 ' HB2' ' A' ' 35' ' ' GLU . 2.7 mp -78.81 111.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.385 -1.709 . . . . 62.530000000000001 106.385 168.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.52 -28.24 69.81 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.014 0.925 . . . . 74.340000000000003 112.12 -170.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.9 m -60.0 -54.05 50.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.678 0.791 . . . . 62.409999999999997 110.342 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -83.74 -12.77 55.32 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.798 0.839 . . . . 70.549999999999997 111.432 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.0 p 53.69 33.96 17.82 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.661 1.584 . . . . 54.200000000000003 112.312 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -136.98 150.38 48.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.697 0.799 . . . . 71.239999999999995 110.144 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -81.59 119.15 23.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.882 -0.785 . . . . 33.509999999999998 108.882 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' HD13 ' A' ' 28' ' ' ILE . 35.2 mt-10 -121.01 170.44 9.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.472 0.709 . . . . 62.350000000000001 109.951 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.3 134.15 82.79 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.893 -0.594 . . . . 73.230000000000004 110.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.569 2.236 0 C-N-CA 122.574 2.183 . . . . 73.349999999999994 111.609 172.033 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 108.273 -1.01 . . . . 74.430000000000007 108.273 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -140.89 138.15 33.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.326 -0.233 . . . . 44.310000000000002 111.145 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.547 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 105.99 5.18 38.46 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.412 0.525 . . . . 34.219999999999999 114.412 174.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.67 172.37 8.3 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.582 0.753 . . . . 51.210000000000001 111.225 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -67.64 122.17 17.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.44 1.096 . . . . 70.140000000000001 109.253 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 64.39 20.99 12.37 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.166 1.386 . . . . 74.420000000000002 112.319 -175.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -126.32 135.83 27.73 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.193 -0.908 . . . . 70.219999999999999 110.129 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' SER . 1.6 Cg_endo -41.58 133.16 3.68 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.853 3.702 . . . . 63.140000000000001 114.645 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.1 p -93.23 128.35 39.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.48 0.712 . . . . 72.319999999999993 109.304 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.9 p -83.95 101.07 11.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.658 -0.868 . . . . 70.409999999999997 108.658 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -87.39 118.78 5.07 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.671 -0.695 . . . . 74.019999999999996 112.539 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 96.6 mtt180 -56.81 152.83 25.11 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.76 1.224 . . . . 73.019999999999996 111.394 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.68 -23.63 58.61 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.349 2.7 . . . . 72.439999999999998 114.318 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.22 5.52 29.86 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.855 0.862 . . . . 72.239999999999995 112.152 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.0 9.98 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.355 -0.136 . . . . 63.340000000000003 112.97 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -114.73 97.94 6.56 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.432 -0.581 . . . . 44.439999999999998 109.432 175.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 10.1 mtmp? -71.4 111.18 6.51 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.192 0.597 . . . . 75.200000000000003 109.477 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -76.15 113.93 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.08 -0.711 . . . . 73.329999999999998 109.08 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 77.5 m -141.47 143.4 33.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.95 1.3 . . . . 63.420000000000002 108.838 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -80.82 143.64 32.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.161 -1.052 . . . . 72.439999999999998 108.161 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.19 147.76 90.85 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.78 0.432 . . . . 62.409999999999997 110.53 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.52 28.17 17.15 Favored 'Cis proline' 0 C--N 1.378 2.116 0 CA-C-N 119.747 0.946 . . . . 71.049999999999997 113.454 1.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -82.2 117.98 22.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.804 0.442 . . . . 75.310000000000002 110.207 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -97.46 131.29 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.33 1.052 . . . . 73.430000000000007 109.805 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.9 t -79.87 113.5 18.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.65 0.262 . . . . 63.539999999999999 110.755 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.8 mt -79.9 129.03 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.935 -1.135 . . . . 43.340000000000003 107.935 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.29 -42.1 99.06 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.808 0.843 . . . . 72.409999999999997 111.278 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -59.59 -36.69 76.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.194 0.997 . . . . 55.420000000000002 111.836 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.5 p -95.5 -19.26 19.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 50.240000000000002 111.467 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 88.0 p 54.62 30.98 14.21 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.163 1.785 . . . . 51.350000000000001 112.77 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 12.1 ptp180 -140.45 149.28 42.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.353 0.661 . . . . 74.129999999999995 110.998 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 8.2 m -81.65 99.76 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.276 0.63 . . . . 74.049999999999997 110.639 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 36.4 mt-10 -107.72 -172.99 2.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.975 0.91 . . . . 72.209999999999994 111.004 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.1 158.9 74.57 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.743 0.817 . . . . 73.140000000000001 111.022 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 CA--C 1.561 1.872 0 C-N-CA 122.677 2.251 . . . . 71.400000000000006 111.217 166.809 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.035 -0.728 . . . . 65.25 109.035 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.9 p -143.42 143.23 31.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.039 0.381 . . . . 42.549999999999997 111.842 -173.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 105.01 30.49 4.78 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 114.651 0.62 . . . . 63.420000000000002 114.651 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.65 174.26 8.85 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.039 0.936 . . . . 62.240000000000002 110.446 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -68.84 123.76 21.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.244 1.018 . . . . 73.129999999999995 109.1 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 84.9 m-20 60.51 29.88 19.34 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.785 1.234 . . . . 72.450000000000003 112.338 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -113.92 141.05 25.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 107.768 -1.197 . . . . 74.340000000000003 107.768 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.97 145.52 10.25 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 123.397 2.731 . . . . 71.109999999999999 112.035 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -100.74 132.7 46.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.513 -0.551 . . . . 70.409999999999997 109.513 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.31 88.18 6.95 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.322 -0.992 . . . . 62.030000000000001 108.322 170.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -80.89 121.39 5.4 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 115.213 -0.903 . . . . 53.210000000000001 112.849 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -82.29 144.64 50.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.513 -0.551 . . . . 73.239999999999995 109.513 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.09 -12.22 34.46 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.205 2.603 . . . . 74.120000000000005 114.375 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 -17.67 57.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.932 0.893 . . . . 71.310000000000002 111.384 172.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.7 -13.5 9.29 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 113.581 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.17 97.61 6.97 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.067 0.46 . . . . 44.140000000000001 110.65 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 34.6 mtmt -82.45 118.64 23.37 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.846 0.858 . . . . 64.329999999999998 108.687 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.602 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.4 t -77.4 95.53 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 122.079 0.943 . . . . 72.530000000000001 109.691 -175.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 75.2 m -130.24 152.0 50.14 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 112.973 -1.922 . . . . 74.5 108.99 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -79.58 140.72 37.07 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.954 -0.758 . . . . 72.450000000000003 108.954 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.21 147.41 82.96 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.064 0.546 . . . . 65.109999999999999 109.997 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -94.25 22.86 28.01 Favored 'Cis proline' 0 C--N 1.376 2.002 0 CA-C-N 119.39 0.818 . . . . 51.210000000000001 113.284 1.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -79.81 124.94 29.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.414 0.685 . . . . 75.109999999999999 109.221 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.42 144.99 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.703 0.801 . . . . 73.299999999999997 109.803 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.3 t -84.31 113.32 21.05 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.002 0.521 . . . . 61.350000000000001 110.037 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.8 mp -79.89 119.37 29.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 106.813 -1.551 . . . . 75.409999999999997 106.813 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.48 -26.99 65.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.713 . . . . 70.219999999999999 112.645 -173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.3 m -59.65 -54.78 42.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.783 0.833 . . . . 72.239999999999995 111.184 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 p -87.87 -18.79 28.45 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.9 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.8 p 52.27 44.37 29.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.175 1.79 . . . . 51.25 112.802 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 2.2 ptm180 -146.45 144.9 29.99 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.275 0.559 . . . . 70.129999999999995 110.393 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 m -76.47 88.27 3.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.251 1.02 . . . . 74.439999999999998 110.362 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 44.9 mt-10 -103.37 -171.65 1.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.972 0.909 . . . . 65.230000000000004 109.935 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -62.22 139.44 96.21 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 123.851 0.86 . . . . 73.209999999999994 110.987 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.375 1.943 0 C-N-CA 122.902 2.402 . . . . 64.420000000000002 112.262 173.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.421 0.153 . . . . 64.230000000000004 110.66 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -157.97 113.22 2.7 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.846 0.458 . . . . 53.240000000000002 109.842 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.456 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 140.12 -9.12 3.0 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 115.547 0.979 . . . . 61.43 115.547 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.7 173.55 7.55 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.058 0.543 . . . . 35.25 111.215 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.22 116.11 9.27 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.101 0.96 . . . . 62.109999999999999 109.684 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 73.75 16.32 3.83 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.099 2.16 . . . . 74.230000000000004 112.603 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -106.97 135.65 19.54 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 123.892 0.877 . . . . 74.120000000000005 109.442 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.59 133.28 57.13 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.392 2.728 . . . . 71.319999999999993 111.834 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.1 p -80.75 121.67 26.19 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.564 -0.532 . . . . 72.030000000000001 109.564 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 2.4 p -78.82 88.64 4.65 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.87 -0.789 . . . . 64.140000000000001 108.87 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.78 118.07 4.65 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.827 -1.079 . . . . 74.120000000000005 112.417 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -69.32 152.95 96.33 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.45 1.1 . . . . 73.310000000000002 110.387 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.65 -21.52 63.1 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.2 2.6 . . . . 62.509999999999998 114.699 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.93 -21.92 58.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.496 0.719 . . . . 73.540000000000006 111.551 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.79 -0.91 13.67 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 116.016 -0.538 . . . . 55.210000000000001 113.423 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.78 99.31 4.38 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 116.864 0.332 . . . . 72.209999999999994 111.114 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -73.18 114.5 11.42 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.222 -1.029 . . . . 73.129999999999995 108.222 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 97.7 t -76.58 106.66 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.038 -0.727 . . . . 54.439999999999998 109.038 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 79.9 m -143.5 135.82 27.02 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 125.297 1.439 . . . . 52.420000000000002 109.227 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.63 120.57 24.14 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.194 -1.039 . . . . 71.310000000000002 108.194 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.07 149.23 94.24 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.311 0.645 . . . . 61.119999999999997 110.517 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -88.59 15.29 46.39 Favored 'Cis proline' 0 C--N 1.379 2.154 0 CA-C-N 120.082 1.065 . . . . 73.310000000000002 114.707 9.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -75.98 109.41 9.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 75.019999999999996 109.709 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.88 130.89 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.097 0.959 . . . . 75.310000000000002 110.139 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 51.9 t -71.19 110.81 6.08 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.716 0.293 . . . . 72.430000000000007 110.765 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.31 127.18 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.963 -1.125 . . . . 71.430000000000007 107.963 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.27 -34.35 77.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.259 0.624 . . . . 62.5 111.328 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -57.56 -43.76 84.74 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.763 0.825 . . . . 50.200000000000003 111.169 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 p -91.01 -16.12 28.49 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.953 0.901 . . . . 61.0 111.767 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p 52.93 30.43 9.27 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.594 1.558 . . . . 63.039999999999999 112.18 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -140.74 147.75 39.65 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.648 0.379 . . . . 74.209999999999994 111.138 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.4 m -74.15 130.71 40.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.349 0.66 . . . . 54.439999999999998 110.375 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.44 176.76 10.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.56 0.744 . . . . 74.340000000000003 109.939 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.52 123.01 81.67 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 119.441 -0.314 . . . . 70.420000000000002 110.333 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 C--N 1.386 2.507 0 C-N-CA 122.918 2.412 . . . . 74.129999999999995 112.011 179.119 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.193 -0.669 . . . . 64.310000000000002 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.62 151.11 7.48 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.341 0.257 . . . . 62.229999999999997 111.493 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.62 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.71 -8.09 29.9 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 115.563 0.985 . . . . 23.23 115.563 166.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.71 172.6 8.07 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.411 0.605 . . . . 70.040000000000006 111.655 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 3.6 tmtp? -63.35 125.1 23.03 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.862 0.726 . . . . 75.439999999999998 110.033 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 97.2 m-20 61.51 24.39 14.5 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.162 1.385 . . . . 73.430000000000007 112.328 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -123.1 142.55 38.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.885 0.874 . . . . 74.349999999999994 109.112 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.98 139.87 79.56 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.701 2.934 . . . . 53.240000000000002 112.926 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 26.5 p -90.47 128.04 36.4 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.372 0.669 . . . . 63.039999999999999 109.31 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -78.5 119.53 21.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.845 0.355 . . . . 75.129999999999995 110.191 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.32 120.7 5.5 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 116.058 -0.519 . . . . 64.430000000000007 113.246 -174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -71.08 156.33 92.08 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.24 1.016 . . . . 64.400000000000006 110.838 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.38 -43.82 51.31 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.178 2.585 . . . . 74.25 113.222 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.53 -25.17 67.87 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.257 1.023 . . . . 74.420000000000002 112.364 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.17 2.38 12.34 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-O 119.637 -0.535 . . . . 73.0 113.844 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.33 115.39 8.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 117.255 0.528 . . . . 72.409999999999997 111.583 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.739 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -75.81 106.47 7.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.643 0.777 . . . . 74.109999999999999 109.207 173.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.559 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 60.0 t -79.62 119.61 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.023 0.529 . . . . 64.019999999999996 110.773 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.5 m -142.37 154.15 44.39 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.009 1.323 . . . . 65.239999999999995 109.034 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.55 145.28 25.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.179 -0.675 . . . . 71.209999999999994 109.179 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.24 146.16 94.27 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 122.961 0.504 . . . . 44.25 110.606 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -91.0 14.88 49.33 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.581 0.886 . . . . 23.34 114.225 5.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -78.23 124.41 28.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.949 0.404 . . . . 73.439999999999998 110.369 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.19 131.25 59.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.455 1.102 . . . . 65.430000000000007 108.6 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.8 t -69.11 107.63 3.26 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.016 0.436 . . . . 45.210000000000001 110.029 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.29 113.24 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.386 -1.339 . . . . 72.129999999999995 107.386 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.01 -28.47 66.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.521 1.128 . . . . 73.140000000000001 111.638 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.9 m -64.45 -52.39 58.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.785 0.834 . . . . 64.239999999999995 111.208 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.8 p -90.96 -4.06 56.79 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.135 0.574 . . . . 73.340000000000003 111.564 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p 53.55 29.56 9.33 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.952 1.701 . . . . 63.25 113.022 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.4 ptt180 -138.28 148.73 44.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.667 0.787 . . . . 75.349999999999994 109.509 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 45.6 m -71.09 91.27 0.9 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.961 -0.755 . . . . 65.099999999999994 108.961 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 36' ' ' ASN . 29.6 tt0 -101.18 -178.79 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.356 1.062 . . . . 74.540000000000006 108.627 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 3.1 p-10 -72.62 145.76 87.67 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 109.602 -0.518 . . . . 64.109999999999999 109.602 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.365 1.423 0 C-N-CA 122.902 2.401 . . . . 74.420000000000002 112.807 173.327 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.715 -0.476 . . . . 71.310000000000002 109.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.64 13.84 66.4 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.779 0.675 . . . . 74.010000000000005 113.572 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -119.7 178.66 4.49 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.067 0.947 . . . . 72.010000000000005 109.18 -175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 p -147.91 140.1 24.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.534 0.334 . . . . 73.310000000000002 110.722 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.541 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 109.95 -4.22 30.37 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 114.973 0.749 . . . . 62.329999999999998 114.973 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -100.2 176.29 5.44 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.338 0.655 . . . . 74.0 112.073 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -61.37 117.16 5.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.78 0.832 . . . . 71.230000000000004 110.623 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.4 m-20 64.14 21.42 12.55 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.97 1.308 . . . . 75.430000000000007 111.624 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -112.84 132.22 22.39 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 108.126 -1.064 . . . . 65.519999999999996 108.126 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.6 Cg_endo -53.88 140.91 67.91 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 123.232 2.621 . . . . 65.030000000000001 112.864 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 28.4 p -88.66 133.4 34.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.919 0.487 . . . . 71.140000000000001 109.938 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.9 p -93.16 104.92 17.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.693 0.797 . . . . 70.340000000000003 109.985 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -78.06 129.18 9.25 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.52 -0.632 . . . . 65.340000000000003 111.52 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -89.22 168.06 16.3 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.833 0.853 . . . . 64.099999999999994 111.665 -170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.25 -33.07 53.46 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.349 2.699 . . . . 71.420000000000002 114.564 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.26 -8.92 58.13 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.908 0.483 . . . . 63.299999999999997 111.619 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.12 -24.99 29.34 Favored Glycine 0 N--CA 1.469 0.888 0 N-CA-C 114.163 0.425 . . . . 64.219999999999999 114.163 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 128.09 34.59 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.966 0.383 . . . . 55.229999999999997 110.629 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 39.3 mtmt -76.64 129.86 36.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 108.899 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 87.4 t -77.84 117.81 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.086 0.47 . . . . 73.540000000000006 110.121 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.8 m -146.48 136.56 23.54 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.003 1.321 . . . . 75.409999999999997 107.538 169.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -78.63 139.6 38.53 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.523 -0.918 . . . . 64.099999999999994 108.523 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.32 141.83 96.22 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 122.747 0.419 . . . . 75.099999999999994 110.104 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -96.12 19.36 32.14 Favored 'Cis proline' 0 C--N 1.375 1.929 0 N-CA-C 114.649 0.98 . . . . 72.319999999999993 114.649 4.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -67.97 125.95 27.93 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.001 -0.37 . . . . 74.150000000000006 110.001 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.55 129.56 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.727 1.211 . . . . 72.219999999999999 109.817 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.686 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 39.0 t -78.77 110.25 13.76 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.999 0.52 . . . . 75.120000000000005 109.781 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.52 140.46 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.721 -0.844 . . . . 73.030000000000001 108.721 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 -37.42 87.33 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.537 0.94 . . . . 42.25 113.537 -165.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -75.26 -50.93 14.54 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.919 0.39 . . . . 54.5 110.204 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -70.65 -26.36 63.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.699 0.8 . . . . 63.399999999999999 111.874 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.1 p 54.29 27.08 7.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.033 1.733 . . . . 64.540000000000006 112.688 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 12.0 ptp180 -126.94 142.4 51.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.962 0.905 . . . . 64.340000000000003 110.294 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 30.8 m -75.38 100.17 4.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.334 0.654 . . . . 64.530000000000001 109.8 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 -177.96 3.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.564 0.746 . . . . 63.25 110.492 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -71.96 139.4 82.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 122.61 0.364 . . . . 72.439999999999998 110.787 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.381 2.284 0 C-N-CA 123.093 2.529 . . . . 71.540000000000006 112.342 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.429 -0.582 . . . . 74.109999999999999 109.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.95 -30.38 9.1 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.237 -0.438 . . . . 61.229999999999997 112.736 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.81 176.93 5.0 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.156 0.582 . . . . 71.319999999999993 109.88 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -134.87 149.82 50.37 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.068 0.547 . . . . 52.130000000000003 109.926 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.448 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 97.71 2.26 58.6 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.171 0.828 . . . . 72.430000000000007 115.171 170.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.63 164.96 13.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.359 0.663 . . . . 74.340000000000003 109.849 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -70.24 137.46 50.84 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.356 0.263 . . . . 72.129999999999995 110.396 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.34 28.31 17.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.446 1.498 . . . . 63.450000000000003 111.064 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -140.99 134.87 14.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 108.801 -0.814 . . . . 61.119999999999997 108.801 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.3 Cg_endo -54.47 146.22 53.54 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 123.995 3.13 . . . . 75.010000000000005 114.09 -172.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.504 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.5 p -91.82 137.68 32.17 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.588 -0.733 . . . . 74.239999999999995 109.409 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -80.16 88.36 5.45 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.136 -1.061 . . . . 74.530000000000001 108.136 171.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.19 120.83 5.53 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 114.978 -1.01 . . . . 64.420000000000002 111.981 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -74.68 151.15 86.88 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.136 0.974 . . . . 54.420000000000002 111.44 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.87 -22.54 68.86 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.958 2.439 . . . . 71.430000000000007 113.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -79.04 -15.27 58.46 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.659 0.784 . . . . 72.319999999999993 111.222 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.64 -6.15 24.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.891 -0.394 . . . . 60.210000000000001 114.041 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.77 98.51 3.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.104 0.478 . . . . 74.120000000000005 110.94 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -71.83 112.8 8.23 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.533 0.733 . . . . 72.230000000000004 109.273 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 85.9 t -78.82 110.09 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 122.771 0.429 . . . . 63.229999999999997 110.588 -176.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 62.9 m -147.7 151.01 35.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.858 1.263 . . . . 61.43 109.0 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -84.26 138.91 32.68 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.779 -0.822 . . . . 75.230000000000004 108.779 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.5 146.3 97.69 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.145 0.578 . . . . 71.329999999999998 110.814 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -87.18 10.14 60.0 Favored 'Cis proline' 0 C--N 1.376 1.978 0 N-CA-C 114.697 0.999 . . . . 54.409999999999997 114.697 3.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -73.09 114.01 10.77 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.133 0.573 . . . . 73.430000000000007 111.006 -171.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.46 133.53 37.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.7 1.2 . . . . 53.009999999999998 109.77 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.3 t -70.72 105.41 3.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.127 0.489 . . . . 72.510000000000005 110.675 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mm -79.5 118.4 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.084 -1.08 . . . . 65.340000000000003 108.084 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.42 -36.97 84.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.065 0.946 . . . . 62.119999999999997 112.559 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.3 p -62.51 -38.78 91.25 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.556 0.742 . . . . 71.230000000000004 111.643 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.9 p -97.12 -7.76 31.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.307 0.643 . . . . 65.239999999999995 111.493 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p 55.08 21.27 3.74 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.231 1.812 . . . . 53.229999999999997 113.521 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 ptp180 -133.16 148.92 52.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.796 0.438 . . . . 74.040000000000006 111.751 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.7 m -74.08 114.82 12.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.773 -0.649 . . . . 63.140000000000001 109.672 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.1 -171.17 2.62 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.477 1.111 . . . . 61.109999999999999 109.001 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.82 148.25 87.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 119.08 -0.486 . . . . 75.200000000000003 111.325 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo . . . . . 0 C--N 1.375 1.927 0 C-N-CA 123.401 2.734 . . . . 72.129999999999995 112.501 169.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 109.438 -0.578 . . . . 75.109999999999999 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.92 -22.37 7.23 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-O 119.681 -0.511 . . . . 74.450000000000003 113.496 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -97.11 -166.35 1.38 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 117.446 0.623 . . . . 61.439999999999998 109.51 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.93 134.47 40.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.665 0.386 . . . . 72.120000000000005 110.612 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 118.92 0.73 14.87 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.572 0.989 . . . . 70.5 115.572 169.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 9.4 m-20 -92.79 174.82 7.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.106 0.953 . . . . 72.219999999999999 110.655 -178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -68.06 122.97 19.39 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.799 -0.815 . . . . 64.129999999999995 108.799 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 66.56 19.48 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.876 1.671 . . . . 65.310000000000002 112.418 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 4.6 tp10 -113.17 129.59 24.41 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 123.855 0.862 . . . . 73.219999999999999 109.108 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 5.2 Cg_endo -43.56 126.74 5.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 124.274 3.316 . . . . 62.310000000000002 112.981 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.5 p -84.52 130.76 34.71 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.114 -0.698 . . . . 73.519999999999996 109.114 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.1 p -80.63 139.56 36.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.464 -0.569 . . . . 73.319999999999993 109.464 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.34 114.71 4.94 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.315 -0.314 . . . . 65.319999999999993 112.315 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -61.5 148.78 85.59 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.196 0.998 . . . . 72.430000000000007 111.248 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -67.45 -5.14 13.31 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.91 2.407 . . . . 55.240000000000002 114.413 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.41 2.12 47.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.521 0.728 . . . . 74.439999999999998 111.625 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.57 4.04 62.43 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.892 -0.393 . . . . 52.030000000000001 113.862 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.82 155.81 19.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 117.042 0.421 . . . . 52.119999999999997 110.301 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -101.95 127.45 48.8 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.152 0.581 . . . . 54.43 109.883 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.8 t -78.5 109.67 13.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.895 -0.78 . . . . 55.020000000000003 108.895 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 71.8 m -141.64 141.1 33.41 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 124.592 1.182 . . . . 71.140000000000001 108.604 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 7.2 p30 -78.88 135.27 36.96 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.428 -1.323 . . . . 73.150000000000006 107.428 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.61 141.7 98.32 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.343 0.657 . . . . 44.240000000000002 110.073 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -99.26 28.33 15.15 Favored 'Cis proline' 0 C--N 1.371 1.744 0 CA-C-N 119.766 0.952 . . . . 62.43 114.446 5.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -85.29 143.21 28.84 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.785 -0.45 . . . . 71.209999999999994 109.785 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG22 ' HG3' ' A' ' 37' ' ' PRO . 27.9 m -126.0 140.69 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.432 0.693 . . . . 63.420000000000002 109.797 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.0 t -80.62 116.6 20.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.49 0.716 . . . . 73.129999999999995 111.398 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.29 123.75 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.762 -1.57 . . . . 72.040000000000006 106.762 173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.31 -29.15 70.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.606 0.762 . . . . 71.219999999999999 111.527 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m -71.04 -36.65 72.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.776 0.831 . . . . 65.439999999999998 111.098 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.9 p -92.1 -21.04 20.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.342 0.657 . . . . 71.340000000000003 111.034 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.7 p 53.38 37.95 26.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.825 1.65 . . . . 52.030000000000001 111.784 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HA ' ' H ' ' A' ' 11' ' ' CYS . 15.9 ptp180 -145.06 146.89 32.05 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.259 0.624 . . . . 75.200000000000003 111.192 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 22.4 m -75.98 123.22 25.38 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.277 0.631 . . . . 72.340000000000003 109.644 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.92 -177.75 4.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.163 0.985 . . . . 72.439999999999998 109.622 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.34 127.85 86.99 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.229 0.612 . . . . 74.439999999999998 109.711 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG3' HG22 ' A' ' 26' ' ' VAL . 15.1 Cg_exo . . . . . 0 C--N 1.373 1.846 0 C-N-CA 123.034 2.489 . . . . 73.439999999999998 111.847 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.463 -0.569 . . . . 71.329999999999998 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.78 -31.57 3.31 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.32 0.388 . . . . 43.32 113.823 177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -85.58 177.62 7.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.584 0.754 . . . . 71.329999999999998 110.33 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.05 150.51 34.05 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.672 0.389 . . . . 62.539999999999999 110.733 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.67 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.07 -6.85 58.44 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 114.923 0.729 . . . . 71.030000000000001 114.923 170.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.491 ' HA ' HD21 ' A' ' 22' ' ' ASN . 2.9 m-20 -94.78 175.38 6.67 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.494 0.718 . . . . 73.120000000000005 110.902 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -67.11 122.87 18.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.312 -0.625 . . . . 63.020000000000003 109.312 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 80.3 m-20 63.36 31.66 15.06 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.564 1.146 . . . . 72.450000000000003 110.662 -176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.14 131.32 23.92 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.27 -1.011 . . . . 63.240000000000002 108.27 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.14 130.55 32.44 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.626 2.884 . . . . 54.310000000000002 112.382 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 29.0 p -79.29 127.2 31.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.8 -0.444 . . . . 74.400000000000006 109.8 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -79.86 125.09 29.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.367 0.667 . . . . 74.109999999999999 109.311 177.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.22 132.17 10.98 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.935 -0.575 . . . . 65.329999999999998 113.337 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -73.72 139.01 77.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.534 1.134 . . . . 72.140000000000001 111.059 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.45 -31.46 48.33 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.385 2.723 . . . . 63.140000000000001 113.876 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.26 -27.53 63.51 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.725 0.41 . . . . 74.400000000000006 111.267 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.35 0.83 11.28 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.705 -0.497 . . . . 72.239999999999995 114.219 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 163.05 26.92 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.675 0.737 . . . . 63.409999999999997 110.583 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.568 -0.901 . . . . 64.120000000000005 108.568 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 99.6 t -77.55 110.6 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.408 0.683 . . . . 73.450000000000003 109.58 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 84.4 m -139.2 138.52 36.96 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.563 1.145 . . . . 72.150000000000006 108.988 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.491 HD21 ' HA ' ' A' ' 6' ' ' ASP . 9.4 p30 -79.5 142.53 35.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.623 -0.88 . . . . 74.540000000000006 108.623 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.61 144.82 97.92 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 122.959 0.504 . . . . 64.25 110.874 -174.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -93.12 14.76 46.76 Favored 'Cis proline' 0 C--N 1.377 2.055 0 C-N-CA 124.704 -0.957 . . . . 75.409999999999997 114.309 4.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.89 132.27 46.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.694 0.398 . . . . 74.319999999999993 110.938 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -115.77 126.89 73.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.338 1.055 . . . . 73.140000000000001 108.835 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -75.14 112.76 11.73 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.686 0.279 . . . . 74.519999999999996 110.984 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -78.88 132.46 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.26 -1.015 . . . . 74.120000000000005 108.26 172.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.07 -46.25 88.73 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 124.01 0.819 . . . . 73.109999999999999 111.782 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -66.58 -45.61 78.68 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.978 0.799 . . . . 62.329999999999998 111.499 -174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -80.91 -15.38 56.44 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.105 0.562 . . . . 74.019999999999996 111.17 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.3 p 54.26 24.51 5.07 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.627 1.571 . . . . 73.219999999999999 113.029 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 36.4 ptt180 -131.28 148.78 52.72 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.634 0.774 . . . . 61.539999999999999 109.24 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 53.8 m -71.81 94.37 1.4 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.832 -0.803 . . . . 65.319999999999993 108.832 173.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -99.33 170.35 8.71 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.801 -1.09 . . . . 63.310000000000002 108.843 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.58 139.16 88.81 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 122.666 0.386 . . . . 75.420000000000002 110.25 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 C--N 1.369 1.606 0 C-N-CA 122.904 2.402 . . . . 74.140000000000001 112.022 173.436 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 109.49 -0.559 . . . . 71.209999999999994 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.28 -25.24 27.91 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.979 -0.448 . . . . 54.340000000000003 111.979 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.87 -168.29 0.26 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.827 1.251 . . . . 65.519999999999996 110.492 167.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.5 p -155.31 128.68 8.36 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.742 -0.599 . . . . 75.409999999999997 111.458 -176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 136.65 -13.37 3.95 Favored Glycine 0 C--N 1.355 1.639 0 N-CA-C 116.062 1.185 . . . . 60.210000000000001 116.062 164.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 23.2 m-20 -94.86 175.72 6.54 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.71 1.255 . . . . 74.120000000000005 112.37 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -59.93 131.33 50.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.151 -0.931 . . . . 71.439999999999998 110.096 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.591 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 62.3 m-20 57.98 27.13 14.33 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.737 1.215 . . . . 75.200000000000003 112.195 -176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 14.3 tp10 -119.69 125.98 27.17 Favored Pre-proline 0 N--CA 1.472 0.627 0 C-N-CA 123.971 0.909 . . . . 53.210000000000001 108.587 175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 10.8 Cg_endo -49.2 140.76 25.04 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.934 3.089 . . . . 75.439999999999998 112.65 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.558 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 29.0 p -88.2 136.69 32.86 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 41.130000000000003 109.695 177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -85.53 134.36 34.03 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.605 -0.887 . . . . 52.25 108.605 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.2 138.4 13.91 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 116.502 -0.317 . . . . 65.540000000000006 112.559 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.72 151.22 57.92 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.431 1.092 . . . . 65.150000000000006 108.834 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -54.49 -34.93 83.84 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.154 2.569 . . . . 72.109999999999999 114.088 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.72 -13.61 60.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.887 0.475 . . . . 74.129999999999995 111.831 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.86 12.3 20.96 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.496 0.558 . . . . 44.219999999999999 114.496 172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.58 136.32 38.26 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.273 0.536 . . . . 72.209999999999994 110.614 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -95.85 114.58 26.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.205 0.602 . . . . 60.450000000000003 109.652 176.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.563 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 47.5 t -79.6 101.76 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.416 0.686 . . . . 75.439999999999998 110.183 -177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 59.0 m -138.64 140.58 38.94 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.864 1.266 . . . . 45.539999999999999 108.565 174.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.16 144.18 33.23 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.161 -0.681 . . . . 75.200000000000003 109.161 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.6 139.84 97.27 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.212 0.605 . . . . 70.129999999999995 110.901 -175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -94.01 13.96 45.95 Favored 'Cis proline' 0 C--N 1.375 1.95 0 N-CA-C 114.642 0.978 . . . . 73.230000000000004 114.642 6.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -67.88 126.15 28.52 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 118.031 0.378 . . . . 61.43 110.629 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -112.63 129.52 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.841 1.256 . . . . 73.540000000000006 108.403 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 48.8 t -72.09 108.2 5.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.763 0.316 . . . . 73.310000000000002 110.612 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.4 mt -79.36 120.27 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 107.775 -1.194 . . . . 62.210000000000001 107.775 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.58 -34.45 77.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.629 0.772 . . . . 73.150000000000006 112.42 -170.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -76.4 -25.32 54.41 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.654 0.382 . . . . 74.239999999999995 111.408 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.9 p -95.43 -14.16 24.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.91 0.484 . . . . 70.409999999999997 110.637 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.6 p 54.96 33.91 21.2 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.16 1.784 . . . . 75.400000000000006 113.049 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.591 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.4 ptp180 -144.53 150.82 38.17 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.313 0.645 . . . . 74.049999999999997 111.032 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 34.3 m -70.09 121.69 17.96 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.655 -0.702 . . . . 61.5 109.244 172.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 14.1 mm-40 -132.26 173.76 10.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.526 1.131 . . . . 74.200000000000003 110.502 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -75.37 126.7 87.39 Favored Pre-proline 0 CA--C 1.558 1.255 0 N-CA-C 108.857 -0.794 . . . . 73.420000000000002 108.857 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.383 2.371 0 C-N-CA 123.161 2.574 . . . . 71.420000000000002 112.344 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.694 -0.484 . . . . 74.200000000000003 109.694 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.17 -30.05 7.94 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-O 119.991 -0.338 . . . . 61.43 113.602 171.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -84.75 144.87 28.22 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.09 0.445 . . . . 71.310000000000002 110.526 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' PRO . 27.2 p -101.32 148.47 25.1 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.554 0.576 . . . . 72.109999999999999 112.554 -170.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.92 -11.8 24.84 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.257 -0.883 . . . . 74.030000000000001 113.645 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 4.2 m-20 -96.96 161.46 13.83 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.676 0.738 . . . . 64.510000000000005 111.044 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 12.4 tmtt? -73.6 133.11 43.43 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.973 -1.012 . . . . 70.239999999999995 108.996 177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 82.2 m-20 61.92 20.18 11.3 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.698 1.599 . . . . 52.329999999999998 112.282 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -120.11 152.06 53.89 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.774 1.23 . . . . 71.219999999999999 108.02 172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 Cg_endo -55.11 153.8 24.97 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.744 2.962 . . . . 62.350000000000001 113.294 -175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 28.4 p -100.4 122.54 43.32 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.362 -0.977 . . . . 65.420000000000002 108.362 166.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.0 p -84.2 107.31 16.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.81 -0.811 . . . . 70.340000000000003 108.81 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.42 122.56 5.97 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.786 -0.525 . . . . 72.450000000000003 111.786 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -57.4 156.64 15.2 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.638 1.175 . . . . 70.010000000000005 110.026 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -42.58 -39.26 6.81 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 123.764 2.976 . . . . 75.140000000000001 115.872 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -72.48 -31.21 65.22 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.932 0.893 . . . . 70.319999999999993 111.336 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.81 14.75 4.6 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.958 -0.565 . . . . 70.209999999999994 113.437 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.93 103.37 9.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.066 0.546 . . . . 65.310000000000002 110.997 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -71.62 123.64 22.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 70.430000000000007 110.606 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 90.1 t -78.91 104.87 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.229 0.538 . . . . 71.340000000000003 110.383 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 78.4 m -141.75 136.07 30.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.428 -1.26 . . . . 72.329999999999998 108.868 175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -80.17 146.49 31.76 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.585 -0.524 . . . . 64.439999999999998 109.585 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.36 145.58 93.34 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 123.047 0.539 . . . . 72.430000000000007 110.722 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -90.85 13.18 54.18 Favored 'Cis proline' 0 C--N 1.38 2.201 0 CA-C-N 119.977 1.028 . . . . 73.209999999999994 113.882 2.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 36.2 m95 -70.88 118.75 14.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.358 0.663 . . . . 73.540000000000006 110.779 -174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.83 135.02 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.252 1.021 . . . . 75.450000000000003 109.023 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 54.0 t -78.57 122.47 25.95 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 122.578 0.351 . . . . 72.129999999999995 111.033 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mm -80.98 136.87 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.176 -1.046 . . . . 63.149999999999999 108.176 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.71 -39.97 73.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.021 0.528 . . . . 73.239999999999995 110.689 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 m -58.88 -36.91 75.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.136 0.975 . . . . 55.439999999999998 111.643 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 p -94.15 -25.97 16.9 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.76 0.824 . . . . 73.209999999999994 111.283 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.9 p 54.22 32.18 15.55 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.774 1.63 . . . . 51.210000000000001 112.187 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 37.8 ptt180 -124.28 144.89 49.72 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.811 0.844 . . . . 71.310000000000002 109.773 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 33.6 m -69.32 127.27 32.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.846 -0.798 . . . . 74.409999999999997 108.846 169.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 16.1 pt-20 -156.54 -168.29 2.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.461 0.705 . . . . 74.540000000000006 109.323 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -59.15 154.21 41.85 Favored Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 122.88 0.472 . . . . 74.340000000000003 112.182 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.372 1.806 0 C-N-CA 122.415 2.077 . . . . 75.329999999999998 110.773 169.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 109.202 -0.666 . . . . 74.299999999999997 109.202 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.27 31.88 27.0 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.158 0.286 . . . . 73.120000000000005 112.722 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.39 159.77 15.89 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.166 0.986 . . . . 74.510000000000005 109.784 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -132.83 137.55 46.78 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.054 0.39 . . . . 74.310000000000002 112.054 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.4 5.32 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.076 -0.847 . . . . 73.099999999999994 114.134 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -119.55 163.25 17.59 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 117.94 0.87 . . . . 54.100000000000001 110.505 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 35' ' ' GLU . 59.5 tttm -64.98 141.58 58.73 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.076 0.55 . . . . 64.230000000000004 110.742 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 56.17 19.14 3.64 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.113 1.765 . . . . 55.43 112.057 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -114.99 146.89 37.12 Favored Pre-proline 0 N--CA 1.476 0.832 0 N-CA-C 107.314 -1.365 . . . . 64.209999999999994 107.314 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.75 141.68 92.03 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.081 2.521 . . . . 70.409999999999997 111.934 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.612 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 27.6 p -92.84 117.82 30.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.566 -0.902 . . . . 74.099999999999994 108.566 175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 11.5 p -87.73 130.3 34.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.85 -0.426 . . . . 61.0 109.85 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.55 145.05 20.07 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 116.383 -0.371 . . . . 73.420000000000002 112.924 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -104.58 156.62 35.62 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.594 0.758 . . . . 73.420000000000002 109.132 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 -21.04 71.56 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.839 2.359 . . . . 75.340000000000003 114.426 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.01 -24.92 59.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.096 0.558 . . . . 51.43 110.701 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.8 38.17 2.6 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.556 -0.747 . . . . 74.150000000000006 112.819 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.37 141.05 48.79 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.031 0.532 . . . . 43.32 111.059 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 10.0 mmpt? -88.14 123.26 32.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.834 0.853 . . . . 63.539999999999999 110.093 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 94.9 t -77.76 101.4 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.39 0.614 . . . . 74.420000000000002 109.846 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 72.3 m -145.91 135.69 23.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.042 1.337 . . . . 72.530000000000001 107.924 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -79.48 142.21 36.04 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.887 -0.412 . . . . 74.010000000000005 109.887 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -67.26 144.24 98.02 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 122.72 0.408 . . . . 73.25 109.924 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.67 19.7 36.36 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 119.77 0.954 . . . . 60.299999999999997 114.062 3.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -85.31 130.27 34.63 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.264 0.626 . . . . 71.430000000000007 109.567 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.45 148.6 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.077 0.951 . . . . 53.030000000000001 109.541 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.1 t -84.77 131.89 34.5 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.818 0.342 . . . . 64.010000000000005 111.315 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.1 122.22 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 106.919 -1.511 . . . . 72.420000000000002 106.919 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.59 -32.32 73.75 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.528 0.731 . . . . 74.340000000000003 111.652 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.3 m -60.93 -42.04 97.38 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.05 0.94 . . . . 73.140000000000001 111.227 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.2 p -90.52 -15.34 30.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.454 0.702 . . . . 61.109999999999999 111.571 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.3 p 54.47 26.66 7.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.264 1.425 . . . . 53.229999999999997 112.349 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.48 150.81 45.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.176 0.591 . . . . 72.430000000000007 110.438 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 m -72.53 132.8 44.29 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.372 -0.603 . . . . 74.530000000000001 109.372 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HA ' ' HG3' ' A' ' 7' ' ' LYS . 48.1 mt-10 -144.86 -175.01 4.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.054 0.941 . . . . 73.230000000000004 110.308 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.8 138.13 85.46 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 65.239999999999995 110.422 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 CA--C 1.563 1.96 0 C-N-CA 122.159 1.906 . . . . 64.25 111.735 172.58 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.085 -0.339 . . . . 72.439999999999998 110.085 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.67 24.22 72.56 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.47 0.481 . . . . 75.310000000000002 113.651 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -120.27 -166.53 1.32 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.635 1.174 . . . . 63.310000000000002 108.523 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p -148.59 142.52 25.8 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.976 0.807 . . . . 74.099999999999994 111.91 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 89.74 32.82 9.66 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.786 -0.643 . . . . 21.309999999999999 113.624 177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.16 177.61 7.54 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.127 0.971 . . . . 63.450000000000003 109.612 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -71.23 128.58 36.4 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 74.030000000000001 109.572 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 60.62 19.83 9.75 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.009 1.324 . . . . 63.340000000000003 112.708 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.39 132.79 23.37 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 118.477 -0.773 . . . . 73.200000000000003 109.505 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -48.4 133.54 25.47 Favored 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 124.072 3.182 . . . . 73.349999999999994 113.584 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 19' ' ' LYS . 31.7 p -80.34 123.1 27.71 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.584 -0.525 . . . . 63.140000000000001 109.584 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.8 p -80.19 131.29 35.68 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.409 -0.589 . . . . 23.52 109.409 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.84 119.65 5.12 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 116.206 -0.452 . . . . 61.030000000000001 112.07 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -59.25 145.46 81.18 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.401 1.08 . . . . 72.540000000000006 111.591 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 -27.6 82.17 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.558 2.172 . . . . 64.230000000000004 112.56 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.85 -24.22 59.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.308 0.643 . . . . 72.519999999999996 111.531 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.3 10.73 14.75 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-O 119.691 -0.505 . . . . 73.400000000000006 114.346 173.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.65 162.51 18.77 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.324 0.562 . . . . 74.340000000000003 110.915 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 75.1 mmtt -100.77 126.35 47.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.043 -0.725 . . . . 73.430000000000007 109.043 172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.438 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 80.8 t -77.84 109.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.428 -0.582 . . . . 61.439999999999998 109.428 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 85.4 m -145.09 139.54 27.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.499 1.12 . . . . 65.329999999999998 109.33 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -78.32 143.66 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.267 0.627 . . . . 71.219999999999999 109.717 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.22 145.2 85.43 Favored Pre-proline 0 CA--C 1.554 1.118 0 CA-C-O 119.377 -0.344 . . . . 71.129999999999995 110.101 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.38 19.63 34.79 Favored 'Cis proline' 0 C--N 1.377 2.029 0 CA-C-N 119.571 0.882 . . . . 72.530000000000001 113.249 -0.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -74.62 128.09 34.71 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.611 0.764 . . . . 64.549999999999997 110.166 -174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.02 143.04 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.494 1.117 . . . . 73.010000000000005 109.606 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 45.1 t -79.05 113.9 17.56 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.065 -0.346 . . . . 51.229999999999997 110.065 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.89 121.1 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.647 -1.242 . . . . 70.510000000000005 107.647 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.83 -26.37 65.74 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.662 0.785 . . . . 72.030000000000001 112.996 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -68.16 -50.91 51.42 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.499 0.72 . . . . 52.439999999999998 111.217 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.3 p -86.05 -14.66 43.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.667 0.787 . . . . 62.039999999999999 111.852 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.1 p 53.07 32.29 12.74 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 125.508 1.523 . . . . 55.130000000000003 112.236 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -144.84 150.6 37.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.506 0.67 . . . . 74.430000000000007 112.682 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 m -80.02 96.77 6.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.687 -1.142 . . . . 70.019999999999996 111.013 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.74 -173.23 2.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.921 0.888 . . . . 71.5 110.156 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.59 132.13 92.84 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 122.917 0.487 . . . . 71.129999999999995 110.833 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.373 1.827 0 C-N-CA 122.601 2.201 . . . . 75.109999999999999 111.937 171.346 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.491 0.186 . . . . 72.299999999999997 110.588 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.7 74.15 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 114.861 0.704 . . . . 75.129999999999995 114.861 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.64 -170.55 1.66 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.387 0.593 . . . . 74.129999999999995 110.254 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.0 p -132.67 147.32 52.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.37 0.668 . . . . 64.120000000000005 109.405 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.754 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.73 11.16 57.12 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 115.123 0.809 . . . . 60.420000000000002 115.123 171.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.9 -179.95 3.79 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.663 0.732 . . . . 51.219999999999999 110.86 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -60.09 118.46 6.34 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.413 0.685 . . . . 72.030000000000001 111.073 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.661 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 39.9 m-20 66.95 20.0 10.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.307 1.443 . . . . 73.340000000000003 111.692 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -118.77 130.51 24.77 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.184 -1.043 . . . . 63.100000000000001 108.184 -176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 13.2 Cg_endo -53.22 138.57 63.86 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.752 2.968 . . . . 63.299999999999997 113.269 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.587 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.0 p -79.7 127.95 32.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.058 -0.519 . . . . 74.319999999999993 110.103 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 145.78 32.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.335 -0.617 . . . . 65.409999999999997 109.335 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.06 125.41 8.52 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 120.002 -0.332 . . . . 60.310000000000002 112.521 -173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -65.96 152.56 93.3 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.602 0.761 . . . . 74.549999999999997 109.782 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.01 -31.41 95.67 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.763 2.308 . . . . 73.010000000000005 112.994 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -73.13 -27.42 61.67 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.655 0.782 . . . . 73.219999999999999 111.345 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.66 1.69 11.88 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.803 0.681 . . . . 73.25 114.803 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.85 119.01 14.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.375 0.588 . . . . 73.349999999999994 111.112 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -71.33 114.54 9.5 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.054 -0.721 . . . . 63.020000000000003 109.054 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.69 115.86 20.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 124.074 0.949 . . . . 64.540000000000006 110.072 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 63.7 m -147.9 141.11 25.1 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.563 1.164 . . . . 60.119999999999997 108.281 174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.15 137.17 35.03 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.576 -0.898 . . . . 54.240000000000002 108.576 172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.94 143.6 98.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.136 0.574 . . . . 74.239999999999995 111.011 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -93.8 16.98 41.13 Favored 'Cis proline' 0 C--N 1.378 2.108 0 N-CA-C 114.57 0.95 . . . . 72.25 114.57 5.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -69.99 120.38 15.63 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.326 -0.62 . . . . 62.329999999999998 109.326 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -107.89 135.12 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.254 1.022 . . . . 74.409999999999997 108.686 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 47.6 t -69.76 97.39 1.08 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.24 0.543 . . . . 75.230000000000004 109.654 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.24 111.15 13.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 107.273 -1.38 . . . . 73.530000000000001 107.273 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.42 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.9 mm? -59.04 -32.07 69.42 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.573 1.149 . . . . 73.239999999999995 111.399 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 m -56.94 -48.5 78.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.548 1.139 . . . . 72.099999999999994 111.141 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.5 p -96.99 -7.59 32.66 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.587 0.755 . . . . 70.120000000000005 111.83 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.1 p 53.66 36.35 23.46 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 126.053 1.741 . . . . 72.129999999999995 112.455 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 15.5 ptp180 -141.93 151.2 42.38 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 73.030000000000001 110.787 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.754 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 35.4 m -73.56 98.56 2.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.943 0.878 . . . . 75.239999999999995 109.051 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -123.11 164.76 18.01 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.613 1.165 . . . . 75.219999999999999 108.815 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -58.87 147.31 73.18 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.22 0.608 . . . . 64.120000000000005 110.885 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.373 1.835 0 C-N-CA 123.169 2.58 . . . . 75.209999999999994 112.297 171.833 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.4 t70 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.145 -0.687 . . . . 74.540000000000006 109.145 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.13 -29.7 4.2 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.895 0.283 . . . . 71.329999999999998 113.479 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -121.57 -170.24 2.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.247 1.019 . . . . 72.120000000000005 110.006 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.3 p -153.93 149.31 27.15 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.833 0.349 . . . . 72.439999999999998 111.282 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.652 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 100.32 25.28 8.91 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 116.027 1.171 . . . . 72.140000000000001 116.027 164.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 9' ' ' GLU . 8.9 m-20 -123.06 172.57 8.44 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.577 0.751 . . . . 72.5 109.625 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.99 125.08 23.77 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 109.025 -0.731 . . . . 75.019999999999996 109.025 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.695 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 74.6 m-20 66.78 18.43 10.68 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.549 1.54 . . . . 71.329999999999998 112.681 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' HB3' ' H ' ' A' ' 6' ' ' ASP . 15.4 tp10 -118.3 118.56 33.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.461 -0.94 . . . . 72.010000000000005 108.461 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 8.1 Cg_endo -45.41 124.33 6.37 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.646 3.564 . . . . 74.510000000000005 113.325 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 20.0 p -76.0 130.14 37.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.745 0.418 . . . . 74.409999999999997 109.929 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.584 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 3.1 p -84.56 105.8 15.65 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.802 -0.814 . . . . 73.299999999999997 108.802 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.44 122.98 6.08 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.259 -0.736 . . . . 54.210000000000001 111.259 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 97.4 mtt180 -71.54 156.02 91.89 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.708 0.803 . . . . 70.140000000000001 110.587 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.21 -28.57 85.24 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.768 2.312 . . . . 64.349999999999994 113.34 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.77 -28.18 62.45 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.39 0.431 . . . . 73.430000000000007 109.998 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.42 1.24 11.12 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.112 -0.495 . . . . 31.530000000000001 113.586 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -78.82 108.81 12.53 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.819 0.447 . . . . 70.230000000000004 110.605 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 29' ' ' LEU . 46.5 mtmt -72.67 118.95 16.23 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.374 -0.602 . . . . 70.209999999999994 109.374 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.584 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 66.6 t -78.15 108.6 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.042 0.537 . . . . 52.25 109.664 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 70.7 m -150.97 138.85 19.9 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.085 1.354 . . . . 44.439999999999998 108.269 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -78.88 136.64 37.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.085 -1.08 . . . . 70.319999999999993 108.085 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.96 144.87 93.58 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.105 0.562 . . . . 71.239999999999995 109.913 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -87.02 1.84 68.37 Favored 'Cis proline' 0 C--N 1.378 2.126 0 C-N-CA 124.55 -1.021 . . . . 74.129999999999995 114.285 7.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -64.24 109.57 1.92 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.991 0.516 . . . . 63.039999999999999 110.113 -172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.19 140.15 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.066 0.946 . . . . 61.210000000000001 109.578 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.5 t -81.24 118.04 22.26 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.617 0.367 . . . . 74.099999999999994 111.344 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.21 118.05 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.939 -1.504 . . . . 63.25 106.939 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 19' ' ' LYS . 3.7 mm? -67.43 -22.72 65.5 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.567 0.747 . . . . 63.32 111.925 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m -62.23 -42.47 99.34 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.524 0.73 . . . . 71.209999999999994 110.13 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.9 p -95.9 -10.96 27.47 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.905 0.882 . . . . 71.120000000000005 111.055 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.5 p 54.67 26.08 7.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.201 1.801 . . . . 71.329999999999998 113.31 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.695 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 35.2 ptt180 -131.3 151.33 51.61 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.168 0.987 . . . . 63.43 109.936 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -73.8 140.92 46.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.679 -1.23 . . . . 74.510000000000005 107.679 170.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.29 165.76 32.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.621 0.368 . . . . 72.319999999999993 110.056 -169.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -61.49 127.71 88.89 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.65 0.78 . . . . 73.310000000000002 111.165 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.374 1.911 0 C-N-CA 122.918 2.412 . . . . 60.119999999999997 111.919 170.46 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 108.928 -0.767 . . . . 74.310000000000002 108.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 119.73 -33.34 4.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.074 -0.512 . . . . 65.420000000000002 112.409 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.98 160.29 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.2 p -86.23 145.99 26.73 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 62.32 111.354 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 117.28 -4.41 18.05 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.634 1.014 . . . . 74.209999999999994 115.634 168.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 6.1 m-20 -94.42 179.09 5.4 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.223 1.012 . . . . 74.409999999999997 111.873 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -70.86 126.63 30.11 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 116.047 -0.524 . . . . 75.310000000000002 109.909 -174.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.53 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 71.9 m-20 60.63 18.13 8.14 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.775 1.63 . . . . 72.430000000000007 112.359 -172.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -109.06 130.53 22.62 Favored Pre-proline 0 C--O 1.242 0.69 0 N-CA-C 108.564 -0.902 . . . . 65.420000000000002 108.564 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -44.03 120.33 2.4 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 124.317 3.345 . . . . 72.299999999999997 112.916 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 14.0 p -77.03 147.14 36.92 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.098 0.559 . . . . 71.439999999999998 109.662 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -100.08 146.68 26.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.554 -1.276 . . . . 64.540000000000006 107.554 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.17 137.88 14.54 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 122.469 -0.145 . . . . 64.510000000000005 112.984 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -71.79 147.13 91.52 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.88 0.872 . . . . 70.310000000000002 109.458 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.98 -25.73 59.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.406 2.07 . . . . 61.399999999999999 112.191 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.29 -8.82 57.67 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.054 0.942 . . . . 72.329999999999998 111.767 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.18 -0.96 37.88 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 114.793 0.677 . . . . 74.420000000000002 114.793 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.23 130.05 35.07 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 117.554 0.677 . . . . 71.239999999999995 111.074 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD2' HD11 ' A' ' 29' ' ' LEU . 11.6 mmpt? -84.71 122.0 28.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.287 0.635 . . . . 74.109999999999999 109.648 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.54 108.77 17.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 C-N-CA 123.243 0.617 . . . . 61.149999999999999 109.985 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 68.0 m -146.99 149.67 33.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.987 -1.006 . . . . 51.130000000000003 108.331 175.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 6' ' ' ASP . 8.1 p30 -77.07 128.12 33.89 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.53 -1.285 . . . . 74.219999999999999 107.53 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.08 142.14 97.71 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 116.188 -0.46 . . . . 62.009999999999998 110.028 -173.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -97.2 12.56 36.36 Favored 'Cis proline' 0 C--N 1.373 1.828 0 CA-C-N 119.548 0.874 . . . . 72.329999999999998 114.235 6.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -64.31 130.25 43.11 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.993 -0.373 . . . . 65.109999999999999 109.993 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.84 142.65 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.153 0.981 . . . . 73.219999999999999 110.232 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.6 t -83.53 112.28 19.85 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.393 0.277 . . . . 75.430000000000007 110.545 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.01 121.76 31.47 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 N-CA-C 107.353 -1.351 . . . . 54.130000000000003 107.353 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' HD2' ' A' ' 19' ' ' LYS . 4.2 mm? -65.28 -26.65 68.17 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.63 0.772 . . . . 64.049999999999997 112.59 -171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.2 m -63.21 -51.31 66.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.1 0.56 . . . . 75.349999999999994 110.876 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 33' ' ' ARG . 55.5 p -87.68 -18.01 30.5 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.212 -0.904 . . . . 71.239999999999995 111.603 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.7 p 52.75 31.77 11.01 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.77 1.628 . . . . 73.219999999999999 112.482 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.53 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 11.6 ptp180 -131.1 150.92 51.93 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.621 0.768 . . . . 75.420000000000002 110.152 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 14.1 m -81.56 113.03 19.31 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.804 -0.634 . . . . 72.439999999999998 110.109 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.41 -169.36 1.92 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.659 1.184 . . . . 74.019999999999996 109.684 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.09 149.93 89.68 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 122.908 0.483 . . . . 75.120000000000005 110.979 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.374 1.879 0 C-N-CA 122.527 2.151 . . . . 38.119999999999997 111.09 170.482 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.249 -0.278 . . . . 55.329999999999998 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.91 -31.92 7.13 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.481 -0.327 . . . . 72.209999999999994 112.567 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.86 -175.39 3.15 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.554 0.741 . . . . 72.409999999999997 109.277 174.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.3 p -153.5 145.85 23.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 122.503 0.321 . . . . 74.510000000000005 110.955 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.681 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 102.57 4.31 49.48 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 115.436 0.934 . . . . 54.020000000000003 115.436 168.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.531 ' HA ' HD21 ' A' ' 22' ' ' ASN . 7.1 m-20 -92.15 170.44 9.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.46 0.63 . . . . 75.129999999999995 110.599 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -69.96 125.13 25.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.69 -0.856 . . . . 75.109999999999999 108.69 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 62.51 29.04 17.01 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.256 1.422 . . . . 75.140000000000001 111.832 -173.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -127.05 141.24 40.1 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 124.059 0.944 . . . . 61.43 108.513 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 19.9 Cg_endo -55.16 132.14 50.51 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.045 2.497 . . . . 74.409999999999997 112.619 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.608 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.9 p -82.65 141.89 32.14 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.422 0.689 . . . . 64.209999999999994 109.479 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.5 p -92.67 126.93 37.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.107 -1.071 . . . . 75.230000000000004 108.107 170.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.86 126.61 8.72 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 112.231 -0.348 . . . . 61.539999999999999 112.231 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -67.5 144.11 97.58 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.133 0.973 . . . . 72.340000000000003 109.916 171.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.95 -24.78 74.59 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.969 2.446 . . . . 54.530000000000001 113.245 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.75 -8.72 59.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.941 0.896 . . . . 72.129999999999995 112.138 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.08 -9.97 27.06 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.736 -0.48 . . . . 54.310000000000002 114.106 172.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 149.39 41.2 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.387 0.593 . . . . 75.299999999999997 110.788 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -100.23 117.32 34.21 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.898 -0.778 . . . . 61.299999999999997 108.898 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 46.8 t -77.65 94.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.689 -0.856 . . . . 61.119999999999997 108.689 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 66.7 m -128.25 141.68 51.38 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.064 -1.425 . . . . 74.319999999999993 107.867 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.531 HD21 ' HA ' ' A' ' 6' ' ' ASP . 9.6 p30 -78.76 135.83 37.22 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.415 -0.957 . . . . 61.210000000000001 108.415 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.09 143.3 88.53 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 124.047 0.939 . . . . 74.430000000000007 111.264 -174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.2 25.71 20.56 Favored 'Cis proline' 0 C--N 1.383 2.374 0 CA-C-N 119.829 0.975 . . . . 54.310000000000002 113.844 1.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -77.28 142.12 39.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.565 0.346 . . . . 54.329999999999998 110.269 -175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.1 m -125.03 137.28 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.184 0.994 . . . . 75.319999999999993 109.217 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 50.9 t -82.59 124.03 29.77 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.563 0.345 . . . . 62.450000000000003 110.894 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -79.42 123.68 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.777 -1.564 . . . . 64.200000000000003 106.777 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.5 mm? -61.58 -44.19 97.48 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.331 1.02 . . . . 72.019999999999996 111.843 -165.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -68.88 -39.02 80.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.07 0.948 . . . . 74.150000000000006 111.421 -174.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -84.29 -15.87 45.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.118 0.567 . . . . 71.430000000000007 111.279 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.3 p 54.12 37.04 26.23 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 125.444 1.498 . . . . 55.43 112.262 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 30.4 ptt180 -134.73 139.71 45.4 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.313 0.645 . . . . 64.340000000000003 110.771 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.681 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 38.3 m -75.94 128.08 34.32 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.005 -0.739 . . . . 74.129999999999995 109.005 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -147.05 170.09 17.88 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.332 -0.988 . . . . 63.439999999999998 108.332 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.97 134.54 96.09 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 122.921 0.488 . . . . 64.540000000000006 111.071 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 122.721 2.281 . . . . 71.510000000000005 111.893 174.574 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.149 -0.315 . . . . 72.209999999999994 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.25 -25.05 26.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.044 -0.525 . . . . 73.040000000000006 113.025 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.66 175.09 9.45 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.18 -0.674 . . . . 53.509999999999998 109.18 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.0 p -128.96 148.04 50.91 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 122.715 0.406 . . . . 52.130000000000003 110.968 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.572 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.02 -9.95 31.69 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 114.436 0.535 . . . . 65.430000000000007 114.436 169.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.66 169.09 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.358 0.663 . . . . 74.030000000000001 110.866 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -65.65 122.92 18.36 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.167 0.587 . . . . 65.430000000000007 110.113 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 76.8 m-20 64.59 16.96 10.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.508 1.523 . . . . 73.319999999999993 113.769 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -104.88 136.55 19.15 Favored Pre-proline 0 N--CA 1.472 0.64 0 N-CA-C 108.276 -1.009 . . . . 62.200000000000003 108.276 170.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.09 137.03 76.98 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.203 2.602 . . . . 75.129999999999995 112.139 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.6 p -77.36 133.01 38.84 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.25 -0.648 . . . . 62.149999999999999 109.25 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.22 107.21 10.65 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.464 0.649 . . . . 73.219999999999999 109.481 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.21 108.42 2.69 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.52 -1.218 . . . . 60.520000000000003 112.168 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -68.22 145.12 97.35 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.108 0.963 . . . . 70.030000000000001 110.251 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -47.84 -36.66 27.08 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 124.651 3.568 . . . . 74.239999999999995 115.128 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -68.97 -20.13 64.18 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.676 0.79 . . . . 64.329999999999998 111.934 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.83 5.17 11.09 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 116.235 -0.439 . . . . 63.340000000000003 113.443 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.42 131.54 38.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.988 0.515 . . . . 73.099999999999994 111.703 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -92.7 114.45 27.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.085 -1.08 . . . . 73.319999999999993 108.085 171.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.46 124.76 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.564 0.346 . . . . 65.25 110.825 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.9 m -137.12 149.22 47.19 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.246 1.019 . . . . 62.43 109.234 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -84.71 141.02 30.87 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.111 -0.7 . . . . 74.420000000000002 109.111 172.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.09 148.42 98.85 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.641 0.776 . . . . 74.109999999999999 110.759 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.01 23.61 26.26 Favored 'Cis proline' 0 C--N 1.375 1.95 0 CA-C-N 119.527 0.867 . . . . 72.239999999999995 113.91 3.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.09 140.03 31.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.874 0.47 . . . . 55.450000000000003 110.246 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.33 138.0 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.935 1.294 . . . . 71.530000000000001 109.002 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 42.6 t -73.37 109.9 7.25 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.914 0.388 . . . . 73.340000000000003 110.722 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.52 114.31 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.731 -1.211 . . . . 70.219999999999999 107.731 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.3 -26.16 68.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.298 1.039 . . . . 75.299999999999997 112.223 -171.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -63.56 -46.47 85.78 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.806 0.843 . . . . 63.25 110.429 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 p -95.77 -8.87 33.2 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.222 1.009 . . . . 63.539999999999999 111.937 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.5 p 54.84 28.12 9.94 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.793 1.637 . . . . 43.43 113.018 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 5.3 ptp180 -138.58 151.91 47.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.145 0.578 . . . . 74.0 110.613 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.572 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 13.6 m -77.67 125.67 29.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.144 -0.934 . . . . 64.230000000000004 109.804 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -140.49 176.14 9.02 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.256 1.023 . . . . 72.439999999999998 109.834 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.11 143.0 90.8 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.165 -0.445 . . . . 72.439999999999998 110.01 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 CA--C 1.563 1.966 0 C-N-CA 122.734 2.289 . . . . 44.25 112.0 173.419 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.149 -0.315 . . . . 64.319999999999993 110.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.61 -31.17 4.65 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 116.41 -0.359 . . . . 64.230000000000004 112.47 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -114.0 176.88 4.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.216 1.406 . . . . 64.200000000000003 109.127 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.3 p -150.52 144.63 25.47 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.152 -0.342 . . . . 74.230000000000004 110.626 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.636 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.41 20.09 30.76 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 115.291 0.876 . . . . 72.439999999999998 115.291 168.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.77 -179.92 3.88 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.406 0.682 . . . . 75.340000000000003 110.55 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -61.28 122.43 15.08 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.744 0.818 . . . . 54.549999999999997 110.846 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 60.26 27.13 16.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.011 1.324 . . . . 63.229999999999997 111.159 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -124.07 125.41 25.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 109.148 -0.686 . . . . 73.540000000000006 109.148 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.48 125.31 10.63 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 124.328 3.352 . . . . 60.229999999999997 112.858 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p -77.69 132.19 38.06 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.94 -0.763 . . . . 64.439999999999998 108.94 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -81.42 153.04 27.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.84 0.856 . . . . 72.340000000000003 109.091 175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.64 131.56 10.66 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.932 -0.48 . . . . 75.219999999999999 112.835 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -66.57 157.58 82.29 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.959 1.303 . . . . 74.140000000000001 110.999 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.76 -35.41 98.81 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.624 2.216 . . . . 64.409999999999997 112.69 172.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.51 -30.06 57.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.987 0.915 . . . . 60.229999999999997 111.088 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.03 1.54 12.87 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 115.247 0.859 . . . . 61.340000000000003 115.247 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.1 146.75 47.31 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.056 0.928 . . . . 71.349999999999994 110.384 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -86.44 122.67 30.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.538 -0.542 . . . . 74.530000000000001 109.538 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 24.8 t -79.18 109.45 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.55 0.74 . . . . 63.140000000000001 109.832 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.6 m -137.24 139.93 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.82 -1.178 . . . . 62.020000000000003 107.82 169.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -78.06 146.82 35.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.164 -1.05 . . . . 74.420000000000002 108.164 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.55 141.47 97.93 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.041 0.536 . . . . 71.140000000000001 110.716 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -98.65 18.07 27.37 Favored 'Cis proline' 0 C--N 1.372 1.766 0 CA-C-N 119.267 0.774 . . . . 44.140000000000001 113.957 -1.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -65.13 141.58 58.65 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.033 0.533 . . . . 74.439999999999998 110.028 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.57 136.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.343 1.057 . . . . 73.420000000000002 110.302 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.683 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.5 t -80.98 113.61 19.3 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.978 0.511 . . . . 54.200000000000003 110.655 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.7 118.82 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.657 -1.609 . . . . 73.349999999999994 106.657 170.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.2 -36.22 82.93 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.11 0.964 . . . . 74.439999999999998 111.564 -171.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -61.42 -43.46 98.83 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.749 0.82 . . . . 72.340000000000003 111.002 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.5 p -92.51 -11.06 35.58 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.11 0.564 . . . . 71.239999999999995 111.212 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.5 p 54.66 28.84 10.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.987 1.715 . . . . 65.219999999999999 113.137 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -140.49 151.12 44.56 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.328 0.651 . . . . 73.200000000000003 110.265 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 18.4 m -82.75 116.45 22.11 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.838 0.455 . . . . 74.329999999999998 110.794 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -104.48 -170.36 1.75 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.468 1.107 . . . . 73.239999999999995 109.04 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.75 156.77 91.52 Favored Pre-proline 0 N--CA 1.485 1.279 0 CA-C-O 119.051 -0.5 . . . . 74.340000000000003 110.577 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.601 2.201 . . . . 75.120000000000005 111.801 175.743 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.471 0.176 . . . . 75.25 110.8 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 122.82 -4.14 9.91 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.724 -0.487 . . . . 33.43 113.576 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 10.3 pt-20 -87.55 139.43 30.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.259 -0.645 . . . . 63.329999999999998 109.259 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.8 p -97.24 136.92 37.04 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.122 -0.361 . . . . 75.319999999999993 110.65 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 94.6 1.21 64.07 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 115.228 0.851 . . . . 42.130000000000003 115.228 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.04 -179.58 4.73 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.286 0.634 . . . . 64.319999999999993 111.004 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -65.01 121.56 14.97 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.068 0.947 . . . . 62.420000000000002 110.416 -173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 60.03 18.04 7.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.418 1.487 . . . . 43.420000000000002 112.694 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 3' ' ' GLU . 54.4 mm-40 -107.75 138.95 20.16 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.891 0.877 . . . . 63.119999999999997 109.695 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.43 122.61 12.1 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 123.145 2.563 . . . . 74.310000000000002 112.277 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 28.0 p -74.48 128.69 36.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.774 -0.454 . . . . 61.240000000000002 109.774 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 120.03 23.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.268 -0.641 . . . . 70.400000000000006 109.268 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.44 126.01 8.36 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.842 -0.617 . . . . 75.150000000000006 113.552 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -60.43 144.35 88.43 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.157 0.983 . . . . 74.019999999999996 110.805 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.13 -17.57 60.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.502 2.134 . . . . 63.240000000000002 112.98 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.72 -8.09 58.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.835 0.854 . . . . 62.32 111.999 174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.85 -7.2 35.72 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 114.566 0.586 . . . . 74.230000000000004 114.566 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.48 139.57 47.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.543 0.672 . . . . 70.019999999999996 110.293 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -96.06 116.19 28.58 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.353 0.661 . . . . 50.329999999999998 110.278 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.94 108.48 18.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.159 -0.682 . . . . 74.010000000000005 109.159 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 67.3 m -128.81 148.86 50.91 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 124.671 1.188 . . . . 73.409999999999997 108.316 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -83.74 150.69 25.65 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.658 -0.867 . . . . 71.409999999999997 108.658 172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -68.4 143.06 95.14 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 122.942 0.497 . . . . 73.329999999999998 110.888 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -93.63 14.46 46.08 Favored 'Cis proline' 0 C--N 1.38 2.229 0 CA-C-N 119.59 0.889 . . . . 73.420000000000002 113.995 0.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -71.59 134.06 46.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.299 0.64 . . . . 72.120000000000005 110.645 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.08 139.73 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.623 1.169 . . . . 65.349999999999994 109.076 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 46.9 t -79.75 120.05 23.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.114 0.416 . . . . 63.009999999999998 111.244 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.09 120.33 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 106.651 -1.611 . . . . 75.519999999999996 106.651 168.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.35 -39.27 92.12 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.197 0.599 . . . . 54.149999999999999 111.583 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -61.49 -32.47 72.49 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.791 0.837 . . . . 60.109999999999999 111.456 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.2 p -95.84 -16.48 21.81 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.084 0.554 . . . . 64.040000000000006 111.276 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.6 p 54.56 35.38 23.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.245 1.818 . . . . 65.439999999999998 112.045 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -146.88 150.59 35.55 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.112 0.565 . . . . 71.129999999999995 111.093 -176.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 19.8 m -82.74 115.22 21.56 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.005 0.522 . . . . 70.019999999999996 110.547 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -122.26 178.78 4.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 74.310000000000002 109.311 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.41 138.82 97.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.142 0.577 . . . . 62.219999999999999 111.542 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 C--N 1.376 2.023 0 C-N-CA 123.245 2.63 . . . . 64.340000000000003 112.003 176.584 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.48 0.181 . . . . 73.329999999999998 110.847 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.95 30.78 78.9 Favored Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.581 -0.608 . . . . 75.209999999999994 111.581 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -119.37 175.66 5.71 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.182 0.993 . . . . 74.420000000000002 110.17 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.2 p -154.44 150.22 27.63 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 122.607 0.363 . . . . 62.439999999999998 110.952 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.688 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 89.47 3.53 74.85 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 114.511 0.564 . . . . 71.019999999999996 114.511 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -95.88 178.81 5.31 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.297 0.639 . . . . 71.319999999999993 110.341 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 123.68 21.13 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.507 0.723 . . . . 71.409999999999997 109.675 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 58.92 35.56 24.2 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.491 1.516 . . . . 73.239999999999995 111.661 -172.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 12.8 tp10 -130.23 125.68 21.92 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 118.073 -0.965 . . . . 72.319999999999993 109.585 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 9' ' ' GLU . 2.2 Cg_endo -37.87 121.59 0.46 Allowed 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 124.916 3.744 . . . . 74.299999999999997 113.952 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.646 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 30.1 p -76.26 115.11 15.68 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.543 -0.91 . . . . 64.239999999999995 108.543 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.0 p -80.48 108.73 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.186 0.594 . . . . 73.150000000000006 110.395 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.68 121.65 5.56 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.01 -0.541 . . . . 54.229999999999997 112.977 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -61.61 155.16 61.67 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.206 1.003 . . . . 72.549999999999997 110.873 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.98 -23.36 21.17 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.633 2.889 . . . . 72.329999999999998 115.715 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.73 -24.86 33.38 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.745 0.418 . . . . 71.340000000000003 111.416 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.22 3.85 10.37 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.825 -0.43 . . . . 71.019999999999996 113.793 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.41 123.38 25.3 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.968 0.507 . . . . 74.540000000000006 111.462 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.646 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -80.39 110.19 15.61 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.653 0.781 . . . . 70.329999999999998 109.713 176.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.0 t -79.43 111.18 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.096 0.558 . . . . 70.439999999999998 110.154 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 82.5 m -140.53 135.39 31.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.575 -1.193 . . . . 54.32 108.193 171.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.59 127.15 31.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.311 -0.996 . . . . 74.120000000000005 108.311 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.37 144.61 97.54 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.24 0.616 . . . . 51.539999999999999 110.558 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.13 8.15 67.01 Favored 'Cis proline' 0 C--N 1.379 2.174 0 N-CA-C 114.706 1.002 . . . . 60.299999999999997 114.706 8.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.37 127.47 33.08 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.499 -0.556 . . . . 74.319999999999993 109.499 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.89 138.64 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.759 0.824 . . . . 74.450000000000003 109.788 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.0 t -77.67 113.42 15.5 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.232 0.469 . . . . 62.450000000000003 110.224 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.439 HD13 ' HB2' ' A' ' 35' ' ' GLU . 2.7 mp -78.81 111.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 106.385 -1.709 . . . . 62.530000000000001 106.385 168.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.52 -28.24 69.81 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.014 0.925 . . . . 74.340000000000003 112.12 -170.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.9 m -60.0 -54.05 50.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.678 0.791 . . . . 62.409999999999997 110.342 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -83.74 -12.77 55.32 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.798 0.839 . . . . 70.549999999999997 111.432 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.0 p 53.69 33.96 17.82 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.661 1.584 . . . . 54.200000000000003 112.312 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -136.98 150.38 48.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.697 0.799 . . . . 71.239999999999995 110.144 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HA2' ' A' ' 5' ' ' GLY . 4.4 m -81.59 119.15 23.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.882 -0.785 . . . . 33.509999999999998 108.882 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HB2' HD13 ' A' ' 28' ' ' ILE . 35.2 mt-10 -121.01 170.44 9.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.472 0.709 . . . . 62.350000000000001 109.951 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -72.3 134.15 82.79 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.893 -0.594 . . . . 73.230000000000004 110.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 CA--C 1.569 2.236 0 C-N-CA 122.574 2.183 . . . . 73.349999999999994 111.609 172.033 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 108.498 -0.927 . . . . 73.530000000000001 108.498 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.3 -30.34 7.69 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.533 -0.627 . . . . 61.32 111.533 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.24 167.06 11.87 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.493 1.117 . . . . 74.430000000000007 108.273 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.7 p -140.89 138.15 33.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.326 -0.233 . . . . 44.310000000000002 111.145 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.547 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 105.99 5.18 38.46 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 114.412 0.525 . . . . 34.219999999999999 114.412 174.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -93.67 172.37 8.3 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.582 0.753 . . . . 51.210000000000001 111.225 -174.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -67.64 122.17 17.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.44 1.096 . . . . 70.140000000000001 109.253 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 64.39 20.99 12.37 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.166 1.386 . . . . 74.420000000000002 112.319 -175.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -126.32 135.83 27.73 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 118.193 -0.908 . . . . 70.219999999999999 110.129 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' SER . 1.6 Cg_endo -41.58 133.16 3.68 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.853 3.702 . . . . 63.140000000000001 114.645 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 31.1 p -93.23 128.35 39.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.48 0.712 . . . . 72.319999999999993 109.304 177.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.9 p -83.95 101.07 11.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.658 -0.868 . . . . 70.409999999999997 108.658 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -87.39 118.78 5.07 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.671 -0.695 . . . . 74.019999999999996 112.539 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 96.6 mtt180 -56.81 152.83 25.11 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.76 1.224 . . . . 73.019999999999996 111.394 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.68 -23.63 58.61 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.349 2.7 . . . . 72.439999999999998 114.318 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.22 5.52 29.86 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.855 0.862 . . . . 72.239999999999995 112.152 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.97 42.0 9.98 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.355 -0.136 . . . . 63.340000000000003 112.97 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HB3' ' HD2' ' A' ' 14' ' ' ARG . . . -114.73 97.94 6.56 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.432 -0.581 . . . . 44.439999999999998 109.432 175.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 10.1 mtmp? -71.4 111.18 6.51 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 123.192 0.597 . . . . 75.200000000000003 109.477 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -76.15 113.93 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.08 -0.711 . . . . 73.329999999999998 109.08 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 77.5 m -141.47 143.4 33.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.95 1.3 . . . . 63.420000000000002 108.838 177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -80.82 143.64 32.66 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.161 -1.052 . . . . 72.439999999999998 108.161 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.19 147.76 90.85 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.78 0.432 . . . . 62.409999999999997 110.53 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.52 28.17 17.15 Favored 'Cis proline' 0 C--N 1.378 2.116 0 CA-C-N 119.747 0.946 . . . . 71.049999999999997 113.454 1.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -82.2 117.98 22.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.804 0.442 . . . . 75.310000000000002 110.207 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -97.46 131.29 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.33 1.052 . . . . 73.430000000000007 109.805 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 53.9 t -79.87 113.5 18.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.65 0.262 . . . . 63.539999999999999 110.755 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.8 mt -79.9 129.03 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.935 -1.135 . . . . 43.340000000000003 107.935 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.29 -42.1 99.06 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.808 0.843 . . . . 72.409999999999997 111.278 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -59.59 -36.69 76.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.194 0.997 . . . . 55.420000000000002 111.836 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.5 p -95.5 -19.26 19.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 50.240000000000002 111.467 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 88.0 p 54.62 30.98 14.21 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.163 1.785 . . . . 51.350000000000001 112.77 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 12.1 ptp180 -140.45 149.28 42.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.353 0.661 . . . . 74.129999999999995 110.998 -175.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 8.2 m -81.65 99.76 9.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.276 0.63 . . . . 74.049999999999997 110.639 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 36.4 mt-10 -107.72 -172.99 2.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.975 0.91 . . . . 72.209999999999994 111.004 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -66.1 158.9 74.57 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.743 0.817 . . . . 73.140000000000001 111.022 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo . . . . . 0 CA--C 1.561 1.872 0 C-N-CA 122.677 2.251 . . . . 71.400000000000006 111.217 166.809 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 109.299 -0.63 . . . . 72.150000000000006 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.93 -30.74 9.51 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 123.526 0.584 . . . . 43.340000000000003 112.426 176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.3 169.56 8.79 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.569 1.147 . . . . 65.25 109.035 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.9 p -143.42 143.23 31.53 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.039 0.381 . . . . 42.549999999999997 111.842 -173.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 21' ' ' CYS . . . 105.01 30.49 4.78 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 114.651 0.62 . . . . 63.420000000000002 114.651 173.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.65 174.26 8.85 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.039 0.936 . . . . 62.240000000000002 110.446 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -68.84 123.76 21.85 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.244 1.018 . . . . 73.129999999999995 109.1 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 84.9 m-20 60.51 29.88 19.34 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.785 1.234 . . . . 72.450000000000003 112.338 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -113.92 141.05 25.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 107.768 -1.197 . . . . 74.340000000000003 107.768 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.97 145.52 10.25 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 123.397 2.731 . . . . 71.109999999999999 112.035 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -100.74 132.7 46.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.513 -0.551 . . . . 70.409999999999997 109.513 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.31 88.18 6.95 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.322 -0.992 . . . . 62.030000000000001 108.322 170.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . -80.89 121.39 5.4 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 115.213 -0.903 . . . . 53.210000000000001 112.849 -174.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -82.29 144.64 50.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.513 -0.551 . . . . 73.239999999999995 109.513 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.09 -12.22 34.46 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.205 2.603 . . . . 74.120000000000005 114.375 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 -17.67 57.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.932 0.893 . . . . 71.310000000000002 111.384 172.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.7 -13.5 9.29 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 116.135 -0.484 . . . . 75.230000000000004 113.581 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.17 97.61 6.97 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.067 0.46 . . . . 44.140000000000001 110.65 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 34.6 mtmt -82.45 118.64 23.37 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.846 0.858 . . . . 64.329999999999998 108.687 177.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.602 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 59.4 t -77.4 95.53 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 122.079 0.943 . . . . 72.530000000000001 109.691 -175.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 75.2 m -130.24 152.0 50.14 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 112.973 -1.922 . . . . 74.5 108.99 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -79.58 140.72 37.07 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.954 -0.758 . . . . 72.450000000000003 108.954 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.21 147.41 82.96 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.064 0.546 . . . . 65.109999999999999 109.997 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -94.25 22.86 28.01 Favored 'Cis proline' 0 C--N 1.376 2.002 0 CA-C-N 119.39 0.818 . . . . 51.210000000000001 113.284 1.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -79.81 124.94 29.08 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.414 0.685 . . . . 75.109999999999999 109.221 -174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.42 144.99 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.703 0.801 . . . . 73.299999999999997 109.803 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.576 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 52.3 t -84.31 113.32 21.05 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.002 0.521 . . . . 61.350000000000001 110.037 175.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 28' ' ' ILE . 3.8 mp -79.89 119.37 29.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 106.813 -1.551 . . . . 75.409999999999997 106.813 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.48 -26.99 65.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.484 0.713 . . . . 70.219999999999999 112.645 -173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.3 m -59.65 -54.78 42.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.783 0.833 . . . . 72.239999999999995 111.184 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.9 p -87.87 -18.79 28.45 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.9 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.8 p 52.27 44.37 29.83 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.175 1.79 . . . . 51.25 112.802 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HG3' ' HG3' ' A' ' 35' ' ' GLU . 2.2 ptm180 -146.45 144.9 29.99 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.275 0.559 . . . . 70.129999999999995 110.393 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.9 m -76.47 88.27 3.22 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.251 1.02 . . . . 74.439999999999998 110.362 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG3' ' HG3' ' A' ' 33' ' ' ARG . 44.9 mt-10 -103.37 -171.65 1.98 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.972 0.909 . . . . 65.230000000000004 109.935 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -62.22 139.44 96.21 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 123.851 0.86 . . . . 73.209999999999994 110.987 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.375 1.943 0 C-N-CA 122.902 2.402 . . . . 64.420000000000002 112.262 173.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 119.527 -0.273 . . . . 65.400000000000006 110.68 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.33 21.5 68.48 Favored Glycine 0 C--N 1.358 1.752 0 O-C-N 123.57 0.544 . . . . 42.439999999999998 113.756 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -105.68 161.9 13.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.001 0.92 . . . . 64.230000000000004 110.66 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.9 p -157.97 113.22 2.7 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.846 0.458 . . . . 53.240000000000002 109.842 -176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.456 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 140.12 -9.12 3.0 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 115.547 0.979 . . . . 61.43 115.547 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.7 173.55 7.55 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.058 0.543 . . . . 35.25 111.215 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.22 116.11 9.27 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.101 0.96 . . . . 62.109999999999999 109.684 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 73.75 16.32 3.83 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.099 2.16 . . . . 74.230000000000004 112.603 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -106.97 135.65 19.54 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 123.892 0.877 . . . . 74.120000000000005 109.442 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.59 133.28 57.13 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.392 2.728 . . . . 71.319999999999993 111.834 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 30.1 p -80.75 121.67 26.19 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.564 -0.532 . . . . 72.030000000000001 109.564 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 2.4 p -78.82 88.64 4.65 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.87 -0.789 . . . . 64.140000000000001 108.87 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.78 118.07 4.65 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.827 -1.079 . . . . 74.120000000000005 112.417 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -69.32 152.95 96.33 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.45 1.1 . . . . 73.310000000000002 110.387 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -59.65 -21.52 63.1 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.2 2.6 . . . . 62.509999999999998 114.699 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.93 -21.92 58.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.496 0.719 . . . . 73.540000000000006 111.551 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.79 -0.91 13.67 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 116.016 -0.538 . . . . 55.210000000000001 113.423 176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.78 99.31 4.38 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 116.864 0.332 . . . . 72.209999999999994 111.114 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -73.18 114.5 11.42 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.222 -1.029 . . . . 73.129999999999995 108.222 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 97.7 t -76.58 106.66 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.038 -0.727 . . . . 54.439999999999998 109.038 -178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 79.9 m -143.5 135.82 27.02 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 125.297 1.439 . . . . 52.420000000000002 109.227 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -79.63 120.57 24.14 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.194 -1.039 . . . . 71.310000000000002 108.194 172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.07 149.23 94.24 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.311 0.645 . . . . 61.119999999999997 110.517 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -88.59 15.29 46.39 Favored 'Cis proline' 0 C--N 1.379 2.154 0 CA-C-N 120.082 1.065 . . . . 73.310000000000002 114.707 9.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -75.98 109.41 9.59 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 75.019999999999996 109.709 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.88 130.89 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.097 0.959 . . . . 75.310000000000002 110.139 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 51.9 t -71.19 110.81 6.08 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.716 0.293 . . . . 72.430000000000007 110.765 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.31 127.18 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.963 -1.125 . . . . 71.430000000000007 107.963 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.27 -34.35 77.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.259 0.624 . . . . 62.5 111.328 -170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -57.56 -43.76 84.74 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.763 0.825 . . . . 50.200000000000003 111.169 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 p -91.01 -16.12 28.49 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.953 0.901 . . . . 61.0 111.767 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p 52.93 30.43 9.27 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.594 1.558 . . . . 63.039999999999999 112.18 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -140.74 147.75 39.65 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.648 0.379 . . . . 74.209999999999994 111.138 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 5.4 m -74.15 130.71 40.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.349 0.66 . . . . 54.439999999999998 110.375 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -161.44 176.76 10.77 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.56 0.744 . . . . 74.340000000000003 109.939 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.52 123.01 81.67 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 119.441 -0.314 . . . . 70.420000000000002 110.333 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 C--N 1.386 2.507 0 C-N-CA 122.918 2.412 . . . . 74.129999999999995 112.011 179.119 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.335 -0.246 . . . . 64.530000000000001 110.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.1 -33.14 5.59 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 111.786 -0.526 . . . . 73.400000000000006 111.786 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -122.07 -178.23 3.8 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.866 0.867 . . . . 64.310000000000002 109.193 171.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.62 151.11 7.48 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.341 0.257 . . . . 62.229999999999997 111.493 -175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.62 ' HA2' ' SG ' ' A' ' 34' ' ' CYS . . . 110.71 -8.09 29.9 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 115.563 0.985 . . . . 23.23 115.563 166.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.71 172.6 8.07 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.411 0.605 . . . . 70.040000000000006 111.655 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 3.6 tmtp? -63.35 125.1 23.03 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.862 0.726 . . . . 75.439999999999998 110.033 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 97.2 m-20 61.51 24.39 14.5 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.162 1.385 . . . . 73.430000000000007 112.328 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -123.1 142.55 38.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.885 0.874 . . . . 74.349999999999994 109.112 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.98 139.87 79.56 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.701 2.934 . . . . 53.240000000000002 112.926 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.739 ' SG ' ' HD3' ' A' ' 19' ' ' LYS . 26.5 p -90.47 128.04 36.4 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.372 0.669 . . . . 63.039999999999999 109.31 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 20' ' ' VAL . 1.6 p -78.5 119.53 21.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.845 0.355 . . . . 75.129999999999995 110.191 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.32 120.7 5.5 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 116.058 -0.519 . . . . 64.430000000000007 113.246 -174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -71.08 156.33 92.08 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.24 1.016 . . . . 64.400000000000006 110.838 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.38 -43.82 51.31 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.178 2.585 . . . . 74.25 113.222 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.53 -25.17 67.87 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.257 1.023 . . . . 74.420000000000002 112.364 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.17 2.38 12.34 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-O 119.637 -0.535 . . . . 73.0 113.844 174.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.33 115.39 8.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 117.255 0.528 . . . . 72.409999999999997 111.583 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.739 ' HD3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -75.81 106.47 7.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.643 0.777 . . . . 74.109999999999999 109.207 173.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.559 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 60.0 t -79.62 119.61 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.023 0.529 . . . . 64.019999999999996 110.773 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 64.5 m -142.37 154.15 44.39 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.009 1.323 . . . . 65.239999999999995 109.034 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.55 145.28 25.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.179 -0.675 . . . . 71.209999999999994 109.179 169.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.24 146.16 94.27 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 122.961 0.504 . . . . 44.25 110.606 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -91.0 14.88 49.33 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.581 0.886 . . . . 23.34 114.225 5.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -78.23 124.41 28.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.949 0.404 . . . . 73.439999999999998 110.369 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.19 131.25 59.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.455 1.102 . . . . 65.430000000000007 108.6 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 43.8 t -69.11 107.63 3.26 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.016 0.436 . . . . 45.210000000000001 110.029 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.29 113.24 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 107.386 -1.339 . . . . 72.129999999999995 107.386 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.01 -28.47 66.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.521 1.128 . . . . 73.140000000000001 111.638 -176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.9 m -64.45 -52.39 58.28 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.785 0.834 . . . . 64.239999999999995 111.208 176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.8 p -90.96 -4.06 56.79 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.135 0.574 . . . . 73.340000000000003 111.564 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.8 p 53.55 29.56 9.33 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.952 1.701 . . . . 63.25 113.022 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 37.4 ptt180 -138.28 148.73 44.98 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.667 0.787 . . . . 75.349999999999994 109.509 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 11' ' ' CYS . 45.6 m -71.09 91.27 0.9 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.961 -0.755 . . . . 65.099999999999994 108.961 173.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 36' ' ' ASN . 29.6 tt0 -101.18 -178.79 3.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.356 1.062 . . . . 74.540000000000006 108.627 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 35' ' ' GLU . 3.1 p-10 -72.62 145.76 87.67 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 109.602 -0.518 . . . . 64.109999999999999 109.602 171.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.365 1.423 0 C-N-CA 122.902 2.401 . . . . 74.420000000000002 112.807 173.327 . . . . . . . . 0 0 . 1 stop_ save_